data_6oqh_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6oqh _Structure_validation_residue.Date_analyzed 2019-05-31 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.884 0.373 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 60.85 103.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.96 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -148.93 136.8 20.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.854 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -116.07 152.12 34.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -143.1 117.52 9.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.757 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 pp -128.39 132.29 68.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.01 170.65 27.14 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.467 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.47 177.13 8.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.827 0.346 . . . . 0.0 111.031 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.8 tpp -159.25 137.22 10.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.974 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.405 ' CZ ' HG12 ' A' ' 265' ' ' VAL . 11.2 p90 -147.15 161.78 40.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.885 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.7 mp . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.886 0.374 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.85 131.41 55.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.064 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -115.31 94.0 37.85 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.982 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.51 128.44 12.71 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.527 2.151 . . . . 0.0 112.34 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.6 m -122.39 150.35 42.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.875 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.01 158.79 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.063 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -143.02 133.8 25.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.013 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -132.34 116.06 16.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -118.55 133.27 55.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.924 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.24 123.8 44.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.49 116.31 31.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -136.72 83.52 2.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.803 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.63 -137.34 36.89 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.364 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.45 -21.37 46.83 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.408 2.072 . . . . 0.0 112.312 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.3 m95 -94.82 115.21 27.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.884 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -117.36 116.32 26.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mp -95.33 142.77 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.171 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -145.36 126.9 15.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.051 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.66 153.61 47.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.958 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -142.56 141.36 32.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.964 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -119.95 152.12 37.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.975 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -116.77 165.76 12.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.853 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.93 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.5 p90 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.745 0.307 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.24 164.8 14.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.834 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -136.82 95.81 12.1 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.67 130.53 17.17 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.541 2.161 . . . . 0.0 112.263 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -128.67 132.23 48.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.8 mt -127.76 167.05 17.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.784 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -159.29 151.28 20.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.033 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.01 111.37 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.025 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -98.81 132.7 43.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.851 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -135.47 135.84 40.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.795 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -103.12 121.08 41.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -98.8 -50.39 4.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.17 162.66 0.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.806 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -160.85 -58.86 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.841 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.8 164.91 27.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -63.36 -36.49 83.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.959 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.73 -59.88 2.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.979 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.446 ' CE1' ' CG1' ' A' ' 120' ' ' VAL . 5.3 m-85 -100.72 128.62 46.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.4 m -109.81 170.02 8.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.873 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.54 156.73 46.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -170.03 168.83 41.73 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.551 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 tp -138.53 125.04 20.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.349 . . . . 0.0 110.836 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.62 146.57 43.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.63 174.49 21.28 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.535 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.74 150.63 17.88 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.496 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -133.34 116.19 15.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.876 0.369 . . . . 0.0 110.862 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.64 135.58 54.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -149.91 133.49 16.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -126.61 133.27 51.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.003 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.429 -179.93 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.829 0.347 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -147.04 118.07 7.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.922 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -147.72 150.55 34.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.818 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.407 ' HB2' ' CD1' ' A' ' 137' ' ' PHE . 5.0 mt-30 -132.37 177.36 7.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.029 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.8 mtp85 -148.64 114.92 5.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.893 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.35 130.09 42.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.776 0.322 . . . . 0.0 110.474 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -104.03 126.72 51.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.011 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.6 mp -140.8 104.41 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.949 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -142.88 100.78 5.42 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.182 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.3 161.2 46.83 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.35 2.033 . . . . 0.0 112.155 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.07 134.79 48.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.98 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -129.05 134.55 48.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.736 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.16 141.51 51.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.959 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.446 ' CG1' ' CE1' ' A' ' 83' ' ' PHE . 21.6 t -143.44 113.16 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -97.0 110.78 23.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 tp -95.0 -31.94 13.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.8 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -153.5 176.01 12.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.722 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.77 -19.86 61.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.18 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.52 30.2 7.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.748 0.308 . . . . 0.0 111.136 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 60.0 mt -149.55 109.22 4.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.899 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -114.72 119.31 36.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.42 ' CG ' HD23 ' A' ' 157' ' ' LEU . 55.0 m-85 -103.03 148.4 25.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.983 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -158.48 140.58 14.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.05 147.87 18.34 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.587 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 42.2 p90 -159.87 134.43 7.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.734 0.302 . . . . 0.0 110.903 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.3 mp -102.81 126.22 49.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.99 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 88.4 p -92.83 114.54 27.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.969 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.8 ttm -106.94 141.36 38.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.848 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.06 115.75 18.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.98 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 137' ' ' PHE . 13.1 mttp -149.21 132.51 16.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.835 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.407 ' CD1' ' HB2' ' A' ' 110' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.222 0 CA-C-O 120.848 0.356 . . . . 0.0 111.104 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.3 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.699 0.285 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -163.07 166.35 23.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.093 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 30.1 m -107.99 141.64 22.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.12 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -119.66 158.72 25.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.727 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.5 m -132.05 120.44 22.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.064 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -134.79 107.21 7.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.723 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 6.1 t -92.37 168.69 11.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -158.25 120.66 0.99 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.556 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' A' ' 128' ' ' PHE . 0.2 OUTLIER -113.27 152.64 29.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.776 0.322 . . . . 0.0 110.867 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -128.84 123.81 33.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.065 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 157' ' ' LEU . 24.8 m-85 -120.53 117.32 27.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.86 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.9 118.81 19.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.928 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.66 -63.59 1.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.917 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -125.79 176.06 7.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -64.89 -30.68 71.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.004 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 43.0 p -120.21 27.25 8.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.044 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 23.0 t -153.72 125.21 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.038 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -126.8 169.63 13.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.276 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.19 145.16 47.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.795 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -139.04 136.12 34.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.022 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.5 t -119.0 158.98 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.981 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -153.53 133.12 12.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.026 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -116.36 111.2 19.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.709 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -89.87 135.64 33.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.086 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 22.8 mt -132.13 113.16 12.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.718 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -89.05 148.95 23.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.29 148.41 36.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.901 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -149.84 144.59 12.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.568 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 54.0 t80 . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 0.0 110.874 179.946 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.805 0.336 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.2 m -132.42 100.14 4.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 2.4 m -106.65 150.51 26.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.9 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -130.42 132.14 45.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -135.61 120.99 19.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 24.8 mt -91.41 128.7 42.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.218 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.38 125.21 14.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.645 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -135.63 154.55 51.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.968 0.413 . . . . 0.0 111.533 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -143.16 148.5 36.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.342 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.411 ' O ' ' HD2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -114.04 109.46 49.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.272 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.43 121.68 6.95 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.393 2.062 . . . . 0.0 112.312 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.65 105.87 13.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.866 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 7.0 p -99.25 116.29 31.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.24 103.7 3.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.942 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 59.17 -132.18 52.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.534 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -98.58 30.84 3.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.783 0.325 . . . . 0.0 110.901 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -129.96 116.83 19.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.699 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.71 123.95 49.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.983 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 15.8 m -141.76 109.71 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.828 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 18.6 m -117.49 92.66 41.26 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.305 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.411 ' HD2' ' O ' ' A' ' 197' ' ' LEU . 23.1 Cg_exo -64.79 147.77 89.77 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.512 2.142 . . . . 0.0 111.933 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -111.18 134.7 52.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.852 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.3 p -107.5 138.24 44.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.949 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.2 118.13 8.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 2.1 pt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.106 179.984 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.541 -0.224 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.92 127.35 7.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 0.0 110.882 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -111.13 118.74 36.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.843 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -100.83 160.63 14.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -164.34 117.02 0.73 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.157 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -133.66 124.25 26.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 110.891 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -123.38 101.37 7.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.793 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -75.98 -1.39 25.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.23 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -149.35 26.23 0.86 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.72 0.295 . . . . 0.0 111.106 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 2.2 m120 64.74 -75.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.137 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -52.93 -50.04 52.41 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.727 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.99 122.63 32.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.754 0.311 . . . . 0.0 110.88 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 4.0 t -135.39 174.93 10.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.969 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.32 122.61 25.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.815 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 5.0 m -107.77 139.57 42.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.121 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.4 mp -132.22 129.59 39.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.781 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.26 121.08 43.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.87 136.05 54.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.781 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.1 -179.899 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.73 0.3 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -156.2 152.07 23.51 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.546 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.405 HG12 ' CZ ' ' A' ' 14' ' ' TYR . 17.8 t -135.54 143.52 36.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.808 0.337 . . . . 0.0 111.123 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -154.99 167.18 32.71 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.494 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 31.5 m -124.98 160.42 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 0.0 111.09 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -147.4 139.78 24.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -144.66 156.87 44.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 53.2 p -134.48 140.66 46.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.855 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.1 t0 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.834 0.349 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -172.0 159.66 5.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -148.88 109.37 4.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.898 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -97.18 136.39 37.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -147.18 121.74 9.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.19 129.57 72.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.1 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.96 172.19 22.73 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.543 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.29 142.85 10.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.841 0.353 . . . . 0.0 111.087 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.7 ttm -116.9 158.13 24.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -144.88 130.66 19.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.919 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.95 179.961 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.4 mp . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 120.864 0.364 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.9 128.2 32.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.146 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.62 94.15 48.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.72 178.8 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.503 2.135 . . . . 0.0 112.236 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.64 128.53 8.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.418 HG12 ' CZ ' ' A' ' 36' ' ' PHE . 16.4 t -108.72 159.31 8.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.185 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -148.83 127.89 12.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.418 ' CZ ' HG12 ' A' ' 34' ' ' VAL . 51.2 m-85 -121.49 147.41 45.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -146.36 143.22 28.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.11 134.74 23.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.975 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.66 147.52 32.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.109 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -174.19 120.52 0.27 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.881 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.37 -149.42 48.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.496 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.418 ' HG2' ' CE3' ' A' ' 43' ' ' TRP . 92.1 Cg_endo -78.93 0.99 9.54 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.656 2.237 . . . . 0.0 112.87 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.418 ' CE3' ' HG2' ' A' ' 42' ' ' PRO . 14.7 p90 -127.48 170.36 12.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.81 0.338 . . . . 0.0 111.045 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -141.08 154.07 45.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.5 mt -121.0 127.26 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.063 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -122.14 148.31 45.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.067 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.6 tp -139.52 164.33 30.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.009 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.82 147.95 30.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.062 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -128.26 153.16 47.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -116.51 151.14 36.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 -179.935 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.845 0.355 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.76 165.99 24.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.86 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.75 95.96 6.23 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.22 135.86 35.64 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.405 2.07 . . . . 0.0 112.259 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.58 129.63 56.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.6 mt -116.37 143.05 46.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -146.51 136.23 23.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.7 t -116.26 149.71 18.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.066 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.413 ' CE1' ' HB ' ' A' ' 88' ' ' THR . 0.6 OUTLIER -131.96 139.11 48.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -153.93 145.02 22.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -125.6 111.07 14.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.933 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -67.91 -56.36 9.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.81 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.3 mt 58.65 98.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.956 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -80.82 -62.88 1.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -126.86 -179.11 4.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -71.75 -30.57 65.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -80.26 -49.87 11.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.417 ' CE2' HG12 ' A' ' 120' ' ' VAL . 5.5 m-85 -92.61 167.89 11.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.968 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.7 t -156.88 162.81 39.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.947 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.496 ' CZ ' ' CD1' ' A' ' 118' ' ' TRP . 0.3 OUTLIER -127.73 177.36 6.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.831 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -172.48 116.35 0.61 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.443 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -123.02 119.34 30.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.371 . . . . 0.0 110.991 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.413 ' HB ' ' CE1' ' A' ' 74' ' ' HIS . 1.9 t -125.33 104.81 8.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.745 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -128.28 144.31 15.14 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.488 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -141.37 178.63 20.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.542 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -127.54 118.74 24.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.824 0.345 . . . . 0.0 110.839 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.2 tpt85 -100.77 139.34 36.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -167.35 166.37 14.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -142.62 128.78 19.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.9 0.381 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -141.13 104.34 4.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 56.1 tpp -154.11 143.34 21.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.929 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -138.62 103.93 4.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.8 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -111.91 111.43 22.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.986 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -91.35 130.85 37.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.849 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -130.84 120.24 23.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.052 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 9.0 tp -146.44 115.55 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.863 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -128.79 93.22 37.92 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.334 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.02 178.03 7.81 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.579 2.186 . . . . 0.0 112.223 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -159.52 134.9 8.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.935 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.496 ' CD1' ' CZ ' ' A' ' 85' ' ' PHE . 0.9 OUTLIER -112.25 126.66 55.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.811 179.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.02 113.22 26.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.027 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.417 HG12 ' CE2' ' A' ' 83' ' ' PHE . 25.6 t -119.88 102.11 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.015 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.36 142.45 39.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.014 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.7 tt -119.83 -44.41 2.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.69 175.1 11.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -61.16 -31.37 71.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.919 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -116.44 39.96 3.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 tt -156.86 116.23 3.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.5 mtm-85 -126.12 138.37 53.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.929 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.411 ' CD1' HD11 ' A' ' 157' ' ' LEU . 5.3 t80 -112.46 139.61 47.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.812 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -148.47 143.54 26.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.977 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 144.9 153.06 5.76 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.563 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -172.97 170.93 4.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 0.0 110.813 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 18.9 mt -74.51 132.5 41.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.948 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.5 m -106.91 160.43 15.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 18.0 mtm -142.04 148.24 38.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -154.46 150.31 27.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.22 154.98 42.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.8 p90 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.839 179.924 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.768 0.318 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -109.47 122.72 48.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.925 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.06 117.26 9.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.091 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -124.11 153.78 40.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.011 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.7 m -121.69 123.93 43.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.729 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -116.86 129.76 56.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.986 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 61.5 p -153.41 115.45 4.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.755 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -140.37 -169.37 11.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.776 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.411 HD11 ' CD1' ' A' ' 128' ' ' PHE . 0.3 OUTLIER -139.94 178.12 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.348 . . . . 0.0 110.833 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -140.02 143.56 36.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.9 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.464 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 1.3 t80 -135.25 101.24 4.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.0 m -97.55 108.82 21.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.823 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.464 ' CE2' ' CD1' ' A' ' 159' ' ' TYR . 20.5 m-85 -79.57 -36.99 37.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.95 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -176.53 -165.15 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.78 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -86.58 6.08 32.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.332 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 8.8 t -93.23 -35.83 12.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.746 0.308 . . . . 0.0 110.943 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 30.5 m -156.81 150.3 9.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.119 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -131.34 152.24 50.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.15 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.63 146.66 37.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.773 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.22 129.61 15.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.95 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.6 t -131.92 146.63 33.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.978 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -152.41 125.62 8.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.065 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -95.76 161.23 14.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.737 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -135.58 151.11 49.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.008 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.77 105.19 3.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.762 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -101.57 140.8 35.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.962 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.81 113.11 6.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -124.73 146.7 16.28 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.527 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 4.7 p90 . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.859 0.362 . . . . 0.0 110.815 -179.964 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 28.1 p90 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.845 0.355 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 17.5 t -137.61 142.08 41.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 72.1 p -133.45 147.8 51.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.901 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -118.39 135.09 54.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.85 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -130.09 140.92 50.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 46.1 pt -119.05 138.97 48.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.185 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.75 113.58 11.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.891 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -120.72 116.55 25.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.047 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -136.5 131.3 33.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.932 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.35 109.46 42.17 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.722 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.76 136.58 58.51 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.439 2.092 . . . . 0.0 112.393 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.62 101.27 8.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.772 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 8.8 t -78.12 127.07 31.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 4.2 mp -139.84 148.06 41.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -81.88 58.3 4.92 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.503 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -179.8 -62.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.872 0.368 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -136.15 137.93 41.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.863 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 10.5 m -90.54 140.05 30.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.7 t -128.28 111.37 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.033 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.93 92.89 5.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.01 171.84 16.7 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.621 2.214 . . . . 0.0 112.294 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -158.05 161.56 38.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.863 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.7 m -139.9 116.1 10.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.3 mtt180 -139.41 134.89 33.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.063 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 32.4 mt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.125 179.942 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.408 -0.277 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.86 122.92 29.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.886 0.374 . . . . 0.0 110.938 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -109.89 118.04 35.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.814 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.13 159.4 20.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.064 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -154.42 117.01 0.76 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.045 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.27 115.61 15.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.714 0.292 . . . . 0.0 111.106 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 240' ' ' SER . 3.6 m-20 -81.36 122.7 27.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -60.88 -15.13 27.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.964 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.98 -39.39 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.826 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 178.55 -60.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.001 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -74.19 -70.27 1.27 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.672 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -66.35 146.84 54.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.718 0.294 . . . . 0.0 110.832 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -148.49 176.87 9.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.274 -179.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . 0.41 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 11.4 p -122.86 131.32 73.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.831 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 9.8 m -107.6 139.8 41.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.092 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.66 141.93 46.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.972 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -105.25 120.68 42.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.948 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -108.98 143.94 37.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.833 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.074 -179.96 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.829 0.347 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -78.08 144.62 28.76 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.529 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 23.1 t -117.04 119.8 63.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.834 0.349 . . . . 0.0 111.029 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -137.09 160.39 24.95 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.543 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 12.3 m -135.86 153.13 31.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 0.0 111.157 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -152.03 131.9 13.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.49 ' CE1' ' CE2' ' A' ' 271' ' ' PHE . 4.6 t80 -131.01 126.18 35.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 39.5 t -113.68 147.76 37.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' PHE . . . . . 0.49 ' CE2' ' CE1' ' A' ' 269' ' ' TYR . 3.3 m-85 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.933 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.8 t70 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.803 0.335 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -60.0 99.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -94.81 146.17 24.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -126.69 137.01 53.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -151.15 131.57 13.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.419 HG12 ' CD2' ' A' ' 36' ' ' PHE . 22.7 mt -130.53 139.33 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.031 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.81 165.07 29.2 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.549 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.49 170.54 18.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.797 0.332 . . . . 0.0 111.059 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 57.2 mtm -143.27 153.57 42.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.969 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.41 ' CZ ' ' HB3' ' A' ' 32' ' ' PRO . 10.9 m-85 -146.53 106.08 3.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.838 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.915 -179.948 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.841 0.353 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.75 146.66 41.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.083 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.76 93.89 30.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.018 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 14' ' ' TYR . 39.4 Cg_exo -60.52 178.68 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.681 2.254 . . . . 0.0 112.201 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.1 123.57 5.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.967 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.3 138.31 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.091 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -138.92 155.32 48.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.419 ' CD2' HG12 ' A' ' 10' ' ' ILE . 62.5 m-85 -146.5 153.13 40.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -147.35 129.64 15.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.01 141.9 47.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.006 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.49 116.52 23.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.086 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -126.08 73.78 1.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.789 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.83 -135.58 32.78 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.411 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.31 -20.99 48.31 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.377 2.051 . . . . 0.0 112.346 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -101.57 120.72 40.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.909 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -113.17 153.15 28.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -141.71 140.78 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.129 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.22 130.04 30.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.977 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.8 mt -116.45 166.79 11.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -165.53 141.5 5.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -122.54 160.2 26.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.946 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -141.51 128.67 20.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.938 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.84 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.424 ' N ' ' CD1' ' A' ' 66' ' ' PHE . 4.1 p90 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.868 0.366 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -125.23 145.98 49.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.984 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.72 95.79 2.82 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.942 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.47 153.25 44.47 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.506 2.137 . . . . 0.0 112.267 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.38 128.47 17.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.006 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 mp -132.15 154.18 49.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.832 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -154.82 157.58 38.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.885 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.6 m -144.69 156.79 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.055 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -134.81 117.68 16.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -103.62 114.43 28.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -83.03 99.38 9.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.66 -54.68 5.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.84 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.8 tp 61.79 152.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -154.42 -60.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.965 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -147.92 -172.72 4.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.92 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -84.01 -32.95 24.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.29 -55.9 20.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.808 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -133.67 148.29 51.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.9 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -122.04 160.38 25.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -127.56 164.37 22.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -179.75 -177.65 48.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.482 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.7 155.62 43.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.817 0.341 . . . . 0.0 110.901 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.8 p -142.97 110.12 5.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -113.98 179.93 18.86 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.505 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -177.71 170.41 42.77 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.471 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -148.59 144.43 27.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.341 . . . . 0.0 110.895 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.8 mtp85 -141.05 174.45 10.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.9 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -151.51 169.31 22.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -138.0 122.16 18.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.441 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.782 0.325 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -129.93 154.69 47.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.829 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.3 mtm -137.95 124.84 21.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.956 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -89.23 135.97 33.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.844 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -123.58 126.7 47.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.027 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -107.12 145.25 32.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.792 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.415 ' HG3' ' CE1' ' A' ' 135' ' ' TYR . 20.6 tttm -139.91 134.3 31.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.034 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.1 tt -152.76 126.2 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.905 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.57 106.35 3.1 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.305 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.86 137.31 34.88 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.452 2.101 . . . . 0.0 112.072 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -105.92 141.05 37.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.024 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 70.4 p-90 -148.64 131.66 16.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.853 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -123.13 143.94 49.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.967 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.4 m -144.26 125.59 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.059 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.87 151.71 30.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.891 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.6 tp -124.01 -48.47 1.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.953 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.27 -176.99 5.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.44 132.01 46.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 60.13 32.63 21.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.53 107.9 4.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -118.53 137.76 52.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.42 ' CE1' HD13 ' A' ' 157' ' ' LEU . 2.9 m-85 -102.08 141.19 35.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.834 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -132.32 138.59 47.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.77 147.27 14.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.472 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . 0.417 ' CE2' ' HB3' ' A' ' 154' ' ' GLU . 26.2 p-90 -173.06 149.5 1.85 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.862 0.363 . . . . 0.0 111.102 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.27 135.74 53.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.617 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.6 t -108.37 153.5 23.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.132 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 53.4 mtp -134.98 118.38 16.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.768 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.415 ' CE1' ' HG3' ' A' ' 113' ' ' LYS . 1.9 m-85 -102.45 133.82 46.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.949 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -138.73 114.12 9.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.79 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 43.5 p90 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.97 -179.952 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.812 0.339 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -103.06 121.41 42.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.89 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 27.6 m -106.0 129.12 59.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.077 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -110.77 127.61 55.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.858 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.44 114.54 26.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.417 ' HB3' ' CE2' ' A' ' 131' ' ' TRP . 0.6 OUTLIER -121.09 116.39 24.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.851 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.0 m -145.28 145.95 31.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.833 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -163.57 -162.82 15.06 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.53 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.42 HD13 ' CE1' ' A' ' 128' ' ' PHE . 6.6 tt -151.62 149.9 29.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.845 0.355 . . . . 0.0 110.91 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -118.59 131.7 56.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -127.74 100.16 5.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.701 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 9.4 t -99.81 126.23 45.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.983 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -104.11 -30.09 10.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.775 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -165.36 177.22 7.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.711 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -81.92 0.63 38.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.363 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.84 -26.56 8.88 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.653 0.263 . . . . 0.0 111.172 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 28.4 m -145.75 141.52 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.232 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -150.66 -172.24 4.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.013 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.66 143.24 31.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.627 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.79 145.31 32.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.057 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.5 p -144.56 137.88 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.944 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -133.12 155.19 49.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.989 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.42 ' CE2' HG21 ' A' ' 193' ' ' ILE . 79.3 m-85 -127.85 119.35 25.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -96.37 136.1 37.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.002 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.9 125.24 10.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.802 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -111.08 145.59 38.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.949 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.85 117.47 3.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -146.67 169.83 27.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.525 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.774 0.321 . . . . 0.0 110.943 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.818 0.342 . . . . 0.0 110.836 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.7 t -117.16 136.34 53.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 4.0 m -137.12 145.97 44.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -144.4 121.87 11.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.925 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -144.52 136.37 25.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.989 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.42 HG21 ' CE2' ' A' ' 171' ' ' TYR . 4.0 mp -107.07 124.97 63.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.132 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -128.23 115.74 18.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.776 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -133.49 125.78 29.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.215 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -121.52 141.36 51.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.722 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 8.2 tt -105.66 109.31 63.06 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.134 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.35 111.21 3.04 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.368 2.046 . . . . 0.0 112.318 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.76 127.82 35.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.912 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.17 114.16 10.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.09 105.52 7.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.838 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 102.44 -133.3 11.33 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.43 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -105.45 17.18 24.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.721 0.296 . . . . 0.0 111.266 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -136.42 159.89 40.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.791 0.329 . . . . 0.0 110.945 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.35 148.43 47.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.83 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 5.8 m -144.17 122.3 6.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.2 m -125.04 92.91 46.69 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.123 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.0 171.7 5.8 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.57 2.18 . . . . 0.0 112.178 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.83 143.25 50.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.783 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.97 136.48 49.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.913 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.8 117.69 14.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.939 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 7.6 pt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 -179.939 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.375 -0.29 . . . . 0.0 112.375 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -160.04 141.65 12.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 111.045 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -122.61 145.51 48.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.768 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -112.53 159.47 18.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.04 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -142.87 117.06 1.08 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.097 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -121.13 136.09 55.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.362 . . . . 0.0 110.998 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.1 100.22 7.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.625 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -65.86 -10.67 40.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.22 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.9 37.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.796 0.331 . . . . 0.0 111.005 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 5.0 t30 69.71 -64.97 0.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -52.78 -43.54 60.34 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.738 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.5 tt -87.0 144.77 26.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.762 0.315 . . . . 0.0 110.891 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 16.0 m -134.22 151.48 51.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.815 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . 0.466 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 38.9 t -120.98 141.07 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.77 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.88 118.75 31.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.037 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.1 mp -120.68 154.95 34.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.702 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -116.76 131.55 56.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.951 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -133.32 146.47 51.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.815 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.147 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.791 0.329 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -97.82 161.71 21.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.561 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 4.8 m -144.81 146.56 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 111.119 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -160.92 164.3 34.68 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.453 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 6.7 m -126.78 150.15 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 0.0 111.163 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -143.72 146.45 33.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.835 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -144.11 139.33 28.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.68 147.52 50.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 24.4 t80 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.892 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.883 0.373 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 61.09 84.54 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -105.98 141.51 37.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.998 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -129.59 163.04 26.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.738 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -160.26 146.32 15.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.997 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.417 HG23 ' CE2' ' A' ' 36' ' ' PHE . 3.7 mp -140.81 134.35 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.108 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.81 159.28 24.51 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.571 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.49 138.99 27.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.865 0.364 . . . . 0.0 111.001 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.29 149.1 42.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.993 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -132.15 111.06 11.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 -179.905 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.848 0.356 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.47 153.61 24.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.029 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.68 94.0 46.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.988 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.48 158.0 20.72 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.53 2.153 . . . . 0.0 112.198 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.51 133.89 44.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.819 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.72 142.15 30.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.091 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.88 143.68 43.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.967 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.417 ' CE2' HG23 ' A' ' 10' ' ' ILE . 50.2 m-85 -133.89 132.57 40.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -132.0 125.05 30.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.94 136.73 53.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.019 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -118.96 122.76 42.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.17 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -139.95 86.39 2.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.0 -143.44 44.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.363 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.62 -14.23 41.41 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.457 2.105 . . . . 0.0 112.486 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.6 134.12 45.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.987 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.23 145.46 49.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.467 HG21 HD13 ' A' ' 45' ' ' ILE . 30.7 mt -131.46 155.36 41.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.217 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -160.04 136.48 8.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.112 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.82 146.62 49.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.979 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.48 134.02 51.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.019 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -126.04 110.19 13.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.994 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.19 138.02 36.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.786 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.933 179.974 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.803 0.335 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.91 124.58 31.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.27 95.85 4.64 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.877 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.06 142.61 24.94 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.536 2.158 . . . . 0.0 112.408 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -137.79 114.79 10.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.87 133.89 47.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.741 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -132.68 127.74 35.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.038 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 p -124.9 136.15 61.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.004 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -122.94 129.13 51.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.029 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -125.62 137.66 53.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.799 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -122.15 121.45 36.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -106.39 -43.31 4.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.728 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 59.65 160.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.981 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -141.63 -47.34 0.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.835 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -147.31 174.91 11.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.79 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -75.17 -29.13 60.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.002 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -84.74 -42.34 15.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.986 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.422 ' CE2' HG11 ' A' ' 120' ' ' VAL . 11.7 m-85 -101.6 169.82 8.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.01 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.57 162.43 33.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.797 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -158.12 144.32 17.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.955 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.82 -176.25 47.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.497 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.92 134.06 5.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.815 0.34 . . . . 0.0 110.901 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 69.2 p -118.84 159.36 23.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.32 -170.98 15.29 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.488 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 178.08 159.28 22.52 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.515 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -126.29 148.18 49.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.846 0.355 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.1 ttp85 -136.69 133.61 36.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.893 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -132.19 178.91 6.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.773 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -146.52 146.2 30.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.964 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.477 -179.951 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.832 0.348 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -85.14 105.35 15.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.55 148.4 51.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.893 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -156.55 161.76 39.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.85 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.02 109.2 1.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -83.47 140.42 32.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.776 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.54 127.31 17.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.01 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.6 mt -122.47 154.77 27.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.942 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -147.29 79.74 9.61 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.292 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.8 155.0 19.07 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.562 2.175 . . . . 0.0 112.183 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -122.32 146.15 47.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.008 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -164.99 142.75 6.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.08 151.68 41.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.911 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.422 HG11 ' CE2' ' A' ' 83' ' ' PHE . 23.4 t -147.59 108.23 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -88.35 133.18 34.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.888 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.0 tt -110.99 -32.84 6.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -166.05 -175.07 3.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.833 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -90.99 51.3 1.93 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -165.88 -43.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.43 124.31 51.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -125.29 146.56 49.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.773 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -101.95 146.02 28.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.014 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -125.45 123.32 38.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -110.95 106.77 2.09 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.517 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -133.1 136.18 45.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.788 0.328 . . . . 0.0 110.775 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.3 mt -131.02 161.45 31.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.801 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.3 151.24 49.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.041 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -140.1 133.78 30.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.822 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -130.57 127.72 39.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.971 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -146.51 168.1 22.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.774 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.777 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.864 0.364 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -162.91 179.04 7.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.984 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.1 m -118.19 131.96 69.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.098 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -101.23 169.43 8.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 8.9 m -132.8 140.28 47.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.876 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -135.38 142.91 45.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.32 127.88 23.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.743 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -116.8 142.13 17.24 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.662 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.7 mp -115.23 117.37 30.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.755 0.312 . . . . 0.0 110.787 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -101.26 117.51 35.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.961 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -127.04 102.47 6.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 34.3 p -93.11 128.08 38.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.909 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.07 -31.46 12.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.643 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -150.92 174.94 12.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.814 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -76.24 -6.39 51.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.43 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.1 m -113.07 -28.95 7.49 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.635 0.255 . . . . 0.0 111.23 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.6 m -123.11 139.94 48.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.865 0.364 . . . . 0.0 111.385 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -141.17 -178.42 5.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.004 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 41.3 tp -141.2 134.73 29.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.934 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 196' ' ' TYR . 51.7 mtt-85 -137.52 114.54 10.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.2 t -99.85 142.67 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.998 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -118.96 123.34 44.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.021 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.42 ' CE1' HG23 ' A' ' 193' ' ' ILE . 0.4 OUTLIER -116.17 114.85 25.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.723 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -106.43 140.98 38.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.091 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.61 105.17 5.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.689 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.74 145.74 29.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.029 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -136.28 136.16 39.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.752 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -130.51 152.69 19.9 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.498 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 31.1 t80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.359 . . . . 0.0 110.846 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.763 0.316 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.3 m -122.4 105.53 10.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.968 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.31 114.01 27.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.813 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -109.01 129.4 55.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.017 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -118.28 152.56 35.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.79 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.42 HG23 ' CE1' ' A' ' 171' ' ' TYR . 0.2 OUTLIER -136.52 148.09 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.267 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -150.31 127.55 11.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.723 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -119.31 117.26 28.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.97 0.414 . . . . 0.0 111.273 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.423 ' HB3' ' CD1' ' A' ' 209' ' ' TYR . 11.5 p90 -138.28 151.24 47.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.592 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.449 ' O ' ' HD2' ' A' ' 208' ' ' PRO . 0.3 OUTLIER -118.54 111.23 38.13 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.242 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.8 123.29 8.86 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.385 2.056 . . . . 0.0 112.371 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.7 mt -126.74 104.48 8.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.845 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.3 t -117.12 117.8 30.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.57 121.63 9.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 65.46 -119.8 15.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.534 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -118.43 30.57 7.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.905 0.383 . . . . 0.0 110.93 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.71 110.57 9.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 49.3 m -102.71 128.74 49.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.006 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.4 m -144.18 124.06 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.759 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 16.0 p -133.0 92.96 24.21 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.421 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.449 ' HD2' ' O ' ' A' ' 197' ' ' LEU . 59.0 Cg_exo -52.52 171.77 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.457 2.105 . . . . 0.0 112.113 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.423 ' CD1' ' HB3' ' A' ' 196' ' ' TYR . 0.2 OUTLIER -148.11 140.68 24.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.727 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.6 m -128.9 150.12 50.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.97 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -142.3 112.41 7.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.83 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 1.9 pp . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 -179.97 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 208' ' ' PRO . 0.6 OUTLIER -149.99 119.13 6.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.825 0.345 . . . . 0.0 111.009 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -81.26 144.32 31.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.845 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.63 160.48 27.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.975 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -161.1 117.12 0.75 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.164 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -128.6 116.38 19.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.864 0.364 . . . . 0.0 111.163 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 240' ' ' SER . 3.1 p30 -117.88 135.62 53.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.946 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.1 -26.48 60.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.29 -45.76 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.872 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -178.5 -61.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -56.76 -75.83 0.23 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.715 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.414 HD11 ' CD1' ' A' ' 269' ' ' TYR . 7.7 tt -66.45 124.64 23.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.749 0.309 . . . . 0.0 110.764 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 234' ' ' ASP . 2.0 t -148.56 175.86 10.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.178 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . 0.499 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 27.8 m -129.0 167.6 24.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.61 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.63 134.69 43.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.021 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 3.3 mp -137.55 152.2 49.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.892 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -138.83 141.45 38.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.84 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -131.51 165.62 23.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.033 -179.979 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.798 0.332 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -145.38 150.73 22.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.453 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.85 153.55 27.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 0.0 111.12 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -158.62 155.95 26.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.495 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.11 147.83 25.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.811 0.339 . . . . 0.0 111.14 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -138.24 129.93 28.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.943 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.414 ' CD1' HD11 ' A' ' 239' ' ' LEU . 1.9 t80 -124.8 126.12 45.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.951 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 35.0 t -97.85 151.57 20.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.875 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 t70 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.874 0.368 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -71.57 125.16 26.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.77 132.92 52.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.923 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.87 140.43 38.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -141.5 120.14 12.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.022 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.1 pt -110.68 140.72 28.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.09 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.79 159.74 26.94 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.618 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.25 143.89 46.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 111.065 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 30.6 mtt -131.25 138.72 49.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.997 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -147.32 113.83 5.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.787 0.327 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.56 126.23 27.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.037 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -143.18 94.15 6.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.93 146.43 47.42 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.492 2.128 . . . . 0.0 112.363 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.1 m -140.21 152.8 46.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.857 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.2 m -133.6 159.53 42.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -143.93 122.28 12.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -119.85 141.7 49.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.946 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -143.34 132.52 23.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.998 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.69 124.08 39.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.041 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.58 113.24 25.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.154 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -122.33 98.56 5.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.816 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.77 -141.79 45.79 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.45 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.58 -18.34 48.6 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.499 2.133 . . . . 0.0 112.441 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -101.47 144.6 30.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 111.016 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -137.73 132.77 33.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 23.7 pt -117.68 156.38 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.131 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -142.95 157.79 44.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.055 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.0 tt -150.48 120.96 7.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.907 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.61 139.1 49.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.041 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.99 109.66 11.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -95.91 125.05 40.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.862 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.93 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.881 0.372 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -139.64 134.39 31.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.953 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.97 95.85 14.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.86 159.83 11.06 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.536 2.157 . . . . 0.0 112.275 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.89 149.96 47.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.871 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.92 141.12 23.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.97 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -128.4 151.16 49.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.813 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.2 t -127.81 130.67 70.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.151 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.449 ' CD2' ' CG2' ' A' ' 88' ' ' THR . 4.3 m170 -123.9 121.09 34.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.787 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.451 ' N ' ' CD1' ' A' ' 75' ' ' TYR . 1.7 p90 -153.33 106.53 2.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.845 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -92.43 141.03 28.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.957 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -88.52 -47.96 7.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.866 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.8 mt -143.12 171.08 14.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -169.75 111.91 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -143.71 -178.51 5.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.89 -31.45 59.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.916 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.09 -56.14 6.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.968 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -156.76 134.15 10.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.2 m -109.69 138.19 46.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.94 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -124.63 139.84 53.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.18 172.33 35.85 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.502 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.43 ' HB2' ' CE2' ' A' ' 75' ' ' TYR . 17.2 mt -143.31 143.41 31.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.816 0.341 . . . . 0.0 110.817 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.449 ' CG2' ' CD2' ' A' ' 74' ' ' HIS . 25.2 p -140.82 131.75 26.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.07 -177.93 15.12 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.494 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.87 153.38 24.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.484 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 111' ' ' ARG . 6.4 t80 -131.63 136.61 47.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.86 0.362 . . . . 0.0 110.89 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.6 mtm180 -137.23 159.83 40.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.54 169.77 17.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.824 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.15 130.74 25.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.513 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.876 0.37 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -107.77 141.25 39.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.827 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.408 ' HE2' ' CD1' ' A' ' 137' ' ' PHE . 19.9 ptm -112.69 133.78 54.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.47 127.19 36.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.4 ' O ' ' CD1' ' A' ' 91' ' ' PHE . 12.4 mtt180 -109.97 128.21 55.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.923 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -127.74 113.83 16.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.85 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -119.58 144.27 47.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.953 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.2 tp -140.97 143.54 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.998 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.08 99.78 3.06 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.081 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.63 155.2 69.68 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.433 2.089 . . . . 0.0 112.242 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -112.93 142.96 45.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.998 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.68 130.37 20.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.781 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.15 132.32 29.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.8 m -143.44 109.99 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.151 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -72.66 123.31 23.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.951 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.7 tp -101.78 -46.64 4.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.961 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.31 167.62 12.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.85 -30.13 71.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.025 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -123.87 40.97 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.011 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mp -156.85 133.8 10.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.56 140.51 48.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.836 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -104.92 126.82 52.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.978 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -114.86 147.37 39.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.802 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -152.38 133.53 4.15 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.676 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . 0.427 ' N ' ' CD1' ' A' ' 131' ' ' TRP . 0.1 OUTLIER -160.81 165.19 30.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.819 0.342 . . . . 0.0 110.841 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.46 156.06 47.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.01 110.33 17.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.83 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.5 ttp -113.92 111.57 21.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.839 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -104.9 121.77 44.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -140.53 110.55 6.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.819 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.408 ' CD1' ' HE2' ' A' ' 109' ' ' MET . 21.4 p90 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.963 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 69.8 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.79 0.328 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -153.53 -178.56 7.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.917 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.4 p -129.68 157.82 42.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.993 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -124.62 157.43 35.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.975 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 68.6 p -116.77 118.0 31.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.754 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -126.2 138.05 53.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.028 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 7.9 t -139.4 138.91 36.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.671 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -132.36 158.33 22.92 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.644 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.9 mp -139.14 130.19 26.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.823 0.344 . . . . 0.0 110.738 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -93.95 146.73 23.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.975 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -139.72 100.15 3.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.787 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.69 115.06 16.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.958 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.6 -49.89 3.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.729 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -131.01 163.89 26.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.799 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -30.95 70.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.931 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -119.22 27.41 8.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.079 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.4 t -148.95 117.62 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.105 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -124.03 149.96 45.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.184 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.4 mt -132.06 121.97 24.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.733 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.411 ' HD3' ' CE1' ' A' ' 196' ' ' TYR . 40.3 mtt180 -125.27 147.07 49.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.067 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.5 m -147.02 138.61 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 44.1 p30 -146.89 156.41 43.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.118 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.412 ' CD1' HG23 ' A' ' 193' ' ' ILE . 5.2 m-85 -110.13 144.57 38.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.785 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -121.7 115.87 23.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.97 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.99 106.93 16.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.14 147.26 24.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -151.36 124.09 8.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.939 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -144.71 178.66 22.42 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.518 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 12.6 t80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.778 0.323 . . . . 0.0 110.97 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 13.0 t80 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.83 0.348 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.3 p -122.83 110.08 15.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 5.0 t -106.3 139.91 40.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.942 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -98.97 130.45 45.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -134.44 157.35 46.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.945 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.412 HG23 ' CD1' ' A' ' 171' ' ' TYR . 1.8 pt -141.18 137.09 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.43 114.31 16.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.846 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -101.3 115.43 30.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.228 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.437 ' HB3' ' CD1' ' A' ' 209' ' ' TYR . 8.4 p90 -128.98 114.95 17.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.623 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.2 109.38 61.8 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.216 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -61.73 136.08 60.12 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.561 2.174 . . . . 0.0 112.18 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.2 tp -132.88 127.98 35.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.929 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 7.1 m -132.19 123.18 26.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.967 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 26.8 tp -147.15 102.68 3.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.923 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 77.06 52.03 5.92 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.499 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 59.69 29.61 19.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.77 0.319 . . . . 0.0 110.941 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -104.09 126.21 51.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.09 104.92 16.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 22.1 t -118.66 127.42 75.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.05 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.93 92.72 33.03 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.961 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -79.89 172.14 14.47 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.679 2.253 . . . . 0.0 112.244 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.437 ' CD1' ' HB3' ' A' ' 196' ' ' TYR . 0.3 OUTLIER -161.72 143.65 11.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.691 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 32.6 m -131.69 145.39 51.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.017 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.31 141.63 22.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.766 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 14.7 pt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.181 -179.919 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.23 110.93 21.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.778 0.323 . . . . 0.0 110.598 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.39 133.43 33.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.979 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -116.95 155.31 29.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -134.81 117.06 1.69 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.399 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -110.36 116.37 31.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.838 0.351 . . . . 0.0 111.027 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -115.45 111.09 20.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.676 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -72.78 -5.42 37.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.347 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.36 41.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.757 0.313 . . . . 0.0 110.938 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 70.0 -64.1 0.37 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.152 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -47.66 -75.66 0.18 Allowed Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.793 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 7.4 tt -66.51 142.49 57.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.775 0.322 . . . . 0.0 110.799 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.95 164.39 29.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.867 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . 0.416 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 8.2 t -131.29 151.42 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.942 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.57 126.2 52.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.98 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.28 122.91 12.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.809 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -105.32 141.16 37.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -124.85 153.05 43.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.898 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.061 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.795 0.331 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -128.38 147.43 17.43 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.504 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.24 142.97 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.769 0.319 . . . . 0.0 111.135 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -172.48 159.99 31.05 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.517 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.62 152.34 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 111.142 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -136.23 136.04 39.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.969 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -134.35 157.88 45.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 4.8 p -118.86 147.02 44.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.851 -179.93 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 t0 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.836 0.351 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 11.6 t90 -96.68 102.28 14.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.79 160.16 18.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.798 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.53 125.25 14.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -125.09 120.81 32.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.837 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 pp -130.52 126.74 61.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.12 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.98 164.56 25.79 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.539 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -125.8 147.81 49.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.796 0.332 . . . . 0.0 111.075 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.58 150.92 48.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.924 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -141.44 117.86 10.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.817 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.831 179.994 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.826 0.346 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.88 150.81 33.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.075 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -120.0 94.07 48.32 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.42 178.75 0.21 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.55 2.166 . . . . 0.0 112.258 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.09 135.08 26.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.836 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.59 141.53 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.113 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -140.26 122.25 15.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.929 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -144.55 123.76 12.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.76 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -135.82 162.5 32.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.983 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.82 129.61 36.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.013 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.54 109.28 21.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.104 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -108.69 85.44 2.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.803 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.31 -147.57 47.41 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.4 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -51.26 -25.78 18.61 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.506 2.137 . . . . 0.0 112.36 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -92.64 148.4 22.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.809 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -140.6 137.23 33.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.945 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.6 pt -129.92 145.49 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.964 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.19 155.78 49.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.222 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 mp -142.3 144.85 33.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.31 143.43 46.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.08 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -141.47 160.02 41.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.63 148.04 32.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.868 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.81 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.878 0.37 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.03 134.91 47.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.75 95.87 24.86 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.884 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.34 170.25 18.8 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.484 2.123 . . . . 0.0 112.253 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -153.59 140.34 19.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.025 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mt -126.04 146.31 49.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.804 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -152.28 119.89 6.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.031 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.39 138.87 31.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.042 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -129.52 135.14 48.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.064 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -124.05 110.8 15.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.712 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -65.59 137.14 57.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.043 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -50.92 147.09 5.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.199 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 16.8 mt -72.37 -66.3 0.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.743 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -71.1 -173.5 0.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.689 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -175.2 -32.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.41 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -45.88 -30.15 1.62 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.489 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.403 ' HB3' ' CD2' ' A' ' 83' ' ' PHE . 1.2 t70 -164.34 -64.97 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.97 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.404 ' CD1' HG13 ' A' ' 120' ' ' VAL . 23.5 m-85 -104.31 118.61 37.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.85 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.37 173.79 6.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.74 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -162.36 117.06 1.84 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.032 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.19 -162.42 10.37 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.261 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mp -155.73 145.24 21.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 0.0 110.981 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 81.7 p -142.84 121.94 12.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.931 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -151.32 -159.01 8.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.522 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 174.3 176.64 42.84 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.554 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.433 ' CD2' ' N ' ' A' ' 91' ' ' PHE . 3.9 m-85 -122.27 173.82 7.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.845 0.355 . . . . 0.0 110.818 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -150.26 128.23 11.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.024 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -131.45 149.44 52.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.827 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.22 138.22 52.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.933 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.426 -179.973 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.764 0.316 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -144.06 119.87 10.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.981 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.46 159.28 18.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -146.61 104.64 3.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -105.04 127.12 52.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -96.76 122.22 39.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.94 121.72 45.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.899 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.5 mt -130.99 132.14 63.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.04 76.43 8.71 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.348 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.426 ' HB2' ' CD1' ' A' ' 131' ' ' TRP . 44.2 Cg_exo -56.52 168.17 2.35 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.526 2.15 . . . . 0.0 112.132 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -147.17 134.75 20.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.164 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -120.73 124.81 46.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.66 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -100.14 125.92 46.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.959 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.404 HG13 ' CD1' ' A' ' 83' ' ' PHE . 22.3 t -140.37 116.96 8.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.059 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -88.66 144.36 26.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.922 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.29 -42.8 2.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.27 -170.75 2.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.841 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -74.94 -47.99 26.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.88 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -110.19 29.78 7.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.9 mp -138.15 133.86 33.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -142.51 152.71 42.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -141.51 135.29 30.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.802 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -154.55 168.12 27.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.062 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 151.83 177.37 25.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.562 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . 0.455 ' HA ' ' CE3' ' A' ' 131' ' ' TRP . 0.0 OUTLIER -173.21 -172.67 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.77 0.319 . . . . 0.0 110.777 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.1 mt -100.83 150.39 22.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.956 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.67 152.19 21.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.936 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 5.0 mtp -132.37 125.43 30.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -118.51 125.6 50.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.938 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.07 156.3 41.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.897 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.716 -179.948 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 37.2 p . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.763 0.316 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -105.26 120.69 42.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.833 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.2 m -120.67 116.97 51.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.091 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -108.2 153.72 22.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.932 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.4 m -101.12 132.49 46.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -129.43 116.94 19.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.4 t -140.69 113.82 8.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -114.53 147.28 18.82 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.678 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.9 pp -123.0 117.29 25.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 110.738 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.68 127.06 35.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.106 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -140.81 100.16 3.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.8 m -106.95 137.21 45.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.079 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -99.72 -30.92 11.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.798 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -151.11 -179.09 7.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.808 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -87.61 6.23 35.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.373 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 60.2 p -103.41 -31.04 10.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.818 0.342 . . . . 0.0 110.982 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.67 152.03 13.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.145 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -141.7 158.9 43.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.019 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.7 tp -115.52 143.01 45.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.952 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 32.1 mtp180 -147.36 124.0 11.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.024 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.41 123.76 66.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.007 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -121.1 145.98 47.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.141 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.41 ' CE2' HG23 ' A' ' 193' ' ' ILE . 13.3 m-85 -112.92 130.85 55.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.746 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -111.18 138.12 48.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.037 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.6 tp -139.95 151.1 45.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.808 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -138.09 144.73 41.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.006 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.06 116.58 2.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.959 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -123.06 169.91 15.41 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.398 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 34.8 t80 . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.804 0.335 . . . . 0.0 110.928 -179.941 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.791 0.329 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.9 m -142.24 148.83 38.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.944 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 17.0 p -130.39 162.6 28.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -137.45 133.24 34.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.936 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -134.74 173.18 11.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.41 HG23 ' CE2' ' A' ' 171' ' ' TYR . 1.1 pt -137.36 142.33 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.249 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.51 114.49 16.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.761 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -115.76 118.97 34.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.251 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.442 ' CD2' ' N ' ' A' ' 196' ' ' TYR . 1.9 p90 -145.36 137.09 25.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.706 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.37 109.41 19.37 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.053 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.15 142.54 80.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.5 2.133 . . . . 0.0 112.152 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.02 100.01 5.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.791 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 35.1 p -107.04 102.97 12.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.957 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 2.9 tt -140.54 129.86 23.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.884 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 72.32 -128.78 13.87 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.472 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -117.52 30.1 7.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.359 . . . . 0.0 110.931 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -135.6 149.08 49.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 88.8 p -121.01 121.51 38.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.936 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.31 139.94 45.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.825 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.0 m -138.69 92.97 11.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.403 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.01 111.52 2.47 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.618 2.212 . . . . 0.0 112.116 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -111.23 169.03 9.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 0.0 111.109 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.6 p -138.62 138.86 38.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.843 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -125.2 164.81 19.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.934 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 179.986 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.312 -0.315 . . . . 0.0 112.312 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.22 113.68 9.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.808 0.337 . . . . 0.0 111.048 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -97.71 130.6 44.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.721 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -111.05 155.72 22.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.05 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -165.51 117.21 0.74 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.041 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -132.38 121.16 23.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.748 0.309 . . . . 0.0 111.181 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 240' ' ' SER . 2.4 p30 -108.71 128.53 54.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -54.98 -24.71 25.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.998 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -156.36 -45.44 0.07 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.836 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 179.51 -55.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -63.72 -78.88 0.17 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.691 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.416 HD23 ' CD2' ' A' ' 269' ' ' TYR . 3.1 mp -66.42 140.0 58.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.794 0.33 . . . . 0.0 110.9 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -157.14 176.84 12.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.048 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . 0.487 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 30.2 m -122.01 170.39 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.825 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 36.4 t -142.27 131.84 23.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.828 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 2.3 tt -136.35 126.86 26.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.002 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -119.45 139.39 52.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -152.02 151.83 31.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.979 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.048 -179.982 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.809 0.337 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -144.58 148.08 19.65 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.445 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 21.8 m -147.47 141.83 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 111.134 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -158.47 175.04 35.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.54 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 9.2 m -130.33 162.86 37.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.79 0.329 . . . . 0.0 111.148 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -136.33 143.12 43.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.862 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.416 ' CD2' HD23 ' A' ' 239' ' ' LEU . 25.1 m-85 -139.18 101.7 4.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 59.4 p -110.77 131.7 54.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.903 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.5 t70 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.84 0.352 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 60.6 p-90 -107.83 149.89 27.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.943 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -118.2 144.71 45.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -118.72 130.03 55.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.51 128.61 19.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.7 tt -155.29 131.21 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.051 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.98 -157.99 7.73 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.553 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.79 -176.95 1.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.332 . . . . 0.0 111.04 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.5 ttt -152.94 150.13 28.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.34 138.21 26.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.854 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.952 179.987 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.901 0.381 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.7 119.5 19.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.066 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -121.75 94.09 48.45 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.05 123.83 10.38 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.482 2.121 . . . . 0.0 112.269 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.28 137.97 46.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.026 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -137.22 142.1 38.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -133.29 156.21 48.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.942 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -153.5 132.52 12.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.881 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.23 126.55 19.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.966 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.16 135.41 45.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.053 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.45 149.82 46.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.169 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -173.91 140.41 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.83 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.16 -149.39 17.37 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.511 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -86.19 42.03 0.91 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.807 2.338 . . . . 0.0 112.729 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -170.95 163.7 7.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.804 0.335 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -141.28 163.74 32.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.938 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mp -142.31 139.62 29.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.74 144.68 45.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.173 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.06 165.0 24.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.36 135.11 11.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -139.65 118.96 12.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -146.53 160.96 41.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.795 0.331 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -141.12 139.67 34.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.0 mtp180 -130.67 95.89 25.1 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.953 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.86 157.91 34.94 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.559 2.173 . . . . 0.0 112.365 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -137.87 121.23 17.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 mp -114.65 145.21 42.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -153.82 160.27 42.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.3 p -158.17 125.85 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.069 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -104.47 153.39 21.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -157.32 119.1 3.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -94.25 148.91 21.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -115.31 -62.51 1.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.837 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.7 mt -123.42 136.48 54.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.94 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -129.96 74.44 1.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -92.19 168.33 11.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -73.71 -27.75 61.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.956 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.423 ' HB3' ' CD2' ' A' ' 83' ' ' PHE . 12.7 m-20 -83.26 -64.21 1.21 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.939 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.423 ' CD2' ' HB3' ' A' ' 82' ' ' ASP . 12.6 m-85 -124.2 154.59 39.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.954 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.12 147.92 50.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.821 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.462 ' CE2' ' CZ3' ' A' ' 118' ' ' TRP . 29.3 m-85 -123.07 157.72 32.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.916 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -174.04 166.06 38.0 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.51 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.8 mt -144.3 137.07 26.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 0.0 110.874 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.93 123.37 19.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.53 149.81 16.88 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.547 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -161.48 156.68 28.2 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.41 ' HB3' ' CD1' ' A' ' 112' ' ' TRP . 8.1 p90 -150.1 167.71 26.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.789 0.328 . . . . 0.0 110.91 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.0 mtp85 -127.88 150.93 49.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.864 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -129.83 154.17 47.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.852 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -126.62 145.26 50.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.52 179.955 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 120.801 0.334 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -139.71 104.31 4.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.026 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.3 mtm -143.44 154.15 43.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.728 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -166.94 -179.28 4.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.961 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -145.02 134.58 23.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.41 ' CD1' ' HB3' ' A' ' 91' ' ' PHE . 0.3 OUTLIER -107.71 164.54 12.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.814 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -164.02 138.8 5.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.934 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.1 mt -137.77 125.82 31.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.051 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -135.91 107.89 9.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.072 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.51 177.12 5.72 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.474 2.116 . . . . 0.0 112.296 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -131.62 135.43 46.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.929 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.462 ' CZ3' ' CE2' ' A' ' 85' ' ' PHE . 2.9 t-105 -145.34 139.4 26.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.867 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -143.47 149.5 37.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.83 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.67 115.89 15.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.158 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.62 103.51 15.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.7 mp -81.37 -51.45 8.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -147.47 177.52 9.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.848 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -60.02 -29.91 68.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.993 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -118.96 36.2 4.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.008 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.85 125.09 5.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -146.36 128.68 15.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.829 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.34 151.66 19.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -133.84 154.14 51.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.76 136.16 3.82 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.449 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 4.3 p-90 -164.59 138.78 5.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.333 . . . . 0.0 110.987 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.3 mp -95.25 161.57 14.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.9 m -139.29 113.62 8.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.902 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 1.6 ttt -111.44 148.45 33.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -125.37 119.49 28.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.21 167.23 11.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.764 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.827 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.777 0.322 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.74 129.92 50.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.75 129.08 47.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.091 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.76 151.2 45.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 29.4 m -117.29 139.78 50.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.837 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.95 115.5 23.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.838 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 17.6 m -125.7 137.05 53.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.903 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -150.33 160.34 28.51 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.599 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.38 134.24 47.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.86 0.362 . . . . 0.0 110.921 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -113.79 114.29 26.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.961 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -126.78 113.44 16.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 6.2 m -103.12 136.49 42.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.102 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -103.99 -31.1 9.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.764 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -170.96 173.14 5.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.766 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.62 -14.39 62.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.344 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 9.1 t -76.24 -46.52 27.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.714 0.292 . . . . 0.0 111.032 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.2 p -156.22 154.06 6.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.2 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -133.36 -172.74 3.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.028 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.5 mp -135.87 138.14 42.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.958 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.38 128.31 14.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.921 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.2 t -122.27 136.78 57.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.117 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -118.97 149.47 41.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.407 ' CE1' HG12 ' A' ' 193' ' ' ILE . 0.5 OUTLIER -134.81 144.9 47.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -124.48 136.19 53.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.977 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.2 tp -147.52 114.51 6.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.2 pm0 -143.67 162.53 35.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.023 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.4 ptt180 -140.17 166.55 24.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.817 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -138.49 160.02 25.45 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.558 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 7.1 t80 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 0.0 110.904 179.987 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.892 0.377 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 11.9 m -130.69 121.47 25.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.956 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 14.0 p -124.35 153.63 41.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -153.96 128.44 9.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.834 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.21 137.85 54.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.407 HG12 ' CE1' ' A' ' 171' ' ' TYR . 22.6 mt -102.12 139.22 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.094 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 15.5 ttt85 -134.04 133.42 41.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -111.3 126.44 54.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.139 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.4 ' CD1' ' HB3' ' A' ' 209' ' ' TYR . 0.3 OUTLIER -131.67 116.14 16.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.772 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.81 109.67 42.94 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.087 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.413 ' HA ' ' CG2' ' A' ' 207' ' ' THR . 91.0 Cg_endo -79.0 138.22 14.36 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.409 2.073 . . . . 0.0 112.388 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.7 tt -132.76 155.91 48.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.929 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 44.0 m -132.93 116.94 17.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.22 102.57 3.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.76 -137.52 15.31 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.485 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.03 23.66 14.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 0.0 111.043 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -136.44 132.99 36.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.764 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 84.8 p -96.69 134.44 39.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.954 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 20.8 t -135.38 131.5 51.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.85 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.413 ' CG2' ' HA ' ' A' ' 198' ' ' PRO . 14.3 p -133.61 92.82 22.59 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.302 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.34 124.71 9.15 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.432 2.088 . . . . 0.0 111.951 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.431 ' CZ ' ' HA3' ' A' ' 228' ' ' GLY . 48.2 p90 -111.12 136.23 50.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.932 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 24.7 m -111.12 159.64 17.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.938 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -127.35 126.76 43.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.851 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.205 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.431 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.08 129.53 11.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.918 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -107.01 114.5 28.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.748 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -90.93 162.1 14.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.035 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -153.95 117.03 0.77 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.111 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -110.86 115.45 29.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.791 0.329 . . . . 0.0 111.142 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -120.06 85.44 2.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.564 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.95 -12.7 19.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.272 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.31 35.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.736 0.303 . . . . 0.0 111.137 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 68.91 -65.44 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.061 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -48.43 -59.33 6.59 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.725 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.416 ' HG ' ' CE1' ' A' ' 269' ' ' TYR . 7.6 tt -80.95 107.37 13.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.764 0.316 . . . . 0.0 110.766 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 30.5 t -113.19 154.37 26.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.931 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . 0.463 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 39.1 t -122.38 142.53 38.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.779 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 27.3 m -116.45 118.84 33.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.008 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.34 124.37 36.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.771 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -105.23 133.56 49.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.945 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -121.9 159.38 26.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.073 179.984 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.845 0.355 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -103.45 136.13 12.75 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.543 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 16.5 t -120.11 141.71 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 111.092 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -166.2 164.31 37.46 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.518 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 5.7 m -132.72 166.73 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.853 0.358 . . . . 0.0 111.109 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -158.75 120.76 3.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.956 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.416 ' CE1' ' HG ' ' A' ' 239' ' ' LEU . 62.3 m-85 -112.78 105.75 13.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.794 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.59 118.34 36.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.873 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.827 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.783 0.325 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -123.84 112.88 17.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.84 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.99 146.17 46.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.4 130.48 52.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.2 129.32 51.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.0 mm -138.9 127.78 29.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.098 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.96 -178.77 35.23 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.508 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.35 -176.89 5.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 0.0 111.072 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.44 152.36 21.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.82 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -150.89 118.42 6.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.92 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.863 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.864 0.364 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.84 138.11 31.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.138 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -136.64 94.13 13.54 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.926 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.72 167.41 25.76 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.555 2.17 . . . . 0.0 112.254 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.9 t -152.95 136.45 15.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -115.02 144.76 21.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.159 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -125.77 136.57 53.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -131.51 161.87 31.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.873 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -165.01 144.72 6.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.3 117.46 9.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.125 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.06 135.41 47.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.122 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -158.12 111.4 2.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.76 -149.29 37.49 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.579 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.76 -10.7 28.28 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.571 2.181 . . . . 0.0 112.6 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -99.87 143.04 30.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 110.941 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -129.99 142.08 50.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.8 mt -129.64 147.54 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.206 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.71 147.46 25.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.027 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.16 169.22 19.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.934 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.43 137.37 20.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.042 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -115.89 148.94 39.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.951 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -131.46 144.63 51.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 . . . . . 0 N--CA 1.458 -0.073 0 CA-C-O 120.844 0.354 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.37 146.44 46.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -151.2 95.87 3.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.902 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.91 133.33 16.6 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.556 2.17 . . . . 0.0 112.33 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -106.87 125.76 51.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.419 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -121.29 141.25 51.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.804 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -145.67 141.14 27.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.942 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.2 t -127.85 119.54 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.07 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -107.98 121.91 45.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -97.59 140.31 32.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -109.81 105.22 14.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.922 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.47 -46.47 5.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.808 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 tp -138.91 145.3 39.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.861 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -156.63 79.77 0.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.77 -170.59 1.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.978 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -85.38 -22.28 28.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.15 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -120.86 -47.21 2.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.787 0.327 . . . . 0.0 111.065 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.411 ' CE2' HG13 ' A' ' 120' ' ' VAL . 1.6 t80 -103.28 143.67 32.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.057 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.4 t -143.52 155.24 44.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.83 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -153.14 149.39 27.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 171.17 -178.67 43.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.438 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mp -142.39 145.18 33.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.823 0.344 . . . . 0.0 110.939 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.9 m -132.89 123.23 25.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.16 177.61 19.43 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.553 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.47 -175.37 46.97 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.441 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.419 ' CZ ' HD13 ' A' ' 71' ' ' LEU . 36.9 p90 -163.43 149.65 11.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.783 0.325 . . . . 0.0 111.014 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.1 159.88 18.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -130.74 143.43 50.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.851 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -148.84 119.43 7.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.952 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.478 -179.965 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.822 0.344 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -105.02 111.07 23.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -131.23 141.09 49.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.409 ' HG2' ' CD2' ' A' ' 137' ' ' PHE . 5.3 pt20 -163.11 172.16 15.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.0 mtt-85 -152.97 109.23 3.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -87.38 154.51 20.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.815 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -145.05 125.39 13.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.043 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.3 mt -140.17 124.91 19.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.983 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -149.15 99.49 3.44 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.222 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.07 169.94 0.26 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.463 2.109 . . . . 0.0 112.22 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -125.78 134.9 51.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.001 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -144.56 127.05 15.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.52 142.75 45.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.411 HG13 ' CE2' ' A' ' 83' ' ' PHE . 6.9 m -153.93 118.35 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.188 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -88.09 139.07 30.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.8 tt -102.89 -31.18 10.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 12.4 t -156.35 -164.01 1.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.851 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -93.79 20.58 7.43 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.35 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -158.11 26.13 0.26 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.714 0.293 . . . . 0.0 111.094 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.09 108.72 2.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.823 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -113.41 122.36 47.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -105.39 130.89 53.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -145.61 137.29 25.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.04 156.78 26.63 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.545 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 37.4 p-90 -173.01 127.0 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.743 0.306 . . . . 0.0 110.959 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.1 pp -104.33 124.97 50.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.843 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.7 t -99.76 150.13 22.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.991 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 15.1 mtm -130.56 145.32 51.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.738 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.45 ' CD2' ' N ' ' A' ' 135' ' ' TYR . 2.7 m-85 -119.12 133.62 55.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.907 0.384 . . . . 0.0 110.976 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -128.99 145.63 51.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.802 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.409 ' CD2' ' HG2' ' A' ' 110' ' ' GLN . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.781 0.325 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.422 ' HG2' ' CD2' ' A' ' 135' ' ' TYR . 5.8 tpp180 -105.12 136.42 44.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.828 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.3 m -149.66 142.58 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.174 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -144.6 127.86 16.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.8 m -96.92 131.93 43.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.893 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.4 ' OE1' ' CD1' ' A' ' 172' ' ' TYR . 25.5 mp0 -124.93 120.39 31.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.977 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 14.9 p -119.19 122.92 43.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -106.3 136.7 13.44 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.3 mt -119.25 118.25 30.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.848 0.356 . . . . 0.0 110.9 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -100.0 142.61 31.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -140.82 100.2 3.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.848 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.28 113.8 14.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.931 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.73 -32.75 16.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.807 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -158.06 -173.38 4.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.813 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -87.73 6.05 36.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.406 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 22.8 m -136.39 12.89 3.26 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.559 0.219 . . . . 0.0 111.324 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.6 m -158.28 155.12 4.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.852 0.358 . . . . 0.0 111.131 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -149.43 176.79 10.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.093 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.7 124.09 12.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.42 ' HD2' ' CE2' ' A' ' 196' ' ' TYR . 79.6 mtt180 -124.74 142.04 51.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.1 118.83 16.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.113 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -97.88 138.85 34.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.22 112.33 18.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.4 ' CD1' ' OE1' ' A' ' 154' ' ' GLU . 5.3 m-85 -96.33 138.02 34.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.868 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 6.5 mt -143.5 108.72 5.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.87 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -125.07 152.12 44.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -151.23 136.83 17.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.946 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -99.05 150.29 19.25 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.536 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 1.4 t80 . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 0.0 110.887 -179.994 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 42.9 t80 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.805 0.336 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.57 129.75 43.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.956 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.7 t -150.25 114.86 5.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.79 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -122.02 143.27 49.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.092 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -142.8 152.37 42.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.767 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.65 134.84 46.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.937 0.398 . . . . 0.0 111.366 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -139.51 124.94 19.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.581 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -119.41 154.43 33.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.058 0.456 . . . . 0.0 111.591 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.44 ' N ' ' CD1' ' A' ' 196' ' ' TYR . 1.8 p90 -155.35 138.83 15.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.318 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.441 ' O ' ' HD2' ' A' ' 208' ' ' PRO . 5.4 mp -97.94 109.37 51.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.263 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -83.2 108.76 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.486 2.124 . . . . 0.0 112.358 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.29 140.75 52.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.974 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 60.3 p -131.59 128.13 38.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.9 mt -127.82 104.69 7.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 65.63 -96.37 0.25 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.584 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -127.92 31.2 5.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.802 0.334 . . . . 0.0 110.946 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -125.85 155.34 41.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.765 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.57 128.66 29.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.986 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.2 t -140.12 110.97 4.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.855 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 2.1 m -121.33 93.06 48.81 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.404 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.441 ' HD2' ' O ' ' A' ' 197' ' ' LEU . 33.8 Cg_exo -61.72 171.76 4.33 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.587 2.191 . . . . 0.0 111.949 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -134.21 127.9 32.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.957 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.1 p -116.81 126.18 52.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -146.59 121.45 9.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.849 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 10.8 mt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.091 -179.877 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.02 146.12 25.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.85 0.357 . . . . 0.0 111.054 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -109.25 148.82 30.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.732 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.85 137.4 54.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -133.49 117.18 1.84 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.284 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -113.11 122.5 47.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.898 0.38 . . . . 0.0 111.033 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.44 92.59 3.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.58 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -69.12 -6.84 31.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.431 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.59 31.49 0.13 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.667 0.27 . . . . 0.0 111.117 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 1.2 m120 67.91 -66.1 0.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.037 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -50.6 -59.35 7.96 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.601 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.1 mt -69.25 142.59 54.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.69 0.281 . . . . 0.0 110.698 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.8 p -137.0 148.91 47.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.943 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . 0.403 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 40.2 t -116.27 141.18 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.818 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 20.1 m -111.4 126.37 54.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.136 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.1 tt -149.42 124.86 10.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.741 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -105.32 150.64 25.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.059 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -155.54 149.67 25.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.166 -179.993 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.817 0.342 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -109.1 164.79 12.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.509 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 21.5 t -150.8 138.55 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.952 0.406 . . . . 0.0 111.128 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -153.0 179.03 29.76 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.501 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 6.2 m -149.99 139.45 15.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.904 0.383 . . . . 0.0 111.198 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -129.38 129.36 44.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -125.7 123.98 40.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 37.6 p -109.2 134.86 51.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.864 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.922 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.772 0.32 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -89.79 96.99 10.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.825 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -107.83 157.11 18.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.951 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.11 144.45 50.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.726 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -151.48 133.32 14.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.06 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.5 mp -128.44 154.93 39.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.9 153.4 25.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.666 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -129.29 154.84 46.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.825 0.345 . . . . 0.0 110.933 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.9 mtt -139.34 141.48 37.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.96 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.418 ' CE1' ' HB3' ' A' ' 32' ' ' PRO . 18.8 m-85 -137.83 113.59 9.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.808 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.858 -179.856 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.852 0.358 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.38 143.65 47.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.133 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -131.7 94.04 26.54 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.418 ' HB3' ' CE1' ' A' ' 14' ' ' TYR . 72.2 Cg_endo -74.84 156.68 43.73 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.555 2.17 . . . . 0.0 112.389 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 p -123.61 140.27 53.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.6 m -112.6 127.61 69.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -124.63 122.16 36.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.947 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -112.71 153.43 27.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -147.8 142.9 27.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.981 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.03 128.24 31.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.064 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.72 124.18 45.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.103 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -136.36 85.93 2.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.22 -150.43 37.08 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.527 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.05 -23.74 22.86 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.566 2.177 . . . . 0.0 112.388 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 20.6 m95 -101.54 150.21 23.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.988 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -142.34 151.76 42.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.804 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.7 pt -127.44 158.36 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.173 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.24 128.85 10.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.974 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 tp -120.28 129.2 53.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.929 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.88 139.75 50.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.025 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -133.02 155.43 49.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -115.88 109.73 18.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.756 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.849 -179.945 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.2 t80 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.761 0.315 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.57 144.22 51.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.763 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -123.57 95.86 44.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.979 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.01 125.93 9.64 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.53 2.153 . . . . 0.0 112.178 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -127.74 118.49 23.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.057 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 mp -102.48 165.09 11.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.734 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -160.81 138.19 9.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.126 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.3 t -123.95 115.93 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.797 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -102.03 123.97 46.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.161 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -114.15 123.08 48.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.656 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -65.52 122.9 18.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.053 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -66.09 132.12 47.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.911 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 tp -161.25 140.57 10.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -176.72 -40.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.83 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -143.82 -169.29 3.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.853 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.74 -37.97 48.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.925 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -112.93 -32.24 6.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.022 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -92.43 137.49 32.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.921 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.6 m -145.26 173.2 12.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' A' ' 117' ' ' ASP . 6.5 t80 -162.39 117.08 1.84 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.919 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.67 -162.3 21.35 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.548 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 tp -160.38 116.3 2.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.823 0.344 . . . . 0.0 110.968 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.1 m -111.23 107.81 17.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.827 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -102.93 176.24 24.65 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -172.23 163.15 35.32 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.571 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 92' ' ' ARG . 13.0 t80 -135.12 153.97 51.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.808 0.337 . . . . 0.0 110.862 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.425 ' N ' ' CD1' ' A' ' 91' ' ' PHE . 1.9 ttt180 -149.12 129.89 14.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -137.15 158.9 43.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -132.66 138.98 47.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.533 179.982 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.809 0.338 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -140.51 111.13 6.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 47.7 mtt -113.85 134.02 55.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.999 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.4 96.67 5.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.778 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.53 131.52 52.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.965 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -122.23 143.23 49.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.789 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -140.61 131.97 26.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.049 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.6 mp -139.34 147.0 24.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.951 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.58 85.96 5.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.237 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.14 170.49 3.89 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.613 2.209 . . . . 0.0 112.159 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.404 ' O ' ' CD2' ' A' ' 85' ' ' PHE . 7.1 m-20 -131.58 149.77 52.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.823 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -141.52 125.94 17.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.919 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -112.01 135.04 53.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.4 t -142.58 121.74 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.179 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.04 123.44 49.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.4 mp -117.76 -41.15 2.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.56 168.86 11.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.973 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.76 -41.23 96.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.923 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -113.4 36.36 3.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.3 tp -139.27 102.07 4.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.933 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -110.29 123.05 49.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -97.62 149.34 22.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -138.05 135.85 36.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.962 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -117.56 117.17 3.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.508 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -116.2 136.7 52.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 0.0 110.93 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.34 151.63 44.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.82 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.51 130.21 53.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.859 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.4 mtt -150.93 117.84 5.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.423 ' CD2' ' N ' ' A' ' 135' ' ' TYR . 4.9 m-85 -129.2 149.36 51.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -132.99 119.91 20.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.951 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 17.3 t80 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 -179.926 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.822 0.344 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -109.86 129.73 55.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.981 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.1 p -152.0 124.3 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.056 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -142.51 155.45 45.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.3 m -117.83 130.28 56.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.849 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.0 132.28 53.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.3 m -109.28 158.42 17.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -142.65 126.02 2.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.422 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.1 mp -115.98 142.46 46.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.788 0.328 . . . . 0.0 110.856 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -124.98 126.76 45.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -138.49 100.15 4.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.83 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.2 p -80.84 128.2 33.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.955 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -104.06 -31.94 9.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.659 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -154.91 165.54 36.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.62 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -69.0 -12.18 61.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.342 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.0 p -113.43 -17.9 12.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.588 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 28.7 m -139.35 147.86 24.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.922 0.391 . . . . 0.0 111.466 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -146.91 179.92 7.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.119 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.1 tp -135.53 138.02 42.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.959 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.423 ' HB3' ' CE2' ' A' ' 196' ' ' TYR . 2.3 ttp180 -144.08 149.45 36.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.071 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.3 m -147.24 139.84 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.992 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.79 161.34 19.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.981 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.01 151.89 43.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.737 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -127.41 128.36 45.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.046 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.91 105.21 5.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.729 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -89.63 156.05 18.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -150.42 120.92 7.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.799 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -140.38 154.95 24.4 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.509 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 53.2 t80 . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 120.759 0.314 . . . . 0.0 110.919 -179.987 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.749 0.309 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 72.8 p -131.58 130.9 42.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.004 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.92 162.96 13.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.728 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -132.02 122.11 24.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.17 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -140.59 155.59 46.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.637 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 11.8 tt -142.08 141.53 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.971 0.415 . . . . 0.0 111.368 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -128.75 155.36 45.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.436 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.1 130.7 14.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.994 0.426 . . . . 0.0 111.499 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.432 ' HB3' ' CD2' ' A' ' 209' ' ' TYR . 3.0 p90 -140.15 168.58 19.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.339 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 207' ' ' THR . 0.1 OUTLIER -120.02 109.4 37.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.325 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.33 120.68 4.11 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.382 2.055 . . . . 0.0 112.418 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.3 mp -125.79 134.42 51.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.955 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.05 103.94 6.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.904 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 5.7 tt -119.39 96.56 5.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.991 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 56.35 -116.02 6.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.521 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -99.03 29.78 3.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.855 0.36 . . . . 0.0 110.913 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.85 121.99 22.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.766 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.81 128.49 50.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.072 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.3 m -144.27 129.73 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.606 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 57.1 m -138.67 93.17 11.04 Favored Pre-proline 0 C--N 1.327 -0.386 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.681 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . 0.453 ' HD2' ' O ' ' A' ' 197' ' ' LEU . 58.6 Cg_endo -71.82 137.98 30.71 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.308 2.006 . . . . 0.0 112.001 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.432 ' CD2' ' HB3' ' A' ' 196' ' ' TYR . 6.7 m-85 -111.04 136.46 50.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.808 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 35.8 p -127.14 143.32 51.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.865 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.93 143.19 27.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 1.6 pt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 N-CA-C 112.613 -0.195 . . . . 0.0 112.613 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.9 mt -116.71 121.41 41.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.769 0.319 . . . . 0.0 110.941 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -93.78 123.63 37.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 242' ' ' SER . 6.2 m-85 -112.74 155.45 24.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -168.76 117.01 0.69 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.982 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . 0.427 ' CZ ' ' HB ' ' A' ' 241' ' ' VAL . 39.1 p90 -148.03 144.76 28.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.87 0.367 . . . . 0.0 111.246 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -103.56 131.15 50.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.822 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -69.83 -12.8 61.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.358 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -176.09 47.43 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.918 0.389 . . . . 0.0 111.033 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.55 25.96 10.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.985 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -139.51 -71.3 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.377 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.419 ' HG ' ' CD1' ' A' ' 269' ' ' TYR . 8.6 mp -83.39 107.37 15.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.72 0.295 . . . . 0.0 110.833 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 4.8 m -92.59 153.13 19.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.983 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . 0.427 ' HB ' ' CZ ' ' A' ' 233' ' ' TYR . 29.9 t -131.9 122.64 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.77 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 231' ' ' TYR . 1.5 m -107.77 151.17 26.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.231 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.25 131.14 17.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.875 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -117.85 124.24 47.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.849 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -147.25 146.88 29.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.051 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.787 0.327 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -84.57 150.85 25.98 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.484 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 14.3 m -136.84 135.74 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.807 0.336 . . . . 0.0 111.193 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -146.98 163.53 28.62 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.425 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 6.1 m -142.7 148.94 19.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.0 111.137 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -131.94 142.57 49.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.787 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . 0.419 ' CD1' ' HG ' ' A' ' 239' ' ' LEU . 4.8 m-85 -130.65 105.56 7.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 7.1 m -100.88 124.11 46.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 9.3 t80 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.859 179.95 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.875 0.369 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.94 116.1 6.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.882 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -134.25 141.73 47.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -119.8 166.42 13.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -165.11 128.03 2.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.8 tt -129.69 122.87 55.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.139 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.59 155.68 22.72 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.437 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -127.88 163.88 23.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.748 0.308 . . . . 0.0 111.179 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.98 140.02 29.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.886 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -142.68 110.43 5.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 -179.942 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.881 0.372 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -131.99 146.63 52.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.059 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -107.59 93.98 11.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.948 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.53 134.82 15.71 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.527 2.152 . . . . 0.0 112.321 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.34 146.06 25.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.887 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.0 m -145.13 162.6 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.041 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -146.23 139.53 25.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.956 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -116.37 164.21 14.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.823 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.66 141.86 22.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.961 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.84 131.51 18.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.04 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.23 121.53 43.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.106 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.02 71.59 1.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.758 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.54 -143.43 46.98 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.356 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.55 -26.36 16.53 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.554 2.169 . . . . 0.0 112.355 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -100.93 127.27 47.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.975 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -109.54 157.16 19.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mp -133.81 141.27 44.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.222 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.91 138.5 44.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.023 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.62 165.1 20.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.982 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.16 149.57 24.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.006 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -137.08 155.98 48.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -153.52 114.99 4.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.787 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.998 -179.97 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.2 p90 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.791 0.329 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.8 137.31 39.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.01 95.95 40.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.956 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.54 155.6 54.73 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.506 2.137 . . . . 0.0 112.29 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.57 125.63 24.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.8 mt -115.18 141.0 48.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.902 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -149.34 146.65 27.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.791 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.7 m -126.09 150.19 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.217 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.24 143.73 50.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.796 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -141.76 144.0 33.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.69 117.53 25.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.944 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -87.4 -57.82 2.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 61.19 155.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -154.42 -46.79 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -158.62 179.69 8.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.761 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -74.36 -31.47 62.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.827 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -69.57 -72.44 0.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -96.88 161.58 13.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.957 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.32 173.15 11.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.801 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -162.27 152.67 16.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.916 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.77 -177.31 35.67 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.526 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.56 138.56 26.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 110.984 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.0 m -138.66 124.96 20.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -121.09 174.02 15.71 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.481 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.68 148.82 12.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.429 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -142.23 129.47 21.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.837 0.351 . . . . 0.0 110.895 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -109.76 145.38 36.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -164.28 125.57 2.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.871 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -132.77 122.13 24.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.934 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.563 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 -0.068 0 CA-C-O 120.926 0.394 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -130.7 107.86 9.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -146.09 160.08 42.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -143.77 110.46 5.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.938 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -110.6 111.86 23.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 44.5 t-105 -107.92 142.97 37.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.853 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -138.27 137.5 37.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.11 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.1 tp -152.78 133.18 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.29 113.05 2.46 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.224 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.8 154.57 53.9 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.428 2.086 . . . . 0.0 112.24 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -106.11 134.95 48.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.947 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -134.59 127.21 30.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.12 138.18 53.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.766 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.2 m -147.98 121.23 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.5 140.95 29.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.835 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.8 mt -119.88 -77.1 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.34 -172.82 3.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.875 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.46 23.2 12.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.161 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.7 t70 57.01 31.27 19.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.182 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 pp -122.22 136.12 54.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.921 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 -102.76 132.91 48.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.918 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.414 ' CD1' HD11 ' A' ' 157' ' ' LEU . 0.1 OUTLIER -84.87 125.34 32.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.412 ' HB3' ' CZ3' ' A' ' 131' ' ' TRP . 2.9 m-80 -113.8 155.66 25.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.977 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.28 135.88 2.8 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.443 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . 0.412 ' CZ3' ' HB3' ' A' ' 129' ' ' ASN . 17.4 p90 -162.76 131.98 4.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.779 0.323 . . . . 0.0 110.912 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.1 pp -100.44 136.01 40.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.3 t -103.9 152.22 22.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.07 122.85 26.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -104.16 141.24 36.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.908 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -133.3 110.43 10.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.888 -179.941 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 37.4 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.832 0.349 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 25.9 mtp180 -133.09 123.48 25.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.36 115.27 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.094 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -114.94 151.4 34.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 33.1 m -128.58 128.31 43.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.818 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.405 ' HB2' ' CD1' ' A' ' 131' ' ' TRP . 0.8 OUTLIER -122.36 145.21 48.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.004 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.57 138.38 25.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.769 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -137.57 171.69 23.11 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.48 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.414 HD11 ' CD1' ' A' ' 128' ' ' PHE . 1.0 OUTLIER -141.44 117.37 10.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.803 0.335 . . . . 0.0 110.854 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -92.75 121.8 34.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.937 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -126.83 104.09 7.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.73 125.59 51.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.95 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -102.79 -31.22 10.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.795 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.32 -178.12 7.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.703 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -87.43 6.15 35.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.4 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 51.5 p -115.73 -32.25 5.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.648 0.261 . . . . 0.0 111.162 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.2 136.06 57.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.311 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -139.16 179.24 6.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.002 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.42 141.33 45.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.011 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.31 107.51 4.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.837 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.5 m -106.21 155.0 7.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.07 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -135.72 156.05 49.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.993 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.01 106.47 5.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.821 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -90.06 134.78 34.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.926 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 8.2 tt -153.65 105.24 2.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.772 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -104.22 166.09 10.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.998 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -145.92 151.31 37.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.769 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -139.19 151.98 22.1 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.492 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 110.876 179.996 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.879 0.371 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.3 111.37 6.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.882 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.69 155.57 29.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.802 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -148.84 142.15 25.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.956 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -143.0 144.13 32.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.768 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 27.3 mt -105.65 138.37 31.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.263 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.08 109.69 4.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.766 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -106.53 136.96 45.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.255 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' TYR . . . . . 0.416 ' CD2' ' HB3' ' A' ' 209' ' ' TYR . 28.0 m-85 -140.47 123.3 16.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.615 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.408 ' N ' ' CD1' ' A' ' 197' ' ' LEU . 2.3 mp -111.02 109.64 57.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.055 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.48 120.64 4.47 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.491 2.128 . . . . 0.0 112.308 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.46 115.24 18.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.836 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.4 m -134.37 118.39 17.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.959 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.64 104.44 5.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 84.85 -117.3 4.47 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.513 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -116.76 30.72 7.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.849 0.357 . . . . 0.0 110.926 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -134.87 117.99 16.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.1 m -104.44 130.23 52.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.974 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.26 124.07 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.779 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 41.9 m -138.78 92.8 11.07 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.477 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.16 143.39 11.31 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.612 2.208 . . . . 0.0 112.185 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.423 ' CZ ' ' HA3' ' A' ' 228' ' ' GLY . 15.1 p90 -111.23 142.38 43.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.983 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 11.6 p -131.58 142.29 49.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -145.06 124.0 12.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.885 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.438 HD12 HG22 ' A' ' 212' ' ' ILE . 16.1 tt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.094 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.423 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.653 -0.179 . . . . 0.0 112.653 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.94 119.85 13.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.709 0.29 . . . . 0.0 111.072 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.89 145.55 25.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.869 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -126.74 148.55 49.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.125 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -137.79 117.08 1.42 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.292 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -102.7 118.09 36.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 111.192 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -123.53 90.49 3.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.417 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -56.83 -17.33 8.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.384 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -176.38 46.23 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.846 0.355 . . . . 0.0 111.172 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.93 23.71 5.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.219 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -122.22 -72.26 0.28 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.248 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.78 107.44 11.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.736 0.303 . . . . 0.0 110.625 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.22 134.13 42.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.948 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . 0.481 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 26.0 t -112.89 148.34 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.689 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 4.7 m -119.21 126.04 50.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.937 0.399 . . . . 0.0 111.052 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 9.4 tt -143.86 123.6 13.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.782 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -105.25 157.53 17.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.973 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.36 147.62 41.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.836 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.117 -179.974 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.831 0.348 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -126.75 156.91 20.29 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.482 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 4.9 m -141.24 152.93 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.914 0.388 . . . . 0.0 111.139 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -163.83 173.2 39.86 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.49 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 21.4 t -145.26 152.82 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.776 0.322 . . . . 0.0 111.185 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -142.33 125.37 16.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -127.34 120.81 29.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.923 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.2 p -90.81 141.06 29.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.827 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.794 0.331 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -95.58 91.07 5.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.923 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.79 146.42 53.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.953 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -110.06 126.75 54.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.82 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.72 -60.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.902 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 60.85 103.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.96 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -148.93 136.8 20.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.854 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -116.07 152.12 34.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -143.1 117.52 9.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.757 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 pp -128.39 132.29 68.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.01 170.65 27.14 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.467 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.47 177.13 8.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.827 0.346 . . . . 0.0 111.031 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.8 tpp -159.25 137.22 10.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.974 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.405 ' CZ ' HG12 ' A' ' 265' ' ' VAL . 11.2 p90 -147.15 161.78 40.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.885 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.03 110.6 13.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.8 mt 67.01 -71.35 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.288 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 57.18 168.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.894 0.378 . . . . 0.0 110.891 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -74.77 76.28 2.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.15 -60.27 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.64 117.14 25.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.865 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -165.09 160.34 33.63 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.509 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -141.21 105.14 4.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.818 0.342 . . . . 0.0 110.925 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.64 138.61 2.63 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.571 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -121.07 31.64 6.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.804 0.335 . . . . 0.0 110.868 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.94 34.15 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.825 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -175.04 155.23 1.95 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.821 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.37 160.01 40.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.921 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -118.42 -168.81 14.39 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.518 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.7 mp -122.47 133.8 54.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.886 0.374 . . . . 0.0 110.973 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.85 131.41 55.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.064 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -115.31 94.0 37.85 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.982 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.51 128.44 12.71 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.527 2.151 . . . . 0.0 112.34 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.6 m -122.39 150.35 42.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.875 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.01 158.79 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.063 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -143.02 133.8 25.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.013 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -132.34 116.06 16.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -118.55 133.27 55.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.924 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.24 123.8 44.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.49 116.31 31.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -136.72 83.52 2.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.803 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.63 -137.34 36.89 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.364 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.45 -21.37 46.83 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.408 2.072 . . . . 0.0 112.312 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.3 m95 -94.82 115.21 27.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.884 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -117.36 116.32 26.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mp -95.33 142.77 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.171 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -145.36 126.9 15.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.051 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.66 153.61 47.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.958 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -142.56 141.36 32.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.964 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -119.95 152.12 37.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.975 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -116.77 165.76 12.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.853 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -167.33 167.4 14.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -145.3 128.51 16.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -136.3 57.01 0.68 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.473 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.35 175.92 8.69 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.647 2.231 . . . . 0.0 112.286 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.8 t -85.05 122.24 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.027 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -75.07 149.82 39.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.947 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -161.24 30.0 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.94 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m 58.91 76.78 0.33 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.95 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.41 -70.85 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.65 -101.19 2.2 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.514 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -117.51 -68.03 0.95 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.773 0.32 . . . . 0.0 110.884 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -119.6 165.34 14.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -104.83 106.17 2.66 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.488 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.8 t -95.79 115.88 28.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.801 0.334 . . . . 0.0 111.011 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -94.49 161.63 14.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.829 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -150.36 136.94 18.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.976 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.24 164.8 14.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.834 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -136.82 95.81 12.1 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.67 130.53 17.17 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.541 2.161 . . . . 0.0 112.263 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -128.67 132.23 48.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.8 mt -127.76 167.05 17.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.784 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -159.29 151.28 20.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.033 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.01 111.37 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.025 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -98.81 132.7 43.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.851 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -135.47 135.84 40.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.795 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -103.12 121.08 41.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -98.8 -50.39 4.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.17 162.66 0.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.806 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -160.85 -58.86 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.841 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.8 164.91 27.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -63.36 -36.49 83.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.959 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.73 -59.88 2.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.979 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.446 ' CE1' ' CG1' ' A' ' 120' ' ' VAL . 5.3 m-85 -100.72 128.62 46.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.4 m -109.81 170.02 8.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.873 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.54 156.73 46.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -170.03 168.83 41.73 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.551 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 tp -138.53 125.04 20.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.349 . . . . 0.0 110.836 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.62 146.57 43.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.63 174.49 21.28 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.535 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.74 150.63 17.88 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.496 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -133.34 116.19 15.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.876 0.369 . . . . 0.0 110.862 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.64 135.58 54.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -149.91 133.49 16.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -126.61 133.27 51.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.003 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.32 143.3 16.48 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.429 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.62 127.0 54.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.893 0.378 . . . . 0.0 110.836 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -123.67 124.33 42.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.969 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -123.32 94.74 4.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.854 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.8 p -98.54 35.01 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.045 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -107.4 -31.56 8.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.866 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -153.41 87.66 3.82 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -51.07 155.38 6.22 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.603 2.202 . . . . 0.0 112.337 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 143.61 46.02 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.477 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.2 mttp 60.7 30.98 20.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.891 0.377 . . . . 0.0 110.905 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -81.14 85.23 6.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.1 m -153.42 140.05 18.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.92 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -111.48 173.79 6.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.021 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -147.04 118.07 7.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.922 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -147.72 150.55 34.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.818 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.407 ' HB2' ' CD1' ' A' ' 137' ' ' PHE . 5.0 mt-30 -132.37 177.36 7.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.029 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.8 mtp85 -148.64 114.92 5.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.893 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.35 130.09 42.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.776 0.322 . . . . 0.0 110.474 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -104.03 126.72 51.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.011 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.6 mp -140.8 104.41 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.949 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -142.88 100.78 5.42 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.182 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.3 161.2 46.83 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.35 2.033 . . . . 0.0 112.155 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.07 134.79 48.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.98 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -129.05 134.55 48.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.736 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.16 141.51 51.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.959 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.446 ' CG1' ' CE1' ' A' ' 83' ' ' PHE . 21.6 t -143.44 113.16 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -97.0 110.78 23.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 tp -95.0 -31.94 13.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.8 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -153.5 176.01 12.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.722 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.77 -19.86 61.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.18 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.52 30.2 7.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.748 0.308 . . . . 0.0 111.136 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 60.0 mt -149.55 109.22 4.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.899 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -114.72 119.31 36.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.42 ' CG ' HD23 ' A' ' 157' ' ' LEU . 55.0 m-85 -103.03 148.4 25.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.983 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -158.48 140.58 14.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.05 147.87 18.34 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.587 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 42.2 p90 -159.87 134.43 7.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.734 0.302 . . . . 0.0 110.903 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.3 mp -102.81 126.22 49.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.99 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 88.4 p -92.83 114.54 27.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.969 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 9.8 ttm -106.94 141.36 38.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.848 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.06 115.75 18.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.98 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 137' ' ' PHE . 13.1 mttp -149.21 132.51 16.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.835 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.407 ' CD1' ' HB2' ' A' ' 110' ' ' GLN . 0.2 OUTLIER 177.63 -69.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.848 0.356 . . . . 0.0 111.104 179.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -87.77 163.95 16.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.334 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -96.11 -29.08 14.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.78 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 61.27 81.31 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.7 mp -70.79 -34.85 72.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -96.08 -38.2 10.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.364 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 36.4 m -77.62 -3.54 41.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.774 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.6 t -56.51 -23.73 41.59 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.818 0.342 . . . . 0.0 111.171 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -55.54 -25.72 43.27 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.829 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.14 -79.87 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.669 0.271 . . . . 0.0 111.041 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -148.99 -177.85 6.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.195 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -177.83 -46.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.041 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.3 m -133.31 111.44 10.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.877 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -163.07 166.35 23.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.093 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 30.1 m -107.99 141.64 22.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.12 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -119.66 158.72 25.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.727 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.5 m -132.05 120.44 22.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.064 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -134.79 107.21 7.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.723 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 6.1 t -92.37 168.69 11.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -158.25 120.66 0.99 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.556 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' A' ' 128' ' ' PHE . 0.2 OUTLIER -113.27 152.64 29.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.776 0.322 . . . . 0.0 110.867 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -128.84 123.81 33.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.065 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 157' ' ' LEU . 24.8 m-85 -120.53 117.32 27.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.86 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.9 118.81 19.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.928 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.66 -63.59 1.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.917 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -125.79 176.06 7.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -64.89 -30.68 71.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.004 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 43.0 p -120.21 27.25 8.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.044 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 23.0 t -153.72 125.21 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.038 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -126.8 169.63 13.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.276 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.19 145.16 47.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.795 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -139.04 136.12 34.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.022 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.5 t -119.0 158.98 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.981 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -153.53 133.12 12.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.026 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -116.36 111.2 19.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.709 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -89.87 135.64 33.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.086 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 22.8 mt -132.13 113.16 12.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.718 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -89.05 148.95 23.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.29 148.41 36.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.901 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -149.84 144.59 12.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.568 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.407 ' CD2' ' O ' ' A' ' 178' ' ' ASN . 54.0 t80 -172.38 149.46 2.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 0.0 110.874 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . 0.407 ' O ' ' CD2' ' A' ' 177' ' ' PHE . 34.8 m120 -87.48 161.76 17.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.003 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.22 -35.71 76.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -175.36 103.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.9 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -151.11 135.52 16.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.905 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.96 94.56 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.76 160.63 39.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.852 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -113.51 -35.85 5.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -137.37 30.61 2.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.924 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -68.83 -28.1 73.34 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.468 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.19 136.5 55.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.79 0.329 . . . . 0.0 110.947 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -105.13 137.13 43.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.2 m -132.42 100.14 4.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 2.4 m -106.65 150.51 26.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.9 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -130.42 132.14 45.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -135.61 120.99 19.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 24.8 mt -91.41 128.7 42.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.218 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.38 125.21 14.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.645 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -135.63 154.55 51.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.968 0.413 . . . . 0.0 111.533 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -143.16 148.5 36.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.342 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.411 ' O ' ' HD2' ' A' ' 208' ' ' PRO . 0.1 OUTLIER -114.04 109.46 49.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.272 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.43 121.68 6.95 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.393 2.062 . . . . 0.0 112.312 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.65 105.87 13.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.866 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 7.0 p -99.25 116.29 31.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.24 103.7 3.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.942 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 59.17 -132.18 52.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.534 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -98.58 30.84 3.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.783 0.325 . . . . 0.0 110.901 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -129.96 116.83 19.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.699 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.71 123.95 49.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.983 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 15.8 m -141.76 109.71 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.828 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 18.6 m -117.49 92.66 41.26 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.305 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.411 ' HD2' ' O ' ' A' ' 197' ' ' LEU . 23.1 Cg_exo -64.79 147.77 89.77 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.512 2.142 . . . . 0.0 111.933 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -111.18 134.7 52.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.852 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.3 p -107.5 138.24 44.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.949 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.2 118.13 8.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 2.1 pt -76.91 162.32 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.106 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -151.8 -172.42 20.54 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.555 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 7.6 tp 60.92 37.7 18.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.828 0.347 . . . . 0.0 110.884 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -140.38 26.0 2.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.075 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 18.0 t-105 -177.17 165.88 2.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.849 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 66.62 145.57 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.989 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -65.71 -65.32 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.997 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -72.16 -165.93 8.28 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.573 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -92.69 152.85 19.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.808 0.337 . . . . 0.0 110.856 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -159.44 -57.45 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.505 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -91.1 150.04 21.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.774 0.321 . . . . 0.0 110.888 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -162.53 151.36 14.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.931 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 60.95 168.25 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -92.62 -67.82 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.892 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.74 102.47 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 12.6 m -113.55 -31.82 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.291 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -111.42 167.96 12.65 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.541 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.92 127.35 7.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 0.0 110.882 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -111.13 118.74 36.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.843 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -100.83 160.63 14.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -164.34 117.02 0.73 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.157 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -133.66 124.25 26.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 110.891 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -123.38 101.37 7.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.793 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -75.98 -1.39 25.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.23 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -149.35 26.23 0.86 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.72 0.295 . . . . 0.0 111.106 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 2.2 m120 64.74 -75.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.137 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -52.93 -50.04 52.41 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.727 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.99 122.63 32.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.754 0.311 . . . . 0.0 110.88 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 4.0 t -135.39 174.93 10.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.969 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.32 122.61 25.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.815 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 5.0 m -107.77 139.57 42.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.121 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.4 mp -132.22 129.59 39.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.781 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.26 121.08 43.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.87 136.05 54.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.781 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -124.27 174.15 7.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.1 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -158.36 31.55 0.24 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.813 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -94.1 173.35 7.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.88 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER 59.98 162.19 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.926 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -101.34 142.17 33.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.854 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.11 83.48 1.99 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.853 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -131.25 79.44 1.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -162.82 167.3 23.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -137.8 150.81 47.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.898 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -158.59 -160.13 10.11 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.544 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -173.14 36.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.35 . . . . 0.0 110.876 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.1 m -166.08 -44.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.82 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -108.19 139.7 42.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -167.72 129.35 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.899 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -136.32 121.31 18.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.908 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.98 -173.54 2.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -122.71 31.14 6.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -125.73 167.16 15.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.082 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -156.2 152.07 23.51 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.546 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.405 HG12 ' CZ ' ' A' ' 14' ' ' TYR . 17.8 t -135.54 143.52 36.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.808 0.337 . . . . 0.0 111.123 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -154.99 167.18 32.71 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.494 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 31.5 m -124.98 160.42 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 0.0 111.09 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -147.4 139.78 24.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -144.66 156.87 44.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 53.2 p -134.48 140.66 46.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.855 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.822 0.344 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.53 -60.99 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.87 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -154.87 -53.75 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 60.87 159.88 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -170.4 -60.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.773 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -172.0 159.66 5.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -148.88 109.37 4.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.898 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -97.18 136.39 37.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -147.18 121.74 9.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.19 129.57 72.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.1 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.96 172.19 22.73 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.543 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.29 142.85 10.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.841 0.353 . . . . 0.0 111.087 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.7 ttm -116.9 158.13 24.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -144.88 130.66 19.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.919 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -93.16 133.66 36.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.95 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 pp -118.61 148.98 21.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.132 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.37 -55.59 2.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.904 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -166.04 133.17 2.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.928 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.1 p -109.47 136.35 45.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.147 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 60.51 100.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.851 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 147.89 -150.57 22.8 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.537 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -99.98 106.0 17.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.339 . . . . 0.0 110.899 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -126.5 -41.8 0.31 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.499 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -74.21 94.18 2.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.349 . . . . 0.0 110.915 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -153.21 -63.22 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -105.65 -54.22 2.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -148.77 125.92 11.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.06 33.97 0.86 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.609 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.4 mp -82.33 157.56 23.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.864 0.364 . . . . 0.0 110.871 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.9 128.2 32.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.146 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.62 94.15 48.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.72 178.8 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.503 2.135 . . . . 0.0 112.236 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.64 128.53 8.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.418 HG12 ' CZ ' ' A' ' 36' ' ' PHE . 16.4 t -108.72 159.31 8.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.185 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -148.83 127.89 12.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.418 ' CZ ' HG12 ' A' ' 34' ' ' VAL . 51.2 m-85 -121.49 147.41 45.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -146.36 143.22 28.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.11 134.74 23.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.975 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.66 147.52 32.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.109 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -174.19 120.52 0.27 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.881 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.37 -149.42 48.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.496 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.418 ' HG2' ' CE3' ' A' ' 43' ' ' TRP . 92.1 Cg_endo -78.93 0.99 9.54 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.656 2.237 . . . . 0.0 112.87 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.418 ' CE3' ' HG2' ' A' ' 42' ' ' PRO . 14.7 p90 -127.48 170.36 12.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.81 0.338 . . . . 0.0 111.045 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -141.08 154.07 45.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.5 mt -121.0 127.26 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.063 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -122.14 148.31 45.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.067 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.6 tp -139.52 164.33 30.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.009 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -147.82 147.95 30.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.062 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -128.26 153.16 47.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -116.51 151.14 36.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -134.91 126.79 29.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -124.45 126.85 46.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -141.95 91.81 0.18 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.541 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.97 138.13 39.56 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.616 2.21 . . . . 0.0 112.401 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.5 p -63.69 139.26 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.104 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -59.6 174.75 0.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -173.79 -41.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.52 -59.05 0.77 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.23 118.09 7.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.12 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -130.15 36.66 2.28 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.543 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.28 -31.35 21.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 0.0 110.866 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.8 mmt-85 -120.88 -172.54 2.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 120.36 117.85 2.61 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.499 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 m -92.11 119.12 31.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.743 0.306 . . . . 0.0 110.945 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -95.33 155.4 16.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -99.62 170.56 8.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.777 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.76 165.99 24.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.86 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.75 95.96 6.23 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.22 135.86 35.64 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.405 2.07 . . . . 0.0 112.259 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.58 129.63 56.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.6 mt -116.37 143.05 46.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -146.51 136.23 23.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.7 t -116.26 149.71 18.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.066 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.413 ' CE1' ' HB ' ' A' ' 88' ' ' THR . 0.6 OUTLIER -131.96 139.11 48.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -153.93 145.02 22.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -125.6 111.07 14.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.933 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -67.91 -56.36 9.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.81 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.3 mt 58.65 98.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.956 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -80.82 -62.88 1.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -126.86 -179.11 4.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -71.75 -30.57 65.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -80.26 -49.87 11.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.417 ' CE2' HG12 ' A' ' 120' ' ' VAL . 5.5 m-85 -92.61 167.89 11.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.968 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.7 t -156.88 162.81 39.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.947 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.496 ' CZ ' ' CD1' ' A' ' 118' ' ' TRP . 0.3 OUTLIER -127.73 177.36 6.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.831 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -172.48 116.35 0.61 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.443 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -123.02 119.34 30.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.371 . . . . 0.0 110.991 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.413 ' HB ' ' CE1' ' A' ' 74' ' ' HIS . 1.9 t -125.33 104.81 8.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.745 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -128.28 144.31 15.14 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.488 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -141.37 178.63 20.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.542 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -127.54 118.74 24.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.824 0.345 . . . . 0.0 110.839 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.2 tpt85 -100.77 139.34 36.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -167.35 166.37 14.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -142.62 128.78 19.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.49 175.85 43.26 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.03 143.16 26.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.825 0.345 . . . . 0.0 110.889 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -158.32 94.19 1.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.913 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.25 167.0 10.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.3 t -127.7 -50.77 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.08 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -69.33 -30.47 68.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.936 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -148.16 104.03 3.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.15 142.8 57.04 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.443 2.095 . . . . 0.0 112.281 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -99.36 -110.22 3.08 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.52 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -176.38 -39.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.798 0.333 . . . . 0.0 110.938 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -57.59 123.32 15.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.973 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.5 m -127.79 157.24 40.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.942 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.63 170.36 15.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.065 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -141.13 104.34 4.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 56.1 tpp -154.11 143.34 21.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.929 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -138.62 103.93 4.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.8 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -111.91 111.43 22.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.986 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -91.35 130.85 37.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.849 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -130.84 120.24 23.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.052 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 9.0 tp -146.44 115.55 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.863 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -128.79 93.22 37.92 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.334 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.02 178.03 7.81 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.579 2.186 . . . . 0.0 112.223 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -159.52 134.9 8.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.935 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.496 ' CD1' ' CZ ' ' A' ' 85' ' ' PHE . 0.9 OUTLIER -112.25 126.66 55.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.811 179.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.02 113.22 26.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.027 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.417 HG12 ' CE2' ' A' ' 83' ' ' PHE . 25.6 t -119.88 102.11 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.015 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.36 142.45 39.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.014 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.7 tt -119.83 -44.41 2.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.69 175.1 11.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -61.16 -31.37 71.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.919 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -116.44 39.96 3.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 tt -156.86 116.23 3.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.5 mtm-85 -126.12 138.37 53.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.929 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.411 ' CD1' HD11 ' A' ' 157' ' ' LEU . 5.3 t80 -112.46 139.61 47.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.812 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -148.47 143.54 26.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.977 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 144.9 153.06 5.76 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.563 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -172.97 170.93 4.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 0.0 110.813 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 18.9 mt -74.51 132.5 41.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.948 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.5 m -106.91 160.43 15.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 18.0 mtm -142.04 148.24 38.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -154.46 150.31 27.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.22 154.98 42.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -156.27 113.65 3.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.839 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -161.36 168.72 23.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.138 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -94.59 -56.09 2.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -177.49 -39.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.44 -28.33 22.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.95 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -75.18 -27.28 59.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.038 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.92 -36.76 72.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.071 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 13.4 t -72.08 -10.67 60.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.365 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.43 -29.96 57.9 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.628 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 60.66 32.64 20.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.792 0.329 . . . . 0.0 110.946 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -150.04 -179.68 7.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.144 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.45 37.1 16.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.21 153.01 26.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.941 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -109.47 122.72 48.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.925 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.06 117.26 9.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.091 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -124.11 153.78 40.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.011 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.7 m -121.69 123.93 43.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.729 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -116.86 129.76 56.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.986 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 61.5 p -153.41 115.45 4.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.755 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -140.37 -169.37 11.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.776 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.411 HD11 ' CD1' ' A' ' 128' ' ' PHE . 0.3 OUTLIER -139.94 178.12 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.348 . . . . 0.0 110.833 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -140.02 143.56 36.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.9 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.464 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 1.3 t80 -135.25 101.24 4.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.0 m -97.55 108.82 21.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.823 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.464 ' CE2' ' CD1' ' A' ' 159' ' ' TYR . 20.5 m-85 -79.57 -36.99 37.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.95 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -176.53 -165.15 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.78 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -86.58 6.08 32.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.332 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 8.8 t -93.23 -35.83 12.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.746 0.308 . . . . 0.0 110.943 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 30.5 m -156.81 150.3 9.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.119 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -131.34 152.24 50.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.15 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.63 146.66 37.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.773 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.22 129.61 15.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.95 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.6 t -131.92 146.63 33.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.978 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -152.41 125.62 8.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.065 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -95.76 161.23 14.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.737 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -135.58 151.11 49.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.008 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.77 105.19 3.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.762 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -101.57 140.8 35.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.962 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.81 113.11 6.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -124.73 146.7 16.28 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.527 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -164.11 160.34 21.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.859 0.362 . . . . 0.0 110.815 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.89 125.32 38.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -23.85 66.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -54.99 -74.41 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.106 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -169.9 37.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.973 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.11 121.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.902 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.44 33.18 2.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 68.77 -67.45 0.21 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.976 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -97.28 34.24 1.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.943 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -118.61 -36.73 0.89 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.507 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -93.52 102.91 15.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 0.0 110.985 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -156.36 172.44 18.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.881 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 17.5 t -137.61 142.08 41.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 72.1 p -133.45 147.8 51.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.901 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -118.39 135.09 54.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.85 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -130.09 140.92 50.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 46.1 pt -119.05 138.97 48.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.185 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.75 113.58 11.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.891 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -120.72 116.55 25.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.047 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -136.5 131.3 33.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.932 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.35 109.46 42.17 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.722 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.76 136.58 58.51 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.439 2.092 . . . . 0.0 112.393 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.62 101.27 8.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.772 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 8.8 t -78.12 127.07 31.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 4.2 mp -139.84 148.06 41.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -81.88 58.3 4.92 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.503 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -179.8 -62.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.872 0.368 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -136.15 137.93 41.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.863 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 10.5 m -90.54 140.05 30.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.7 t -128.28 111.37 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.033 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.93 92.89 5.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.01 171.84 16.7 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.621 2.214 . . . . 0.0 112.294 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -158.05 161.56 38.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.863 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.7 m -139.9 116.1 10.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.3 mtt180 -139.41 134.89 33.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.063 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 32.4 mt -76.65 141.7 15.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.125 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -103.62 -2.88 46.83 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.838 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 73.6 mt 61.28 179.97 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.343 . . . . 0.0 110.841 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.83 126.54 36.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -142.24 -60.24 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 58.3 m -105.86 -179.21 3.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -160.0 128.27 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.907 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -176.18 -111.42 0.28 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.533 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -64.88 138.54 58.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.83 0.348 . . . . 0.0 110.892 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 72.84 -158.01 52.85 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.53 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -131.04 -48.23 1.01 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.812 0.339 . . . . 0.0 110.842 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.65 154.42 44.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.829 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.23 -58.82 2.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -151.88 123.65 7.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.06 -34.45 1.68 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.227 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.0 m -147.87 139.85 18.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 0.0 111.167 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -116.27 150.23 18.64 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.408 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.86 122.92 29.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.886 0.374 . . . . 0.0 110.938 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -109.89 118.04 35.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.814 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.13 159.4 20.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.064 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -154.42 117.01 0.76 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.045 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.27 115.61 15.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.714 0.292 . . . . 0.0 111.106 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 240' ' ' SER . 3.6 m-20 -81.36 122.7 27.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -60.88 -15.13 27.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.964 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.98 -39.39 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.826 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 178.55 -60.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.001 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -74.19 -70.27 1.27 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.672 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -66.35 146.84 54.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.718 0.294 . . . . 0.0 110.832 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -148.49 176.87 9.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.274 -179.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . 0.41 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 11.4 p -122.86 131.32 73.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.831 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 9.8 m -107.6 139.8 41.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.092 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.66 141.93 46.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.972 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -105.25 120.68 42.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.948 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -108.98 143.94 37.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.833 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -172.09 -167.92 0.52 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.074 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 61.96 107.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.925 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.75 -46.68 0.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 4.9 m0 68.68 -68.06 0.19 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.99 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -131.26 -72.86 0.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.936 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 35.6 t0 61.05 77.51 0.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.822 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -105.93 -36.13 7.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.897 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -145.28 105.01 4.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.926 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.7 111.59 2.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -119.2 45.94 1.19 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.572 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.72 135.81 40.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.854 0.359 . . . . 0.0 110.869 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 48.1 t -76.61 -31.63 57.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.929 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -130.68 129.93 43.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.877 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -164.19 139.19 5.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -155.12 112.74 3.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.961 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -143.02 106.69 4.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.918 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 62.22 117.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.991 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -163.72 132.74 3.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.05 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -78.08 144.62 28.76 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.529 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 23.1 t -117.04 119.8 63.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.834 0.349 . . . . 0.0 111.029 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -137.09 160.39 24.95 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.543 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 12.3 m -135.86 153.13 31.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 0.0 111.157 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -152.03 131.9 13.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.49 ' CE1' ' CE2' ' A' ' 271' ' ' PHE . 4.6 t80 -131.01 126.18 35.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 39.5 t -113.68 147.76 37.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' PHE . . . . . 0.49 ' CE2' ' CE1' ' A' ' 269' ' ' TYR . 3.3 m-85 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.933 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.851 0.358 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -123.14 85.48 2.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.72 -55.71 3.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.78 -176.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.828 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -160.97 81.44 0.64 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -60.0 99.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -94.81 146.17 24.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -126.69 137.01 53.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -151.15 131.57 13.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.419 HG12 ' CD2' ' A' ' 36' ' ' PHE . 22.7 mt -130.53 139.33 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.031 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.81 165.07 29.2 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.549 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.49 170.54 18.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.797 0.332 . . . . 0.0 111.059 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 57.2 mtm -143.27 153.57 42.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.969 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.41 ' CZ ' ' HB3' ' A' ' 32' ' ' PRO . 10.9 m-85 -146.53 106.08 3.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.838 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -105.76 162.95 13.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.915 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.6 mt -119.84 77.09 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.05 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -94.39 137.01 34.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.946 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -159.34 161.78 35.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.3 p -156.43 53.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -149.07 -173.52 4.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.907 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.17 129.96 1.07 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.558 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.78 -47.72 0.33 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 110.889 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.34 126.36 0.82 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.526 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 60.25 173.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.852 0.358 . . . . 0.0 110.914 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -70.14 96.36 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 12.8 ttp -74.81 -62.29 1.59 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.948 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -142.93 162.55 35.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -126.61 89.3 0.35 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.413 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.34 132.7 42.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.841 0.353 . . . . 0.0 110.908 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.75 146.66 41.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.083 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.76 93.89 30.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.018 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 14' ' ' TYR . 39.4 Cg_exo -60.52 178.68 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.681 2.254 . . . . 0.0 112.201 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.1 123.57 5.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.967 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.3 138.31 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.091 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -138.92 155.32 48.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.419 ' CD2' HG12 ' A' ' 10' ' ' ILE . 62.5 m-85 -146.5 153.13 40.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -147.35 129.64 15.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.01 141.9 47.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.006 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.49 116.52 23.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.086 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -126.08 73.78 1.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.789 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.83 -135.58 32.78 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.411 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.31 -20.99 48.31 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.377 2.051 . . . . 0.0 112.346 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -101.57 120.72 40.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.909 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -113.17 153.15 28.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -141.71 140.78 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.129 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.22 130.04 30.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.977 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.8 mt -116.45 166.79 11.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -165.53 141.5 5.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -122.54 160.2 26.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.946 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -141.51 128.67 20.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.938 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.67 119.21 4.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.84 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -64.11 151.56 42.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -119.01 95.95 0.64 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.47 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.2 146.28 69.32 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.51 2.14 . . . . 0.0 112.263 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.3 p -67.31 147.56 12.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.061 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -59.15 154.65 15.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.003 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 61.17 87.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.861 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.0 t -104.65 166.32 10.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.4 -68.19 0.91 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.078 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 144.11 44.92 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.484 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -84.2 -58.81 2.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 110.94 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -176.69 135.24 0.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.84 115.85 0.72 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.563 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.5 p -117.57 164.02 15.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 0.0 110.866 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -104.74 163.65 12.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.424 ' N ' ' CD1' ' A' ' 66' ' ' PHE . 4.1 p90 -152.69 165.41 35.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -125.23 145.98 49.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.984 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.72 95.79 2.82 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.942 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.47 153.25 44.47 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.506 2.137 . . . . 0.0 112.267 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.38 128.47 17.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.006 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 mp -132.15 154.18 49.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.832 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -154.82 157.58 38.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.885 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.6 m -144.69 156.79 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.055 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -134.81 117.68 16.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -103.62 114.43 28.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -83.03 99.38 9.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.66 -54.68 5.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.84 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.8 tp 61.79 152.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -154.42 -60.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.965 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -147.92 -172.72 4.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.92 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -84.01 -32.95 24.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.29 -55.9 20.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.808 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -133.67 148.29 51.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.9 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -122.04 160.38 25.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -127.56 164.37 22.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -179.75 -177.65 48.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.482 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.7 155.62 43.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.817 0.341 . . . . 0.0 110.901 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.8 p -142.97 110.12 5.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -113.98 179.93 18.86 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.505 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -177.71 170.41 42.77 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.471 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -148.59 144.43 27.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.341 . . . . 0.0 110.895 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.8 mtp85 -141.05 174.45 10.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.9 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -151.51 169.31 22.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -138.0 122.16 18.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -95.4 127.75 9.26 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.441 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.08 130.84 39.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.774 0.321 . . . . 0.0 110.916 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -133.86 139.7 46.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.896 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -152.92 31.61 0.49 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.86 127.95 59.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.74 -31.02 66.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.963 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -119.83 89.16 41.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.957 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.23 168.2 21.56 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.546 2.164 . . . . 0.0 112.321 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -176.54 -65.66 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.535 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.83 32.52 0.4 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -137.89 93.84 2.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.43 -175.76 3.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.823 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -138.2 124.4 20.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.152 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -129.93 154.69 47.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.829 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.3 mtm -137.95 124.84 21.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.956 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -89.23 135.97 33.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.844 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -123.58 126.7 47.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.027 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -107.12 145.25 32.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.792 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.415 ' HG3' ' CE1' ' A' ' 135' ' ' TYR . 20.6 tttm -139.91 134.3 31.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.034 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.1 tt -152.76 126.2 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.905 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.57 106.35 3.1 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.305 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.86 137.31 34.88 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.452 2.101 . . . . 0.0 112.072 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -105.92 141.05 37.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.024 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 70.4 p-90 -148.64 131.66 16.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.853 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -123.13 143.94 49.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.967 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.4 m -144.26 125.59 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.059 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.87 151.71 30.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.891 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.6 tp -124.01 -48.47 1.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.953 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.27 -176.99 5.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.44 132.01 46.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 60.13 32.63 21.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.53 107.9 4.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -118.53 137.76 52.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.42 ' CE1' HD13 ' A' ' 157' ' ' LEU . 2.9 m-85 -102.08 141.19 35.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.834 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -132.32 138.59 47.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.77 147.27 14.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.472 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . 0.417 ' CE2' ' HB3' ' A' ' 154' ' ' GLU . 26.2 p-90 -173.06 149.5 1.85 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.862 0.363 . . . . 0.0 111.102 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.27 135.74 53.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.617 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.6 t -108.37 153.5 23.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.132 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 53.4 mtp -134.98 118.38 16.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.768 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.415 ' CE1' ' HG3' ' A' ' 113' ' ' LYS . 1.9 m-85 -102.45 133.82 46.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.949 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -138.73 114.12 9.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.79 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -121.08 141.16 51.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.97 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -172.84 140.38 0.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.055 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -96.08 -52.9 3.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.023 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 176.38 -48.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.981 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 mt -80.92 -23.24 39.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -54.58 -29.45 51.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.052 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.6 p -59.74 -27.51 66.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.023 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.7 m -56.79 -34.13 67.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.966 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -90.78 -28.9 14.45 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.476 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 59.93 84.31 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.869 0.366 . . . . 0.0 110.841 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -87.8 164.06 16.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.108 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.26 158.43 19.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.855 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.4 m -84.74 154.55 22.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.911 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -103.06 121.41 42.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.89 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 27.6 m -106.0 129.12 59.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.077 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -110.77 127.61 55.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.858 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.44 114.54 26.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.417 ' HB3' ' CE2' ' A' ' 131' ' ' TRP . 0.6 OUTLIER -121.09 116.39 24.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.851 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.0 m -145.28 145.95 31.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.833 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -163.57 -162.82 15.06 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.53 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.42 HD13 ' CE1' ' A' ' 128' ' ' PHE . 6.6 tt -151.62 149.9 29.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.845 0.355 . . . . 0.0 110.91 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -118.59 131.7 56.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -127.74 100.16 5.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.701 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 9.4 t -99.81 126.23 45.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.983 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -104.11 -30.09 10.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.775 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -165.36 177.22 7.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.711 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -81.92 0.63 38.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.363 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.84 -26.56 8.88 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.653 0.263 . . . . 0.0 111.172 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 28.4 m -145.75 141.52 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.232 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -150.66 -172.24 4.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.013 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.66 143.24 31.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.627 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.79 145.31 32.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.057 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 11.5 p -144.56 137.88 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.944 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -133.12 155.19 49.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.989 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.42 ' CE2' HG21 ' A' ' 193' ' ' ILE . 79.3 m-85 -127.85 119.35 25.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -96.37 136.1 37.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.002 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.9 125.24 10.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.802 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -111.08 145.59 38.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.949 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.85 117.47 3.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -146.67 169.83 27.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.525 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.42 ' CE1' ' HG3' ' A' ' 187' ' ' GLU . 0.3 OUTLIER -133.79 142.34 47.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.774 0.321 . . . . 0.0 110.943 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.48 135.51 53.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 1.6 tpt -84.74 -53.19 5.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 62.85 -79.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.057 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.41 -62.59 0.49 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.873 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.97 -68.98 0.61 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -173.02 137.95 0.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -168.84 34.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.936 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 20.7 m120 60.52 63.19 1.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -95.78 25.61 24.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.499 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.42 ' HG3' ' CE1' ' A' ' 177' ' ' PHE . 15.7 mt-10 -76.49 164.67 25.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.843 0.354 . . . . 0.0 110.897 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -147.14 117.6 7.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.7 t -117.16 136.34 53.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 4.0 m -137.12 145.97 44.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -144.4 121.87 11.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.925 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -144.52 136.37 25.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.989 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.42 HG21 ' CE2' ' A' ' 171' ' ' TYR . 4.0 mp -107.07 124.97 63.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.132 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -128.23 115.74 18.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.776 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -133.49 125.78 29.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.215 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -121.52 141.36 51.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.722 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 8.2 tt -105.66 109.31 63.06 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.134 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.35 111.21 3.04 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.368 2.046 . . . . 0.0 112.318 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.76 127.82 35.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.912 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.17 114.16 10.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.09 105.52 7.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.838 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 102.44 -133.3 11.33 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.43 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -105.45 17.18 24.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.721 0.296 . . . . 0.0 111.266 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -136.42 159.89 40.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.791 0.329 . . . . 0.0 110.945 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.35 148.43 47.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.83 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 5.8 m -144.17 122.3 6.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.2 m -125.04 92.91 46.69 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.123 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.0 171.7 5.8 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.57 2.18 . . . . 0.0 112.178 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.83 143.25 50.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.783 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.97 136.48 49.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.913 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.8 117.69 14.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.939 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 7.6 pt -99.03 125.98 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.4 -132.89 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.547 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -163.92 145.15 8.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 110.842 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? 60.25 175.79 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.818 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.406 ' O ' ' CG ' ' A' ' 216' ' ' TRP . 31.0 p-90 -104.09 106.22 16.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.44 -169.58 1.97 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.894 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -85.18 -65.49 1.0 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 168.43 176.02 38.45 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.522 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -154.7 -46.39 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.942 0.401 . . . . 0.0 110.921 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 164.15 48.85 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.55 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -132.0 172.57 12.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.832 0.348 . . . . 0.0 110.904 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -111.23 -15.16 13.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.29 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 70.63 -65.46 0.33 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.779 0.324 . . . . 0.0 110.815 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -60.25 -27.5 67.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.948 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -154.52 148.05 25.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.018 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.0 p -114.94 -34.31 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.14 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -160.77 -166.83 20.31 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.375 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -160.04 141.65 12.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 111.045 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -122.61 145.51 48.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.768 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -112.53 159.47 18.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.04 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -142.87 117.06 1.08 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.097 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -121.13 136.09 55.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.362 . . . . 0.0 110.998 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.1 100.22 7.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.625 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -65.86 -10.67 40.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.22 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.9 37.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.796 0.331 . . . . 0.0 111.005 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 5.0 t30 69.71 -64.97 0.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -52.78 -43.54 60.34 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.738 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.5 tt -87.0 144.77 26.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.762 0.315 . . . . 0.0 110.891 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 16.0 m -134.22 151.48 51.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.815 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . 0.466 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 38.9 t -120.98 141.07 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.77 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.88 118.75 31.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.037 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.1 mp -120.68 154.95 34.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.702 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -116.76 131.55 56.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.951 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -133.32 146.47 51.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.815 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -172.99 113.46 0.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.147 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -100.59 -41.19 7.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.776 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 59.95 162.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 19.0 t-105 -80.2 110.83 15.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.417 ' HB3' ' CD2' ' A' ' 252' ' ' HIS . 12.0 mt-30 -147.41 117.05 7.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.949 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.18 109.24 20.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' HIS . . . . . 0.417 ' CD2' ' HB3' ' A' ' 250' ' ' GLN . 12.7 p80 -177.0 174.22 1.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.825 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -133.85 152.51 51.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.95 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -112.65 94.44 4.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.922 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -69.81 -107.07 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.514 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.44 109.03 2.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.874 0.368 . . . . 0.0 110.839 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 12.4 m -170.84 145.17 2.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 -135.33 25.24 3.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.017 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -148.38 129.31 14.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.839 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -154.94 43.5 0.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.965 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -100.95 91.78 4.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.909 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -132.57 105.24 7.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -170.69 169.97 6.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.143 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -97.82 161.71 21.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.561 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 4.8 m -144.81 146.56 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 111.119 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -160.92 164.3 34.68 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.453 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 6.7 m -126.78 150.15 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 0.0 111.163 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -143.72 146.45 33.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.835 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -144.11 139.33 28.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.68 147.52 50.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 24.4 t80 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.892 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.831 0.348 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.38 168.66 8.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.18 146.71 29.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -158.63 161.28 37.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.982 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 -177.67 54.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 61.09 84.54 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -105.98 141.51 37.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.998 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -129.59 163.04 26.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.738 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -160.26 146.32 15.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.997 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.417 HG23 ' CE2' ' A' ' 36' ' ' PHE . 3.7 mp -140.81 134.35 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.108 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.81 159.28 24.51 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.571 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.49 138.99 27.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.865 0.364 . . . . 0.0 111.001 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.29 149.1 42.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.993 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -132.15 111.06 11.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -94.48 150.48 20.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.6 pt -140.55 147.79 22.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.027 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -160.18 118.93 2.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -94.06 179.94 5.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.7 m -101.78 127.22 55.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.12 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -89.72 -36.57 15.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.858 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 150.15 -34.59 1.0 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.549 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.51 31.31 3.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.857 0.36 . . . . 0.0 110.908 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.85 35.23 0.37 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.531 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.92 86.22 3.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.853 0.359 . . . . 0.0 110.93 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -177.11 130.29 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.867 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.56 168.71 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.856 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 60.33 -177.63 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 142.05 -27.67 2.28 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.544 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.16 149.42 26.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.848 0.356 . . . . 0.0 110.956 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.47 153.61 24.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.029 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.68 94.0 46.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.988 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.48 158.0 20.72 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.53 2.153 . . . . 0.0 112.198 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.51 133.89 44.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.819 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.72 142.15 30.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.091 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.88 143.68 43.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.967 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.417 ' CE2' HG23 ' A' ' 10' ' ' ILE . 50.2 m-85 -133.89 132.57 40.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -132.0 125.05 30.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.94 136.73 53.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.019 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -118.96 122.76 42.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.17 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -139.95 86.39 2.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.0 -143.44 44.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.363 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.62 -14.23 41.41 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.457 2.105 . . . . 0.0 112.486 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.6 134.12 45.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.987 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.23 145.46 49.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.467 HG21 HD13 ' A' ' 45' ' ' ILE . 30.7 mt -131.46 155.36 41.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.217 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -160.04 136.48 8.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.112 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.82 146.62 49.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.979 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.48 134.02 51.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.019 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -126.04 110.19 13.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.994 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.19 138.02 36.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.786 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -161.34 166.16 27.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.933 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.65 173.9 6.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.956 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -174.14 90.96 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.562 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.13 148.08 61.91 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.574 2.183 . . . . 0.0 112.288 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.9 p -77.92 123.8 35.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.098 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.89 129.16 34.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.928 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.49 -69.74 0.83 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.843 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -124.34 -56.93 1.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.84 -60.42 1.92 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.066 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.0 60.43 5.25 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.421 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -114.72 -38.02 4.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.847 0.356 . . . . 0.0 110.999 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.8 ttt-85 -66.15 138.74 57.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.81 128.21 2.31 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.512 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 t -104.59 154.63 19.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.815 0.34 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 18.3 m95 -97.17 159.59 14.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.942 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.67 151.85 34.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.833 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.91 124.58 31.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.27 95.85 4.64 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.877 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.06 142.61 24.94 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.536 2.158 . . . . 0.0 112.408 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -137.79 114.79 10.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.87 133.89 47.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.741 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -132.68 127.74 35.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.038 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 p -124.9 136.15 61.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.004 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -122.94 129.13 51.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.029 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -125.62 137.66 53.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.799 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -122.15 121.45 36.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -106.39 -43.31 4.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.728 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 59.65 160.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.981 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -141.63 -47.34 0.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.835 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -147.31 174.91 11.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.79 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -75.17 -29.13 60.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.002 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -84.74 -42.34 15.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.986 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.422 ' CE2' HG11 ' A' ' 120' ' ' VAL . 11.7 m-85 -101.6 169.82 8.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.01 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.57 162.43 33.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.797 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -158.12 144.32 17.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.955 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.82 -176.25 47.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.497 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.92 134.06 5.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.815 0.34 . . . . 0.0 110.901 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 69.2 p -118.84 159.36 23.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.32 -170.98 15.29 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.488 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 178.08 159.28 22.52 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.515 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -126.29 148.18 49.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.846 0.355 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.1 ttp85 -136.69 133.61 36.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.893 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -132.19 178.91 6.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.773 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -146.52 146.2 30.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.964 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -134.41 165.26 24.48 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.477 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -111.34 129.63 55.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 0.0 110.935 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -152.64 35.97 0.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -66.41 -43.11 86.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.4 t -87.2 140.78 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.027 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -59.44 -30.54 68.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.89 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -126.1 74.34 72.07 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.6 163.37 5.32 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.56 2.174 . . . . 0.0 112.245 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -140.18 -100.81 0.46 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.455 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.13 31.47 3.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 110.88 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.72 104.78 15.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.872 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -152.99 159.2 42.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.911 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.69 138.17 24.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.109 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -85.14 105.35 15.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.55 148.4 51.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.893 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -156.55 161.76 39.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.85 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.02 109.2 1.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -83.47 140.42 32.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.776 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.54 127.31 17.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.01 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.6 mt -122.47 154.77 27.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.942 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -147.29 79.74 9.61 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.292 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.8 155.0 19.07 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.562 2.175 . . . . 0.0 112.183 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -122.32 146.15 47.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.008 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -164.99 142.75 6.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.08 151.68 41.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.911 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.422 HG11 ' CE2' ' A' ' 83' ' ' PHE . 23.4 t -147.59 108.23 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -88.35 133.18 34.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.888 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.0 tt -110.99 -32.84 6.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -166.05 -175.07 3.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.833 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -90.99 51.3 1.93 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -165.88 -43.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.43 124.31 51.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -125.29 146.56 49.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.773 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -101.95 146.02 28.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.014 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -125.45 123.32 38.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -110.95 106.77 2.09 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.517 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -133.1 136.18 45.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.788 0.328 . . . . 0.0 110.775 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.3 mt -131.02 161.45 31.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.801 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.3 151.24 49.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.041 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -140.1 133.78 30.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.822 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -130.57 127.72 39.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.971 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -146.51 168.1 22.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.774 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 59.55 -176.59 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.777 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -176.49 -165.95 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.124 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -87.61 -27.47 22.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.967 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -176.65 -39.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.035 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.3 mp -51.21 -27.77 9.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.178 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -72.47 -29.42 63.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.967 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.51 -62.81 1.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.099 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.7 -47.67 13.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.018 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.22 -35.68 91.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.572 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 60.28 35.27 20.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.884 0.373 . . . . 0.0 110.843 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -134.24 -164.95 1.58 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.048 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.1 t0 65.59 49.04 1.86 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.91 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.9 m -149.07 110.7 4.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.846 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -162.91 179.04 7.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.984 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.1 m -118.19 131.96 69.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.098 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -101.23 169.43 8.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 8.9 m -132.8 140.28 47.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.876 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -135.38 142.91 45.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.32 127.88 23.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.743 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -116.8 142.13 17.24 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.662 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.7 mp -115.23 117.37 30.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.755 0.312 . . . . 0.0 110.787 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -101.26 117.51 35.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.961 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -127.04 102.47 6.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 34.3 p -93.11 128.08 38.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.909 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.07 -31.46 12.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.643 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -150.92 174.94 12.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.814 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -76.24 -6.39 51.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.43 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.1 m -113.07 -28.95 7.49 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.635 0.255 . . . . 0.0 111.23 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.6 m -123.11 139.94 48.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.865 0.364 . . . . 0.0 111.385 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -141.17 -178.42 5.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.004 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 41.3 tp -141.2 134.73 29.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.934 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 196' ' ' TYR . 51.7 mtt-85 -137.52 114.54 10.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.2 t -99.85 142.67 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.998 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -118.96 123.34 44.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.021 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.42 ' CE1' HG23 ' A' ' 193' ' ' ILE . 0.4 OUTLIER -116.17 114.85 25.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.723 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -106.43 140.98 38.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.091 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.61 105.17 5.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.689 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.74 145.74 29.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.029 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -136.28 136.16 39.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.752 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -130.51 152.69 19.9 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.498 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -160.41 134.94 7.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.359 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -96.07 131.56 42.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -34.06 35.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.23 83.51 7.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.911 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -176.8 132.76 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 15.5 m -102.35 31.87 3.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -159.98 172.69 17.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.928 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.7 88.34 3.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -155.95 148.49 23.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 96.7 -28.34 13.95 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.519 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -71.44 125.45 27.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.743 0.306 . . . . 0.0 110.942 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -144.56 153.61 42.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.824 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.3 m -122.4 105.53 10.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.968 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.31 114.01 27.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.813 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -109.01 129.4 55.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.017 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -118.28 152.56 35.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.79 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.42 HG23 ' CE1' ' A' ' 171' ' ' TYR . 0.2 OUTLIER -136.52 148.09 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.267 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -150.31 127.55 11.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.723 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -119.31 117.26 28.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.97 0.414 . . . . 0.0 111.273 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.423 ' HB3' ' CD1' ' A' ' 209' ' ' TYR . 11.5 p90 -138.28 151.24 47.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.592 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.449 ' O ' ' HD2' ' A' ' 208' ' ' PRO . 0.3 OUTLIER -118.54 111.23 38.13 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.242 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.8 123.29 8.86 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.385 2.056 . . . . 0.0 112.371 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.7 mt -126.74 104.48 8.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.845 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.3 t -117.12 117.8 30.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.57 121.63 9.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 65.46 -119.8 15.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.534 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -118.43 30.57 7.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.905 0.383 . . . . 0.0 110.93 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.71 110.57 9.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 49.3 m -102.71 128.74 49.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.006 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 18.4 m -144.18 124.06 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.759 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 16.0 p -133.0 92.96 24.21 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.421 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.449 ' HD2' ' O ' ' A' ' 197' ' ' LEU . 59.0 Cg_exo -52.52 171.77 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.457 2.105 . . . . 0.0 112.113 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.423 ' CD1' ' HB3' ' A' ' 196' ' ' TYR . 0.2 OUTLIER -148.11 140.68 24.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.727 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.6 m -128.9 150.12 50.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.97 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -142.3 112.41 7.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.83 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 1.9 pp -65.33 119.71 10.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -103.96 -125.41 5.61 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.497 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.4 mp -126.8 158.42 36.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.877 0.37 . . . . 0.0 110.812 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -149.37 166.73 28.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.817 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -114.03 -66.27 1.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.964 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 2.6 p -147.62 -56.28 0.23 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.914 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -131.98 -176.46 4.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -82.82 -171.85 47.68 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.462 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -164.1 31.54 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.831 0.348 . . . . 0.0 110.881 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 106.57 -38.11 3.48 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -114.94 151.5 33.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.782 0.325 . . . . 0.0 110.892 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -138.05 163.9 30.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.86 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -98.68 30.07 3.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.935 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.48 120.97 29.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.764 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 61.25 102.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 14.7 m -72.09 -32.38 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.339 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -167.42 -164.67 23.5 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.488 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 208' ' ' PRO . 0.6 OUTLIER -149.99 119.13 6.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.825 0.345 . . . . 0.0 111.009 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -81.26 144.32 31.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.845 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.63 160.48 27.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.975 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -161.1 117.12 0.75 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.164 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -128.6 116.38 19.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.864 0.364 . . . . 0.0 111.163 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 240' ' ' SER . 3.1 p30 -117.88 135.62 53.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.946 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.1 -26.48 60.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.29 -45.76 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.872 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -178.5 -61.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -56.76 -75.83 0.23 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.715 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.414 HD11 ' CD1' ' A' ' 269' ' ' TYR . 7.7 tt -66.45 124.64 23.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.749 0.309 . . . . 0.0 110.764 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 234' ' ' ASP . 2.0 t -148.56 175.86 10.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.178 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . 0.499 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 27.8 m -129.0 167.6 24.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.61 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.63 134.69 43.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.021 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 3.3 mp -137.55 152.2 49.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.892 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -138.83 141.45 38.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.84 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -131.51 165.62 23.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -99.9 -169.68 1.77 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.033 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -114.44 158.57 21.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -170.58 120.5 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -60.1 -34.73 73.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.949 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -132.27 107.8 8.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.957 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.62 116.89 19.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.888 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -102.42 47.52 0.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -97.43 38.0 1.31 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.932 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.51 106.89 15.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.846 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 80.17 -127.41 7.93 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.495 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.98 161.75 17.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.816 0.341 . . . . 0.0 110.868 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.17 127.05 6.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -100.13 31.06 3.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.57 161.38 33.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.975 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -122.01 178.35 4.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.896 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -142.58 158.39 43.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -68.05 104.31 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -133.69 178.09 7.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.08 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -145.38 150.73 22.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.453 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.85 153.55 27.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 0.0 111.12 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -158.62 155.95 26.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.495 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.11 147.83 25.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.811 0.339 . . . . 0.0 111.14 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -138.24 129.93 28.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.943 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.414 ' CD1' HD11 ' A' ' 239' ' ' LEU . 1.9 t80 -124.8 126.12 45.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.951 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 35.0 t -97.85 151.57 20.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.875 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.783 0.325 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -72.83 119.48 17.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.942 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -61.5 -36.21 79.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.8 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -81.74 -172.57 3.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -166.44 83.8 0.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.95 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -71.57 125.16 26.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.77 132.92 52.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.923 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.87 140.43 38.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -141.5 120.14 12.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.022 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 27.1 pt -110.68 140.72 28.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.09 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.79 159.74 26.94 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.618 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.25 143.89 46.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 111.065 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 30.6 mtt -131.25 138.72 49.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.997 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -147.32 113.83 5.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.92 161.18 17.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.2 tt -154.23 52.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.038 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.35 98.11 11.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.844 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -153.9 -45.8 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.1 t 66.99 86.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.124 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -111.74 -55.4 2.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.871 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.82 -163.57 9.57 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.518 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -72.35 165.09 25.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.855 0.36 . . . . 0.0 110.938 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.81 -173.56 42.61 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.517 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 60.94 19.58 9.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.663 0.268 . . . . 0.0 111.141 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.65 -30.44 3.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.209 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 67.67 82.03 0.18 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.867 0.365 . . . . 0.0 110.886 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -154.17 116.83 4.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.855 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 158.87 -137.27 5.11 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.54 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.81 150.24 24.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.787 0.327 . . . . 0.0 110.85 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.56 126.23 27.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.037 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -143.18 94.15 6.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.93 146.43 47.42 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.492 2.128 . . . . 0.0 112.363 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.1 m -140.21 152.8 46.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.857 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.2 m -133.6 159.53 42.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -143.93 122.28 12.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -119.85 141.7 49.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.946 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -143.34 132.52 23.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.998 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.69 124.08 39.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.041 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.58 113.24 25.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.154 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -122.33 98.56 5.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.816 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.77 -141.79 45.79 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.45 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.58 -18.34 48.6 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.499 2.133 . . . . 0.0 112.441 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -101.47 144.6 30.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 111.016 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -137.73 132.77 33.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 23.7 pt -117.68 156.38 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.131 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -142.95 157.79 44.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.055 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.0 tt -150.48 120.96 7.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.907 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.61 139.1 49.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.041 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.99 109.66 11.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -95.91 125.05 40.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.862 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -120.19 144.51 47.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.93 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -130.13 140.29 50.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.934 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -156.69 73.97 0.23 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.478 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.5 156.66 53.91 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.563 2.175 . . . . 0.0 112.27 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.6 t -103.56 133.74 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.14 168.32 19.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -167.16 -57.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.6 m -113.85 -40.02 3.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -116.58 126.52 53.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.05 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.42 82.65 0.13 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.474 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -158.57 31.12 0.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.338 . . . . 0.0 110.822 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.9 ttm105 -162.81 33.04 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.909 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.29 82.8 0.44 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.459 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.67 116.77 27.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.795 0.331 . . . . 0.0 110.926 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -77.89 124.28 27.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -135.18 141.67 45.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.848 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -139.64 134.39 31.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.953 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.97 95.85 14.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.86 159.83 11.06 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.536 2.157 . . . . 0.0 112.275 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.89 149.96 47.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.871 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.92 141.12 23.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.97 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -128.4 151.16 49.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.813 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.2 t -127.81 130.67 70.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.151 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.449 ' CD2' ' CG2' ' A' ' 88' ' ' THR . 4.3 m170 -123.9 121.09 34.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.787 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.451 ' N ' ' CD1' ' A' ' 75' ' ' TYR . 1.7 p90 -153.33 106.53 2.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.845 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -92.43 141.03 28.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.957 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -88.52 -47.96 7.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.866 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.8 mt -143.12 171.08 14.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -169.75 111.91 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -143.71 -178.51 5.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.89 -31.45 59.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.916 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.09 -56.14 6.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.968 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -156.76 134.15 10.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.2 m -109.69 138.19 46.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.94 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -124.63 139.84 53.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.18 172.33 35.85 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.502 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.43 ' HB2' ' CE2' ' A' ' 75' ' ' TYR . 17.2 mt -143.31 143.41 31.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.816 0.341 . . . . 0.0 110.817 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.449 ' CG2' ' CD2' ' A' ' 74' ' ' HIS . 25.2 p -140.82 131.75 26.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.07 -177.93 15.12 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.494 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.87 153.38 24.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.484 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 111' ' ' ARG . 6.4 t80 -131.63 136.61 47.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.86 0.362 . . . . 0.0 110.89 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.6 mtm180 -137.23 159.83 40.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.54 169.77 17.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.824 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.15 130.74 25.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -143.09 129.45 3.76 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.513 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -70.37 169.42 13.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.328 . . . . 0.0 110.906 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.59 114.82 13.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.984 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.1 88.44 2.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.918 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.6 m -62.75 -34.63 66.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.036 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -60.51 -47.39 86.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -115.21 87.55 16.24 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.42 119.63 6.57 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.573 2.182 . . . . 0.0 112.335 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 178.42 151.2 9.27 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.607 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.8 tttm -98.48 34.57 1.98 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.784 0.325 . . . . 0.0 110.879 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -98.52 41.26 1.14 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.841 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.87 179.34 4.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -107.09 116.01 31.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.068 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -107.77 141.25 39.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.827 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.408 ' HE2' ' CD1' ' A' ' 137' ' ' PHE . 19.9 ptm -112.69 133.78 54.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.47 127.19 36.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.4 ' O ' ' CD1' ' A' ' 91' ' ' PHE . 12.4 mtt180 -109.97 128.21 55.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.923 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -127.74 113.83 16.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.85 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -119.58 144.27 47.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.953 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.2 tp -140.97 143.54 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.998 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.08 99.78 3.06 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.081 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.63 155.2 69.68 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.433 2.089 . . . . 0.0 112.242 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -112.93 142.96 45.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.998 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.68 130.37 20.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.781 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.15 132.32 29.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.8 m -143.44 109.99 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.151 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -72.66 123.31 23.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.951 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.7 tp -101.78 -46.64 4.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.961 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.31 167.62 12.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.85 -30.13 71.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.025 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -123.87 40.97 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.011 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mp -156.85 133.8 10.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.56 140.51 48.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.836 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -104.92 126.82 52.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.978 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -114.86 147.37 39.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.802 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -152.38 133.53 4.15 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.676 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . 0.427 ' N ' ' CD1' ' A' ' 131' ' ' TRP . 0.1 OUTLIER -160.81 165.19 30.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.819 0.342 . . . . 0.0 110.841 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.46 156.06 47.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.01 110.33 17.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.83 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.5 ttp -113.92 111.57 21.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.839 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -104.9 121.77 44.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -140.53 110.55 6.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.819 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 148' ' ' ASP . 21.4 p90 -129.23 157.8 40.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.963 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -160.66 154.85 23.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.12 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -94.7 -63.99 1.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -173.29 -63.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.88 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.4 tt -85.51 -31.46 22.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -60.24 -20.38 58.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.119 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.408 ' O ' ' CD2' ' A' ' 146' ' ' TYR . 0.8 OUTLIER -52.41 -29.54 24.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.863 0.364 . . . . 0.0 111.176 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 9.9 t -70.06 -29.68 66.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.25 -39.42 44.06 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.518 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.408 ' CD2' ' O ' ' A' ' 143' ' ' THR . 7.0 m-85 60.82 76.57 0.36 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.831 0.348 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -139.4 162.56 34.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.101 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . 53.7 m-20 60.48 35.34 20.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.975 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 69.8 p -137.25 112.8 9.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.814 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -153.53 -178.56 7.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.917 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.4 p -129.68 157.82 42.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.993 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -124.62 157.43 35.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.975 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 68.6 p -116.77 118.0 31.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.754 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -126.2 138.05 53.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.028 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 7.9 t -139.4 138.91 36.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.671 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -132.36 158.33 22.92 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.644 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.9 mp -139.14 130.19 26.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.823 0.344 . . . . 0.0 110.738 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -93.95 146.73 23.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.975 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -139.72 100.15 3.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.787 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.69 115.06 16.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.958 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.6 -49.89 3.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.729 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -131.01 163.89 26.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.799 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -30.95 70.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.931 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -119.22 27.41 8.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.079 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.4 t -148.95 117.62 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.105 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -124.03 149.96 45.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.184 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 2.4 mt -132.06 121.97 24.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.733 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.411 ' HD3' ' CE1' ' A' ' 196' ' ' TYR . 40.3 mtt180 -125.27 147.07 49.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.067 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.5 m -147.02 138.61 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 44.1 p30 -146.89 156.41 43.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.118 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.412 ' CD1' HG23 ' A' ' 193' ' ' ILE . 5.2 m-85 -110.13 144.57 38.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.785 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -121.7 115.87 23.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.97 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.99 106.93 16.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.14 147.26 24.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -151.36 124.09 8.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.939 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -144.71 178.66 22.42 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.518 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -130.17 146.63 51.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.778 0.323 . . . . 0.0 110.97 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -131.23 173.83 10.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -82.73 -51.32 7.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.853 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -152.09 162.5 41.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.84 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.2 175.75 5.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.925 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.25 34.56 3.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -174.7 -43.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -68.14 122.31 18.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.914 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.32 -30.98 33.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.973 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -176.21 -53.82 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.89 126.86 54.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.331 . . . . 0.0 110.945 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -102.94 118.75 37.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.014 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.3 p -122.83 110.08 15.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 5.0 t -106.3 139.91 40.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.942 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -98.97 130.45 45.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -134.44 157.35 46.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.945 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.412 HG23 ' CD1' ' A' ' 171' ' ' TYR . 1.8 pt -141.18 137.09 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.43 114.31 16.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.846 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -101.3 115.43 30.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.228 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.437 ' HB3' ' CD1' ' A' ' 209' ' ' TYR . 8.4 p90 -128.98 114.95 17.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.623 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.2 109.38 61.8 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.216 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -61.73 136.08 60.12 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.561 2.174 . . . . 0.0 112.18 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.2 tp -132.88 127.98 35.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.929 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 7.1 m -132.19 123.18 26.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.967 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 26.8 tp -147.15 102.68 3.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.923 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 77.06 52.03 5.92 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.499 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 59.69 29.61 19.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.77 0.319 . . . . 0.0 110.941 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -104.09 126.21 51.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.09 104.92 16.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 22.1 t -118.66 127.42 75.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.05 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.93 92.72 33.03 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.961 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -79.89 172.14 14.47 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.679 2.253 . . . . 0.0 112.244 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.437 ' CD1' ' HB3' ' A' ' 196' ' ' TYR . 0.3 OUTLIER -161.72 143.65 11.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.691 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 32.6 m -131.69 145.39 51.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.017 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.31 141.63 22.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.766 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 14.7 pt -108.85 128.5 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.181 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 95.16 157.48 32.41 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.514 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.1 tp -96.14 164.33 12.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 0.0 110.869 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 1.7 ptt-85 -70.12 -39.82 75.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -104.76 -67.28 0.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 57.6 p -176.72 143.89 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.938 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -166.98 104.01 0.56 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.851 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -86.82 -43.68 5.97 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.523 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -101.41 157.4 16.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.877 0.37 . . . . 0.0 110.848 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 140.53 163.87 9.69 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.517 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -106.25 129.2 54.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.8 0.333 . . . . 0.0 110.843 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.77 134.1 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.918 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -98.38 29.39 3.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.951 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.72 132.3 47.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.831 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.89 -59.16 1.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.951 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 47.4 t -92.28 -81.15 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.153 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 132.83 -149.63 19.59 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.484 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.23 110.93 21.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.778 0.323 . . . . 0.0 110.598 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.39 133.43 33.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.979 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -116.95 155.31 29.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -134.81 117.06 1.69 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.399 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -110.36 116.37 31.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.838 0.351 . . . . 0.0 111.027 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -115.45 111.09 20.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.676 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -72.78 -5.42 37.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.347 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.36 41.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.757 0.313 . . . . 0.0 110.938 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 70.0 -64.1 0.37 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.152 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -47.66 -75.66 0.18 Allowed Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.793 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 7.4 tt -66.51 142.49 57.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.775 0.322 . . . . 0.0 110.799 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.95 164.39 29.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.867 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . 0.416 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 8.2 t -131.29 151.42 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.942 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.57 126.2 52.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.98 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.28 122.91 12.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.809 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -105.32 141.16 37.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -124.85 153.05 43.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.898 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -97.25 -171.2 2.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.061 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.08 112.9 3.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.878 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.02 97.77 11.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER 60.32 159.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -85.98 -65.5 1.01 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.806 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.4 157.39 17.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.733 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 69.89 -59.4 0.51 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.268 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.2 t70 78.22 79.68 0.07 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.881 0.372 . . . . 0.0 110.851 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.09 83.25 6.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.85 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -133.88 -54.84 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.494 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 68.49 -67.84 0.19 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.313 . . . . 0.0 110.955 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 72.6 m 61.37 155.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.922 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -123.53 -44.05 2.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -114.39 178.6 4.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.97 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -83.4 159.71 21.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.6 117.85 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.878 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -91.14 -178.65 5.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.937 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -122.87 -54.71 1.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.067 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -128.38 147.43 17.43 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.504 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.24 142.97 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.769 0.319 . . . . 0.0 111.135 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -172.48 159.99 31.05 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.517 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.62 152.34 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 111.142 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -136.23 136.04 39.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.969 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -134.35 157.88 45.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 4.8 p -118.86 147.02 44.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.851 -179.93 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.832 0.349 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.75 57.01 0.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 18.2 mtt85 61.04 29.92 19.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.986 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -133.45 66.6 1.55 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.753 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -173.77 -59.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.801 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 11.6 t90 -96.68 102.28 14.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.79 160.16 18.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.798 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.53 125.25 14.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -125.09 120.81 32.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.837 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 pp -130.52 126.74 61.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.12 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.98 164.56 25.79 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.539 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -125.8 147.81 49.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.796 0.332 . . . . 0.0 111.075 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.58 150.92 48.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.924 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -141.44 117.86 10.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.817 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -125.34 139.99 53.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.831 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.1 tp -96.21 139.68 18.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.047 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.79 147.36 44.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.963 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -140.84 131.55 25.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.822 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.4 m -147.96 32.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.081 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.85 172.68 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 153.97 45.82 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.434 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -112.26 114.17 26.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.779 0.324 . . . . 0.0 110.894 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.29 -68.58 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.46 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -133.58 -49.98 0.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.871 0.367 . . . . 0.0 110.909 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.75 118.04 31.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.846 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.43 148.17 30.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.843 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.23 -178.27 4.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.21 46.33 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.488 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.7 mp -89.4 144.63 25.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.826 0.346 . . . . 0.0 110.877 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.88 150.81 33.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.075 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -120.0 94.07 48.32 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.42 178.75 0.21 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.55 2.166 . . . . 0.0 112.258 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.09 135.08 26.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.836 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.59 141.53 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.113 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -140.26 122.25 15.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.929 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -144.55 123.76 12.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.76 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -135.82 162.5 32.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.983 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.82 129.61 36.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.013 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.54 109.28 21.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.104 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -108.69 85.44 2.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.803 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.31 -147.57 47.41 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.4 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -51.26 -25.78 18.61 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.506 2.137 . . . . 0.0 112.36 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -92.64 148.4 22.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.809 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -140.6 137.23 33.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.945 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.6 pt -129.92 145.49 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.964 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.19 155.78 49.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.222 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 mp -142.3 144.85 33.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.31 143.43 46.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.08 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -141.47 160.02 41.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.63 148.04 32.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.868 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.56 -179.53 4.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.81 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -153.03 139.83 19.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.981 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.23 65.63 0.25 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.459 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 145.01 56.06 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.563 2.175 . . . . 0.0 112.294 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.05 139.8 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.17 104.8 2.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -125.3 -44.58 1.87 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.935 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -152.38 150.33 29.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -97.29 153.99 17.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.145 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.95 38.22 3.2 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.504 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.24 67.14 0.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.946 0.403 . . . . 0.0 110.827 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -73.58 85.34 1.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.909 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -121.19 147.67 17.46 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.533 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.8 p -85.95 140.98 29.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.804 0.335 . . . . 0.0 110.904 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 7.6 m0 -122.37 135.45 54.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.823 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -116.44 173.39 6.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.03 134.91 47.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.75 95.87 24.86 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.884 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.34 170.25 18.8 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.484 2.123 . . . . 0.0 112.253 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -153.59 140.34 19.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.025 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mt -126.04 146.31 49.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.804 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -152.28 119.89 6.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.031 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.39 138.87 31.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.042 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -129.52 135.14 48.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.064 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -124.05 110.8 15.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.712 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -65.59 137.14 57.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.043 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -50.92 147.09 5.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.199 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 16.8 mt -72.37 -66.3 0.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.743 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -71.1 -173.5 0.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.689 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -175.2 -32.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.41 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -45.88 -30.15 1.62 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.489 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.403 ' HB3' ' CD2' ' A' ' 83' ' ' PHE . 1.2 t70 -164.34 -64.97 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.97 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.404 ' CD1' HG13 ' A' ' 120' ' ' VAL . 23.5 m-85 -104.31 118.61 37.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.85 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.37 173.79 6.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.74 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -162.36 117.06 1.84 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.032 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -132.19 -162.42 10.37 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.261 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mp -155.73 145.24 21.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 0.0 110.981 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 81.7 p -142.84 121.94 12.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.931 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -151.32 -159.01 8.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.522 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 174.3 176.64 42.84 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.554 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.433 ' CD2' ' N ' ' A' ' 91' ' ' PHE . 3.9 m-85 -122.27 173.82 7.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.845 0.355 . . . . 0.0 110.818 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -150.26 128.23 11.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.024 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -131.45 149.44 52.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.827 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.22 138.22 52.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.933 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -106.11 134.8 12.3 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.426 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -122.8 139.28 54.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.347 . . . . 0.0 110.955 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -151.36 102.54 2.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.805 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -173.36 -40.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.962 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.8 m 42.03 72.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.788 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.63 -31.43 72.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -115.72 97.68 49.41 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.25 114.17 1.2 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.499 2.133 . . . . 0.0 112.5 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 166.3 -86.17 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.486 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.67 30.58 0.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.921 0.391 . . . . 0.0 110.948 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.79 98.73 10.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.71 161.03 32.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -128.13 125.99 40.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.056 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -144.06 119.87 10.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.981 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.46 159.28 18.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -146.61 104.64 3.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -105.04 127.12 52.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -96.76 122.22 39.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.94 121.72 45.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.899 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.5 mt -130.99 132.14 63.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.04 76.43 8.71 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.348 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.426 ' HB2' ' CD1' ' A' ' 131' ' ' TRP . 44.2 Cg_exo -56.52 168.17 2.35 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.526 2.15 . . . . 0.0 112.132 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -147.17 134.75 20.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.164 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -120.73 124.81 46.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.66 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -100.14 125.92 46.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.959 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.404 HG13 ' CD1' ' A' ' 83' ' ' PHE . 22.3 t -140.37 116.96 8.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.059 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -88.66 144.36 26.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.922 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.29 -42.8 2.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.27 -170.75 2.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.841 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -74.94 -47.99 26.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.88 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -110.19 29.78 7.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.9 mp -138.15 133.86 33.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -142.51 152.71 42.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -141.51 135.29 30.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.802 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -154.55 168.12 27.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.062 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 151.83 177.37 25.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.562 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . 0.455 ' HA ' ' CE3' ' A' ' 131' ' ' TRP . 0.0 OUTLIER -173.21 -172.67 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.77 0.319 . . . . 0.0 110.777 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.1 mt -100.83 150.39 22.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.956 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.67 152.19 21.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.936 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 5.0 mtp -132.37 125.43 30.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -118.51 125.6 50.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.938 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.07 156.3 41.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.897 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -110.35 -170.15 1.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.716 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.47 149.72 28.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.078 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -62.97 -29.18 70.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.074 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -63.47 -40.12 96.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.008 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 19.1 mt -95.38 -30.22 14.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.084 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -59.23 -27.19 65.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.945 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 p -57.77 -36.09 71.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.018 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 5.6 t -90.67 -33.72 15.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.969 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.68 -29.38 61.49 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.521 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 66.49 -75.8 0.05 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.816 0.341 . . . . 0.0 111.065 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -91.4 -86.92 0.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.21 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.0 t0 51.51 27.0 3.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.824 0.345 . . . . 0.0 111.148 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 37.2 p -83.43 120.83 26.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.971 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -105.26 120.69 42.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.833 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.2 m -120.67 116.97 51.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.091 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -108.2 153.72 22.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.932 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.4 m -101.12 132.49 46.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -129.43 116.94 19.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.4 t -140.69 113.82 8.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -114.53 147.28 18.82 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.678 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.9 pp -123.0 117.29 25.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 110.738 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.68 127.06 35.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.106 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -140.81 100.16 3.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.8 m -106.95 137.21 45.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.079 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -99.72 -30.92 11.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.798 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -151.11 -179.09 7.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.808 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -87.61 6.23 35.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.373 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 60.2 p -103.41 -31.04 10.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.818 0.342 . . . . 0.0 110.982 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 11.3 p -147.67 152.03 13.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.145 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -141.7 158.9 43.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.019 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 4.7 tp -115.52 143.01 45.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.952 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 32.1 mtp180 -147.36 124.0 11.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.024 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.5 t -124.41 123.76 66.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.007 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -121.1 145.98 47.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.141 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.41 ' CE2' HG23 ' A' ' 193' ' ' ILE . 13.3 m-85 -112.92 130.85 55.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.746 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -111.18 138.12 48.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.037 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.6 tp -139.95 151.1 45.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.808 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -138.09 144.73 41.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.006 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.06 116.58 2.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.959 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -123.06 169.91 15.41 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.398 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -150.19 163.93 36.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.804 0.335 . . . . 0.0 110.928 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -128.89 124.22 34.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.854 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 10.7 mtt -78.17 -27.24 47.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.048 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.84 -51.14 70.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.968 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -156.55 173.67 16.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.904 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.0 m -97.58 38.04 1.32 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -64.39 166.4 8.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -73.49 -43.14 60.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -78.09 86.07 4.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 154.4 -34.44 0.7 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.428 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.74 110.84 20.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.857 0.36 . . . . 0.0 110.845 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -177.13 179.29 1.02 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.82 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.9 m -142.24 148.83 38.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.944 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 17.0 p -130.39 162.6 28.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -137.45 133.24 34.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.936 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -134.74 173.18 11.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.41 HG23 ' CE2' ' A' ' 171' ' ' TYR . 1.1 pt -137.36 142.33 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.249 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.51 114.49 16.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.761 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -115.76 118.97 34.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.251 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.442 ' CD2' ' N ' ' A' ' 196' ' ' TYR . 1.9 p90 -145.36 137.09 25.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.706 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.37 109.41 19.37 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.053 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.15 142.54 80.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.5 2.133 . . . . 0.0 112.152 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.02 100.01 5.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.791 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 35.1 p -107.04 102.97 12.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.957 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 2.9 tt -140.54 129.86 23.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.884 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 72.32 -128.78 13.87 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.472 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -117.52 30.1 7.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.359 . . . . 0.0 110.931 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -135.6 149.08 49.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 88.8 p -121.01 121.51 38.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.936 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.31 139.94 45.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.825 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.0 m -138.69 92.97 11.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.403 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.01 111.52 2.47 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.618 2.212 . . . . 0.0 112.116 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -111.23 169.03 9.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 0.0 111.109 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.6 p -138.62 138.86 38.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.843 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -125.2 164.81 19.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.934 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 1.2 pp -64.02 148.97 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.92 -178.52 18.24 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.524 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.3 tt -121.44 159.39 26.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.772 0.32 . . . . 0.0 110.902 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 20.9 ttt85 -154.97 146.22 22.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -171.22 36.52 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.64 -178.34 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -120.07 144.93 47.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.893 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 140.09 -35.1 1.94 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.554 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 60.7 80.13 0.22 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.802 0.334 . . . . 0.0 110.914 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -107.04 -29.85 4.43 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.45 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -115.31 -176.31 2.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.821 0.343 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -110.87 161.81 15.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -97.46 40.22 1.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -117.36 85.48 2.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.991 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.4 144.41 26.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.737 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 16.7 m -145.1 153.32 14.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.259 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -139.44 160.01 25.88 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.312 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.22 113.68 9.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.808 0.337 . . . . 0.0 111.048 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -97.71 130.6 44.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.721 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -111.05 155.72 22.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.05 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -165.51 117.21 0.74 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.041 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -132.38 121.16 23.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.748 0.309 . . . . 0.0 111.181 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 240' ' ' SER . 2.4 p30 -108.71 128.53 54.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -54.98 -24.71 25.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.998 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -156.36 -45.44 0.07 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.836 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 179.51 -55.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -63.72 -78.88 0.17 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.691 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.416 HD23 ' CD2' ' A' ' 269' ' ' TYR . 3.1 mp -66.42 140.0 58.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.794 0.33 . . . . 0.0 110.9 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -157.14 176.84 12.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.048 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . 0.487 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 30.2 m -122.01 170.39 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.825 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 36.4 t -142.27 131.84 23.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.828 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 2.3 tt -136.35 126.86 26.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.002 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -119.45 139.39 52.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -152.02 151.83 31.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.979 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -160.19 -76.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.048 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 63.13 125.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.986 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -76.71 -176.44 3.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER 60.27 109.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.821 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -75.87 145.38 40.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -128.21 160.64 31.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.41 -51.8 2.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.932 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -143.7 -59.28 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.83 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -148.22 156.02 42.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -150.69 -61.94 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.42 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -137.23 173.11 12.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.847 0.356 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 2.9 t -106.46 52.23 0.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.919 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -98.44 27.54 4.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.982 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? 56.84 174.97 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.932 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -83.03 -41.12 19.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 59.7 103.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -72.42 151.91 42.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.86 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -85.77 -72.73 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.045 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -144.58 148.08 19.65 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.445 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 21.8 m -147.47 141.83 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 111.134 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -158.47 175.04 35.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.54 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 9.2 m -130.33 162.86 37.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.79 0.329 . . . . 0.0 111.148 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -136.33 143.12 43.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.862 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.416 ' CD2' HD23 ' A' ' 239' ' ' LEU . 25.1 m-85 -139.18 101.7 4.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 59.4 p -110.77 131.7 54.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.903 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.838 0.352 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -120.76 36.11 4.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.929 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.26 -44.47 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.99 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -154.9 167.81 29.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.957 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -167.73 96.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.803 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 60.6 p-90 -107.83 149.89 27.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.943 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -118.2 144.71 45.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -118.72 130.03 55.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.51 128.61 19.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.7 tt -155.29 131.21 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.051 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.98 -157.99 7.73 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.553 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.79 -176.95 1.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.332 . . . . 0.0 111.04 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.5 ttt -152.94 150.13 28.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.34 138.21 26.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.854 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -129.98 124.19 32.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.952 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.8 mt 59.71 87.48 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.54 31.35 5.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.901 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.96 124.24 26.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.851 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.23 83.59 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.101 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -65.27 -67.94 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 173.97 -119.67 0.75 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.493 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 60.44 87.63 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.358 . . . . 0.0 110.921 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.65 14.58 77.81 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.776 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 55.72 -178.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.788 0.327 . . . . 0.0 111.119 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -167.04 92.64 0.43 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.921 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.4 mtt -68.53 -67.99 0.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.19 91.47 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.942 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.24 135.44 13.47 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.486 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.36 113.5 25.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.901 0.381 . . . . 0.0 110.918 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.7 119.5 19.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.066 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -121.75 94.09 48.45 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.05 123.83 10.38 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.482 2.121 . . . . 0.0 112.269 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.28 137.97 46.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.026 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -137.22 142.1 38.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -133.29 156.21 48.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.942 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -153.5 132.52 12.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.881 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.23 126.55 19.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.966 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.16 135.41 45.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.053 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.45 149.82 46.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.169 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -173.91 140.41 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.83 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.16 -149.39 17.37 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.511 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -86.19 42.03 0.91 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.807 2.338 . . . . 0.0 112.729 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -170.95 163.7 7.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.804 0.335 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -141.28 163.74 32.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.938 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mp -142.31 139.62 29.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.74 144.68 45.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.173 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.06 165.0 24.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.36 135.11 11.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -139.65 118.96 12.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -146.53 160.96 41.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -127.82 144.0 51.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -132.27 127.95 36.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.37 157.24 7.17 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.582 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.93 158.14 57.73 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.645 2.23 . . . . 0.0 112.283 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.8 m -90.25 121.06 40.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.108 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.11 155.9 26.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.943 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -128.35 101.62 6.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.05 -177.51 5.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.871 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -135.44 -47.27 0.69 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.125 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -159.51 72.16 0.23 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.556 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -162.38 -44.87 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.826 0.346 . . . . 0.0 110.817 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.0 mtt-85 -103.55 -176.47 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 165.88 65.64 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.493 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.52 122.44 47.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.815 0.34 . . . . 0.0 110.918 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -120.14 161.5 20.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -150.27 139.98 21.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -141.12 139.67 34.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.0 mtp180 -130.67 95.89 25.1 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.953 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.86 157.91 34.94 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.559 2.173 . . . . 0.0 112.365 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -137.87 121.23 17.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 mp -114.65 145.21 42.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -153.82 160.27 42.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.3 p -158.17 125.85 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.069 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -104.47 153.39 21.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -157.32 119.1 3.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -94.25 148.91 21.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -115.31 -62.51 1.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.837 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.7 mt -123.42 136.48 54.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.94 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -129.96 74.44 1.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -92.19 168.33 11.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -73.71 -27.75 61.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.956 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.423 ' HB3' ' CD2' ' A' ' 83' ' ' PHE . 12.7 m-20 -83.26 -64.21 1.21 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.939 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.423 ' CD2' ' HB3' ' A' ' 82' ' ' ASP . 12.6 m-85 -124.2 154.59 39.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.954 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.12 147.92 50.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.821 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.462 ' CE2' ' CZ3' ' A' ' 118' ' ' TRP . 29.3 m-85 -123.07 157.72 32.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.916 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -174.04 166.06 38.0 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.51 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.8 mt -144.3 137.07 26.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 0.0 110.874 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.93 123.37 19.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.53 149.81 16.88 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.547 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -161.48 156.68 28.2 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.41 ' HB3' ' CD1' ' A' ' 112' ' ' TRP . 8.1 p90 -150.1 167.71 26.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.789 0.328 . . . . 0.0 110.91 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.0 mtp85 -127.88 150.93 49.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.864 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -129.83 154.17 47.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.852 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.432 ' CD2' ' ND2' ' A' ' 139' ' ' ASN . 6.1 m-85 -126.62 145.26 50.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -126.67 130.04 6.84 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.52 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -124.29 139.13 54.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.767 0.318 . . . . 0.0 110.914 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -99.21 175.9 5.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -122.59 119.2 30.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.5 t -128.86 -52.15 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.116 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.84 -31.34 23.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.851 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.35 89.92 2.9 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.41 157.02 63.57 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.501 2.134 . . . . 0.0 112.353 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 114.05 20.08 6.13 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.647 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? 56.74 36.48 27.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.839 0.352 . . . . 0.0 111.092 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.57 122.69 20.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.6 t -140.76 167.37 22.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.926 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -124.49 173.78 8.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.076 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -139.71 104.31 4.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.026 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.3 mtm -143.44 154.15 43.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.728 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -166.94 -179.28 4.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.961 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -145.02 134.58 23.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.41 ' CD1' ' HB3' ' A' ' 91' ' ' PHE . 0.3 OUTLIER -107.71 164.54 12.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.814 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -164.02 138.8 5.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.934 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.1 mt -137.77 125.82 31.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.051 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -135.91 107.89 9.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.072 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.51 177.12 5.72 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.474 2.116 . . . . 0.0 112.296 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -131.62 135.43 46.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.929 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.462 ' CZ3' ' CE2' ' A' ' 85' ' ' PHE . 2.9 t-105 -145.34 139.4 26.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.867 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -143.47 149.5 37.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.83 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.67 115.89 15.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.158 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.62 103.51 15.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.7 mp -81.37 -51.45 8.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -147.47 177.52 9.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.848 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -60.02 -29.91 68.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.993 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -118.96 36.2 4.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.008 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.85 125.09 5.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -146.36 128.68 15.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.829 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.34 151.66 19.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -133.84 154.14 51.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.76 136.16 3.82 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.449 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 4.3 p-90 -164.59 138.78 5.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.333 . . . . 0.0 110.987 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.3 mp -95.25 161.57 14.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.9 m -139.29 113.62 8.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.902 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 1.6 ttt -111.44 148.45 33.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -125.37 119.49 28.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.21 167.23 11.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.764 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 60.18 -174.18 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.827 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -168.43 144.63 3.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.893 0.378 . . . . 0.0 111.242 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.432 ' ND2' ' CD2' ' A' ' 94' ' ' TYR . 16.1 m120 -87.19 -29.59 21.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.903 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -130.5 71.81 1.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.8 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.0 mt -56.59 -25.0 51.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.101 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -60.42 -39.87 88.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 72.3 p -96.45 -34.51 11.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.2 m -91.65 12.66 20.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.361 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.69 -24.66 62.47 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.539 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -89.12 52.88 2.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 0.0 110.901 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -176.09 108.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.108 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.51 -75.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.6 t -135.72 163.46 30.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.983 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.74 129.92 50.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.75 129.08 47.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.091 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.76 151.2 45.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 29.4 m -117.29 139.78 50.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.837 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.95 115.5 23.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.838 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 17.6 m -125.7 137.05 53.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.903 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -150.33 160.34 28.51 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.599 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.38 134.24 47.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.86 0.362 . . . . 0.0 110.921 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -113.79 114.29 26.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.961 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -126.78 113.44 16.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 6.2 m -103.12 136.49 42.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.102 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -103.99 -31.1 9.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.764 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -170.96 173.14 5.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.766 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.62 -14.39 62.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.344 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 9.1 t -76.24 -46.52 27.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.714 0.292 . . . . 0.0 111.032 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 10.2 p -156.22 154.06 6.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.2 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -133.36 -172.74 3.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.028 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.5 mp -135.87 138.14 42.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.958 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.38 128.31 14.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.921 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.2 t -122.27 136.78 57.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.117 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -118.97 149.47 41.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.407 ' CE1' HG12 ' A' ' 193' ' ' ILE . 0.5 OUTLIER -134.81 144.9 47.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -124.48 136.19 53.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.977 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.2 tp -147.52 114.51 6.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.2 pm0 -143.67 162.53 35.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.023 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.4 ptt180 -140.17 166.55 24.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.817 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -138.49 160.02 25.45 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.558 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -119.1 130.7 55.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -97.34 162.12 13.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.03 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.99 -31.7 17.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -80.26 125.06 29.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.926 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -107.0 -31.77 8.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.835 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.11 63.94 1.9 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.17 -58.85 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.958 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -173.84 -61.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -176.8 132.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.836 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -96.47 27.97 15.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.512 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -102.33 80.81 1.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.763 0.316 . . . . 0.0 110.862 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.52 137.01 35.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.858 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 11.9 m -130.69 121.47 25.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.956 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 14.0 p -124.35 153.63 41.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -153.96 128.44 9.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.834 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.21 137.85 54.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.407 HG12 ' CE1' ' A' ' 171' ' ' TYR . 22.6 mt -102.12 139.22 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.094 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 15.5 ttt85 -134.04 133.42 41.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -111.3 126.44 54.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.139 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.4 ' CD1' ' HB3' ' A' ' 209' ' ' TYR . 0.3 OUTLIER -131.67 116.14 16.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.772 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.81 109.67 42.94 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.087 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.413 ' HA ' ' CG2' ' A' ' 207' ' ' THR . 91.0 Cg_endo -79.0 138.22 14.36 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.409 2.073 . . . . 0.0 112.388 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.7 tt -132.76 155.91 48.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.929 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 44.0 m -132.93 116.94 17.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.22 102.57 3.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.76 -137.52 15.31 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.485 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.03 23.66 14.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 0.0 111.043 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -136.44 132.99 36.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.764 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 84.8 p -96.69 134.44 39.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.954 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 20.8 t -135.38 131.5 51.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.85 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.413 ' CG2' ' HA ' ' A' ' 198' ' ' PRO . 14.3 p -133.61 92.82 22.59 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.302 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.34 124.71 9.15 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.432 2.088 . . . . 0.0 111.951 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.431 ' CZ ' ' HA3' ' A' ' 228' ' ' GLY . 48.2 p90 -111.12 136.23 50.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.932 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 24.7 m -111.12 159.64 17.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.938 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -127.35 126.76 43.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.851 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -72.58 136.14 26.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.205 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 177.66 56.77 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.57 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.7 tt -152.34 74.66 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.864 0.364 . . . . 0.0 110.907 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -109.74 88.17 2.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.83 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -131.06 -53.9 1.04 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.977 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.19 -70.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.867 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -151.13 36.23 0.6 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.804 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 71.4 172.57 14.83 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.454 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.34 -56.89 1.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.859 0.361 . . . . 0.0 110.907 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 169.3 -33.81 0.18 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.491 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -84.64 160.68 20.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.776 0.322 . . . . 0.0 110.942 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 60.14 177.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 4.0 t80 60.92 43.27 11.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -157.16 57.25 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.929 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 48.1 mtm-85 60.33 98.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.906 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 17.6 m -86.65 -13.62 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.477 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.431 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . -149.8 171.65 29.82 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.452 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.08 129.53 11.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.918 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -107.01 114.5 28.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.748 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -90.93 162.1 14.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.035 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -153.95 117.03 0.77 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.111 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -110.86 115.45 29.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.791 0.329 . . . . 0.0 111.142 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -120.06 85.44 2.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.564 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.95 -12.7 19.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.272 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.31 35.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.736 0.303 . . . . 0.0 111.137 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 68.91 -65.44 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.061 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -48.43 -59.33 6.59 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.725 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.416 ' HG ' ' CE1' ' A' ' 269' ' ' TYR . 7.6 tt -80.95 107.37 13.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.764 0.316 . . . . 0.0 110.766 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 30.5 t -113.19 154.37 26.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.931 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . 0.463 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 39.1 t -122.38 142.53 38.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.779 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 27.3 m -116.45 118.84 33.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.008 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.34 124.37 36.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.771 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -105.23 133.56 49.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.945 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -121.9 159.38 26.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -116.76 -79.22 0.59 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.073 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 60.95 98.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -155.42 162.45 40.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -133.02 112.13 11.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -90.83 167.45 12.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -141.74 132.58 25.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 60.26 166.05 0.07 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.865 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.44 104.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.849 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -124.31 -61.8 1.32 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 71.51 -129.71 17.18 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -99.5 -178.07 3.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.86 0.362 . . . . 0.0 110.862 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.25 95.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.985 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -75.18 177.89 6.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -134.7 119.99 18.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.953 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -130.83 177.58 7.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -73.14 120.9 19.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.912 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -94.58 -63.28 1.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -158.11 134.75 9.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.042 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -103.45 136.13 12.75 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.543 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 16.5 t -120.11 141.71 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 111.092 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -166.2 164.31 37.46 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.518 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 5.7 m -132.72 166.73 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.853 0.358 . . . . 0.0 111.109 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -158.75 120.76 3.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.956 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.416 ' CE1' ' HG ' ' A' ' 239' ' ' LEU . 62.3 m-85 -112.78 105.75 13.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.794 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.59 118.34 36.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.873 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.827 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.883 0.373 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -100.18 103.96 15.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.945 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.79 109.2 5.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.902 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -116.92 -48.43 2.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.916 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -125.76 32.14 5.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -123.84 112.88 17.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.84 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.99 146.17 46.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.4 130.48 52.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.2 129.32 51.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.0 mm -138.9 127.78 29.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.098 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.96 -178.77 35.23 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.508 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.35 -176.89 5.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 0.0 111.072 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.44 152.36 21.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.82 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -150.89 118.42 6.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.92 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.29 151.06 51.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.863 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.9 mt -148.29 86.61 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.092 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -117.68 175.49 5.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -163.82 117.88 1.52 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.93 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.2 -37.82 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.068 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.65 -68.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.855 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.24 -159.05 4.19 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.457 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 23' ' ' GLY . 29.6 p90 -170.53 -42.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.83 0.348 . . . . 0.0 110.914 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.449 ' N ' ' CD1' ' A' ' 22' ' ' TYR . . . -66.42 105.24 1.23 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.56 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -143.36 137.94 29.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.85 0.357 . . . . 0.0 110.929 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -87.62 -71.76 0.55 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.5 ptm -158.36 -47.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.44 178.14 6.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 157.94 -157.46 28.26 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.529 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.05 159.9 32.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.902 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.84 138.11 31.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.138 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -136.64 94.13 13.54 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.926 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.72 167.41 25.76 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.555 2.17 . . . . 0.0 112.254 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.9 t -152.95 136.45 15.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -115.02 144.76 21.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.159 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -125.77 136.57 53.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -131.51 161.87 31.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.873 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -165.01 144.72 6.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.3 117.46 9.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.125 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.06 135.41 47.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.122 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -158.12 111.4 2.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.76 -149.29 37.49 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.579 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.76 -10.7 28.28 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.571 2.181 . . . . 0.0 112.6 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -99.87 143.04 30.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 110.941 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -129.99 142.08 50.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.8 mt -129.64 147.54 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.206 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.71 147.46 25.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.027 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.16 169.22 19.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.934 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.43 137.37 20.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.042 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -115.89 148.94 39.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.951 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -131.46 144.63 51.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.2 162.78 31.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -137.17 119.43 15.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.968 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -142.95 60.95 0.53 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.533 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.52 177.93 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.577 2.185 . . . . 0.0 112.238 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 p -77.42 131.06 35.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.065 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -77.55 154.92 31.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.949 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -150.07 -63.07 0.21 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.86 133.71 9.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.814 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.95 -74.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.077 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.66 -49.72 3.16 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.49 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -141.25 31.38 1.74 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.85 0.357 . . . . 0.0 110.93 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.76 97.49 5.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.8 88.74 0.18 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.531 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.1 t -107.36 114.34 28.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.843 0.354 . . . . 0.0 110.899 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.39 153.77 28.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.877 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -140.27 136.84 33.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.37 146.44 46.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -151.2 95.87 3.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.902 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.91 133.33 16.6 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.556 2.17 . . . . 0.0 112.33 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -106.87 125.76 51.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.419 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -121.29 141.25 51.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.804 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -145.67 141.14 27.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.942 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.2 t -127.85 119.54 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.07 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -107.98 121.91 45.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -97.59 140.31 32.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -109.81 105.22 14.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.922 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.47 -46.47 5.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.808 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 tp -138.91 145.3 39.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.861 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -156.63 79.77 0.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.77 -170.59 1.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.978 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -85.38 -22.28 28.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.15 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -120.86 -47.21 2.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.787 0.327 . . . . 0.0 111.065 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.411 ' CE2' HG13 ' A' ' 120' ' ' VAL . 1.6 t80 -103.28 143.67 32.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.057 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.4 t -143.52 155.24 44.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.83 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -153.14 149.39 27.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 171.17 -178.67 43.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.438 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mp -142.39 145.18 33.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.823 0.344 . . . . 0.0 110.939 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.9 m -132.89 123.23 25.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.16 177.61 19.43 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.553 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.47 -175.37 46.97 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.441 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.419 ' CZ ' HD13 ' A' ' 71' ' ' LEU . 36.9 p90 -163.43 149.65 11.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.783 0.325 . . . . 0.0 111.014 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.1 159.88 18.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -130.74 143.43 50.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.851 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -148.84 119.43 7.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.952 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.63 -174.85 43.46 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.478 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -60.58 171.72 1.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.858 0.361 . . . . 0.0 110.852 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -113.73 -47.68 2.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.795 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -142.94 139.4 30.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.3 p -140.93 113.45 4.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.111 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.17 -41.22 81.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.006 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -116.03 82.82 11.49 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.39 146.95 39.04 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.572 2.181 . . . . 0.0 112.216 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.39 -19.07 52.45 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.669 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.69 -68.06 0.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.837 0.351 . . . . 0.0 111.069 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -154.11 123.5 6.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.887 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.5 t -160.31 147.57 16.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -134.84 162.65 31.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -105.02 111.07 23.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -131.23 141.09 49.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.409 ' HG2' ' CD2' ' A' ' 137' ' ' PHE . 5.3 pt20 -163.11 172.16 15.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.0 mtt-85 -152.97 109.23 3.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -87.38 154.51 20.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.815 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -145.05 125.39 13.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.043 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.3 mt -140.17 124.91 19.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.983 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -149.15 99.49 3.44 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.222 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.07 169.94 0.26 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.463 2.109 . . . . 0.0 112.22 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -125.78 134.9 51.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.001 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -144.56 127.05 15.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.52 142.75 45.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.411 HG13 ' CE2' ' A' ' 83' ' ' PHE . 6.9 m -153.93 118.35 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.188 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -88.09 139.07 30.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.8 tt -102.89 -31.18 10.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 12.4 t -156.35 -164.01 1.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.851 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -93.79 20.58 7.43 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.35 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -158.11 26.13 0.26 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.714 0.293 . . . . 0.0 111.094 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.09 108.72 2.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.823 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -113.41 122.36 47.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -105.39 130.89 53.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -145.61 137.29 25.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.04 156.78 26.63 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.545 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 37.4 p-90 -173.01 127.0 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.743 0.306 . . . . 0.0 110.959 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.1 pp -104.33 124.97 50.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.843 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.7 t -99.76 150.13 22.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.991 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 15.1 mtm -130.56 145.32 51.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.738 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.45 ' CD2' ' N ' ' A' ' 135' ' ' TYR . 2.7 m-85 -119.12 133.62 55.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.907 0.384 . . . . 0.0 110.976 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -128.99 145.63 51.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.802 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.409 ' CD2' ' HG2' ' A' ' 110' ' ' GLN . 0.5 OUTLIER 60.67 164.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -172.28 -177.3 1.79 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.156 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -68.95 -63.89 0.97 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -165.34 32.44 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.888 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 mp -92.91 -31.7 14.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -60.09 -30.89 69.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.943 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 70.2 p -68.66 -31.05 69.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.63 -34.7 19.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.832 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.68 -33.85 20.73 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.474 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 59.75 33.74 21.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 0.0 110.946 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -88.12 174.47 8.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.096 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -101.02 -66.73 0.89 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.884 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.79 148.45 45.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.933 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.422 ' HG2' ' CD2' ' A' ' 135' ' ' TYR . 5.8 tpp180 -105.12 136.42 44.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.828 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.3 m -149.66 142.58 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.174 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -144.6 127.86 16.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.8 m -96.92 131.93 43.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.893 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.4 ' OE1' ' CD1' ' A' ' 172' ' ' TYR . 25.5 mp0 -124.93 120.39 31.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.977 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 14.9 p -119.19 122.92 43.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -106.3 136.7 13.44 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.3 mt -119.25 118.25 30.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.848 0.356 . . . . 0.0 110.9 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -100.0 142.61 31.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -140.82 100.2 3.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.848 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.28 113.8 14.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.931 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.73 -32.75 16.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.807 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -158.06 -173.38 4.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.813 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -87.73 6.05 36.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.406 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 22.8 m -136.39 12.89 3.26 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.559 0.219 . . . . 0.0 111.324 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 16.6 m -158.28 155.12 4.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.852 0.358 . . . . 0.0 111.131 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -149.43 176.79 10.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.093 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.7 124.09 12.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.42 ' HD2' ' CE2' ' A' ' 196' ' ' TYR . 79.6 mtt180 -124.74 142.04 51.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.1 118.83 16.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.113 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -97.88 138.85 34.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.22 112.33 18.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.4 ' CD1' ' OE1' ' A' ' 154' ' ' GLU . 5.3 m-85 -96.33 138.02 34.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.868 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 6.5 mt -143.5 108.72 5.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.87 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -125.07 152.12 44.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -151.23 136.83 17.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.946 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -99.05 150.29 19.25 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.536 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -122.22 162.03 22.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 0.0 110.887 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.83 176.71 7.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.805 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 40.4 mtm -60.49 -42.9 97.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.88 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.5 96.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.904 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -139.35 -55.81 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.1 m -96.85 -53.48 3.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.57 160.49 26.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.841 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -128.28 89.37 2.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -152.56 30.93 0.52 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -113.38 32.73 5.92 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.521 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.34 100.54 11.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.825 0.345 . . . . 0.0 110.82 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -80.48 138.12 36.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.807 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.57 129.75 43.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.956 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.7 t -150.25 114.86 5.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.79 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -122.02 143.27 49.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.092 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -142.8 152.37 42.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.767 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.65 134.84 46.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.937 0.398 . . . . 0.0 111.366 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -139.51 124.94 19.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.581 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -119.41 154.43 33.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.058 0.456 . . . . 0.0 111.591 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.44 ' N ' ' CD1' ' A' ' 196' ' ' TYR . 1.8 p90 -155.35 138.83 15.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.318 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.441 ' O ' ' HD2' ' A' ' 208' ' ' PRO . 5.4 mp -97.94 109.37 51.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.263 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -83.2 108.76 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.486 2.124 . . . . 0.0 112.358 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.29 140.75 52.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.974 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 60.3 p -131.59 128.13 38.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.9 mt -127.82 104.69 7.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 65.63 -96.37 0.25 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.584 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -127.92 31.2 5.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.802 0.334 . . . . 0.0 110.946 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -125.85 155.34 41.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.765 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.57 128.66 29.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.986 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.2 t -140.12 110.97 4.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.855 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 2.1 m -121.33 93.06 48.81 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.404 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.441 ' HD2' ' O ' ' A' ' 197' ' ' LEU . 33.8 Cg_exo -61.72 171.76 4.33 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.587 2.191 . . . . 0.0 111.949 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -134.21 127.9 32.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.957 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.1 p -116.81 126.18 52.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -146.59 121.45 9.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.849 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 10.8 mt -66.37 134.68 29.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.091 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -129.98 47.74 1.0 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.477 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.6 132.44 35.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 110.974 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.58 33.49 18.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -98.0 -30.31 12.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 1.6 m -174.54 -69.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.908 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -79.49 135.87 36.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -134.44 58.82 0.68 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.601 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.5 -40.11 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.775 0.321 . . . . 0.0 110.912 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 142.78 51.29 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.537 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.71 166.87 23.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.835 0.35 . . . . 0.0 110.831 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 60.52 111.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.928 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -124.76 -59.32 1.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.868 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.79 -56.53 0.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.925 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 5.0 tpp180 -58.07 103.68 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.1 m -113.37 -31.51 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.331 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -161.62 179.93 36.7 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.483 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.02 146.12 25.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.85 0.357 . . . . 0.0 111.054 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -109.25 148.82 30.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.732 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.85 137.4 54.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -133.49 117.18 1.84 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.284 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -113.11 122.5 47.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.898 0.38 . . . . 0.0 111.033 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.44 92.59 3.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.58 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -69.12 -6.84 31.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.431 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.59 31.49 0.13 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.667 0.27 . . . . 0.0 111.117 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 1.2 m120 67.91 -66.1 0.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.037 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -50.6 -59.35 7.96 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.601 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.1 mt -69.25 142.59 54.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.69 0.281 . . . . 0.0 110.698 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.8 p -137.0 148.91 47.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.943 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . 0.403 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 40.2 t -116.27 141.18 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.818 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 20.1 m -111.4 126.37 54.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.136 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.1 tt -149.42 124.86 10.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.741 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -105.32 150.64 25.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.059 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -155.54 149.67 25.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -122.69 116.23 23.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.166 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -75.18 -67.94 0.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.8 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 59.48 166.23 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 59.97 162.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.46 155.4 16.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.843 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.06 76.15 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -118.24 -38.77 3.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.957 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.3 t0 62.62 86.16 0.12 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -117.13 -67.26 1.01 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 133.82 170.1 12.25 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.488 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 60.41 30.68 19.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.82 0.343 . . . . 0.0 110.911 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.11 -52.78 0.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.48 138.11 54.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.913 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -144.33 -47.22 0.26 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.847 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -140.15 170.81 15.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.976 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -154.36 152.48 30.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.923 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.84 -53.81 6.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.818 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . 60.88 165.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.16 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -109.1 164.79 12.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.509 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 21.5 t -150.8 138.55 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.952 0.406 . . . . 0.0 111.128 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -153.0 179.03 29.76 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.501 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 6.2 m -149.99 139.45 15.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.904 0.383 . . . . 0.0 111.198 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -129.38 129.36 44.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -125.7 123.98 40.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 37.6 p -109.2 134.86 51.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.864 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.922 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.873 0.368 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -145.03 30.56 1.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.839 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -85.87 -60.43 2.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.944 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -76.23 -175.07 3.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -170.66 97.37 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.994 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -89.79 96.99 10.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.825 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -107.83 157.11 18.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.951 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.11 144.45 50.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.726 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -151.48 133.32 14.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.06 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.5 mp -128.44 154.93 39.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.9 153.4 25.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.666 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -129.29 154.84 46.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.825 0.345 . . . . 0.0 110.933 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.9 mtt -139.34 141.48 37.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.96 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.418 ' CE1' ' HB3' ' A' ' 32' ' ' PRO . 18.8 m-85 -137.83 113.59 9.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.808 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -146.98 159.07 44.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.858 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 pt -77.8 -179.01 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.1 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.28 -63.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.842 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -160.63 98.89 1.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.968 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.0 m -99.2 87.47 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.111 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -60.69 147.01 43.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.892 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -153.59 -179.52 29.08 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.459 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -171.84 114.72 0.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.797 0.332 . . . . 0.0 110.927 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.94 -132.73 11.37 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.547 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -113.4 110.17 19.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.81 0.338 . . . . 0.0 110.885 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.62 150.41 48.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.813 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.8 ttp -104.35 -45.73 4.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.931 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -76.31 161.18 28.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -135.12 168.76 23.6 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.567 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mp -94.0 140.62 29.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.852 0.358 . . . . 0.0 110.911 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.38 143.65 47.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.133 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -131.7 94.04 26.54 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.418 ' HB3' ' CE1' ' A' ' 14' ' ' TYR . 72.2 Cg_endo -74.84 156.68 43.73 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.555 2.17 . . . . 0.0 112.389 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 p -123.61 140.27 53.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.6 m -112.6 127.61 69.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -124.63 122.16 36.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.947 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -112.71 153.43 27.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -147.8 142.9 27.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.981 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.03 128.24 31.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.064 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.72 124.18 45.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.103 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -136.36 85.93 2.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.22 -150.43 37.08 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.527 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.05 -23.74 22.86 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.566 2.177 . . . . 0.0 112.388 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 20.6 m95 -101.54 150.21 23.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.988 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -142.34 151.76 42.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.804 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 18.7 pt -127.44 158.36 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.173 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.24 128.85 10.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.974 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 tp -120.28 129.2 53.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.929 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.88 139.75 50.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.025 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -133.02 155.43 49.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -115.88 109.73 18.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.756 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -110.86 149.29 30.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -137.32 139.96 41.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.798 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.456 ' N ' ' HD3' ' A' ' 54' ' ' PRO . . . -139.05 61.78 0.57 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.568 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.456 ' HD3' ' N ' ' A' ' 53' ' ' GLY . 4.0 Cg_exo -76.58 177.93 8.21 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.859 2.372 . . . . 0.0 111.986 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.1 t -65.65 129.14 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.953 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -57.33 155.72 8.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.995 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -131.81 159.2 39.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.0 m -112.44 118.42 35.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.783 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -140.19 -47.12 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.106 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 120.94 41.53 0.51 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.483 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.6 tttt 60.2 73.13 0.49 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.883 0.373 . . . . 0.0 110.892 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.86 30.87 3.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.856 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.98 152.86 24.9 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.436 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 p -115.36 149.21 38.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 0.0 110.871 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.5 165.92 23.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.809 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -144.37 133.51 22.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.031 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.57 144.22 51.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.763 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -123.57 95.86 44.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.979 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.01 125.93 9.64 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.53 2.153 . . . . 0.0 112.178 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -127.74 118.49 23.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.057 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 mp -102.48 165.09 11.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.734 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -160.81 138.19 9.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.126 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.3 t -123.95 115.93 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.797 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -102.03 123.97 46.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.161 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -114.15 123.08 48.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.656 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -65.52 122.9 18.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.053 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -66.09 132.12 47.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.911 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 tp -161.25 140.57 10.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -176.72 -40.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.83 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -143.82 -169.29 3.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.853 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.74 -37.97 48.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.925 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -112.93 -32.24 6.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.022 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -92.43 137.49 32.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.921 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.6 m -145.26 173.2 12.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.404 ' CD2' ' O ' ' A' ' 117' ' ' ASP . 6.5 t80 -162.39 117.08 1.84 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.919 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.67 -162.3 21.35 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.548 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 tp -160.38 116.3 2.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.823 0.344 . . . . 0.0 110.968 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.1 m -111.23 107.81 17.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.827 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -102.93 176.24 24.65 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -172.23 163.15 35.32 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.571 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 92' ' ' ARG . 13.0 t80 -135.12 153.97 51.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.808 0.337 . . . . 0.0 110.862 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.425 ' N ' ' CD1' ' A' ' 91' ' ' PHE . 1.9 ttt180 -149.12 129.89 14.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -137.15 158.9 43.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -132.66 138.98 47.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.69 173.28 39.97 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.533 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -65.84 164.09 15.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.922 0.391 . . . . 0.0 110.829 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -117.59 -178.82 3.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.21 31.54 0.92 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.58 -42.93 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.118 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.89 -34.8 26.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -145.4 84.85 8.26 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.915 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.53 130.55 19.82 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.57 2.18 . . . . 0.0 112.305 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 141.22 -124.87 2.63 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.556 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -114.03 32.89 5.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.85 0.357 . . . . 0.0 110.936 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -88.18 108.76 19.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 p -111.38 166.19 11.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -141.66 162.32 35.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.076 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -140.51 111.13 6.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 47.7 mtt -113.85 134.02 55.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.999 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.4 96.67 5.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.778 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.53 131.52 52.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.965 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -122.23 143.23 49.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.789 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -140.61 131.97 26.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.049 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.6 mp -139.34 147.0 24.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.951 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.58 85.96 5.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.237 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.14 170.49 3.89 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.613 2.209 . . . . 0.0 112.159 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.404 ' O ' ' CD2' ' A' ' 85' ' ' PHE . 7.1 m-20 -131.58 149.77 52.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.823 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -141.52 125.94 17.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.919 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -112.01 135.04 53.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.4 t -142.58 121.74 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.179 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.04 123.44 49.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.4 mp -117.76 -41.15 2.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.56 168.86 11.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.973 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.76 -41.23 96.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.923 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -113.4 36.36 3.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.3 tp -139.27 102.07 4.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.933 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -110.29 123.05 49.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -97.62 149.34 22.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -138.05 135.85 36.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.962 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -117.56 117.17 3.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.508 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -116.2 136.7 52.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 0.0 110.93 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.34 151.63 44.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.82 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.51 130.21 53.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.859 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.4 mtt -150.93 117.84 5.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.423 ' CD2' ' N ' ' A' ' 135' ' ' TYR . 4.9 m-85 -129.2 149.36 51.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -132.99 119.91 20.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.951 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -115.01 135.26 54.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -166.76 135.28 2.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.098 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -96.04 -41.05 8.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.943 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -174.73 -40.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.7 mp -89.16 -31.46 17.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -67.58 -21.89 65.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.223 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.3 t -54.71 -41.57 70.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.092 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 8.9 t -97.34 -32.78 11.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.924 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -61.78 -51.39 57.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.5 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 59.88 93.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.849 0.357 . . . . 0.0 110.87 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -163.41 158.54 21.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.125 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.5 t0 61.03 32.99 19.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.863 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.76 160.66 31.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.852 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -109.86 129.73 55.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.981 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.1 p -152.0 124.3 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.056 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -142.51 155.45 45.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.3 m -117.83 130.28 56.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.849 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.0 132.28 53.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.3 m -109.28 158.42 17.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -142.65 126.02 2.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.422 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.1 mp -115.98 142.46 46.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.788 0.328 . . . . 0.0 110.856 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -124.98 126.76 45.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -138.49 100.15 4.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.83 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.2 p -80.84 128.2 33.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.955 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -104.06 -31.94 9.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.659 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -154.91 165.54 36.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.62 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -69.0 -12.18 61.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.342 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.0 p -113.43 -17.9 12.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.588 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 28.7 m -139.35 147.86 24.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.922 0.391 . . . . 0.0 111.466 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -146.91 179.92 7.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.119 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.1 tp -135.53 138.02 42.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.959 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.423 ' HB3' ' CE2' ' A' ' 196' ' ' TYR . 2.3 ttp180 -144.08 149.45 36.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.071 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.3 m -147.24 139.84 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.992 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.79 161.34 19.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.981 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.01 151.89 43.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.737 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -127.41 128.36 45.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.046 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.91 105.21 5.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.729 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -89.63 156.05 18.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -150.42 120.92 7.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.799 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -140.38 154.95 24.4 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.509 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -111.86 130.05 55.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.759 0.314 . . . . 0.0 110.919 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -125.6 157.76 36.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.86 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.84 -51.64 6.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -176.55 152.82 1.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.48 -63.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 64.8 m -134.72 -71.38 0.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.975 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -128.3 33.23 4.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.911 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -67.5 93.33 0.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.921 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.72 -63.75 1.03 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -154.68 -43.95 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.532 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -144.09 130.17 19.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.823 0.344 . . . . 0.0 110.977 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -105.07 129.24 53.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 72.8 p -131.58 130.9 42.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.004 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.92 162.96 13.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.728 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -132.02 122.11 24.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.17 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -140.59 155.59 46.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.637 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 11.8 tt -142.08 141.53 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.971 0.415 . . . . 0.0 111.368 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -128.75 155.36 45.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.436 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.1 130.7 14.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.994 0.426 . . . . 0.0 111.499 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.432 ' HB3' ' CD2' ' A' ' 209' ' ' TYR . 3.0 p90 -140.15 168.58 19.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.339 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 207' ' ' THR . 0.1 OUTLIER -120.02 109.4 37.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.325 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.33 120.68 4.11 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.382 2.055 . . . . 0.0 112.418 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 5.3 mp -125.79 134.42 51.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.955 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.05 103.94 6.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.904 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 5.7 tt -119.39 96.56 5.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.991 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 56.35 -116.02 6.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.521 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -99.03 29.78 3.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.855 0.36 . . . . 0.0 110.913 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.85 121.99 22.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.766 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.81 128.49 50.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.072 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.3 m -144.27 129.73 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.606 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 57.1 m -138.67 93.17 11.04 Favored Pre-proline 0 C--N 1.327 -0.386 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.681 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.453 ' HD2' ' O ' ' A' ' 197' ' ' LEU . 58.6 Cg_endo -71.82 137.98 30.71 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.308 2.006 . . . . 0.0 112.001 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.432 ' CD2' ' HB3' ' A' ' 196' ' ' TYR . 6.7 m-85 -111.04 136.46 50.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.808 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 35.8 p -127.14 143.32 51.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.865 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.93 143.19 27.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 1.6 pt -66.24 109.94 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -94.94 -45.84 3.01 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.532 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.89 141.02 49.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 110.903 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 9.6 mmt85 -89.69 -61.19 1.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -103.63 138.86 39.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 48.7 m -91.11 153.08 20.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.897 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -142.74 -67.15 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.843 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -98.51 177.05 30.56 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.479 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.24 97.4 6.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 110.885 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -172.76 48.23 0.17 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.485 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -74.41 108.04 6.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 0.0 110.882 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -95.26 -46.77 6.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.85 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 59.77 32.95 21.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.984 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -153.7 158.68 41.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.924 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -147.47 -47.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 24.5 t -80.0 -68.94 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.045 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 136.13 -154.74 22.07 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.613 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 1.9 mt -116.71 121.41 41.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.769 0.319 . . . . 0.0 110.941 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -93.78 123.63 37.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 242' ' ' SER . 6.2 m-85 -112.74 155.45 24.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -168.76 117.01 0.69 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.982 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . 0.427 ' CZ ' ' HB ' ' A' ' 241' ' ' VAL . 39.1 p90 -148.03 144.76 28.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.87 0.367 . . . . 0.0 111.246 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -103.56 131.15 50.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.822 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -69.83 -12.8 61.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.358 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -176.09 47.43 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.918 0.389 . . . . 0.0 111.033 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.55 25.96 10.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.985 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -139.51 -71.3 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.377 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.419 ' HG ' ' CD1' ' A' ' 269' ' ' TYR . 8.6 mp -83.39 107.37 15.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.72 0.295 . . . . 0.0 110.833 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 4.8 m -92.59 153.13 19.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.983 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . 0.427 ' HB ' ' CZ ' ' A' ' 233' ' ' TYR . 29.9 t -131.9 122.64 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.77 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 231' ' ' TYR . 1.5 m -107.77 151.17 26.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.231 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.25 131.14 17.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.875 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -117.85 124.24 47.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.849 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -147.25 146.88 29.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -152.48 -70.46 0.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.051 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 61.31 115.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.964 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -75.88 171.64 14.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.936 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -98.28 166.11 11.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.915 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -170.15 167.97 8.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.842 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -91.15 50.77 1.82 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' HIS . . . . . 0.413 ' CD2' ' HA3' ' A' ' 255' ' ' GLY . 0.3 OUTLIER -140.91 86.05 2.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.923 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.4 -54.7 6.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -90.15 51.93 2.15 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . 0.413 ' HA3' ' CD2' ' A' ' 252' ' ' HIS . . . -147.87 39.26 1.02 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.531 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -155.32 132.91 11.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.813 0.34 . . . . 0.0 110.913 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.9 p -146.5 -61.84 0.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.821 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -158.51 94.42 1.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.806 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.89 155.36 12.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.785 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 66.82 -70.27 0.11 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.045 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 3.2 m80 64.25 101.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.893 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -113.45 77.46 1.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.887 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -143.38 113.3 7.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.151 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -84.57 150.85 25.98 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.484 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 14.3 m -136.84 135.74 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.807 0.336 . . . . 0.0 111.193 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -146.98 163.53 28.62 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.425 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 6.1 m -142.7 148.94 19.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.0 111.137 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -131.94 142.57 49.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.787 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . 0.419 ' CD1' ' HG ' ' A' ' 239' ' ' LEU . 4.8 m-85 -130.65 105.56 7.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 7.1 m -100.88 124.11 46.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 9.3 t80 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.859 179.95 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.798 0.332 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.35 111.27 1.88 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.935 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -92.84 73.48 4.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -170.27 156.47 5.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.977 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.04 37.96 1.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.94 116.1 6.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.882 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -134.25 141.73 47.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -119.8 166.42 13.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -165.11 128.03 2.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.8 tt -129.69 122.87 55.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.139 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.59 155.68 22.72 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.437 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -127.88 163.88 23.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.748 0.308 . . . . 0.0 111.179 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.98 140.02 29.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.886 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -142.68 110.43 5.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -139.7 138.68 36.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.5 mp -119.8 152.46 22.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.113 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -133.46 151.84 51.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.77 140.14 29.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.929 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.1 m -121.9 127.36 75.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.146 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 60.17 -178.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.923 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -159.24 45.7 0.44 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.507 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -90.15 -63.61 1.25 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.752 0.311 . . . . 0.0 110.857 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.4 -45.25 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.484 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -69.5 102.54 1.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.763 0.316 . . . . 0.0 110.911 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.77 31.52 2.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.826 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.2 ttt -99.76 170.09 8.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -95.93 132.41 41.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.944 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.78 -41.1 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.551 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.58 136.01 33.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.881 0.372 . . . . 0.0 110.919 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -131.99 146.63 52.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.059 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -107.59 93.98 11.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.948 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.53 134.82 15.71 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.527 2.152 . . . . 0.0 112.321 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.34 146.06 25.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.887 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.0 m -145.13 162.6 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.041 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -146.23 139.53 25.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.956 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -116.37 164.21 14.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.823 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.66 141.86 22.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.961 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.84 131.51 18.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.04 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.23 121.53 43.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.106 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.02 71.59 1.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.758 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.54 -143.43 46.98 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.356 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.55 -26.36 16.53 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.554 2.169 . . . . 0.0 112.355 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -100.93 127.27 47.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.975 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -109.54 157.16 19.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mp -133.81 141.27 44.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.222 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.91 138.5 44.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.023 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.62 165.1 20.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.982 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.16 149.57 24.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.006 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -137.08 155.98 48.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -153.52 114.99 4.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.787 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -121.66 175.56 6.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.998 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -163.43 129.6 3.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.756 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.62 104.9 0.22 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.466 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.59 154.76 72.6 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.477 2.118 . . . . 0.0 112.315 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.1 m -58.93 111.64 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.17 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.88 133.06 34.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.896 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -89.04 -56.83 3.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.84 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.5 t -134.8 85.4 2.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.95 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.85 174.85 12.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.122 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 159.44 -28.45 0.38 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.485 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.59 -60.06 2.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.767 0.318 . . . . 0.0 110.866 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -88.36 119.78 29.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.806 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -172.9 82.67 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.536 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -60.19 153.01 23.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.765 0.317 . . . . 0.0 110.929 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -109.82 119.03 38.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -138.77 122.63 17.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.934 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.8 137.31 39.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.01 95.95 40.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.956 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.54 155.6 54.73 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.506 2.137 . . . . 0.0 112.29 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.57 125.63 24.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.8 mt -115.18 141.0 48.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.902 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -149.34 146.65 27.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.791 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.7 m -126.09 150.19 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.217 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.24 143.73 50.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.796 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -141.76 144.0 33.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.69 117.53 25.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.944 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -87.4 -57.82 2.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 61.19 155.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -154.42 -46.79 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -158.62 179.69 8.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.761 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -74.36 -31.47 62.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.827 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -69.57 -72.44 0.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -96.88 161.58 13.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.957 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.32 173.15 11.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.801 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -162.27 152.67 16.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.916 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.77 -177.31 35.67 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.526 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.56 138.56 26.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 110.984 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.0 m -138.66 124.96 20.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -121.09 174.02 15.71 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.481 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.68 148.82 12.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.429 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -142.23 129.47 21.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.837 0.351 . . . . 0.0 110.895 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -109.76 145.38 36.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -164.28 125.57 2.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.871 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -132.77 122.13 24.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.934 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.03 143.3 6.46 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.563 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -129.35 146.54 51.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.845 0.355 . . . . 0.0 110.896 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -163.67 41.05 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.896 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -89.37 53.38 2.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.853 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.5 m -136.59 166.74 25.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.127 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -100.08 -31.28 11.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.21 101.2 47.24 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.02 138.19 43.25 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.316 2.011 . . . . 0.0 112.299 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -96.35 34.13 5.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.513 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.1 mttm 60.15 41.76 16.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.857 0.36 . . . . 0.0 110.935 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.51 109.11 4.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.45 171.23 14.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.865 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -141.45 128.47 20.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.102 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -130.7 107.86 9.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -146.09 160.08 42.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -143.77 110.46 5.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.938 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -110.6 111.86 23.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 44.5 t-105 -107.92 142.97 37.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.853 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -138.27 137.5 37.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.11 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.1 tp -152.78 133.18 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.29 113.05 2.46 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.224 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.8 154.57 53.9 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.428 2.086 . . . . 0.0 112.24 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -106.11 134.95 48.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.947 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -134.59 127.21 30.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.12 138.18 53.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.766 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.2 m -147.98 121.23 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.5 140.95 29.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.835 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.8 mt -119.88 -77.1 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.34 -172.82 3.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.875 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.46 23.2 12.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.161 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.7 t70 57.01 31.27 19.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.182 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 pp -122.22 136.12 54.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.921 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 -102.76 132.91 48.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.918 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.414 ' CD1' HD11 ' A' ' 157' ' ' LEU . 0.1 OUTLIER -84.87 125.34 32.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.412 ' HB3' ' CZ3' ' A' ' 131' ' ' TRP . 2.9 m-80 -113.8 155.66 25.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.977 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.28 135.88 2.8 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.443 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . 0.412 ' CZ3' ' HB3' ' A' ' 129' ' ' ASN . 17.4 p90 -162.76 131.98 4.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.779 0.323 . . . . 0.0 110.912 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.1 pp -100.44 136.01 40.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.3 t -103.9 152.22 22.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.07 122.85 26.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -104.16 141.24 36.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.908 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -133.3 110.43 10.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -81.17 -175.34 5.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -81.43 -168.4 1.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.024 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -80.16 -30.97 38.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.071 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.21 -29.38 8.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.961 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.6 tp -72.62 -24.6 61.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.114 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -72.14 -27.42 62.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.173 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 48.2 p -71.2 -56.42 6.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.216 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 8.3 m -84.62 -27.82 26.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.239 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.17 -52.93 46.26 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.671 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -177.71 -72.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.806 0.336 . . . . 0.0 110.918 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -143.55 -169.72 3.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.038 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.87 -45.18 12.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 37.4 p -126.67 155.1 43.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 25.9 mtp180 -133.09 123.48 25.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.36 115.27 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.094 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -114.94 151.4 34.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 33.1 m -128.58 128.31 43.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.818 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.405 ' HB2' ' CD1' ' A' ' 131' ' ' TRP . 0.8 OUTLIER -122.36 145.21 48.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.004 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.57 138.38 25.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.769 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -137.57 171.69 23.11 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.48 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.414 HD11 ' CD1' ' A' ' 128' ' ' PHE . 1.0 OUTLIER -141.44 117.37 10.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.803 0.335 . . . . 0.0 110.854 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -92.75 121.8 34.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.937 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -126.83 104.09 7.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.73 125.59 51.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.95 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -102.79 -31.22 10.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.795 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.32 -178.12 7.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.703 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -87.43 6.15 35.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.4 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 51.5 p -115.73 -32.25 5.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.648 0.261 . . . . 0.0 111.162 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.2 136.06 57.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.311 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -139.16 179.24 6.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.002 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.42 141.33 45.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.011 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.31 107.51 4.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.837 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.5 m -106.21 155.0 7.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.07 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -135.72 156.05 49.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.993 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.01 106.47 5.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.821 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -90.06 134.78 34.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.926 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 8.2 tt -153.65 105.24 2.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.772 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -104.22 166.09 10.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.998 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -145.92 151.31 37.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.769 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -139.19 151.98 22.1 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.492 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -120.35 157.72 28.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 110.876 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.3 151.71 20.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.859 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 2.1 ttt -73.58 -47.68 38.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.924 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -176.03 82.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.969 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -170.39 -60.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.922 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.2 m -74.65 80.56 2.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.03 30.36 5.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.38 -46.4 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.916 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -58.78 166.94 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -90.49 49.77 3.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.589 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 45.3 -168.44 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.823 0.344 . . . . 0.0 111.391 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -93.36 130.83 38.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.3 111.37 6.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.882 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.69 155.57 29.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.802 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -148.84 142.15 25.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.956 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -143.0 144.13 32.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.768 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 27.3 mt -105.65 138.37 31.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.263 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.08 109.69 4.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.766 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -106.53 136.96 45.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.255 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' TYR . . . . . 0.416 ' CD2' ' HB3' ' A' ' 209' ' ' TYR . 28.0 m-85 -140.47 123.3 16.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.615 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.408 ' N ' ' CD1' ' A' ' 197' ' ' LEU . 2.3 mp -111.02 109.64 57.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.055 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.48 120.64 4.47 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.491 2.128 . . . . 0.0 112.308 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.46 115.24 18.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.836 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.4 m -134.37 118.39 17.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.959 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.64 104.44 5.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 84.85 -117.3 4.47 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.513 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -116.76 30.72 7.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.849 0.357 . . . . 0.0 110.926 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -134.87 117.99 16.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.1 m -104.44 130.23 52.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.974 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.26 124.07 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.779 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 41.9 m -138.78 92.8 11.07 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.477 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.16 143.39 11.31 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.612 2.208 . . . . 0.0 112.185 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.423 ' CZ ' ' HA3' ' A' ' 228' ' ' GLY . 15.1 p90 -111.23 142.38 43.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.983 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 11.6 p -131.58 142.29 49.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -145.06 124.0 12.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.885 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.438 HD12 HG22 ' A' ' 212' ' ' ILE . 16.1 tt -88.22 147.76 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.094 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -107.02 161.83 13.67 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.454 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 5.5 tp -145.75 40.2 1.17 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.827 0.346 . . . . 0.0 110.926 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 15.4 tpt85 -137.98 153.92 49.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -117.91 96.43 5.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 82.0 p -106.08 31.79 4.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 60.61 103.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.723 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 138.8 149.76 5.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.51 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -91.55 152.37 20.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.774 0.321 . . . . 0.0 110.983 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 96.27 64.42 0.94 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.599 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -98.74 30.42 3.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.743 0.306 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 59.31 94.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.921 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -96.24 -30.38 13.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.922 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -177.0 136.03 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.856 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 63.0 104.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 16.0 m -114.02 -29.91 2.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.337 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.423 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . -150.58 166.13 30.17 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.653 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.94 119.85 13.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.709 0.29 . . . . 0.0 111.072 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.89 145.55 25.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.869 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -126.74 148.55 49.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.125 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -137.79 117.08 1.42 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.292 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -102.7 118.09 36.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 111.192 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -123.53 90.49 3.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.417 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -56.83 -17.33 8.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.384 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -176.38 46.23 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.846 0.355 . . . . 0.0 111.172 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.93 23.71 5.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.219 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -122.22 -72.26 0.28 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.248 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.78 107.44 11.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.736 0.303 . . . . 0.0 110.625 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.22 134.13 42.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.948 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . 0.481 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 26.0 t -112.89 148.34 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.689 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 4.7 m -119.21 126.04 50.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.937 0.399 . . . . 0.0 111.052 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' LEU . . . . . 0.402 HD13 ' CD1' ' A' ' 262' ' ' TYR . 9.4 tt -143.86 123.6 13.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.782 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -105.25 157.53 17.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.973 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.36 147.62 41.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.836 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . 60.75 160.34 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.117 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 263' ' ' ALA . 9.4 m-85 -142.52 -58.38 0.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.887 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -146.98 132.6 18.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.893 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -77.71 84.85 4.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.823 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -149.07 145.12 27.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -81.83 87.12 6.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -90.52 -36.08 14.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.904 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.34 147.03 32.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -108.54 107.01 17.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 65.26 -91.87 0.13 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.505 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -63.52 148.28 49.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.751 0.31 . . . . 0.0 110.899 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.17 141.48 29.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.875 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.16 30.66 7.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 20.4 tttp -72.14 114.41 10.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -153.09 -46.82 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -62.52 -171.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.836 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.402 ' CD1' HD13 ' A' ' 243' ' ' LEU . 94.2 m-85 -100.76 177.87 4.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.939 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ALA . . . . . 0.418 ' HB3' ' CE1' ' A' ' 247' ' ' PHE . . . -94.18 -64.72 1.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.997 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -126.75 156.91 20.29 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.482 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 4.9 m -141.24 152.93 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.914 0.388 . . . . 0.0 111.139 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -163.83 173.2 39.86 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.49 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 21.4 t -145.26 152.82 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.776 0.322 . . . . 0.0 111.185 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -142.33 125.37 16.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -127.34 120.81 29.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.923 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.2 p -90.81 141.06 29.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.827 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.884 0.373 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 60.85 103.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.96 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.642 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 21.5 t60 -148.93 136.8 20.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.854 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -116.07 152.12 34.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -143.1 117.52 9.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.757 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.608 HG22 ' HD2' ' A' ' 36' ' ' PHE . 1.2 pp -128.39 132.29 68.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.01 170.65 27.14 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.467 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.661 ' HB3' HG22 ' A' ' 267' ' ' VAL . . . -137.47 177.13 8.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.827 0.346 . . . . 0.0 111.031 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.8 tpp -159.25 137.22 10.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.974 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -147.15 161.78 40.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.885 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.7 mp . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.886 0.374 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.85 131.41 55.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.064 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -115.31 94.0 37.85 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.982 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.51 128.44 12.71 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.527 2.151 . . . . 0.0 112.34 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.6 m -122.39 150.35 42.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.875 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 35' ' ' TYR . 21.5 t -123.01 158.79 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.063 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.476 ' N ' HG12 ' A' ' 34' ' ' VAL . 47.4 m-85 -143.02 133.8 25.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.013 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.608 ' HD2' HG22 ' A' ' 10' ' ' ILE . 41.6 m-85 -132.34 116.06 16.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.551 ' OD1' ' HB2' ' A' ' 46' ' ' ALA . 1.7 m-80 -118.55 133.27 55.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.924 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.24 123.8 44.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 7' ' ' HIS . . . -107.49 116.31 31.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -136.72 83.52 2.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.803 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.63 -137.34 36.89 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.364 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.45 -21.37 46.83 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.408 2.072 . . . . 0.0 112.312 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.3 m95 -94.82 115.21 27.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.884 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -117.36 116.32 26.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mp -95.33 142.77 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.171 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.551 ' HB2' ' OD1' ' A' ' 37' ' ' ASN . . . -145.36 126.9 15.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.051 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.614 ' HB3' HD23 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -139.66 153.61 47.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.958 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -142.56 141.36 32.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.964 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -119.95 152.12 37.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.975 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -116.77 165.76 12.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.853 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.93 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.5 p90 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.745 0.307 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.24 164.8 14.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.834 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -136.82 95.81 12.1 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.67 130.53 17.17 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.541 2.161 . . . . 0.0 112.263 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -128.67 132.23 48.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.614 HD23 ' HB3' ' A' ' 47' ' ' LEU . 35.8 mt -127.76 167.05 17.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.784 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 46' ' ' ALA . 17.9 mt-10 -159.29 151.28 20.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.033 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.01 111.37 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.025 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -98.81 132.7 43.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.851 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -135.47 135.84 40.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.795 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -103.12 121.08 41.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -98.8 -50.39 4.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.17 162.66 0.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.806 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -160.85 -58.86 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.841 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.8 164.91 27.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -63.36 -36.49 83.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.959 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.73 -59.88 2.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.979 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.889 ' CE1' HG13 ' A' ' 120' ' ' VAL . 5.3 m-85 -100.72 128.62 46.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.4 m -109.81 170.02 8.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.873 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.54 156.73 46.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -170.03 168.83 41.73 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.551 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 tp -138.53 125.04 20.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.349 . . . . 0.0 110.836 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.62 146.57 43.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.63 174.49 21.28 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.535 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.74 150.63 17.88 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.496 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -133.34 116.19 15.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.876 0.369 . . . . 0.0 110.862 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.64 135.58 54.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -149.91 133.49 16.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -126.61 133.27 51.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.003 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.429 -179.93 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.829 0.347 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -147.04 118.07 7.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.922 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -147.72 150.55 34.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.818 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.426 ' HB2' ' CD1' ' A' ' 137' ' ' PHE . 16.9 mt-30 -132.37 177.36 7.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.029 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.8 mtp85 -148.64 114.92 5.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.893 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.409 ' HB2' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -95.35 130.09 42.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.776 0.322 . . . . 0.0 110.474 179.587 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -104.03 126.72 51.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.011 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.6 mp -140.8 104.41 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.949 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.62 ' HB2' ' HA ' ' A' ' 133' ' ' SER . . . -142.88 100.78 5.42 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.182 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.3 161.2 46.83 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.35 2.033 . . . . 0.0 112.155 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.07 134.79 48.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.98 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -129.05 134.55 48.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.736 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.16 141.51 51.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.959 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.889 HG13 ' CE1' ' A' ' 83' ' ' PHE . 21.6 t -143.44 113.16 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -97.0 110.78 23.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 tp -95.0 -31.94 13.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.8 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 124' ' ' ASP . 0.3 OUTLIER -153.5 176.01 12.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.722 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.498 ' H ' HG22 ' A' ' 123' ' ' THR . 0.7 OUTLIER -72.77 -19.86 61.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.18 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.627 ' O ' HD23 ' A' ' 126' ' ' LEU . 0.3 OUTLIER -119.52 30.2 7.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.748 0.308 . . . . 0.0 111.136 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.627 HD23 ' O ' ' A' ' 125' ' ' ASP . 60.0 mt -149.55 109.22 4.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.899 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.515 ' O ' HD23 ' A' ' 157' ' ' LEU . 5.7 mtt180 -114.72 119.31 36.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.843 ' CE2' HD11 ' A' ' 157' ' ' LEU . 55.0 m-85 -103.03 148.4 25.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.983 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -158.48 140.58 14.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 155' ' ' THR . . . -151.05 147.87 18.34 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.587 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 42.2 p90 -159.87 134.43 7.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.734 0.302 . . . . 0.0 110.903 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.3 mp -102.81 126.22 49.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.99 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.62 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 88.4 p -92.83 114.54 27.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.969 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.774 ' HG3' HG12 ' A' ' 151' ' ' VAL . 9.8 ttm -106.94 141.36 38.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.848 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.06 115.75 18.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.98 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.5 ' HE3' HG22 ' A' ' 149' ' ' THR . 13.1 mttp -149.21 132.51 16.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.835 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 110' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.222 0 CA-C-O 120.848 0.356 . . . . 0.0 111.104 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.5 HG22 ' HE3' ' A' ' 136' ' ' LYS . 11.3 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.699 0.285 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -163.07 166.35 23.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.093 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.774 HG12 ' HG3' ' A' ' 134' ' ' MET . 30.1 m -107.99 141.64 22.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -119.66 158.72 25.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.727 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.5 m -132.05 120.44 22.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.064 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -134.79 107.21 7.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.723 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' ' 171' ' ' TYR . 6.1 t -92.37 168.69 11.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -158.25 120.66 0.99 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.556 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.843 HD11 ' CE2' ' A' ' 128' ' ' PHE . 0.2 OUTLIER -113.27 152.64 29.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.776 0.322 . . . . 0.0 110.867 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -128.84 123.81 33.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.065 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.442 ' CZ ' HD22 ' A' ' 157' ' ' LEU . 24.8 m-85 -120.53 117.32 27.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.86 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.9 118.81 19.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.928 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.66 -63.59 1.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.917 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -125.79 176.06 7.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -64.89 -30.68 71.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.004 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 43.0 p -120.21 27.25 8.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.044 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 23.0 t -153.72 125.21 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.038 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.817 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -126.8 169.63 13.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.276 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.561 HD12 ' HB3' ' A' ' 197' ' ' LEU . 0.4 OUTLIER -135.19 145.16 47.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.795 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -139.04 136.12 34.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.022 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 170' ' ' ASN . 29.5 t -119.0 158.98 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.981 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.49 ' N ' HG12 ' A' ' 169' ' ' VAL . 0.4 OUTLIER -153.53 133.12 12.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.026 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.544 ' HE2' HD21 ' A' ' 173' ' ' LEU . 23.5 t80 -116.36 111.2 19.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.709 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -89.87 135.64 33.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.086 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.544 HD21 ' HE2' ' A' ' 171' ' ' TYR . 22.8 mt -132.13 113.16 12.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.718 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -89.05 148.95 23.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.29 148.41 36.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.901 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -149.84 144.59 12.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.568 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 54.0 t80 . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 0.0 110.874 179.946 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.805 0.336 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.2 m -132.42 100.14 4.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 2.4 m -106.65 150.51 26.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.9 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -130.42 132.14 45.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -135.61 120.99 19.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.754 HD12 HD11 ' A' ' 212' ' ' ILE . 24.8 mt -91.41 128.7 42.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.218 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.38 125.21 14.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.645 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -135.63 154.55 51.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.968 0.413 . . . . 0.0 111.533 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -143.16 148.5 36.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.342 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.561 ' HB3' HD12 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -114.04 109.46 49.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.272 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.817 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 70.0 Cg_endo -74.43 121.68 6.95 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.393 2.062 . . . . 0.0 112.312 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.65 105.87 13.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.866 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 7.0 p -99.25 116.29 31.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.24 103.7 3.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.942 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 59.17 -132.18 52.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.534 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -98.58 30.84 3.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.783 0.325 . . . . 0.0 110.901 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' HIS . . . . . 0.417 ' ND1' HG13 ' A' ' 206' ' ' VAL . 58.1 t-80 -129.96 116.83 19.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.699 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.71 123.95 49.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.983 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.493 ' O ' HG23 ' A' ' 206' ' ' VAL . 15.8 m -141.76 109.71 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.828 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.507 HG23 ' C ' ' A' ' 197' ' ' LEU . 18.6 m -117.49 92.66 41.26 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.305 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' A' ' 197' ' ' LEU . 23.1 Cg_exo -64.79 147.77 89.77 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.512 2.142 . . . . 0.0 111.933 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -111.18 134.7 52.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.852 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.3 p -107.5 138.24 44.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.949 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.2 118.13 8.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.754 HD11 HD12 ' A' ' 193' ' ' ILE . 2.1 pt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.106 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.541 -0.224 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.671 HD13 ' N ' ' A' ' 230' ' ' PHE . 0.5 OUTLIER -154.92 127.35 7.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 0.0 110.882 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.671 ' N ' HD13 ' A' ' 229' ' ' LEU . 1.7 t80 -111.13 118.74 36.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.843 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' TYR . . . . . 0.404 ' HE2' ' CE1' ' A' ' 204' ' ' HIS . 35.5 t80 -100.83 160.63 14.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -164.34 117.02 0.73 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.157 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -133.66 124.25 26.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 110.891 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -123.38 101.37 7.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.793 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -75.98 -1.39 25.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.23 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -149.35 26.23 0.86 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.72 0.295 . . . . 0.0 111.106 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 2.2 m120 64.74 -75.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.137 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -52.93 -50.04 52.41 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.727 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.99 122.63 32.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.754 0.311 . . . . 0.0 110.88 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 4.0 t -135.39 174.93 10.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.969 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 241' ' ' VAL . 27.6 m -137.32 122.61 25.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.815 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 5.0 m -107.77 139.57 42.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.121 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.631 HD11 HG13 ' A' ' 265' ' ' VAL . 1.4 mp -132.22 129.59 39.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.781 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.26 121.08 43.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 263' ' ' ALA . 0.1 OUTLIER -123.87 136.05 54.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.781 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.1 -179.899 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ALA . . . . . 0.406 ' HB2' ' CE2' ' A' ' 245' ' ' TYR . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.73 0.3 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -156.2 152.07 23.51 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.546 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.631 HG13 HD11 ' A' ' 243' ' ' LEU . 17.8 t -135.54 143.52 36.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.808 0.337 . . . . 0.0 111.123 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -154.99 167.18 32.71 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.494 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.661 HG22 ' HB3' ' A' ' 12' ' ' ALA . 31.5 m -124.98 160.42 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 0.0 111.09 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -147.4 139.78 24.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -144.66 156.87 44.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 53.2 p -134.48 140.66 46.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.855 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.1 t0 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.834 0.349 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -172.0 159.66 5.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -148.88 109.37 4.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.898 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -97.18 136.39 37.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -147.18 121.74 9.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.572 HG22 ' HD2' ' A' ' 36' ' ' PHE . 2.1 pp -126.19 129.57 72.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.1 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.96 172.19 22.73 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.543 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.29 142.85 10.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.841 0.353 . . . . 0.0 111.087 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.7 ttm -116.9 158.13 24.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -144.88 130.66 19.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.919 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.95 179.961 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.4 mp . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 120.864 0.364 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.9 128.2 32.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.146 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.62 94.15 48.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.72 178.8 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.503 2.135 . . . . 0.0 112.236 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.64 128.53 8.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.577 HG11 ' CZ ' ' A' ' 36' ' ' PHE . 16.4 t -108.72 159.31 8.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.185 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.468 ' N ' HG12 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -148.83 127.89 12.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.577 ' CZ ' HG11 ' A' ' 34' ' ' VAL . 51.2 m-85 -121.49 147.41 45.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -146.36 143.22 28.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.11 134.74 23.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.975 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.597 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -109.66 147.52 32.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.109 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -174.19 120.52 0.27 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.881 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.37 -149.42 48.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.496 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.426 ' HG2' ' CE3' ' A' ' 43' ' ' TRP . 92.1 Cg_endo -78.93 0.99 9.54 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.656 2.237 . . . . 0.0 112.87 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.426 ' CE3' ' HG2' ' A' ' 42' ' ' PRO . 14.7 p90 -127.48 170.36 12.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.81 0.338 . . . . 0.0 111.045 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -141.08 154.07 45.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.5 mt -121.0 127.26 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.063 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -122.14 148.31 45.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.067 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.6 tp -139.52 164.33 30.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.009 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.568 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -147.82 147.95 30.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.062 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -128.26 153.16 47.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -116.51 151.14 36.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 -179.935 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.845 0.355 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.76 165.99 24.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.86 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.75 95.96 6.23 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.22 135.86 35.64 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.405 2.07 . . . . 0.0 112.259 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -115.58 129.63 56.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.6 mt -116.37 143.05 46.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 3.4 mm-40 -146.51 136.23 23.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.7 t -116.26 149.71 18.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.066 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -131.96 139.11 48.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -153.93 145.02 22.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -125.6 111.07 14.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.933 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -67.91 -56.36 9.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.81 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.3 mt 58.65 98.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.956 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -80.82 -62.88 1.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -126.86 -179.11 4.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -71.75 -30.57 65.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -80.26 -49.87 11.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.841 ' CE2' HG13 ' A' ' 120' ' ' VAL . 5.5 m-85 -92.61 167.89 11.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.968 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.7 t -156.88 162.81 39.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.947 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.496 ' CZ ' ' CD1' ' A' ' 118' ' ' TRP . 0.3 OUTLIER -127.73 177.36 6.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.831 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.405 ' O ' HD22 ' A' ' 87' ' ' LEU . . . -172.48 116.35 0.61 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.443 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.868 HD12 HD11 ' A' ' 114' ' ' ILE . 2.3 mm? -123.02 119.34 30.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.371 . . . . 0.0 110.991 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.9 t -125.33 104.81 8.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.745 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -128.28 144.31 15.14 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.488 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -141.37 178.63 20.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.542 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -127.54 118.74 24.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.824 0.345 . . . . 0.0 110.839 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.2 tpt85 -100.77 139.34 36.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -167.35 166.37 14.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -142.62 128.78 19.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.9 0.381 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -141.13 104.34 4.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 56.1 tpp -154.11 143.34 21.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.929 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -138.62 103.93 4.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.8 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -111.91 111.43 22.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.986 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -91.35 130.85 37.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.849 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -130.84 120.24 23.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.052 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.868 HD11 HD12 ' A' ' 87' ' ' LEU . 9.0 tp -146.44 115.55 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.863 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -128.79 93.22 37.92 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.334 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.02 178.03 7.81 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.579 2.186 . . . . 0.0 112.223 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -159.52 134.9 8.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.935 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.496 ' CD1' ' CZ ' ' A' ' 85' ' ' PHE . 0.9 OUTLIER -112.25 126.66 55.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.811 179.852 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.02 113.22 26.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.027 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.841 HG13 ' CE2' ' A' ' 83' ' ' PHE . 25.6 t -119.88 102.11 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.015 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.36 142.45 39.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.014 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.776 ' HB3' HD22 ' A' ' 126' ' ' LEU . 4.7 tt -119.83 -44.41 2.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.69 175.1 11.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -61.16 -31.37 71.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.919 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -116.44 39.96 3.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.776 HD22 ' HB3' ' A' ' 122' ' ' LEU . 2.2 tt -156.86 116.23 3.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.5 mtm-85 -126.12 138.37 53.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.929 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.556 ' CD1' HD12 ' A' ' 157' ' ' LEU . 5.3 t80 -112.46 139.61 47.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.812 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -148.47 143.54 26.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.977 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 144.9 153.06 5.76 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.563 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -172.97 170.93 4.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 0.0 110.813 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.676 HD23 HG23 ' A' ' 153' ' ' THR . 18.9 mt -74.51 132.5 41.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.948 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.5 m -106.91 160.43 15.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 18.0 mtm -142.04 148.24 38.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -154.46 150.31 27.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.22 154.98 42.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.8 p90 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.839 179.924 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.768 0.318 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -109.47 122.72 48.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.925 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.06 117.26 9.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.091 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -124.11 153.78 40.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.011 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.676 HG23 HD23 ' A' ' 132' ' ' LEU . 14.7 m -121.69 123.93 43.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.729 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -116.86 129.76 56.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.986 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 61.5 p -153.41 115.45 4.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.755 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -140.37 -169.37 11.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.776 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.556 HD12 ' CD1' ' A' ' 128' ' ' PHE . 0.3 OUTLIER -139.94 178.12 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.348 . . . . 0.0 110.833 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -140.02 143.56 36.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.9 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.464 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 1.3 t80 -135.25 101.24 4.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.0 m -97.55 108.82 21.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.823 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.464 ' CE2' ' CD1' ' A' ' 159' ' ' TYR . 20.5 m-85 -79.57 -36.99 37.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.95 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -176.53 -165.15 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.78 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -86.58 6.08 32.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.332 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.709 HG23 HG22 ' A' ' 165' ' ' VAL . 8.8 t -93.23 -35.83 12.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.746 0.308 . . . . 0.0 110.943 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.709 HG22 HG23 ' A' ' 164' ' ' THR . 30.5 m -156.81 150.3 9.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.119 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.846 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -131.34 152.24 50.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.15 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.475 HD23 ' H ' ' A' ' 168' ' ' ARG . 0.4 OUTLIER -111.63 146.66 37.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.773 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.475 ' H ' HD23 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -147.22 129.61 15.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.95 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.6 t -131.92 146.63 33.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.978 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -152.41 125.62 8.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.065 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -95.76 161.23 14.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.737 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -135.58 151.11 49.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.008 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.77 105.19 3.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.762 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -101.57 140.8 35.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.962 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.81 113.11 6.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -124.73 146.7 16.28 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.527 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 4.7 p90 . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.859 0.362 . . . . 0.0 110.815 -179.964 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 28.1 p90 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.845 0.355 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 17.5 t -137.61 142.08 41.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 72.1 p -133.45 147.8 51.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.901 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -118.39 135.09 54.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.85 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -130.09 140.92 50.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.727 HD11 HD11 ' A' ' 212' ' ' ILE . 46.1 pt -119.05 138.97 48.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.185 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.75 113.58 11.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.891 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -120.72 116.55 25.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.047 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -136.5 131.3 33.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.932 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.403 ' N ' HD23 ' A' ' 197' ' ' LEU . 0.3 OUTLIER -117.35 109.46 42.17 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.722 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.846 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 28.1 Cg_endo -62.76 136.58 58.51 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.439 2.092 . . . . 0.0 112.393 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.574 HD22 HD11 ' A' ' 201' ' ' LEU . 0.2 OUTLIER -115.62 101.27 8.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.772 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 8.8 t -78.12 127.07 31.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.574 HD11 HD22 ' A' ' 199' ' ' LEU . 4.2 mp -139.84 148.06 41.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -81.88 58.3 4.92 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.503 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -179.8 -62.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.872 0.368 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -136.15 137.93 41.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.863 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 10.5 m -90.54 140.05 30.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.487 ' CG1' HD12 ' A' ' 229' ' ' LEU . 21.7 t -128.28 111.37 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.033 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.93 92.89 5.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.01 171.84 16.7 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.621 2.214 . . . . 0.0 112.294 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -158.05 161.56 38.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.863 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.7 m -139.9 116.1 10.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.3 mtt180 -139.41 134.89 33.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.063 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.727 HD11 HD11 ' A' ' 193' ' ' ILE . 32.4 mt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.125 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.408 -0.277 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.487 HD12 ' CG1' ' A' ' 206' ' ' VAL . 0.8 OUTLIER -129.86 122.92 29.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.886 0.374 . . . . 0.0 110.938 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -109.89 118.04 35.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.814 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.13 159.4 20.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.064 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -154.42 117.01 0.76 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.045 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.517 ' HB3' HG12 ' A' ' 241' ' ' VAL . 0.2 OUTLIER -132.27 115.61 15.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.714 0.292 . . . . 0.0 111.106 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 240' ' ' SER . 3.6 m-20 -81.36 122.7 27.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -60.88 -15.13 27.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.964 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.98 -39.39 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.826 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 178.55 -60.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.001 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -74.19 -70.27 1.27 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.672 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.585 ' H ' HD23 ' A' ' 239' ' ' LEU . 1.2 pt? -66.35 146.84 54.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.718 0.294 . . . . 0.0 110.832 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -148.49 176.87 9.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.274 -179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.517 HG12 ' HB3' ' A' ' 233' ' ' TYR . 11.4 p -122.86 131.32 73.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.831 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 9.8 m -107.6 139.8 41.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.092 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.66 141.93 46.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.972 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -105.25 120.68 42.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.948 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -108.98 143.94 37.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.833 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.074 -179.96 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.829 0.347 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -78.08 144.62 28.76 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.529 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 23.1 t -117.04 119.8 63.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.834 0.349 . . . . 0.0 111.029 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -137.09 160.39 24.95 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.543 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 12.3 m -135.86 153.13 31.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 0.0 111.157 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -152.03 131.9 13.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.49 ' CE1' ' CE2' ' A' ' 271' ' ' PHE . 4.6 t80 -131.01 126.18 35.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 39.5 t -113.68 147.76 37.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' PHE . . . . . 0.49 ' CE2' ' CE1' ' A' ' 269' ' ' TYR . 3.3 m-85 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.933 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.8 t70 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.803 0.335 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -60.0 99.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.471 ' CB ' ' HB3' ' A' ' 39' ' ' ALA . 3.0 t-80 -94.81 146.17 24.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -126.69 137.01 53.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -151.15 131.57 13.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.475 HG23 ' CE2' ' A' ' 36' ' ' PHE . 22.7 mt -130.53 139.33 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.031 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.81 165.07 29.2 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.549 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.566 ' HB3' HG22 ' A' ' 267' ' ' VAL . . . -150.49 170.54 18.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.797 0.332 . . . . 0.0 111.059 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 57.2 mtm -143.27 153.57 42.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.969 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.761 ' HB2' HG23 ' A' ' 265' ' ' VAL . 10.9 m-85 -146.53 106.08 3.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.838 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.915 -179.948 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.841 0.353 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.75 146.66 41.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.083 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.76 93.89 30.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.018 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 14' ' ' TYR . 39.4 Cg_exo -60.52 178.68 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.681 2.254 . . . . 0.0 112.201 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.1 123.57 5.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.967 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.3 138.31 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.091 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -138.92 155.32 48.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.475 ' CE2' HG23 ' A' ' 10' ' ' ILE . 62.5 m-85 -146.5 153.13 40.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -147.35 129.64 15.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.671 ' HB3' HG23 ' A' ' 45' ' ' ILE . . . -134.01 141.9 47.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.006 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.471 ' HB3' ' CB ' ' A' ' 7' ' ' HIS . . . -123.49 116.52 23.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.086 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -126.08 73.78 1.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.789 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.83 -135.58 32.78 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.411 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.31 -20.99 48.31 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.377 2.051 . . . . 0.0 112.346 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -101.57 120.72 40.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.909 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -113.17 153.15 28.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.671 HG23 ' HB3' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -141.71 140.78 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.129 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -137.22 130.04 30.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.977 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.616 HD23 ' HG ' ' A' ' 71' ' ' LEU . 2.8 mt -116.45 166.79 11.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.549 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -165.53 141.5 5.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -122.54 160.2 26.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.946 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -141.51 128.67 20.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.938 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.84 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 66' ' ' PHE . 4.1 p90 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.868 0.366 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -125.23 145.98 49.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.984 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.72 95.79 2.82 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.942 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.47 153.25 44.47 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.506 2.137 . . . . 0.0 112.267 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.549 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -144.38 128.47 17.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.006 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.616 ' HG ' HD23 ' A' ' 47' ' ' LEU . 1.2 mp -132.15 154.18 49.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.832 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -154.82 157.58 38.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.885 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.455 HG23 ' H ' ' A' ' 89' ' ' GLY . 31.6 m -144.69 156.79 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.055 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -134.81 117.68 16.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -103.62 114.43 28.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -83.03 99.38 9.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.66 -54.68 5.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.84 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.8 tp 61.79 152.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -154.42 -60.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.965 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -147.92 -172.72 4.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.92 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -84.01 -32.95 24.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.29 -55.9 20.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.808 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.535 ' HB3' HG12 ' A' ' 120' ' ' VAL . 6.2 p90 -133.67 148.29 51.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.9 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -122.04 160.38 25.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -127.56 164.37 22.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -179.75 -177.65 48.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.482 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.7 155.62 43.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.817 0.341 . . . . 0.0 110.901 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.8 p -142.97 110.12 5.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.455 ' H ' HG23 ' A' ' 73' ' ' VAL . . . -113.98 179.93 18.86 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.505 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -177.71 170.41 42.77 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.471 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -148.59 144.43 27.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.341 . . . . 0.0 110.895 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.8 mtp85 -141.05 174.45 10.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.9 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -151.51 169.31 22.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -138.0 122.16 18.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.441 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.782 0.325 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -129.93 154.69 47.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.829 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.3 mtm -137.95 124.84 21.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.956 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -89.23 135.97 33.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.844 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -123.58 126.7 47.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.027 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -107.12 145.25 32.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.792 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.401 ' HG3' ' CE1' ' A' ' 135' ' ' TYR . 20.6 tttm -139.91 134.3 31.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.034 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.418 ' O ' HG23 ' A' ' 114' ' ' ILE . 2.1 tt -152.76 126.2 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.905 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.597 ' HB2' ' HA ' ' A' ' 133' ' ' SER . . . -150.57 106.35 3.1 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.305 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.86 137.31 34.88 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.452 2.101 . . . . 0.0 112.072 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -105.92 141.05 37.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.024 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 70.4 p-90 -148.64 131.66 16.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.853 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -123.13 143.94 49.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.967 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.535 HG12 ' HB3' ' A' ' 83' ' ' PHE . 30.4 m -144.26 125.59 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.059 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.87 151.71 30.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.891 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.6 tp -124.01 -48.47 1.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.953 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.27 -176.99 5.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.44 132.01 46.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 60.13 32.63 21.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.767 HD23 HD21 ' A' ' 157' ' ' LEU . 0.1 OUTLIER -146.53 107.9 4.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -118.53 137.76 52.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.684 ' CZ ' HD12 ' A' ' 157' ' ' LEU . 2.9 m-85 -102.08 141.19 35.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.834 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -132.32 138.59 47.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.77 147.27 14.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.472 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TRP . . . . . 0.515 ' HE3' ' HB1' ' A' ' 115' ' ' ALA . 26.2 p-90 -173.06 149.5 1.85 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.862 0.363 . . . . 0.0 111.102 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.27 135.74 53.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.617 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.597 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 3.6 t -108.37 153.5 23.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.132 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 53.4 mtp -134.98 118.38 16.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.768 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.401 ' CE1' ' HG3' ' A' ' 113' ' ' LYS . 1.9 m-85 -102.45 133.82 46.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.949 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.839 ' HG3' HG23 ' A' ' 149' ' ' THR . 3.9 mttm -138.73 114.12 9.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.79 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 43.5 p90 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.97 -179.952 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.839 HG23 ' HG3' ' A' ' 136' ' ' LYS . 2.4 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.812 0.339 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -103.06 121.41 42.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.89 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 27.6 m -106.0 129.12 59.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.077 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -110.77 127.61 55.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.858 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.44 114.54 26.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.427 ' HB3' ' CE2' ' A' ' 131' ' ' TRP . 0.6 OUTLIER -121.09 116.39 24.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.851 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.0 m -145.28 145.95 31.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.833 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -163.57 -162.82 15.06 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.53 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.767 HD21 HD23 ' A' ' 126' ' ' LEU . 6.6 tt -151.62 149.9 29.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.845 0.355 . . . . 0.0 110.91 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.453 ' N ' HD23 ' A' ' 157' ' ' LEU . 2.9 mt-30 -118.59 131.7 56.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -127.74 100.16 5.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.701 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 9.4 t -99.81 126.23 45.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.983 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -104.11 -30.09 10.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.775 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -165.36 177.22 7.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.711 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -81.92 0.63 38.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.363 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.605 HG22 ' O ' ' A' ' 200' ' ' THR . 0.2 OUTLIER -111.84 -26.56 8.88 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.653 0.263 . . . . 0.0 111.172 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.75 HG12 ' HG ' ' A' ' 199' ' ' LEU . 28.4 m -145.75 141.52 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.232 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.752 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -150.66 -172.24 4.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.013 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.66 143.24 31.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.627 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.79 145.31 32.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.057 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.645 HG23 ' HB2' ' A' ' 195' ' ' ALA . 11.5 p -144.56 137.88 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.944 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -133.12 155.19 49.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.989 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -127.85 119.35 25.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -96.37 136.1 37.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.002 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.9 125.24 10.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.802 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -111.08 145.59 38.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.949 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.85 117.47 3.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -146.67 169.83 27.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.525 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.774 0.321 . . . . 0.0 110.943 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.818 0.342 . . . . 0.0 110.836 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.7 t -117.16 136.34 53.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 4.0 m -137.12 145.97 44.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -144.4 121.87 11.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.925 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -144.52 136.37 25.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.989 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.524 HD13 ' O ' ' A' ' 212' ' ' ILE . 4.0 mp -107.07 124.97 63.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.132 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -128.23 115.74 18.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.776 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.645 ' HB2' HG23 ' A' ' 169' ' ' VAL . . . -133.49 125.78 29.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.215 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.694 ' HB2' HG22 ' A' ' 207' ' ' THR . 41.8 p90 -121.52 141.36 51.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.722 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.429 ' O ' ' HD2' ' A' ' 208' ' ' PRO . 8.2 tt -105.66 109.31 63.06 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.134 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.752 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 59.0 Cg_endo -71.35 111.21 3.04 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.368 2.046 . . . . 0.0 112.318 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.75 ' HG ' HG12 ' A' ' 165' ' ' VAL . 0.4 OUTLIER -132.76 127.82 35.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.912 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 200' ' ' THR . . . . . 0.605 ' O ' HG22 ' A' ' 164' ' ' THR . 0.7 OUTLIER -137.17 114.16 10.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.09 105.52 7.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.838 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 102.44 -133.3 11.33 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.43 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -105.45 17.18 24.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.721 0.296 . . . . 0.0 111.266 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -136.42 159.89 40.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.791 0.329 . . . . 0.0 110.945 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.35 148.43 47.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.83 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 199' ' ' LEU . 5.8 m -144.17 122.3 6.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.694 HG22 ' HB2' ' A' ' 196' ' ' TYR . 5.2 m -125.04 92.91 46.69 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.123 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 197' ' ' LEU . 26.6 Cg_exo -63.0 171.7 5.8 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.57 2.18 . . . . 0.0 112.178 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.83 143.25 50.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.783 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.97 136.48 49.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.913 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.8 117.69 14.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.939 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.524 ' O ' HD13 ' A' ' 193' ' ' ILE . 7.6 pt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.625 ' O ' HD12 ' A' ' 229' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.375 -0.29 . . . . 0.0 112.375 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 228' ' ' GLY . 0.1 OUTLIER -160.04 141.65 12.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 111.045 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -122.61 145.51 48.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.768 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -112.53 159.47 18.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.04 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -142.87 117.06 1.08 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.097 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -121.13 136.09 55.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.362 . . . . 0.0 110.998 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.1 100.22 7.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.625 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -65.86 -10.67 40.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.22 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.9 37.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.796 0.331 . . . . 0.0 111.005 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 5.0 t30 69.71 -64.97 0.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -52.78 -43.54 60.34 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.738 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.782 HD23 ' N ' ' A' ' 240' ' ' SER . 2.5 tt -87.0 144.77 26.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.762 0.315 . . . . 0.0 110.891 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.782 ' N ' HD23 ' A' ' 239' ' ' LEU . 16.0 m -134.22 151.48 51.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.815 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.477 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 38.9 t -120.98 141.07 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.77 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.88 118.75 31.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.037 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.544 HD23 ' HE2' ' A' ' 245' ' ' TYR . 1.1 mp -120.68 154.95 34.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.702 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -116.76 131.55 56.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.951 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' TYR . . . . . 0.544 ' HE2' HD23 ' A' ' 243' ' ' LEU . 18.6 m-85 -133.32 146.47 51.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.815 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.147 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.791 0.329 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -97.82 161.71 21.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.561 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.761 HG23 ' HB2' ' A' ' 14' ' ' TYR . 4.8 m -144.81 146.56 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 111.119 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -160.92 164.3 34.68 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.453 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.566 HG22 ' HB3' ' A' ' 12' ' ' ALA . 6.7 m -126.78 150.15 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 0.0 111.163 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -143.72 146.45 33.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.835 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -144.11 139.33 28.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.68 147.52 50.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 24.4 t80 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.892 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.883 0.373 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 61.09 84.54 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.864 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 61.5 t60 -105.98 141.51 37.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.998 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -129.59 163.04 26.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.738 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.422 ' C ' HD12 ' A' ' 10' ' ' ILE . 2.0 t30 -160.26 146.32 15.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.997 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.51 HD12 ' N ' ' A' ' 10' ' ' ILE . 3.7 mp -140.81 134.35 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.108 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.81 159.28 24.51 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.571 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.593 ' HB3' ' CG2' ' A' ' 267' ' ' VAL . . . -144.49 138.99 27.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.865 0.364 . . . . 0.0 111.001 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.29 149.1 42.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.993 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -132.15 111.06 11.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 -179.905 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.848 0.356 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.47 153.61 24.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.029 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.68 94.0 46.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.988 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.48 158.0 20.72 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.53 2.153 . . . . 0.0 112.198 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.51 133.89 44.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.819 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.72 142.15 30.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.091 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.88 143.68 43.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.967 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -133.89 132.57 40.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -132.0 125.05 30.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.94 136.73 53.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.019 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.864 ' HB3' ' HB3' ' A' ' 7' ' ' HIS . . . -118.96 122.76 42.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.17 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -139.95 86.39 2.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.0 -143.44 44.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.363 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.62 -14.23 41.41 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.457 2.105 . . . . 0.0 112.486 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.6 134.12 45.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.987 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.23 145.46 49.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 46' ' ' ALA . 30.7 mt -131.46 155.36 41.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.217 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.742 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -160.04 136.48 8.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.112 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.49 ' HG ' HD22 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -124.82 146.62 49.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.979 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.606 ' HB3' ' CB ' ' A' ' 70' ' ' GLU . . . -126.48 134.02 51.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.019 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -126.04 110.19 13.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.994 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.19 138.02 36.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.786 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.933 179.974 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.803 0.335 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.91 124.58 31.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.27 95.85 4.64 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.877 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.06 142.61 24.94 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.536 2.158 . . . . 0.0 112.408 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.606 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . 19.1 mt-10 -137.79 114.79 10.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.899 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.49 HD22 ' HG ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -102.87 133.89 47.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.741 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.742 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 3.7 tt0 -132.68 127.74 35.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.038 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 p -124.9 136.15 61.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.004 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -122.94 129.13 51.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.029 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -125.62 137.66 53.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.799 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -122.15 121.45 36.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -106.39 -43.31 4.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.728 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 59.65 160.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.981 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -141.63 -47.34 0.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.835 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -147.31 174.91 11.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.79 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -75.17 -29.13 60.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.002 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -84.74 -42.34 15.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.986 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.688 ' CE2' HG13 ' A' ' 120' ' ' VAL . 11.7 m-85 -101.6 169.82 8.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.01 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.57 162.43 33.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.797 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -158.12 144.32 17.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.955 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.82 -176.25 47.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.497 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.92 134.06 5.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.815 0.34 . . . . 0.0 110.901 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.61 ' OG1' ' HB3' ' A' ' 115' ' ' ALA . 69.2 p -118.84 159.36 23.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.32 -170.98 15.29 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.488 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 178.08 159.28 22.52 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.515 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -126.29 148.18 49.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.846 0.355 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.1 ttp85 -136.69 133.61 36.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.893 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -132.19 178.91 6.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.773 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -146.52 146.2 30.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.964 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.477 -179.951 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.832 0.348 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -85.14 105.35 15.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.55 148.4 51.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.893 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -156.55 161.76 39.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.85 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.02 109.2 1.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -83.47 140.42 32.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.776 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.54 127.31 17.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.01 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.424 HG22 ' N ' ' A' ' 115' ' ' ALA . 4.6 mt -122.47 154.77 27.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.942 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.61 ' HB3' ' OG1' ' A' ' 88' ' ' THR . . . -147.29 79.74 9.61 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.292 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.8 155.0 19.07 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.562 2.175 . . . . 0.0 112.183 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -122.32 146.15 47.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.008 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -164.99 142.75 6.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.08 151.68 41.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.911 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.688 HG13 ' CE2' ' A' ' 83' ' ' PHE . 23.4 t -147.59 108.23 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -88.35 133.18 34.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.888 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.512 ' O ' HG23 ' A' ' 123' ' ' THR . 3.0 tt -110.99 -32.84 6.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -166.05 -175.07 3.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.833 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -90.99 51.3 1.93 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -165.88 -43.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.43 124.31 51.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -125.29 146.56 49.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.773 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -101.95 146.02 28.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.014 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -125.45 123.32 38.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -110.95 106.77 2.09 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.517 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -133.1 136.18 45.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.788 0.328 . . . . 0.0 110.775 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.3 mt -131.02 161.45 31.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.801 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.3 151.24 49.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.041 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.677 ' SD ' HG12 ' A' ' 151' ' ' VAL . 1.5 mpp? -140.1 133.78 30.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.822 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -130.57 127.72 39.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.971 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.444 ' HA ' HG23 ' A' ' 149' ' ' THR . 3.5 ttpt -146.51 168.1 22.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.774 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.777 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.444 HG23 ' HA ' ' A' ' 136' ' ' LYS . 2.9 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.864 0.364 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -162.91 179.04 7.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.984 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.677 HG12 ' SD ' ' A' ' 134' ' ' MET . 11.1 m -118.19 131.96 69.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.098 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -101.23 169.43 8.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 8.9 m -132.8 140.28 47.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.876 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -135.38 142.91 45.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.32 127.88 23.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.743 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -116.8 142.13 17.24 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.662 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.7 mp -115.23 117.37 30.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.755 0.312 . . . . 0.0 110.787 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -101.26 117.51 35.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.961 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -127.04 102.47 6.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.422 HG22 ' CB ' ' A' ' 166' ' ' ALA . 34.3 p -93.11 128.08 38.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.909 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.07 -31.46 12.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.643 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.584 ' HB2' HG22 ' A' ' 165' ' ' VAL . 7.4 m120 -150.92 174.94 12.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.814 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -76.24 -6.39 51.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.43 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.49 HG23 ' HB2' ' A' ' 201' ' ' LEU . 55.1 m -113.07 -28.95 7.49 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.635 0.255 . . . . 0.0 111.23 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.584 HG22 ' HB2' ' A' ' 162' ' ' ASN . 19.6 m -123.11 139.94 48.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.865 0.364 . . . . 0.0 111.385 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.75 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -141.17 -178.42 5.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.004 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 41.3 tp -141.2 134.73 29.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.934 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 196' ' ' TYR . 51.7 mtt-85 -137.52 114.54 10.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.2 t -99.85 142.67 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.998 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -118.96 123.34 44.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.021 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -116.17 114.85 25.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.723 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -106.43 140.98 38.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.091 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.61 105.17 5.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.689 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.74 145.74 29.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.029 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -136.28 136.16 39.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.752 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -130.51 152.69 19.9 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.498 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 31.1 t80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.359 . . . . 0.0 110.846 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.763 0.316 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.3 m -122.4 105.53 10.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.968 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.31 114.01 27.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.813 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -109.01 129.4 55.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.017 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -118.28 152.56 35.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.79 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.67 HD13 ' H ' ' A' ' 193' ' ' ILE . 0.2 OUTLIER -136.52 148.09 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.267 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -150.31 127.55 11.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.723 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -119.31 117.26 28.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.97 0.414 . . . . 0.0 111.273 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.439 ' HB3' ' CD1' ' A' ' 209' ' ' TYR . 11.5 p90 -138.28 151.24 47.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.592 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.654 HD11 ' HG2' ' A' ' 208' ' ' PRO . 0.3 OUTLIER -118.54 111.23 38.13 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.242 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.75 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 60.5 Cg_endo -72.8 123.29 8.86 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.385 2.056 . . . . 0.0 112.371 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 198' ' ' PRO . 8.7 mt -126.74 104.48 8.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.845 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.3 t -117.12 117.8 30.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.563 HD13 ' N ' ' A' ' 202' ' ' GLY . 0.9 OUTLIER -147.57 121.63 9.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 202' ' ' GLY . . . . . 0.563 ' N ' HD13 ' A' ' 201' ' ' LEU . . . 65.46 -119.8 15.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.534 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -118.43 30.57 7.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.905 0.383 . . . . 0.0 110.93 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.71 110.57 9.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 49.3 m -102.71 128.74 49.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.006 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.521 HG23 ' HB2' ' A' ' 199' ' ' LEU . 18.4 m -144.18 124.06 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.759 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.656 HG22 ' HA ' ' A' ' 198' ' ' PRO . 16.0 p -133.0 92.96 24.21 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.421 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.654 ' HG2' HD11 ' A' ' 197' ' ' LEU . 59.0 Cg_exo -52.52 171.77 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.457 2.105 . . . . 0.0 112.113 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.439 ' CD1' ' HB3' ' A' ' 196' ' ' TYR . 0.2 OUTLIER -148.11 140.68 24.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.727 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.6 m -128.9 150.12 50.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.97 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -142.3 112.41 7.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.83 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 1.9 pp . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 -179.97 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 208' ' ' PRO . 0.6 OUTLIER -149.99 119.13 6.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.825 0.345 . . . . 0.0 111.009 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -81.26 144.32 31.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.845 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.63 160.48 27.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.975 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -161.1 117.12 0.75 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.164 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.474 ' HB3' HG22 ' A' ' 241' ' ' VAL . 33.9 t80 -128.6 116.38 19.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.864 0.364 . . . . 0.0 111.163 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 240' ' ' SER . 3.1 p30 -117.88 135.62 53.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.946 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.1 -26.48 60.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.29 -45.76 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.872 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -178.5 -61.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -56.76 -75.83 0.23 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.715 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.808 HD12 ' CD1' ' A' ' 269' ' ' TYR . 7.7 tt -66.45 124.64 23.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.749 0.309 . . . . 0.0 110.764 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 234' ' ' ASP . 2.0 t -148.56 175.86 10.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.178 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.511 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 27.8 m -129.0 167.6 24.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.61 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.414 ' O ' HD12 ' A' ' 243' ' ' LEU . 0.3 OUTLIER -133.63 134.69 43.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.021 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 242' ' ' SER . 3.3 mp -137.55 152.2 49.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -138.83 141.45 38.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.84 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -131.51 165.62 23.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.033 -179.979 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.798 0.332 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -145.38 150.73 22.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.453 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.85 153.55 27.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 0.0 111.12 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -158.62 155.95 26.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.495 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.593 ' CG2' ' HB3' ' A' ' 12' ' ' ALA . 15.3 m -138.11 147.83 25.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.811 0.339 . . . . 0.0 111.14 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -138.24 129.93 28.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.943 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.808 ' CD1' HD12 ' A' ' 239' ' ' LEU . 1.9 t80 -124.8 126.12 45.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.951 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 35.0 t -97.85 151.57 20.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.875 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 t70 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.874 0.368 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -71.57 125.16 26.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.77 132.92 52.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.923 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.87 140.43 38.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -141.5 120.14 12.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.022 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.62 HG22 ' CE1' ' A' ' 36' ' ' PHE . 27.1 pt -110.68 140.72 28.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.09 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.79 159.74 26.94 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.618 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.25 143.89 46.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 111.065 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 30.6 mtt -131.25 138.72 49.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.997 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -147.32 113.83 5.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.787 0.327 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.56 126.23 27.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.037 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -143.18 94.15 6.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.93 146.43 47.42 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.492 2.128 . . . . 0.0 112.363 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.1 m -140.21 152.8 46.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.857 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.2 m -133.6 159.53 42.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -143.93 122.28 12.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.62 ' CE1' HG22 ' A' ' 10' ' ' ILE . 8.8 m-85 -119.85 141.7 49.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.946 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.666 ' OD1' ' HB2' ' A' ' 46' ' ' ALA . 25.1 t30 -143.34 132.52 23.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.998 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.521 ' HB3' HG13 ' A' ' 45' ' ' ILE . . . -126.69 124.08 39.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.041 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.58 113.24 25.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.154 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -122.33 98.56 5.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.816 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.77 -141.79 45.79 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.45 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.58 -18.34 48.6 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.499 2.133 . . . . 0.0 112.441 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -101.47 144.6 30.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 111.016 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -137.73 132.77 33.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.521 HG13 ' HB3' ' A' ' 38' ' ' ALA . 23.7 pt -117.68 156.38 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.131 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.666 ' HB2' ' OD1' ' A' ' 37' ' ' ASN . . . -142.95 157.79 44.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.055 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.0 tt -150.48 120.96 7.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.907 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.61 139.1 49.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.041 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.99 109.66 11.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -95.91 125.05 40.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.862 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.93 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.881 0.372 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -139.64 134.39 31.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.953 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.97 95.85 14.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.86 159.83 11.06 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.536 2.157 . . . . 0.0 112.275 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.89 149.96 47.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.871 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.92 141.12 23.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.97 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 2.6 tt0 -128.4 151.16 49.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.813 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.506 HG12 ' CD1' ' A' ' 75' ' ' TYR . 28.2 t -127.81 130.67 70.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.151 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.579 ' ND1' HG22 ' A' ' 88' ' ' THR . 0.1 OUTLIER -123.9 121.09 34.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.787 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.506 ' CD1' HG12 ' A' ' 73' ' ' VAL . 1.7 p90 -153.33 106.53 2.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.845 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -92.43 141.03 28.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.957 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -88.52 -47.96 7.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.866 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.8 mt -143.12 171.08 14.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -169.75 111.91 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -143.71 -178.51 5.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.89 -31.45 59.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.916 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.09 -56.14 6.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.968 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -156.76 134.15 10.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.2 m -109.69 138.19 46.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.94 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -124.63 139.84 53.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.18 172.33 35.85 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.502 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.448 ' HB2' ' CE2' ' A' ' 75' ' ' TYR . 17.2 mt -143.31 143.41 31.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.816 0.341 . . . . 0.0 110.817 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.579 HG22 ' ND1' ' A' ' 74' ' ' HIS . 25.2 p -140.82 131.75 26.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.07 -177.93 15.12 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.494 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.87 153.38 24.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.484 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 111' ' ' ARG . 6.4 t80 -131.63 136.61 47.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.86 0.362 . . . . 0.0 110.89 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.6 mtm180 -137.23 159.83 40.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.54 169.77 17.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.824 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.15 130.74 25.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.513 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.876 0.37 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -107.77 141.25 39.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.827 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.9 ptm -112.69 133.78 54.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.47 127.19 36.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.4 ' O ' ' CD1' ' A' ' 91' ' ' PHE . 12.4 mtt180 -109.97 128.21 55.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.923 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -127.74 113.83 16.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.85 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -119.58 144.27 47.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.953 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.2 tp -140.97 143.54 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.998 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.08 99.78 3.06 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.081 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.63 155.2 69.68 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.433 2.089 . . . . 0.0 112.242 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -112.93 142.96 45.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.998 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.68 130.37 20.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.781 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.15 132.32 29.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.56 HG23 ' HB3' ' A' ' 128' ' ' PHE . 11.8 m -143.44 109.99 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.151 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -72.66 123.31 23.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.951 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.7 tp -101.78 -46.64 4.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.961 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.31 167.62 12.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.85 -30.13 71.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.025 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.559 ' OD2' HD12 ' A' ' 126' ' ' LEU . 2.5 p30 -123.87 40.97 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.011 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.559 HD12 ' OD2' ' A' ' 125' ' ' ASP . 1.2 mp -156.85 133.8 10.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.56 140.51 48.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.836 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.56 ' HB3' HG23 ' A' ' 120' ' ' VAL . 68.8 t80 -104.92 126.82 52.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.978 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -114.86 147.37 39.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.802 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -152.38 133.53 4.15 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.676 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TRP . . . . . 0.427 ' CD1' ' N ' ' A' ' 131' ' ' TRP . 0.1 OUTLIER -160.81 165.19 30.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.819 0.342 . . . . 0.0 110.841 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.46 156.06 47.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.01 110.33 17.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.83 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.5 ttp -113.92 111.57 21.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.839 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -104.9 121.77 44.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.477 ' HA ' HG22 ' A' ' 149' ' ' THR . 3.2 tmtm? -140.53 110.55 6.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.819 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.4 p90 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.963 179.984 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 136' ' ' LYS . 69.8 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.79 0.328 . . . . 0.0 110.814 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -153.53 -178.56 7.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.917 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.467 HG22 ' N ' ' A' ' 152' ' ' GLU . 9.4 p -129.68 157.82 42.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.993 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.467 ' N ' HG22 ' A' ' 151' ' ' VAL . 4.3 mp0 -124.62 157.43 35.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.975 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 68.6 p -116.77 118.0 31.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.754 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.401 ' HG2' ' CE1' ' A' ' 172' ' ' TYR . 3.5 mp0 -126.2 138.05 53.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.028 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 7.9 t -139.4 138.91 36.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.671 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -132.36 158.33 22.92 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.644 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.9 mp -139.14 130.19 26.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.823 0.344 . . . . 0.0 110.738 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -93.95 146.73 23.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.975 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -139.72 100.15 3.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.787 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.69 115.06 16.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.958 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.6 -49.89 3.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.729 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -131.01 163.89 26.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.799 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -30.95 70.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.931 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -119.22 27.41 8.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.079 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.4 t -148.95 117.62 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.105 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 198' ' ' PRO . . . -124.03 149.96 45.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.184 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' A' ' 197' ' ' LEU . 2.4 mt -132.06 121.97 24.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.733 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.43 ' HD3' ' CE1' ' A' ' 196' ' ' TYR . 40.3 mtt180 -125.27 147.07 49.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.067 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.5 m -147.02 138.61 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 44.1 p30 -146.89 156.41 43.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.118 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.517 ' CD1' HG22 ' A' ' 193' ' ' ILE . 5.2 m-85 -110.13 144.57 38.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.785 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.401 ' CE1' ' HG2' ' A' ' 154' ' ' GLU . 0.3 OUTLIER -121.7 115.87 23.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.97 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.577 HD13 ' HA ' ' A' ' 191' ' ' GLN . 4.3 mm? -109.99 106.93 16.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.14 147.26 24.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -151.36 124.09 8.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.939 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -144.71 178.66 22.42 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.518 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 12.6 t80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.778 0.323 . . . . 0.0 110.97 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 13.0 t80 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.83 0.348 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.3 p -122.83 110.08 15.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 5.0 t -106.3 139.91 40.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.942 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.577 ' HA ' HD13 ' A' ' 173' ' ' LEU . 2.7 mt-30 -98.97 130.45 45.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -134.44 157.35 46.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.945 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.517 HG22 ' CD1' ' A' ' 171' ' ' TYR . 1.8 pt -141.18 137.09 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.43 114.31 16.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.846 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -101.3 115.43 30.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.228 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.446 ' HB3' ' CD1' ' A' ' 209' ' ' TYR . 8.4 p90 -128.98 114.95 17.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.623 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.536 ' HB2' HD23 ' A' ' 167' ' ' LEU . 0.4 OUTLIER -108.2 109.38 61.8 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.216 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.403 ' HB2' ' HB3' ' A' ' 166' ' ' ALA . 31.0 Cg_exo -61.73 136.08 60.12 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.561 2.174 . . . . 0.0 112.18 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.2 tp -132.88 127.98 35.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.929 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 7.1 m -132.19 123.18 26.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.967 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 26.8 tp -147.15 102.68 3.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.923 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 77.06 52.03 5.92 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.499 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 59.69 29.61 19.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.77 0.319 . . . . 0.0 110.941 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -104.09 126.21 51.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.09 104.92 16.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 230' ' ' PHE . 22.1 t -118.66 127.42 75.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.05 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.93 92.72 33.03 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.961 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -79.89 172.14 14.47 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.679 2.253 . . . . 0.0 112.244 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.446 ' CD1' ' HB3' ' A' ' 196' ' ' TYR . 0.3 OUTLIER -161.72 143.65 11.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.691 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 32.6 m -131.69 145.39 51.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.017 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.31 141.63 22.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.766 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 14.7 pt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.181 -179.919 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.23 110.93 21.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.778 0.323 . . . . 0.0 110.598 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.541 ' O ' HG13 ' A' ' 206' ' ' VAL . 0.1 OUTLIER -87.39 133.43 33.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.979 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -116.95 155.31 29.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -134.81 117.06 1.69 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.399 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.501 ' O ' HG23 ' A' ' 241' ' ' VAL . 17.3 m-85 -110.36 116.37 31.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.838 0.351 . . . . 0.0 111.027 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -115.45 111.09 20.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.676 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -72.78 -5.42 37.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.347 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.36 41.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.757 0.313 . . . . 0.0 110.938 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 70.0 -64.1 0.37 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.152 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -47.66 -75.66 0.18 Allowed Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.793 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 240' ' ' SER . 7.4 tt -66.51 142.49 57.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.775 0.322 . . . . 0.0 110.799 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.43 ' N ' HD23 ' A' ' 239' ' ' LEU . 0.8 OUTLIER -138.95 164.39 29.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.867 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 233' ' ' TYR . 8.2 t -131.29 151.42 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.942 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.57 126.2 52.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.98 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.28 122.91 12.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.809 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -105.32 141.16 37.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -124.85 153.05 43.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.898 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.061 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.795 0.331 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -128.38 147.43 17.43 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.504 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.24 142.97 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.769 0.319 . . . . 0.0 111.135 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -172.48 159.99 31.05 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.517 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.62 152.34 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 111.142 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -136.23 136.04 39.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.969 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -134.35 157.88 45.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 4.8 p -118.86 147.02 44.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.851 -179.93 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 t0 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.836 0.351 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 11.6 t90 -96.68 102.28 14.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.79 160.16 18.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.798 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.53 125.25 14.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -125.09 120.81 32.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.837 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 pp -130.52 126.74 61.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.12 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.98 164.56 25.79 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.539 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -125.8 147.81 49.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.796 0.332 . . . . 0.0 111.075 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.58 150.92 48.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.924 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -141.44 117.86 10.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.817 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.831 179.994 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.826 0.346 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.88 150.81 33.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.075 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -120.0 94.07 48.32 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.42 178.75 0.21 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.55 2.166 . . . . 0.0 112.258 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.09 135.08 26.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.836 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.59 141.53 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.113 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -140.26 122.25 15.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.929 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.411 ' CZ ' ' HB3' ' A' ' 47' ' ' LEU . 3.7 p90 -144.55 123.76 12.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.76 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -135.82 162.5 32.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.983 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.82 129.61 36.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.013 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.54 109.28 21.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.104 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -108.69 85.44 2.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.803 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.31 -147.57 47.41 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.4 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -51.26 -25.78 18.61 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.506 2.137 . . . . 0.0 112.36 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -92.64 148.4 22.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.809 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -140.6 137.23 33.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.945 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.6 pt -129.92 145.49 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.964 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.19 155.78 49.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.222 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 36' ' ' PHE . 3.6 mp -142.3 144.85 33.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.739 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -118.31 143.43 46.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.08 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -141.47 160.02 41.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.63 148.04 32.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.868 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.81 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.878 0.37 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.03 134.91 47.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.75 95.87 24.86 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.884 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.34 170.25 18.8 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.484 2.123 . . . . 0.0 112.253 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.739 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 2.0 tt0 -153.59 140.34 19.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.025 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mt -126.04 146.31 49.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.804 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -152.28 119.89 6.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.031 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.39 138.87 31.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.042 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -129.52 135.14 48.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.064 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -124.05 110.8 15.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.712 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -65.59 137.14 57.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.043 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -50.92 147.09 5.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.199 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 16.8 mt -72.37 -66.3 0.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.743 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -71.1 -173.5 0.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.689 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -175.2 -32.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.41 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -45.88 -30.15 1.62 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.489 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.404 ' HB3' ' CD2' ' A' ' 83' ' ' PHE . 1.2 t70 -164.34 -64.97 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.97 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.437 ' CD1' HG13 ' A' ' 120' ' ' VAL . 23.5 m-85 -104.31 118.61 37.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.85 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.37 173.79 6.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.74 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.46 ' HE1' HD11 ' A' ' 87' ' ' LEU . 12.1 t80 -162.36 117.06 1.84 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.032 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.472 ' C ' HD12 ' A' ' 87' ' ' LEU . . . -132.19 -162.42 10.37 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.261 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.472 HD12 ' C ' ' A' ' 86' ' ' GLY . 4.0 mp -155.73 145.24 21.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 0.0 110.981 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 81.7 p -142.84 121.94 12.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.931 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -151.32 -159.01 8.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.522 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 174.3 176.64 42.84 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.554 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.433 ' CD2' ' N ' ' A' ' 91' ' ' PHE . 3.9 m-85 -122.27 173.82 7.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.845 0.355 . . . . 0.0 110.818 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -150.26 128.23 11.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.024 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -131.45 149.44 52.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.827 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.22 138.22 52.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.933 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.426 -179.973 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.764 0.316 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -144.06 119.87 10.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.981 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.46 159.28 18.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -146.61 104.64 3.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -105.04 127.12 52.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -96.76 122.22 39.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.94 121.72 45.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.899 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.633 HG22 ' HD3' ' A' ' 116' ' ' PRO . 17.5 mt -130.99 132.14 63.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.04 76.43 8.71 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.348 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.633 ' HD3' HG22 ' A' ' 114' ' ' ILE . 44.2 Cg_exo -56.52 168.17 2.35 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.526 2.15 . . . . 0.0 112.132 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -147.17 134.75 20.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.164 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -120.73 124.81 46.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.66 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -100.14 125.92 46.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.959 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.437 HG13 ' CD1' ' A' ' 83' ' ' PHE . 22.3 t -140.37 116.96 8.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.059 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -88.66 144.36 26.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.922 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.29 -42.8 2.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -130.27 -170.75 2.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.841 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.44 ' H ' HG22 ' A' ' 123' ' ' THR . 79.1 m-20 -74.94 -47.99 26.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.88 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.713 ' C ' HD12 ' A' ' 126' ' ' LEU . 22.3 m-20 -110.19 29.78 7.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.713 HD12 ' C ' ' A' ' 125' ' ' ASP . 7.9 mp -138.15 133.86 33.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.864 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -142.51 152.71 42.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -141.51 135.29 30.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.802 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -154.55 168.12 27.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.062 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 151.83 177.37 25.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.562 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TRP . . . . . 0.467 ' HA ' ' CE3' ' A' ' 131' ' ' TRP . 0.0 OUTLIER -173.21 -172.67 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.77 0.319 . . . . 0.0 110.777 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.496 HD23 ' O ' ' A' ' 152' ' ' GLU . 6.1 mt -100.83 150.39 22.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.956 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.67 152.19 21.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.936 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 5.0 mtp -132.37 125.43 30.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -118.51 125.6 50.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.938 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.07 156.3 41.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.897 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.716 -179.948 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 37.2 p . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.763 0.316 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -105.26 120.69 42.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.833 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.416 HG23 ' HG2' ' A' ' 175' ' ' ARG . 6.2 m -120.67 116.97 51.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.091 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.496 ' O ' HD23 ' A' ' 132' ' ' LEU . 6.9 mp0 -108.2 153.72 22.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.932 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.4 m -101.12 132.49 46.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -129.43 116.94 19.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' THR . . . . . 0.623 HG23 ' HB2' ' A' ' 171' ' ' TYR . 1.4 t -140.69 113.82 8.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -114.53 147.28 18.82 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.678 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.42 HD21 ' HB ' ' A' ' 169' ' ' VAL . 1.9 pp -123.0 117.29 25.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 110.738 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.68 127.06 35.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.106 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -140.81 100.16 3.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.795 HG23 ' HB2' ' A' ' 166' ' ' ALA . 2.8 m -106.95 137.21 45.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.079 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -99.72 -30.92 11.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.798 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.408 ' O ' HG22 ' A' ' 160' ' ' THR . 12.9 t30 -151.11 -179.09 7.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.808 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -87.61 6.23 35.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.373 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 60.2 p -103.41 -31.04 10.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.818 0.342 . . . . 0.0 110.982 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.778 HG23 ' HG ' ' A' ' 199' ' ' LEU . 11.3 p -147.67 152.03 13.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.145 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.795 ' HB2' HG23 ' A' ' 160' ' ' THR . . . -141.7 158.9 43.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.019 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.708 HD12 ' HB3' ' A' ' 197' ' ' LEU . 4.7 tp -115.52 143.01 45.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.952 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 32.1 mtp180 -147.36 124.0 11.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.024 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.42 ' HB ' HD21 ' A' ' 157' ' ' LEU . 21.5 t -124.41 123.76 66.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.007 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -121.1 145.98 47.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.141 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.623 ' HB2' HG23 ' A' ' 155' ' ' THR . 13.3 m-85 -112.92 130.85 55.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.746 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -111.18 138.12 48.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.037 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.761 HD12 ' HA ' ' A' ' 191' ' ' GLN . 4.6 tp -139.95 151.1 45.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.808 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -138.09 144.73 41.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.006 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.428 ' NH1' HD23 ' A' ' 173' ' ' LEU . 0.1 OUTLIER -160.06 116.58 2.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.959 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -123.06 169.91 15.41 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.398 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 34.8 t80 . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.804 0.335 . . . . 0.0 110.928 -179.941 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.791 0.329 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.9 m -142.24 148.83 38.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.944 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 17.0 p -130.39 162.6 28.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.761 ' HA ' HD12 ' A' ' 173' ' ' LEU . 4.0 pt20 -137.45 133.24 34.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.936 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -134.74 173.18 11.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.57 HG22 ' CE2' ' A' ' 171' ' ' TYR . 1.1 pt -137.36 142.33 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.249 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.51 114.49 16.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.761 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -115.76 118.97 34.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.251 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.442 ' CD2' ' N ' ' A' ' 196' ' ' TYR . 1.9 p90 -145.36 137.09 25.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.706 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.708 ' HB3' HD12 ' A' ' 167' ' ' LEU . 0.8 OUTLIER -128.37 109.41 19.37 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.053 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.812 ' HA ' HG23 ' A' ' 207' ' ' THR . 23.4 Cg_exo -64.15 142.54 80.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.5 2.133 . . . . 0.0 112.152 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.778 ' HG ' HG23 ' A' ' 165' ' ' VAL . 0.3 OUTLIER -130.02 100.01 5.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.791 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 35.1 p -107.04 102.97 12.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.957 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 2.9 tt -140.54 129.86 23.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.884 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 72.32 -128.78 13.87 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.472 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -117.52 30.1 7.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.359 . . . . 0.0 110.931 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -135.6 149.08 49.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 88.8 p -121.01 121.51 38.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.936 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.653 HG13 ' O ' ' A' ' 230' ' ' PHE . 21.5 t -135.31 139.94 45.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.825 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.812 HG23 ' HA ' ' A' ' 198' ' ' PRO . 2.0 m -138.69 92.97 11.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.403 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.01 111.52 2.47 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.618 2.212 . . . . 0.0 112.116 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -111.23 169.03 9.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 0.0 111.109 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.6 p -138.62 138.86 38.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.843 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -125.2 164.81 19.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.934 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 179.986 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.312 -0.315 . . . . 0.0 112.312 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.22 113.68 9.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.808 0.337 . . . . 0.0 111.048 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.653 ' O ' HG13 ' A' ' 206' ' ' VAL . 2.0 t80 -97.71 130.6 44.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.721 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -111.05 155.72 22.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.05 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -165.51 117.21 0.74 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.041 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.44 ' HB3' HG22 ' A' ' 241' ' ' VAL . 26.2 t80 -132.38 121.16 23.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.748 0.309 . . . . 0.0 111.181 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 240' ' ' SER . 2.4 p30 -108.71 128.53 54.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -54.98 -24.71 25.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.998 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -156.36 -45.44 0.07 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.836 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 179.51 -55.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -63.72 -78.88 0.17 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.691 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.827 HD23 ' CD2' ' A' ' 269' ' ' TYR . 3.1 mp -66.42 140.0 58.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.794 0.33 . . . . 0.0 110.9 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -157.14 176.84 12.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.048 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.565 HG12 HG12 ' A' ' 267' ' ' VAL . 30.2 m -122.01 170.39 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.825 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 36.4 t -142.27 131.84 23.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.828 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.691 ' HG ' HG12 ' A' ' 265' ' ' VAL . 2.3 tt -136.35 126.86 26.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.002 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -119.45 139.39 52.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -152.02 151.83 31.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.979 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.048 -179.982 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.809 0.337 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -144.58 148.08 19.65 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.445 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.691 HG12 ' HG ' ' A' ' 243' ' ' LEU . 21.8 m -147.47 141.83 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 111.134 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -158.47 175.04 35.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.54 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.565 HG12 HG12 ' A' ' 241' ' ' VAL . 9.2 m -130.33 162.86 37.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.79 0.329 . . . . 0.0 111.148 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -136.33 143.12 43.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.862 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.827 ' CD2' HD23 ' A' ' 239' ' ' LEU . 25.1 m-85 -139.18 101.7 4.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 59.4 p -110.77 131.7 54.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.903 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.5 t70 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.84 0.352 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 60.6 p-90 -107.83 149.89 27.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.943 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.505 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -118.2 144.71 45.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -118.72 130.03 55.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.51 128.61 19.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.553 HD12 ' HE1' ' A' ' 36' ' ' PHE . 11.7 tt -155.29 131.21 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.051 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.98 -157.99 7.73 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.553 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.79 -176.95 1.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.332 . . . . 0.0 111.04 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.5 ttt -152.94 150.13 28.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.34 138.21 26.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.854 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.952 179.987 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.901 0.381 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.7 119.5 19.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.066 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -121.75 94.09 48.45 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.05 123.83 10.38 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.482 2.121 . . . . 0.0 112.269 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.28 137.97 46.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.026 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -137.22 142.1 38.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -133.29 156.21 48.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.942 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.553 ' HE1' HD12 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -153.5 132.52 12.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.881 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.23 126.55 19.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.966 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.16 135.41 45.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.053 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.505 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -124.45 149.82 46.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.169 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -173.91 140.41 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.83 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.16 -149.39 17.37 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.511 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -86.19 42.03 0.91 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.807 2.338 . . . . 0.0 112.729 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -170.95 163.7 7.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.804 0.335 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -141.28 163.74 32.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.938 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mp -142.31 139.62 29.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.74 144.68 45.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.173 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.06 165.0 24.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.668 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -156.36 135.11 11.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -139.65 118.96 12.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -146.53 160.96 41.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.795 0.331 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -141.12 139.67 34.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.0 mtp180 -130.67 95.89 25.1 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.953 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.86 157.91 34.94 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.559 2.173 . . . . 0.0 112.365 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.668 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 6.4 tp10 -137.87 121.23 17.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 mp -114.65 145.21 42.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -153.82 160.27 42.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 73' ' ' VAL . 12.3 p -158.17 125.85 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.069 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -104.47 153.39 21.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -157.32 119.1 3.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -94.25 148.91 21.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -115.31 -62.51 1.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.837 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.7 mt -123.42 136.48 54.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.94 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -129.96 74.44 1.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -92.19 168.33 11.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -73.71 -27.75 61.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.956 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.445 ' HB3' ' CD2' ' A' ' 83' ' ' PHE . 12.7 m-20 -83.26 -64.21 1.21 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.939 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.538 ' HD1' HG22 ' A' ' 120' ' ' VAL . 12.6 m-85 -124.2 154.59 39.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.954 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.12 147.92 50.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.821 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.462 ' CE2' ' CZ3' ' A' ' 118' ' ' TRP . 29.3 m-85 -123.07 157.72 32.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.916 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -174.04 166.06 38.0 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.51 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.8 mt -144.3 137.07 26.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 0.0 110.874 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.93 123.37 19.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.53 149.81 16.88 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.547 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -161.48 156.68 28.2 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.422 ' HB3' ' CD1' ' A' ' 112' ' ' TRP . 8.1 p90 -150.1 167.71 26.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.789 0.328 . . . . 0.0 110.91 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.0 mtp85 -127.88 150.93 49.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.864 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -129.83 154.17 47.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.852 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -126.62 145.26 50.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.52 179.955 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 120.801 0.334 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -139.71 104.31 4.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.026 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.3 mtm -143.44 154.15 43.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.728 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -166.94 -179.28 4.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.961 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -145.02 134.58 23.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.422 ' CD1' ' HB3' ' A' ' 91' ' ' PHE . 0.3 OUTLIER -107.71 164.54 12.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.814 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -164.02 138.8 5.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.934 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.1 mt -137.77 125.82 31.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.051 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -135.91 107.89 9.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.072 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.51 177.12 5.72 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.474 2.116 . . . . 0.0 112.296 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -131.62 135.43 46.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.929 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.462 ' CZ3' ' CE2' ' A' ' 85' ' ' PHE . 2.9 t-105 -145.34 139.4 26.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.867 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -143.47 149.5 37.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.83 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.538 HG22 ' HD1' ' A' ' 83' ' ' PHE . 21.4 t -136.67 115.89 15.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.158 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.62 103.51 15.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.7 mp -81.37 -51.45 8.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -147.47 177.52 9.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.848 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -60.02 -29.91 68.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.993 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -118.96 36.2 4.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.008 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.411 HD12 ' CE1' ' A' ' 159' ' ' TYR . 0.8 OUTLIER -156.85 125.09 5.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -146.36 128.68 15.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.829 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.34 151.66 19.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -133.84 154.14 51.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.76 136.16 3.82 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.449 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 4.3 p-90 -164.59 138.78 5.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.333 . . . . 0.0 110.987 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.3 mp -95.25 161.57 14.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.9 m -139.29 113.62 8.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.902 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 1.6 ttt -111.44 148.45 33.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -125.37 119.49 28.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.21 167.23 11.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.764 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.827 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.777 0.322 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.74 129.92 50.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.75 129.08 47.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.091 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.76 151.2 45.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 29.4 m -117.29 139.78 50.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.837 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.95 115.5 23.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.838 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 17.6 m -125.7 137.05 53.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.903 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -150.33 160.34 28.51 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.599 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.418 HD21 ' HB ' ' A' ' 169' ' ' VAL . 0.3 OUTLIER -129.38 134.24 47.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.86 0.362 . . . . 0.0 110.921 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -113.79 114.29 26.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.961 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.411 ' CE1' HD12 ' A' ' 126' ' ' LEU . 9.5 t80 -126.78 113.44 16.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.725 HG23 ' HB2' ' A' ' 166' ' ' ALA . 6.2 m -103.12 136.49 42.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.102 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -103.99 -31.1 9.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.764 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -170.96 173.14 5.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.766 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.62 -14.39 62.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.344 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.711 HG23 HG12 ' A' ' 165' ' ' VAL . 9.1 t -76.24 -46.52 27.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.714 0.292 . . . . 0.0 111.032 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.711 HG12 HG23 ' A' ' 164' ' ' THR . 10.2 p -156.22 154.06 6.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.2 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.885 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -133.36 -172.74 3.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.028 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.404 ' HG ' HD21 ' A' ' 197' ' ' LEU . 1.5 mp -135.87 138.14 42.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.958 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.38 128.31 14.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.921 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.418 ' HB ' HD21 ' A' ' 157' ' ' LEU . 21.2 t -122.27 136.78 57.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.117 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -118.97 149.47 41.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.413 ' CE1' HG12 ' A' ' 193' ' ' ILE . 0.5 OUTLIER -134.81 144.9 47.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -124.48 136.19 53.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.977 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.426 HD12 ' HB3' ' A' ' 191' ' ' GLN . 1.2 tp -147.52 114.51 6.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.2 pm0 -143.67 162.53 35.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.023 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.4 ptt180 -140.17 166.55 24.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.817 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -138.49 160.02 25.45 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.558 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 7.1 t80 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 0.0 110.904 179.987 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.892 0.377 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 11.9 m -130.69 121.47 25.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.956 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 14.0 p -124.35 153.63 41.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.426 ' HB3' HD12 ' A' ' 173' ' ' LEU . 2.8 pp0? -153.96 128.44 9.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.834 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.21 137.85 54.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.5 HD12 HG21 ' A' ' 212' ' ' ILE . 22.6 mt -102.12 139.22 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.094 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 15.5 ttt85 -134.04 133.42 41.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -111.3 126.44 54.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.139 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.418 ' CD1' ' HB3' ' A' ' 209' ' ' TYR . 0.3 OUTLIER -131.67 116.14 16.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.772 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.404 HD21 ' HG ' ' A' ' 167' ' ' LEU . 0.4 OUTLIER -116.81 109.67 42.94 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.087 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.885 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 91.0 Cg_endo -79.0 138.22 14.36 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.409 2.073 . . . . 0.0 112.388 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.526 HD23 ' N ' ' A' ' 200' ' ' THR . 1.7 tt -132.76 155.91 48.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.929 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' THR . . . . . 0.526 ' N ' HD23 ' A' ' 199' ' ' LEU . 44.0 m -132.93 116.94 17.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.22 102.57 3.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.76 -137.52 15.31 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.485 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.03 23.66 14.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 0.0 111.043 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -136.44 132.99 36.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.764 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 84.8 p -96.69 134.44 39.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.954 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 20.8 t -135.38 131.5 51.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.85 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.705 HG22 ' HA ' ' A' ' 198' ' ' PRO . 14.3 p -133.61 92.82 22.59 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.302 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.34 124.71 9.15 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.432 2.088 . . . . 0.0 111.951 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.434 ' CZ ' ' HA3' ' A' ' 228' ' ' GLY . 48.2 p90 -111.12 136.23 50.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.932 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 24.7 m -111.12 159.64 17.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.938 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -127.35 126.76 43.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.851 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.5 HG21 HD12 ' A' ' 193' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.205 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.434 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.08 129.53 11.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.918 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -107.01 114.5 28.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.748 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -90.93 162.1 14.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.035 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -153.95 117.03 0.77 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.111 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 240' ' ' SER . 0.8 OUTLIER -110.86 115.45 29.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.791 0.329 . . . . 0.0 111.142 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -120.06 85.44 2.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.564 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.95 -12.7 19.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.272 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.31 35.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.736 0.303 . . . . 0.0 111.137 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 68.91 -65.44 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.061 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -48.43 -59.33 6.59 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.725 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.519 HD23 ' C ' ' A' ' 239' ' ' LEU . 7.6 tt -80.95 107.37 13.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.764 0.316 . . . . 0.0 110.766 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 233' ' ' TYR . 30.5 t -113.19 154.37 26.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.476 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 39.1 t -122.38 142.53 38.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.779 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 27.3 m -116.45 118.84 33.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.008 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 243' ' ' LEU . 0.9 OUTLIER -128.34 124.37 36.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.771 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -105.23 133.56 49.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.945 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -121.9 159.38 26.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.073 179.984 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.845 0.355 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 264' ' ' GLY . . . . . 0.418 ' O ' HD13 ' A' ' 243' ' ' LEU . . . -103.45 136.13 12.75 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.543 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 16.5 t -120.11 141.71 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 111.092 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -166.2 164.31 37.46 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.518 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 5.7 m -132.72 166.73 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.853 0.358 . . . . 0.0 111.109 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -158.75 120.76 3.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.956 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.45 ' HB2' HG23 ' A' ' 10' ' ' ILE . 62.3 m-85 -112.78 105.75 13.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.794 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.59 118.34 36.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.873 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.827 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.783 0.325 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -123.84 112.88 17.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.84 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.99 146.17 46.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.4 130.48 52.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.716 ' O ' HD13 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -123.2 129.32 51.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.716 HD13 ' O ' ' A' ' 9' ' ' ASN . 24.0 mm -138.9 127.78 29.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.098 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.96 -178.77 35.23 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.508 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.35 -176.89 5.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 0.0 111.072 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.44 152.36 21.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.82 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -150.89 118.42 6.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.92 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.863 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.864 0.364 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.84 138.11 31.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.138 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -136.64 94.13 13.54 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.926 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.72 167.41 25.76 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.555 2.17 . . . . 0.0 112.254 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.9 t -152.95 136.45 15.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -115.02 144.76 21.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.159 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -125.77 136.57 53.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.516 ' CZ ' HD12 ' A' ' 10' ' ' ILE . 1.2 m-85 -131.51 161.87 31.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.873 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -165.01 144.72 6.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.3 117.46 9.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.125 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.06 135.41 47.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.122 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -158.12 111.4 2.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.76 -149.29 37.49 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.579 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.76 -10.7 28.28 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.571 2.181 . . . . 0.0 112.6 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -99.87 143.04 30.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 110.941 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -129.99 142.08 50.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.8 mt -129.64 147.54 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.206 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.71 147.46 25.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.027 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.408 HD12 ' CE2' ' A' ' 49' ' ' TYR . 0.3 OUTLIER -146.16 169.22 19.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.934 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.43 137.37 20.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.042 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.408 ' CE2' HD12 ' A' ' 47' ' ' LEU . 70.9 m-85 -115.89 148.94 39.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.951 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -131.46 144.63 51.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 179.97 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 . . . . . 0 N--CA 1.458 -0.073 0 CA-C-O 120.844 0.354 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.37 146.44 46.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -151.2 95.87 3.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.902 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.91 133.33 16.6 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.556 2.17 . . . . 0.0 112.33 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -106.87 125.76 51.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.433 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -121.29 141.25 51.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.804 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -145.67 141.14 27.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.942 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.2 t -127.85 119.54 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.07 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -107.98 121.91 45.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -97.59 140.31 32.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -109.81 105.22 14.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.922 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.47 -46.47 5.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.808 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 tp -138.91 145.3 39.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.861 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -156.63 79.77 0.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.77 -170.59 1.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.978 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -85.38 -22.28 28.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.15 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -120.86 -47.21 2.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.787 0.327 . . . . 0.0 111.065 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.437 ' CE2' HG12 ' A' ' 120' ' ' VAL . 1.6 t80 -103.28 143.67 32.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.057 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.4 t -143.52 155.24 44.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.83 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -153.14 149.39 27.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 171.17 -178.67 43.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.438 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mp -142.39 145.18 33.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.823 0.344 . . . . 0.0 110.939 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.9 m -132.89 123.23 25.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.16 177.61 19.43 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.553 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.47 -175.37 46.97 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.441 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.433 ' CZ ' HD13 ' A' ' 71' ' ' LEU . 36.9 p90 -163.43 149.65 11.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.783 0.325 . . . . 0.0 111.014 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.1 159.88 18.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -130.74 143.43 50.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.851 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -148.84 119.43 7.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.952 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.478 -179.965 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.56 ' HB3' ' CE ' ' A' ' 109' ' ' MET . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.822 0.344 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -105.02 111.07 23.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.56 ' CE ' ' HB3' ' A' ' 107' ' ' ALA . 1.8 mpt? -131.23 141.09 49.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.432 ' HG2' ' CD2' ' A' ' 137' ' ' PHE . 5.3 pt20 -163.11 172.16 15.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.0 mtt-85 -152.97 109.23 3.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -87.38 154.51 20.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.815 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.402 ' HE2' ' CE1' ' A' ' 135' ' ' TYR . 65.3 mttt -145.05 125.39 13.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.043 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.3 mt -140.17 124.91 19.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.983 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.706 ' HB2' ' HA ' ' A' ' 133' ' ' SER . . . -149.15 99.49 3.44 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.222 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.07 169.94 0.26 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.463 2.109 . . . . 0.0 112.22 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -125.78 134.9 51.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.001 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -144.56 127.05 15.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.52 142.75 45.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.437 HG12 ' CE2' ' A' ' 83' ' ' PHE . 6.9 m -153.93 118.35 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.188 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -88.09 139.07 30.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.8 tt -102.89 -31.18 10.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.737 HG23 ' H ' ' A' ' 125' ' ' ASP . 12.4 t -156.35 -164.01 1.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.851 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -93.79 20.58 7.43 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.35 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.737 ' H ' HG23 ' A' ' 123' ' ' THR . 2.5 p30 -158.11 26.13 0.26 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.714 0.293 . . . . 0.0 111.094 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.598 ' HB2' HG22 ' A' ' 123' ' ' THR . 0.1 OUTLIER -157.09 108.72 2.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.823 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -113.41 122.36 47.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -105.39 130.89 53.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -145.61 137.29 25.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.04 156.78 26.63 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.545 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 37.4 p-90 -173.01 127.0 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.743 0.306 . . . . 0.0 110.959 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.461 ' O ' HD12 ' A' ' 132' ' ' LEU . 3.1 pp -104.33 124.97 50.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.843 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.706 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 30.7 t -99.76 150.13 22.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.991 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.465 ' CG ' HG12 ' A' ' 151' ' ' VAL . 15.1 mtm -130.56 145.32 51.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.738 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.45 ' N ' ' CD2' ' A' ' 135' ' ' TYR . 2.7 m-85 -119.12 133.62 55.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.907 0.384 . . . . 0.0 110.976 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -128.99 145.63 51.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.802 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.432 ' CD2' ' HG2' ' A' ' 110' ' ' GLN . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.781 0.325 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.444 ' HG2' ' CD2' ' A' ' 135' ' ' TYR . 5.8 tpp180 -105.12 136.42 44.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.828 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.465 HG12 ' CG ' ' A' ' 134' ' ' MET . 28.3 m -149.66 142.58 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.174 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -144.6 127.86 16.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.8 m -96.92 131.93 43.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.893 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.4 ' OE1' ' CD1' ' A' ' 172' ' ' TYR . 25.5 mp0 -124.93 120.39 31.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.977 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 14.9 p -119.19 122.92 43.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -106.3 136.7 13.44 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.3 mt -119.25 118.25 30.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.848 0.356 . . . . 0.0 110.9 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -100.0 142.61 31.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -140.82 100.2 3.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.848 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.28 113.8 14.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.931 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.73 -32.75 16.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.807 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.422 ' HB2' HG22 ' A' ' 165' ' ' VAL . 5.9 m-20 -158.06 -173.38 4.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.813 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -87.73 6.05 36.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.406 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.505 ' O ' HG22 ' A' ' 164' ' ' THR . 22.8 m -136.39 12.89 3.26 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.559 0.219 . . . . 0.0 111.324 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 164' ' ' THR . 16.6 m -158.28 155.12 4.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.852 0.358 . . . . 0.0 111.131 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.692 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -149.43 176.79 10.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.093 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.7 124.09 12.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.433 ' HD2' ' CE2' ' A' ' 196' ' ' TYR . 79.6 mtt180 -124.74 142.04 51.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.1 118.83 16.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.113 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -97.88 138.85 34.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.22 112.33 18.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.4 ' CD1' ' OE1' ' A' ' 154' ' ' GLU . 5.3 m-85 -96.33 138.02 34.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.868 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 6.5 mt -143.5 108.72 5.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.87 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.508 ' HB3' HG23 ' A' ' 190' ' ' THR . 1.6 tt0 -125.07 152.12 44.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -151.23 136.83 17.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.946 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -99.05 150.29 19.25 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.536 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 1.4 t80 . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 0.0 110.887 -179.994 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 42.9 t80 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.805 0.336 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.57 129.75 43.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.956 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.508 HG23 ' HB3' ' A' ' 174' ' ' GLU . 1.7 t -150.25 114.86 5.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.79 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -122.02 143.27 49.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.092 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -142.8 152.37 42.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.767 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.597 HD11 HD12 ' A' ' 212' ' ' ILE . 1.7 pp -137.65 134.84 46.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.937 0.398 . . . . 0.0 111.366 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -139.51 124.94 19.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.581 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.547 ' HB3' ' OG1' ' A' ' 210' ' ' THR . . . -119.41 154.43 33.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.058 0.456 . . . . 0.0 111.591 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.573 ' HB2' HG22 ' A' ' 207' ' ' THR . 1.8 p90 -155.35 138.83 15.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.318 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.476 ' O ' ' HD2' ' A' ' 208' ' ' PRO . 5.4 mp -97.94 109.37 51.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.263 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.692 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 87.1 Cg_endo -83.2 108.76 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.486 2.124 . . . . 0.0 112.358 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.29 140.75 52.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.974 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 60.3 p -131.59 128.13 38.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.9 mt -127.82 104.69 7.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 65.63 -96.37 0.25 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.584 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -127.92 31.2 5.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.802 0.334 . . . . 0.0 110.946 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -125.85 155.34 41.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.765 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.57 128.66 29.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.986 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.2 t -140.12 110.97 4.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.855 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.573 HG22 ' HB2' ' A' ' 196' ' ' TYR . 2.1 m -121.33 93.06 48.81 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.404 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 197' ' ' LEU . 33.8 Cg_exo -61.72 171.76 4.33 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.587 2.191 . . . . 0.0 111.949 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.404 ' CD2' ' HB3' ' A' ' 196' ' ' TYR . 0.3 OUTLIER -134.21 127.9 32.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.957 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.547 ' OG1' ' HB3' ' A' ' 195' ' ' ALA . 1.1 p -116.81 126.18 52.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -146.59 121.45 9.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.849 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.597 HD12 HD11 ' A' ' 193' ' ' ILE . 10.8 mt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.091 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 208' ' ' PRO . 0.4 OUTLIER -152.02 146.12 25.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.85 0.357 . . . . 0.0 111.054 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -109.25 148.82 30.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.732 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.85 137.4 54.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -133.49 117.18 1.84 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.284 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.406 ' HB3' ' CG2' ' A' ' 241' ' ' VAL . 0.3 OUTLIER -113.11 122.5 47.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.898 0.38 . . . . 0.0 111.033 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.44 92.59 3.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.58 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -69.12 -6.84 31.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.431 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.59 31.49 0.13 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.667 0.27 . . . . 0.0 111.117 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 1.2 m120 67.91 -66.1 0.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.037 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -50.6 -59.35 7.96 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.601 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.452 HD22 ' CE1' ' A' ' 269' ' ' TYR . 1.1 mt -69.25 142.59 54.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.69 0.281 . . . . 0.0 110.698 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.8 p -137.0 148.91 47.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.943 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.409 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 40.2 t -116.27 141.18 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.818 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 20.1 m -111.4 126.37 54.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.136 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.1 tt -149.42 124.86 10.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.741 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -105.32 150.64 25.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.059 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -155.54 149.67 25.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.166 -179.993 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.817 0.342 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -109.1 164.79 12.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.509 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 21.5 t -150.8 138.55 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.952 0.406 . . . . 0.0 111.128 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -153.0 179.03 29.76 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.501 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 6.2 m -149.99 139.45 15.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.904 0.383 . . . . 0.0 111.198 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -129.38 129.36 44.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.452 ' CE1' HD22 ' A' ' 239' ' ' LEU . 0.4 OUTLIER -125.7 123.98 40.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 37.6 p -109.2 134.86 51.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.864 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.922 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.772 0.32 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -89.79 96.99 10.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.825 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.616 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 1.5 m-70 -107.83 157.11 18.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.951 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.11 144.45 50.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.726 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -151.48 133.32 14.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.06 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 11' ' ' GLY . 3.5 mp -128.44 154.93 39.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.407 ' N ' HG22 ' A' ' 10' ' ' ILE . . . -149.9 153.4 25.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.666 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.504 ' HB3' ' CG2' ' A' ' 267' ' ' VAL . . . -129.29 154.84 46.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.825 0.345 . . . . 0.0 110.933 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.9 mtt -139.34 141.48 37.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.96 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.622 ' HB2' HG23 ' A' ' 265' ' ' VAL . 18.8 m-85 -137.83 113.59 9.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.808 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.858 -179.856 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.852 0.358 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.38 143.65 47.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.133 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -131.7 94.04 26.54 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.425 ' HB3' ' CE1' ' A' ' 14' ' ' TYR . 72.2 Cg_endo -74.84 156.68 43.73 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.555 2.17 . . . . 0.0 112.389 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 p -123.61 140.27 53.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.509 HG23 ' HB2' ' A' ' 49' ' ' TYR . 5.6 m -112.6 127.61 69.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -124.63 122.16 36.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.947 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -112.71 153.43 27.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -147.8 142.9 27.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.981 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.698 ' HB3' HG13 ' A' ' 45' ' ' ILE . . . -135.03 128.24 31.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.064 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.616 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -100.72 124.18 45.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.103 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -136.36 85.93 2.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.22 -150.43 37.08 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.527 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.05 -23.74 22.86 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.566 2.177 . . . . 0.0 112.388 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 20.6 m95 -101.54 150.21 23.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.988 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -142.34 151.76 42.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.804 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.698 HG13 ' HB3' ' A' ' 38' ' ' ALA . 18.7 pt -127.44 158.36 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.173 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.737 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -152.24 128.85 10.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.974 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 tp -120.28 129.2 53.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.929 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.88 139.75 50.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.025 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.509 ' HB2' HG23 ' A' ' 34' ' ' VAL . 2.5 m-85 -133.02 155.43 49.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -115.88 109.73 18.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.756 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.849 -179.945 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.2 t80 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.761 0.315 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.57 144.22 51.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.763 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -123.57 95.86 44.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.979 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.01 125.93 9.64 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.53 2.153 . . . . 0.0 112.178 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -127.74 118.49 23.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.057 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 mp -102.48 165.09 11.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.734 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.737 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 25.3 tt0 -160.81 138.19 9.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.126 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.3 t -123.95 115.93 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.797 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -102.03 123.97 46.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.161 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -114.15 123.08 48.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.656 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -65.52 122.9 18.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.053 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.408 ' HB2' ' N ' ' A' ' 85' ' ' PHE . 9.1 p90 -66.09 132.12 47.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.911 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 tp -161.25 140.57 10.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -176.72 -40.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.83 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -143.82 -169.29 3.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.853 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.74 -37.97 48.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.925 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -112.93 -32.24 6.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.022 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -92.43 137.49 32.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.921 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.6 m -145.26 173.2 12.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.408 ' N ' ' HB2' ' A' ' 77' ' ' PHE . 6.5 t80 -162.39 117.08 1.84 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.919 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.67 -162.3 21.35 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.548 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 tp -160.38 116.3 2.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.823 0.344 . . . . 0.0 110.968 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.1 m -111.23 107.81 17.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.827 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -102.93 176.24 24.65 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -172.23 163.15 35.32 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.571 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 92' ' ' ARG . 13.0 t80 -135.12 153.97 51.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.808 0.337 . . . . 0.0 110.862 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.425 ' N ' ' CD1' ' A' ' 91' ' ' PHE . 1.9 ttt180 -149.12 129.89 14.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -137.15 158.9 43.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -132.66 138.98 47.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.533 179.982 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.809 0.338 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -140.51 111.13 6.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 47.7 mtt -113.85 134.02 55.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.999 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.4 96.67 5.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.778 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.53 131.52 52.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.965 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -122.23 143.23 49.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.789 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -140.61 131.97 26.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.049 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.6 mp -139.34 147.0 24.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.951 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.58 85.96 5.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.237 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.14 170.49 3.89 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.613 2.209 . . . . 0.0 112.159 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.404 ' O ' ' CD2' ' A' ' 85' ' ' PHE . 7.1 m-20 -131.58 149.77 52.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.823 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -141.52 125.94 17.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.919 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -112.01 135.04 53.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.401 HG12 HD12 ' A' ' 122' ' ' LEU . 21.4 t -142.58 121.74 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.179 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.04 123.44 49.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.401 HD12 HG12 ' A' ' 120' ' ' VAL . 2.4 mp -117.76 -41.15 2.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.56 168.86 11.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.973 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.76 -41.23 96.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.923 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -113.4 36.36 3.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.3 tp -139.27 102.07 4.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.933 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -110.29 123.05 49.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -97.62 149.34 22.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -138.05 135.85 36.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.962 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -117.56 117.17 3.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.508 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -116.2 136.7 52.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 0.0 110.93 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.793 ' CD2' HG23 ' A' ' 153' ' ' THR . 0.2 OUTLIER -124.34 151.63 44.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.82 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.695 ' H ' HD13 ' A' ' 132' ' ' LEU . 0.6 OUTLIER -121.51 130.21 53.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.859 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.4 mtt -150.93 117.84 5.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.423 ' N ' ' CD2' ' A' ' 135' ' ' TYR . 4.9 m-85 -129.2 149.36 51.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -132.99 119.91 20.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.951 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 17.3 t80 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 -179.926 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.822 0.344 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -109.86 129.73 55.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.981 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 151' ' ' VAL . 12.1 p -152.0 124.3 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.056 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -142.51 155.45 45.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.793 HG23 ' CD2' ' A' ' 132' ' ' LEU . 1.3 m -117.83 130.28 56.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.849 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.0 132.28 53.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.3 m -109.28 158.42 17.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.531 ' C ' HD12 ' A' ' 157' ' ' LEU . . . -142.65 126.02 2.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.422 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.598 HD12 ' N ' ' A' ' 157' ' ' LEU . 5.1 mp -115.98 142.46 46.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.788 0.328 . . . . 0.0 110.856 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -124.98 126.76 45.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -138.49 100.15 4.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.83 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.2 p -80.84 128.2 33.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.955 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -104.06 -31.94 9.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.659 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -154.91 165.54 36.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.62 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -69.0 -12.18 61.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.342 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.0 p -113.43 -17.9 12.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.588 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.891 HG12 HD23 ' A' ' 199' ' ' LEU . 28.7 m -139.35 147.86 24.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.922 0.391 . . . . 0.0 111.466 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.659 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -146.91 179.92 7.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.119 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.1 tp -135.53 138.02 42.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.959 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.434 ' HB3' ' CE2' ' A' ' 196' ' ' TYR . 2.3 ttp180 -144.08 149.45 36.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.071 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.3 m -147.24 139.84 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.992 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -117.79 161.34 19.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.981 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.01 151.89 43.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.737 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -127.41 128.36 45.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.046 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.91 105.21 5.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.729 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -89.63 156.05 18.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.412 ' CB ' HG13 ' A' ' 151' ' ' VAL . 15.2 mtp180 -150.42 120.92 7.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.799 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -140.38 154.95 24.4 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.509 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 53.2 t80 . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 120.759 0.314 . . . . 0.0 110.919 -179.987 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.749 0.309 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 72.8 p -131.58 130.9 42.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.004 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.92 162.96 13.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.728 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -132.02 122.11 24.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.17 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -140.59 155.59 46.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.637 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 11.8 tt -142.08 141.53 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.971 0.415 . . . . 0.0 111.368 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -128.75 155.36 45.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.436 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.1 130.7 14.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.994 0.426 . . . . 0.0 111.499 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.446 ' HB3' ' CG ' ' A' ' 209' ' ' TYR . 3.0 p90 -140.15 168.58 19.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.339 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.625 ' O ' HD12 ' A' ' 199' ' ' LEU . 0.1 OUTLIER -120.02 109.4 37.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.325 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.659 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 91.5 Cg_endo -80.33 120.68 4.11 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.382 2.055 . . . . 0.0 112.418 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.891 HD23 HG12 ' A' ' 165' ' ' VAL . 5.3 mp -125.79 134.42 51.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.955 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.05 103.94 6.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.904 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 5.7 tt -119.39 96.56 5.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.991 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 56.35 -116.02 6.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.521 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -99.03 29.78 3.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.855 0.36 . . . . 0.0 110.913 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.85 121.99 22.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.766 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.81 128.49 50.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.072 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.3 m -144.27 129.73 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.606 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 57.1 m -138.67 93.17 11.04 Favored Pre-proline 0 C--N 1.327 -0.386 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.681 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' PRO . . . . . 0.758 ' HB3' HD23 ' A' ' 229' ' ' LEU . 58.6 Cg_endo -71.82 137.98 30.71 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.308 2.006 . . . . 0.0 112.001 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.446 ' CG ' ' HB3' ' A' ' 196' ' ' TYR . 6.7 m-85 -111.04 136.46 50.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.808 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 35.8 p -127.14 143.32 51.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.865 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.93 143.19 27.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 1.6 pt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.576 ' CA ' ' HB2' ' A' ' 246' ' ' ALA . . . . . . . . 0 N--CA 1.45 -0.373 0 N-CA-C 112.613 -0.195 . . . . 0.0 112.613 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.758 HD23 ' HB3' ' A' ' 208' ' ' PRO . 1.9 mt -116.71 121.41 41.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.769 0.319 . . . . 0.0 110.941 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -93.78 123.63 37.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 242' ' ' SER . 6.2 m-85 -112.74 155.45 24.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -168.76 117.01 0.69 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.982 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.434 ' CZ ' ' HB ' ' A' ' 241' ' ' VAL . 39.1 p90 -148.03 144.76 28.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.87 0.367 . . . . 0.0 111.246 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -103.56 131.15 50.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.822 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -69.83 -12.8 61.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.358 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -176.09 47.43 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.918 0.389 . . . . 0.0 111.033 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.55 25.96 10.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.985 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -139.51 -71.3 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.377 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 239' ' ' LEU . 8.6 mp -83.39 107.37 15.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.72 0.295 . . . . 0.0 110.833 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 4.8 m -92.59 153.13 19.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.983 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.434 ' HB ' ' CZ ' ' A' ' 233' ' ' TYR . 29.9 t -131.9 122.64 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.77 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 231' ' ' TYR . 1.5 m -107.77 151.17 26.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.231 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.25 131.14 17.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.875 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -117.85 124.24 47.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.849 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -147.25 146.88 29.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ALA . . . . . 0.576 ' HB2' ' CA ' ' A' ' 228' ' ' GLY . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.051 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.787 0.327 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -84.57 150.85 25.98 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.484 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.622 HG23 ' HB2' ' A' ' 14' ' ' TYR . 14.3 m -136.84 135.74 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.807 0.336 . . . . 0.0 111.193 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -146.98 163.53 28.62 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.425 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.504 ' CG2' ' HB3' ' A' ' 12' ' ' ALA . 6.1 m -142.7 148.94 19.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.0 111.137 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -131.94 142.57 49.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.787 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' TYR . . . . . 0.425 ' CD1' ' HG ' ' A' ' 239' ' ' LEU . 4.8 m-85 -130.65 105.56 7.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 7.1 m -100.88 124.11 46.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 9.3 t80 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.859 179.95 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.875 0.369 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.94 116.1 6.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.882 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.836 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 21.0 m-70 -134.25 141.73 47.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -119.8 166.42 13.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -165.11 128.03 2.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 10' ' ' ILE . 6.8 tt -129.69 122.87 55.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.139 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.59 155.68 22.72 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.437 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -127.88 163.88 23.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.748 0.308 . . . . 0.0 111.179 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.98 140.02 29.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.886 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.585 ' HB2' HG23 ' A' ' 265' ' ' VAL . 34.4 m-85 -142.68 110.43 5.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 -179.942 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.881 0.372 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -131.99 146.63 52.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.059 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -107.59 93.98 11.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.948 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.53 134.82 15.71 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.527 2.152 . . . . 0.0 112.321 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.34 146.06 25.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.887 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.66 HG23 ' HB2' ' A' ' 49' ' ' TYR . 26.0 m -145.13 162.6 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.041 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -146.23 139.53 25.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.956 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -116.37 164.21 14.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.823 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.66 141.86 22.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.961 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' A' ' 45' ' ' ILE . . . -145.84 131.51 18.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.04 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.836 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -115.23 121.53 43.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.106 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.02 71.59 1.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.758 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.54 -143.43 46.98 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.356 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.55 -26.36 16.53 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.554 2.169 . . . . 0.0 112.355 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -100.93 127.27 47.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.975 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -109.54 157.16 19.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.431 ' HB ' ' HB3' ' A' ' 38' ' ' ALA . 2.6 mp -133.81 141.27 44.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.222 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -134.91 138.5 44.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.023 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.62 165.1 20.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.982 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -156.16 149.57 24.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.006 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.66 ' HB2' HG23 ' A' ' 34' ' ' VAL . 1.0 OUTLIER -137.08 155.98 48.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -153.52 114.99 4.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.787 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.998 -179.97 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.2 p90 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.791 0.329 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.8 137.31 39.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.01 95.95 40.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.956 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.54 155.6 54.73 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.506 2.137 . . . . 0.0 112.29 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -136.57 125.63 24.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.8 mt -115.18 141.0 48.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.902 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -149.34 146.65 27.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.791 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.7 m -126.09 150.19 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.217 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.24 143.73 50.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.796 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -141.76 144.0 33.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.69 117.53 25.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.944 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -87.4 -57.82 2.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 61.19 155.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -154.42 -46.79 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -158.62 179.69 8.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.761 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -74.36 -31.47 62.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.827 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -69.57 -72.44 0.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -96.88 161.58 13.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.957 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.32 173.15 11.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.801 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -162.27 152.67 16.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.916 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.77 -177.31 35.67 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.526 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.56 138.56 26.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 110.984 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.0 m -138.66 124.96 20.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -121.09 174.02 15.71 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.481 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.68 148.82 12.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.429 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -142.23 129.47 21.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.837 0.351 . . . . 0.0 110.895 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -109.76 145.38 36.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -164.28 125.57 2.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.871 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -132.77 122.13 24.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.934 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.563 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 -0.068 0 CA-C-O 120.926 0.394 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -130.7 107.86 9.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -146.09 160.08 42.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -143.77 110.46 5.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.938 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -110.6 111.86 23.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 44.5 t-105 -107.92 142.97 37.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.853 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -138.27 137.5 37.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.11 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.1 tp -152.78 133.18 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.74 ' HB2' ' HA ' ' A' ' 133' ' ' SER . . . -154.29 113.05 2.46 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.224 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.8 154.57 53.9 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.428 2.086 . . . . 0.0 112.24 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -106.11 134.95 48.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.947 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -134.59 127.21 30.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.12 138.18 53.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.766 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.49 HG23 ' HB3' ' A' ' 128' ' ' PHE . 12.2 m -147.98 121.23 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.5 140.95 29.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.835 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.8 mt -119.88 -77.1 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.34 -172.82 3.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.875 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.573 ' CB ' HD23 ' A' ' 126' ' ' LEU . 0.5 OUTLIER 60.46 23.2 12.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.161 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.7 t70 57.01 31.27 19.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.182 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.573 HD23 ' CB ' ' A' ' 124' ' ' ASP . 1.6 pp -122.22 136.12 54.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.921 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 -102.76 132.91 48.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.918 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.1 OUTLIER -84.87 125.34 32.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.413 ' HB3' ' CZ3' ' A' ' 131' ' ' TRP . 2.9 m-80 -113.8 155.66 25.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.977 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.28 135.88 2.8 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.443 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TRP . . . . . 0.425 ' CD1' ' HB2' ' A' ' 154' ' ' GLU . 17.4 p90 -162.76 131.98 4.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.779 0.323 . . . . 0.0 110.912 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 132' ' ' LEU . 4.1 pp -100.44 136.01 40.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.74 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 17.3 t -103.9 152.22 22.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.07 122.85 26.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -104.16 141.24 36.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.908 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -133.3 110.43 10.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.888 -179.941 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 37.4 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.832 0.349 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 25.9 mtp180 -133.09 123.48 25.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.36 115.27 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.094 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -114.94 151.4 34.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 33.1 m -128.58 128.31 43.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.818 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.425 ' HB2' ' CD1' ' A' ' 131' ' ' TRP . 0.8 OUTLIER -122.36 145.21 48.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.004 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.57 138.38 25.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.769 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -137.57 171.69 23.11 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.48 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.456 HD21 HD13 ' A' ' 126' ' ' LEU . 1.0 OUTLIER -141.44 117.37 10.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.803 0.335 . . . . 0.0 110.854 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -92.75 121.8 34.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.937 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -126.83 104.09 7.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.73 125.59 51.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.95 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -102.79 -31.22 10.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.795 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.32 -178.12 7.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.703 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -87.43 6.15 35.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.4 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 51.5 p -115.73 -32.25 5.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.648 0.261 . . . . 0.0 111.162 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.588 HG13 ' CD1' ' A' ' 199' ' ' LEU . 21.7 t -132.2 136.06 57.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.311 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.89 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -139.16 179.24 6.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.002 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.62 HD21 HD23 ' A' ' 197' ' ' LEU . 0.5 OUTLIER -135.42 141.33 45.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.011 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.31 107.51 4.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.837 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.5 m -106.21 155.0 7.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.07 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -135.72 156.05 49.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.993 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.01 106.47 5.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.821 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -90.06 134.78 34.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.926 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 8.2 tt -153.65 105.24 2.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.772 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -104.22 166.09 10.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.998 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -145.92 151.31 37.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.769 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -139.19 151.98 22.1 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.492 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 110.876 179.996 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.879 0.371 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.3 111.37 6.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.882 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.69 155.57 29.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.802 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -148.84 142.15 25.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.956 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -143.0 144.13 32.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.768 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 27.3 mt -105.65 138.37 31.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.263 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.08 109.69 4.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.766 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 210' ' ' THR . . . -106.53 136.96 45.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.255 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' TYR . . . . . 0.427 ' CD2' ' HB3' ' A' ' 209' ' ' TYR . 28.0 m-85 -140.47 123.3 16.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.615 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 197' ' ' LEU . 2.3 mp -111.02 109.64 57.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.055 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.89 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 96.5 Cg_endo -79.48 120.64 4.47 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.491 2.128 . . . . 0.0 112.308 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.588 ' CD1' HG13 ' A' ' 165' ' ' VAL . 0.1 OUTLIER -127.46 115.24 18.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.836 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.4 m -134.37 118.39 17.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.959 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.632 ' N ' HD23 ' A' ' 201' ' ' LEU . 0.5 OUTLIER -137.64 104.44 5.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 84.85 -117.3 4.47 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.513 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -116.76 30.72 7.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.849 0.357 . . . . 0.0 110.926 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -134.87 117.99 16.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.1 m -104.44 130.23 52.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.974 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.26 124.07 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.779 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.531 HG23 ' C ' ' A' ' 197' ' ' LEU . 41.9 m -138.78 92.8 11.07 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.477 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.16 143.39 11.31 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.612 2.208 . . . . 0.0 112.185 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.427 ' HB3' ' CD2' ' A' ' 196' ' ' TYR . 15.1 p90 -111.23 142.38 43.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.983 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.678 ' O ' ' HB3' ' A' ' 195' ' ' ALA . 11.6 p -131.58 142.29 49.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -145.06 124.0 12.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.885 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.1 tt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.094 -179.952 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.424 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.653 -0.179 . . . . 0.0 112.653 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.94 119.85 13.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.709 0.29 . . . . 0.0 111.072 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.89 145.55 25.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.869 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -126.74 148.55 49.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.125 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -137.79 117.08 1.42 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.292 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' TYR . . . . . 0.402 ' HB2' ' CG2' ' A' ' 241' ' ' VAL . 4.5 m-85 -102.7 118.09 36.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 111.192 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -123.53 90.49 3.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.417 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -56.83 -17.33 8.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.384 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -176.38 46.23 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.846 0.355 . . . . 0.0 111.172 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.93 23.71 5.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.219 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -122.22 -72.26 0.28 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.248 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.78 107.44 11.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.736 0.303 . . . . 0.0 110.625 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.22 134.13 42.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.948 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.493 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 26.0 t -112.89 148.34 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.689 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 4.7 m -119.21 126.04 50.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.937 0.399 . . . . 0.0 111.052 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 9.4 tt -143.86 123.6 13.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.782 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -105.25 157.53 17.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.973 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.36 147.62 41.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.836 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.117 -179.974 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.831 0.348 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -126.75 156.91 20.29 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.482 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' ' 14' ' ' TYR . 4.9 m -141.24 152.93 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.914 0.388 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -163.83 173.2 39.86 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.49 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 21.4 t -145.26 152.82 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.776 0.322 . . . . 0.0 111.185 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -142.33 125.37 16.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -127.34 120.81 29.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.923 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.2 p -90.81 141.06 29.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.827 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.794 0.331 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -95.58 91.07 5.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.923 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.79 146.42 53.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.953 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -110.06 126.75 54.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.82 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.72 -60.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.902 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 60.85 103.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.96 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.642 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 21.5 t60 -148.93 136.8 20.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.854 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -116.07 152.12 34.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -143.1 117.52 9.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.757 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.608 HG22 ' HD2' ' A' ' 36' ' ' PHE . 1.2 pp -128.39 132.29 68.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.01 170.65 27.14 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.467 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.661 ' HB3' HG22 ' A' ' 267' ' ' VAL . . . -137.47 177.13 8.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.827 0.346 . . . . 0.0 111.031 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.8 tpp -159.25 137.22 10.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.974 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -147.15 161.78 40.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.885 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.03 110.6 13.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.8 mt 67.01 -71.35 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.288 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 57.18 168.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.894 0.378 . . . . 0.0 110.891 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -74.77 76.28 2.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.15 -60.27 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.64 117.14 25.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.865 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -165.09 160.34 33.63 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.509 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -141.21 105.14 4.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.818 0.342 . . . . 0.0 110.925 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.64 138.61 2.63 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.571 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -121.07 31.64 6.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.804 0.335 . . . . 0.0 110.868 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.94 34.15 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.825 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -175.04 155.23 1.95 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.821 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.37 160.01 40.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.921 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -118.42 -168.81 14.39 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.518 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.7 mp -122.47 133.8 54.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.886 0.374 . . . . 0.0 110.973 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.85 131.41 55.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.064 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -115.31 94.0 37.85 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.982 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.51 128.44 12.71 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.527 2.151 . . . . 0.0 112.34 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.6 m -122.39 150.35 42.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.875 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 35' ' ' TYR . 21.5 t -123.01 158.79 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.063 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.476 ' N ' HG12 ' A' ' 34' ' ' VAL . 47.4 m-85 -143.02 133.8 25.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.013 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.608 ' HD2' HG22 ' A' ' 10' ' ' ILE . 41.6 m-85 -132.34 116.06 16.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.551 ' OD1' ' HB2' ' A' ' 46' ' ' ALA . 1.7 m-80 -118.55 133.27 55.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.924 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.24 123.8 44.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 7' ' ' HIS . . . -107.49 116.31 31.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -136.72 83.52 2.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.803 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.63 -137.34 36.89 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.364 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.45 -21.37 46.83 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.408 2.072 . . . . 0.0 112.312 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.3 m95 -94.82 115.21 27.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.884 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -117.36 116.32 26.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mp -95.33 142.77 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.171 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.551 ' HB2' ' OD1' ' A' ' 37' ' ' ASN . . . -145.36 126.9 15.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.051 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.614 ' HB3' HD23 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -139.66 153.61 47.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.958 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -142.56 141.36 32.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.964 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -119.95 152.12 37.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.975 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -116.77 165.76 12.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.853 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -167.33 167.4 14.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -145.3 128.51 16.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -136.3 57.01 0.68 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.473 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.35 175.92 8.69 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.647 2.231 . . . . 0.0 112.286 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.8 t -85.05 122.24 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.027 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -75.07 149.82 39.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.947 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -161.24 30.0 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.94 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m 58.91 76.78 0.33 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.95 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.41 -70.85 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.65 -101.19 2.2 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.514 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -117.51 -68.03 0.95 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.773 0.32 . . . . 0.0 110.884 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -119.6 165.34 14.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -104.83 106.17 2.66 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.488 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 64' ' ' THR . 9.8 t -95.79 115.88 28.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.801 0.334 . . . . 0.0 111.011 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -94.49 161.63 14.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.829 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -150.36 136.94 18.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.976 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.24 164.8 14.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.834 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -136.82 95.81 12.1 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.67 130.53 17.17 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.541 2.161 . . . . 0.0 112.263 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -128.67 132.23 48.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.614 HD23 ' HB3' ' A' ' 47' ' ' LEU . 35.8 mt -127.76 167.05 17.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.784 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 46' ' ' ALA . 17.9 mt-10 -159.29 151.28 20.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.033 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.01 111.37 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.025 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -98.81 132.7 43.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.851 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -135.47 135.84 40.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.795 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -103.12 121.08 41.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -98.8 -50.39 4.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.17 162.66 0.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.806 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -160.85 -58.86 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.841 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.8 164.91 27.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -63.36 -36.49 83.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.959 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.73 -59.88 2.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.979 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.889 ' CE1' HG13 ' A' ' 120' ' ' VAL . 5.3 m-85 -100.72 128.62 46.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.4 m -109.81 170.02 8.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.873 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.54 156.73 46.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -170.03 168.83 41.73 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.551 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 tp -138.53 125.04 20.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.349 . . . . 0.0 110.836 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.62 146.57 43.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.63 174.49 21.28 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.535 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.74 150.63 17.88 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.496 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -133.34 116.19 15.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.876 0.369 . . . . 0.0 110.862 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.64 135.58 54.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -149.91 133.49 16.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -126.61 133.27 51.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.003 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.32 143.3 16.48 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.429 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.62 127.0 54.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.893 0.378 . . . . 0.0 110.836 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -123.67 124.33 42.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.969 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -123.32 94.74 4.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.854 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 99' ' ' VAL . 14.8 p -98.54 35.01 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.045 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -107.4 -31.56 8.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.866 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -153.41 87.66 3.82 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -51.07 155.38 6.22 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.603 2.202 . . . . 0.0 112.337 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 143.61 46.02 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.477 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.2 mttp 60.7 30.98 20.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.891 0.377 . . . . 0.0 110.905 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -81.14 85.23 6.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.1 m -153.42 140.05 18.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.92 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -111.48 173.79 6.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.021 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -147.04 118.07 7.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.922 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -147.72 150.55 34.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.818 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.757 ' H ' ' HB2' ' A' ' 138' ' ' ALA . 16.9 mt-30 -132.37 177.36 7.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.029 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.8 mtp85 -148.64 114.92 5.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.893 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.409 ' HB2' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -95.35 130.09 42.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.776 0.322 . . . . 0.0 110.474 179.587 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -104.03 126.72 51.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.011 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.6 mp -140.8 104.41 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.949 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.62 ' HB2' ' HA ' ' A' ' 133' ' ' SER . . . -142.88 100.78 5.42 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.182 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.3 161.2 46.83 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.35 2.033 . . . . 0.0 112.155 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.07 134.79 48.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.98 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -129.05 134.55 48.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.736 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.16 141.51 51.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.959 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.889 HG13 ' CE1' ' A' ' 83' ' ' PHE . 21.6 t -143.44 113.16 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -97.0 110.78 23.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 tp -95.0 -31.94 13.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.8 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 124' ' ' ASP . 0.3 OUTLIER -153.5 176.01 12.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.722 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.498 ' H ' HG22 ' A' ' 123' ' ' THR . 0.7 OUTLIER -72.77 -19.86 61.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.18 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.627 ' O ' HD23 ' A' ' 126' ' ' LEU . 0.3 OUTLIER -119.52 30.2 7.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.748 0.308 . . . . 0.0 111.136 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.627 HD23 ' O ' ' A' ' 125' ' ' ASP . 60.0 mt -149.55 109.22 4.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.899 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.515 ' O ' HD23 ' A' ' 157' ' ' LEU . 5.7 mtt180 -114.72 119.31 36.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.843 ' CE2' HD11 ' A' ' 157' ' ' LEU . 55.0 m-85 -103.03 148.4 25.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.983 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -158.48 140.58 14.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 155' ' ' THR . . . -151.05 147.87 18.34 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.587 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 42.2 p90 -159.87 134.43 7.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.734 0.302 . . . . 0.0 110.903 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.3 mp -102.81 126.22 49.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.99 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.62 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 88.4 p -92.83 114.54 27.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.969 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.774 ' HG3' HG12 ' A' ' 151' ' ' VAL . 9.8 ttm -106.94 141.36 38.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.848 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.06 115.75 18.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.98 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.5 ' HE3' HG22 ' A' ' 149' ' ' THR . 13.1 mttp -149.21 132.51 16.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.835 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 110' ' ' GLN . 0.2 OUTLIER 177.63 -69.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.848 0.356 . . . . 0.0 111.104 179.588 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.757 ' HB2' ' H ' ' A' ' 110' ' ' GLN . . . -87.77 163.95 16.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.334 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -96.11 -29.08 14.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.78 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.419 ' O ' ' HB ' ' A' ' 144' ' ' THR . 7.1 m-20 61.27 81.31 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.442 ' O ' HG22 ' A' ' 144' ' ' THR . 8.7 mp -70.79 -34.85 72.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -96.08 -38.2 10.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.364 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 143' ' ' THR . 36.4 m -77.62 -3.54 41.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.774 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 141' ' ' LEU . 2.6 t -56.51 -23.73 41.59 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.818 0.342 . . . . 0.0 111.171 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -55.54 -25.72 43.27 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.829 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.14 -79.87 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.669 0.271 . . . . 0.0 111.041 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -148.99 -177.85 6.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.195 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.401 ' CB ' ' HB2' ' A' ' 140' ' ' ASP . 7.5 p-10 -177.83 -46.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.041 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.5 HG22 ' HE3' ' A' ' 136' ' ' LYS . 11.3 m -133.31 111.44 10.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.877 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -163.07 166.35 23.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.093 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.774 HG12 ' HG3' ' A' ' 134' ' ' MET . 30.1 m -107.99 141.64 22.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -119.66 158.72 25.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.727 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.5 m -132.05 120.44 22.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.064 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -134.79 107.21 7.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.723 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' ' 171' ' ' TYR . 6.1 t -92.37 168.69 11.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -158.25 120.66 0.99 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.556 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.843 HD11 ' CE2' ' A' ' 128' ' ' PHE . 0.2 OUTLIER -113.27 152.64 29.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.776 0.322 . . . . 0.0 110.867 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -128.84 123.81 33.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.065 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.442 ' CZ ' HD22 ' A' ' 157' ' ' LEU . 24.8 m-85 -120.53 117.32 27.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.86 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.9 118.81 19.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.928 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.66 -63.59 1.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.917 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -125.79 176.06 7.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -64.89 -30.68 71.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.004 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 43.0 p -120.21 27.25 8.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.044 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 23.0 t -153.72 125.21 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.038 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.817 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -126.8 169.63 13.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.276 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.561 HD12 ' HB3' ' A' ' 197' ' ' LEU . 0.4 OUTLIER -135.19 145.16 47.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.795 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -139.04 136.12 34.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.022 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 170' ' ' ASN . 29.5 t -119.0 158.98 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.981 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.49 ' N ' HG12 ' A' ' 169' ' ' VAL . 0.4 OUTLIER -153.53 133.12 12.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.026 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.544 ' HE2' HD21 ' A' ' 173' ' ' LEU . 23.5 t80 -116.36 111.2 19.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.709 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -89.87 135.64 33.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.086 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.544 HD21 ' HE2' ' A' ' 171' ' ' TYR . 22.8 mt -132.13 113.16 12.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.718 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -89.05 148.95 23.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.29 148.41 36.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.901 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -149.84 144.59 12.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.568 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.407 ' CD2' ' O ' ' A' ' 178' ' ' ASN . 54.0 t80 -172.38 149.46 2.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 0.0 110.874 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ASN . . . . . 0.407 ' O ' ' CD2' ' A' ' 177' ' ' PHE . 34.8 m120 -87.48 161.76 17.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.003 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.22 -35.71 76.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -175.36 103.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.9 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -151.11 135.52 16.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.905 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.96 94.56 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.76 160.63 39.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.852 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -113.51 -35.85 5.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.446 ' ND2' ' O ' ' A' ' 185' ' ' ASN . 1.4 t30 -137.37 30.61 2.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.924 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -68.83 -28.1 73.34 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.468 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.19 136.5 55.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.79 0.329 . . . . 0.0 110.947 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -105.13 137.13 43.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.2 m -132.42 100.14 4.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 2.4 m -106.65 150.51 26.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.9 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -130.42 132.14 45.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -135.61 120.99 19.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.754 HD12 HD11 ' A' ' 212' ' ' ILE . 24.8 mt -91.41 128.7 42.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.218 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.38 125.21 14.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.645 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -135.63 154.55 51.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.968 0.413 . . . . 0.0 111.533 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -143.16 148.5 36.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.342 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.561 ' HB3' HD12 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -114.04 109.46 49.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.272 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.817 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 70.0 Cg_endo -74.43 121.68 6.95 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.393 2.062 . . . . 0.0 112.312 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.65 105.87 13.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.866 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 7.0 p -99.25 116.29 31.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.24 103.7 3.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.942 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 59.17 -132.18 52.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.534 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -98.58 30.84 3.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.783 0.325 . . . . 0.0 110.901 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' HIS . . . . . 0.417 ' ND1' HG13 ' A' ' 206' ' ' VAL . 58.1 t-80 -129.96 116.83 19.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.699 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.71 123.95 49.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.983 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.493 ' O ' HG23 ' A' ' 206' ' ' VAL . 15.8 m -141.76 109.71 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.828 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.507 HG23 ' C ' ' A' ' 197' ' ' LEU . 18.6 m -117.49 92.66 41.26 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.305 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' A' ' 197' ' ' LEU . 23.1 Cg_exo -64.79 147.77 89.77 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.512 2.142 . . . . 0.0 111.933 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -111.18 134.7 52.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.852 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.3 p -107.5 138.24 44.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.949 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.2 118.13 8.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.754 HD11 HD12 ' A' ' 193' ' ' ILE . 2.1 pt -76.91 162.32 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.106 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -151.8 -172.42 20.54 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.555 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 7.6 tp 60.92 37.7 18.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.828 0.347 . . . . 0.0 110.884 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -140.38 26.0 2.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.075 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 18.0 t-105 -177.17 165.88 2.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.849 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 66.62 145.57 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.989 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -65.71 -65.32 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.997 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -72.16 -165.93 8.28 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.573 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -92.69 152.85 19.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.808 0.337 . . . . 0.0 110.856 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -159.44 -57.45 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.505 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -91.1 150.04 21.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.774 0.321 . . . . 0.0 110.888 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -162.53 151.36 14.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.931 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 60.95 168.25 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -92.62 -67.82 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.892 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.74 102.47 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 12.6 m -113.55 -31.82 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.291 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -111.42 167.96 12.65 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.541 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.671 HD13 ' N ' ' A' ' 230' ' ' PHE . 0.5 OUTLIER -154.92 127.35 7.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 0.0 110.882 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.671 ' N ' HD13 ' A' ' 229' ' ' LEU . 1.7 t80 -111.13 118.74 36.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.843 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' TYR . . . . . 0.404 ' HE2' ' CE1' ' A' ' 204' ' ' HIS . 35.5 t80 -100.83 160.63 14.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -164.34 117.02 0.73 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.157 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -133.66 124.25 26.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 110.891 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -123.38 101.37 7.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.793 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -75.98 -1.39 25.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.23 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -149.35 26.23 0.86 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.72 0.295 . . . . 0.0 111.106 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 2.2 m120 64.74 -75.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.137 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -52.93 -50.04 52.41 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.727 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.99 122.63 32.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.754 0.311 . . . . 0.0 110.88 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 4.0 t -135.39 174.93 10.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.969 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 241' ' ' VAL . 27.6 m -137.32 122.61 25.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.815 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 5.0 m -107.77 139.57 42.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.121 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.631 HD11 HG13 ' A' ' 265' ' ' VAL . 1.4 mp -132.22 129.59 39.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.781 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.26 121.08 43.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 263' ' ' ALA . 0.1 OUTLIER -123.87 136.05 54.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.781 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -124.27 174.15 7.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.1 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -158.36 31.55 0.24 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.813 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -94.1 173.35 7.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.88 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER 59.98 162.19 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.926 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -101.34 142.17 33.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.854 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.11 83.48 1.99 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.853 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -131.25 79.44 1.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -162.82 167.3 23.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -137.8 150.81 47.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.898 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -158.59 -160.13 10.11 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.544 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -173.14 36.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.35 . . . . 0.0 110.876 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.1 m -166.08 -44.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.82 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -108.19 139.7 42.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -167.72 129.35 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.899 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -136.32 121.31 18.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.908 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.98 -173.54 2.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -122.71 31.14 6.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.406 ' HB2' ' CE2' ' A' ' 245' ' ' TYR . . . -125.73 167.16 15.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.082 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -156.2 152.07 23.51 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.546 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.631 HG13 HD11 ' A' ' 243' ' ' LEU . 17.8 t -135.54 143.52 36.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.808 0.337 . . . . 0.0 111.123 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -154.99 167.18 32.71 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.494 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.661 HG22 ' HB3' ' A' ' 12' ' ' ALA . 31.5 m -124.98 160.42 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 0.0 111.09 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -147.4 139.78 24.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -144.66 156.87 44.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 53.2 p -134.48 140.66 46.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.855 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.822 0.344 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.53 -60.99 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.87 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -154.87 -53.75 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 60.87 159.88 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -170.4 -60.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.773 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -172.0 159.66 5.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -148.88 109.37 4.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.898 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -97.18 136.39 37.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -147.18 121.74 9.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.572 HG22 ' HD2' ' A' ' 36' ' ' PHE . 2.1 pp -126.19 129.57 72.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.1 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.96 172.19 22.73 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.543 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.29 142.85 10.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.841 0.353 . . . . 0.0 111.087 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.7 ttm -116.9 158.13 24.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -144.88 130.66 19.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.919 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -93.16 133.66 36.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.95 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 pp -118.61 148.98 21.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.132 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.37 -55.59 2.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.904 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -166.04 133.17 2.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.928 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.1 p -109.47 136.35 45.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.147 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 60.51 100.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.851 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 147.89 -150.57 22.8 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.537 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -99.98 106.0 17.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.339 . . . . 0.0 110.899 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -126.5 -41.8 0.31 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.499 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -74.21 94.18 2.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.349 . . . . 0.0 110.915 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -153.21 -63.22 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -105.65 -54.22 2.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -148.77 125.92 11.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.06 33.97 0.86 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.609 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.4 mp -82.33 157.56 23.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.864 0.364 . . . . 0.0 110.871 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.9 128.2 32.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.146 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.62 94.15 48.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.72 178.8 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.503 2.135 . . . . 0.0 112.236 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.64 128.53 8.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.577 HG11 ' CZ ' ' A' ' 36' ' ' PHE . 16.4 t -108.72 159.31 8.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.185 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.468 ' N ' HG12 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -148.83 127.89 12.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.577 ' CZ ' HG11 ' A' ' 34' ' ' VAL . 51.2 m-85 -121.49 147.41 45.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -146.36 143.22 28.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.11 134.74 23.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.975 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.597 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -109.66 147.52 32.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.109 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -174.19 120.52 0.27 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.881 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.37 -149.42 48.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.496 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.426 ' HG2' ' CE3' ' A' ' 43' ' ' TRP . 92.1 Cg_endo -78.93 0.99 9.54 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.656 2.237 . . . . 0.0 112.87 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.426 ' CE3' ' HG2' ' A' ' 42' ' ' PRO . 14.7 p90 -127.48 170.36 12.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.81 0.338 . . . . 0.0 111.045 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -141.08 154.07 45.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.5 mt -121.0 127.26 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.063 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -122.14 148.31 45.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.067 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.6 tp -139.52 164.33 30.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.009 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.568 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -147.82 147.95 30.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.062 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -128.26 153.16 47.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -116.51 151.14 36.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -134.91 126.79 29.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -124.45 126.85 46.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -141.95 91.81 0.18 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.541 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.97 138.13 39.56 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.616 2.21 . . . . 0.0 112.401 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.5 p -63.69 139.26 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.104 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -59.6 174.75 0.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -173.79 -41.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.52 -59.05 0.77 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.23 118.09 7.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.12 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -130.15 36.66 2.28 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.543 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.28 -31.35 21.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 0.0 110.866 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.8 mmt-85 -120.88 -172.54 2.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 120.36 117.85 2.61 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.499 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 m -92.11 119.12 31.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.743 0.306 . . . . 0.0 110.945 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -95.33 155.4 16.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -99.62 170.56 8.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.777 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.76 165.99 24.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.86 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.75 95.96 6.23 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.22 135.86 35.64 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.405 2.07 . . . . 0.0 112.259 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -115.58 129.63 56.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.6 mt -116.37 143.05 46.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 3.4 mm-40 -146.51 136.23 23.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.7 t -116.26 149.71 18.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.066 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -131.96 139.11 48.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -153.93 145.02 22.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -125.6 111.07 14.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.933 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -67.91 -56.36 9.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.81 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.3 mt 58.65 98.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.956 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -80.82 -62.88 1.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -126.86 -179.11 4.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -71.75 -30.57 65.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -80.26 -49.87 11.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.841 ' CE2' HG13 ' A' ' 120' ' ' VAL . 5.5 m-85 -92.61 167.89 11.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.968 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.7 t -156.88 162.81 39.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.947 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.496 ' CZ ' ' CD1' ' A' ' 118' ' ' TRP . 0.3 OUTLIER -127.73 177.36 6.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.831 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.405 ' O ' HD22 ' A' ' 87' ' ' LEU . . . -172.48 116.35 0.61 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.443 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.868 HD12 HD11 ' A' ' 114' ' ' ILE . 2.3 mm? -123.02 119.34 30.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.371 . . . . 0.0 110.991 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.9 t -125.33 104.81 8.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.745 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -128.28 144.31 15.14 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.488 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -141.37 178.63 20.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.542 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -127.54 118.74 24.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.824 0.345 . . . . 0.0 110.839 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.2 tpt85 -100.77 139.34 36.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -167.35 166.37 14.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -142.62 128.78 19.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.49 175.85 43.26 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.03 143.16 26.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.825 0.345 . . . . 0.0 110.889 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -158.32 94.19 1.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.913 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.25 167.0 10.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.3 t -127.7 -50.77 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.08 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -69.33 -30.47 68.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.936 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -148.16 104.03 3.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.15 142.8 57.04 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.443 2.095 . . . . 0.0 112.281 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -99.36 -110.22 3.08 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.52 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -176.38 -39.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.798 0.333 . . . . 0.0 110.938 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -57.59 123.32 15.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.973 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.5 m -127.79 157.24 40.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.942 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.63 170.36 15.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.065 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -141.13 104.34 4.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 56.1 tpp -154.11 143.34 21.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.929 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -138.62 103.93 4.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.8 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -111.91 111.43 22.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.986 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -91.35 130.85 37.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.849 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -130.84 120.24 23.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.052 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.868 HD11 HD12 ' A' ' 87' ' ' LEU . 9.0 tp -146.44 115.55 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.863 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -128.79 93.22 37.92 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.334 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.02 178.03 7.81 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.579 2.186 . . . . 0.0 112.223 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -159.52 134.9 8.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.935 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.496 ' CD1' ' CZ ' ' A' ' 85' ' ' PHE . 0.9 OUTLIER -112.25 126.66 55.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.811 179.852 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.02 113.22 26.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.027 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.841 HG13 ' CE2' ' A' ' 83' ' ' PHE . 25.6 t -119.88 102.11 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.015 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.36 142.45 39.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.014 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.776 ' HB3' HD22 ' A' ' 126' ' ' LEU . 4.7 tt -119.83 -44.41 2.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.69 175.1 11.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -61.16 -31.37 71.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.919 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -116.44 39.96 3.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.776 HD22 ' HB3' ' A' ' 122' ' ' LEU . 2.2 tt -156.86 116.23 3.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.5 mtm-85 -126.12 138.37 53.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.929 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.556 ' CD1' HD12 ' A' ' 157' ' ' LEU . 5.3 t80 -112.46 139.61 47.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.812 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -148.47 143.54 26.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.977 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 144.9 153.06 5.76 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.563 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -172.97 170.93 4.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 0.0 110.813 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.676 HD23 HG23 ' A' ' 153' ' ' THR . 18.9 mt -74.51 132.5 41.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.948 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.5 m -106.91 160.43 15.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 18.0 mtm -142.04 148.24 38.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -154.46 150.31 27.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.22 154.98 42.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -156.27 113.65 3.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.839 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -161.36 168.72 23.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.138 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -94.59 -56.09 2.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -177.49 -39.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.795 ' O ' HG22 ' A' ' 144' ' ' THR . 0.2 OUTLIER -87.44 -28.33 22.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.95 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -75.18 -27.28 59.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.038 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.92 -36.76 72.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.071 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.795 HG22 ' O ' ' A' ' 141' ' ' LEU . 13.4 t -72.08 -10.67 60.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.365 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.43 -29.96 57.9 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.628 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 60.66 32.64 20.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.792 0.329 . . . . 0.0 110.946 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -150.04 -179.68 7.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.144 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.45 37.1 16.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.21 153.01 26.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.941 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -109.47 122.72 48.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.925 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.06 117.26 9.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.091 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -124.11 153.78 40.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.011 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.676 HG23 HD23 ' A' ' 132' ' ' LEU . 14.7 m -121.69 123.93 43.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.729 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -116.86 129.76 56.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.986 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 61.5 p -153.41 115.45 4.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.755 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -140.37 -169.37 11.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.776 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.556 HD12 ' CD1' ' A' ' 128' ' ' PHE . 0.3 OUTLIER -139.94 178.12 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.348 . . . . 0.0 110.833 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -140.02 143.56 36.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.9 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.464 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 1.3 t80 -135.25 101.24 4.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.0 m -97.55 108.82 21.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.823 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.464 ' CE2' ' CD1' ' A' ' 159' ' ' TYR . 20.5 m-85 -79.57 -36.99 37.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.95 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -176.53 -165.15 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.78 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -86.58 6.08 32.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.332 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.709 HG23 HG22 ' A' ' 165' ' ' VAL . 8.8 t -93.23 -35.83 12.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.746 0.308 . . . . 0.0 110.943 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.709 HG22 HG23 ' A' ' 164' ' ' THR . 30.5 m -156.81 150.3 9.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.119 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.846 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -131.34 152.24 50.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.15 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.475 HD23 ' H ' ' A' ' 168' ' ' ARG . 0.4 OUTLIER -111.63 146.66 37.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.773 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.475 ' H ' HD23 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -147.22 129.61 15.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.95 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.6 t -131.92 146.63 33.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.978 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -152.41 125.62 8.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.065 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -95.76 161.23 14.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.737 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -135.58 151.11 49.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.008 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.77 105.19 3.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.762 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -101.57 140.8 35.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.962 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.81 113.11 6.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -124.73 146.7 16.28 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.527 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -164.11 160.34 21.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.859 0.362 . . . . 0.0 110.815 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.89 125.32 38.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -23.85 66.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -54.99 -74.41 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.106 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -169.9 37.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.973 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.11 121.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.902 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.44 33.18 2.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 68.77 -67.45 0.21 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.976 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -97.28 34.24 1.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.943 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -118.61 -36.73 0.89 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.507 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -93.52 102.91 15.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 0.0 110.985 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -156.36 172.44 18.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.881 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 17.5 t -137.61 142.08 41.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 72.1 p -133.45 147.8 51.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.901 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -118.39 135.09 54.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.85 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -130.09 140.92 50.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.727 HD11 HD11 ' A' ' 212' ' ' ILE . 46.1 pt -119.05 138.97 48.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.185 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.75 113.58 11.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.891 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -120.72 116.55 25.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.047 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -136.5 131.3 33.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.932 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.403 ' N ' HD23 ' A' ' 197' ' ' LEU . 0.3 OUTLIER -117.35 109.46 42.17 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.722 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.846 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 28.1 Cg_endo -62.76 136.58 58.51 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.439 2.092 . . . . 0.0 112.393 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.574 HD22 HD11 ' A' ' 201' ' ' LEU . 0.2 OUTLIER -115.62 101.27 8.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.772 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 8.8 t -78.12 127.07 31.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.574 HD11 HD22 ' A' ' 199' ' ' LEU . 4.2 mp -139.84 148.06 41.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -81.88 58.3 4.92 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.503 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -179.8 -62.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.872 0.368 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -136.15 137.93 41.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.863 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 10.5 m -90.54 140.05 30.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.487 ' CG1' HD12 ' A' ' 229' ' ' LEU . 21.7 t -128.28 111.37 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.033 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.93 92.89 5.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.01 171.84 16.7 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.621 2.214 . . . . 0.0 112.294 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -158.05 161.56 38.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.863 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.7 m -139.9 116.1 10.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.3 mtt180 -139.41 134.89 33.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.063 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.743 HG22 ' H ' ' A' ' 214' ' ' LEU . 32.4 mt -76.65 141.7 15.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.125 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -103.62 -2.88 46.83 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.838 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.743 ' H ' HG22 ' A' ' 212' ' ' ILE . 73.6 mt 61.28 179.97 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.343 . . . . 0.0 110.841 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.83 126.54 36.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -142.24 -60.24 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 58.3 m -105.86 -179.21 3.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -160.0 128.27 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.907 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -176.18 -111.42 0.28 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.533 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -64.88 138.54 58.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.83 0.348 . . . . 0.0 110.892 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 72.84 -158.01 52.85 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.53 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -131.04 -48.23 1.01 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.812 0.339 . . . . 0.0 110.842 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.65 154.42 44.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.829 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.23 -58.82 2.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -151.88 123.65 7.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.425 ' HG2' HG22 ' A' ' 227' ' ' VAL . 0.0 OUTLIER -130.06 -34.45 1.68 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.227 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.425 HG22 ' HG2' ' A' ' 226' ' ' ARG . 21.0 m -147.87 139.85 18.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 0.0 111.167 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -116.27 150.23 18.64 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.408 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.487 HD12 ' CG1' ' A' ' 206' ' ' VAL . 0.8 OUTLIER -129.86 122.92 29.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.886 0.374 . . . . 0.0 110.938 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -109.89 118.04 35.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.814 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.13 159.4 20.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.064 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -154.42 117.01 0.76 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.045 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.517 ' HB3' HG12 ' A' ' 241' ' ' VAL . 0.2 OUTLIER -132.27 115.61 15.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.714 0.292 . . . . 0.0 111.106 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 240' ' ' SER . 3.6 m-20 -81.36 122.7 27.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -60.88 -15.13 27.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.964 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.98 -39.39 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.826 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 178.55 -60.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.001 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -74.19 -70.27 1.27 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.672 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.585 ' H ' HD23 ' A' ' 239' ' ' LEU . 1.2 pt? -66.35 146.84 54.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.718 0.294 . . . . 0.0 110.832 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -148.49 176.87 9.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.274 -179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.517 HG12 ' HB3' ' A' ' 233' ' ' TYR . 11.4 p -122.86 131.32 73.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.831 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 9.8 m -107.6 139.8 41.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.092 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.66 141.93 46.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.972 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -105.25 120.68 42.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.948 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -108.98 143.94 37.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.833 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -172.09 -167.92 0.52 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.074 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 61.96 107.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.925 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.75 -46.68 0.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 4.9 m0 68.68 -68.06 0.19 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.99 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -131.26 -72.86 0.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.936 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 35.6 t0 61.05 77.51 0.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.822 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -105.93 -36.13 7.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.897 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -145.28 105.01 4.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.926 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.7 111.59 2.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -119.2 45.94 1.19 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.572 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.72 135.81 40.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.854 0.359 . . . . 0.0 110.869 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 48.1 t -76.61 -31.63 57.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.929 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -130.68 129.93 43.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.877 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -164.19 139.19 5.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -155.12 112.74 3.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.961 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -143.02 106.69 4.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.918 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 62.22 117.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.991 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -163.72 132.74 3.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.05 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -78.08 144.62 28.76 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.529 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 23.1 t -117.04 119.8 63.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.834 0.349 . . . . 0.0 111.029 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -137.09 160.39 24.95 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.543 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 12.3 m -135.86 153.13 31.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 0.0 111.157 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -152.03 131.9 13.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.49 ' CE1' ' CE2' ' A' ' 271' ' ' PHE . 4.6 t80 -131.01 126.18 35.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 39.5 t -113.68 147.76 37.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' PHE . . . . . 0.49 ' CE2' ' CE1' ' A' ' 269' ' ' TYR . 3.3 m-85 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.933 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.851 0.358 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -123.14 85.48 2.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.72 -55.71 3.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 60.78 -176.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.828 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -160.97 81.44 0.64 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -60.0 99.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.471 ' CB ' ' HB3' ' A' ' 39' ' ' ALA . 3.0 t-80 -94.81 146.17 24.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -126.69 137.01 53.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -151.15 131.57 13.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.475 HG23 ' CE2' ' A' ' 36' ' ' PHE . 22.7 mt -130.53 139.33 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.031 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.81 165.07 29.2 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.549 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.566 ' HB3' HG22 ' A' ' 267' ' ' VAL . . . -150.49 170.54 18.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.797 0.332 . . . . 0.0 111.059 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 57.2 mtm -143.27 153.57 42.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.969 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.761 ' HB2' HG23 ' A' ' 265' ' ' VAL . 10.9 m-85 -146.53 106.08 3.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.838 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -105.76 162.95 13.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.915 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.6 mt -119.84 77.09 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.05 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -94.39 137.01 34.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.946 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -159.34 161.78 35.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.529 ' O ' HG22 ' A' ' 19' ' ' VAL . 12.3 p -156.43 53.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -149.07 -173.52 4.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.907 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.17 129.96 1.07 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.558 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.78 -47.72 0.33 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 110.889 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.34 126.36 0.82 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.526 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 60.25 173.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.852 0.358 . . . . 0.0 110.914 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -70.14 96.36 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 12.8 ttp -74.81 -62.29 1.59 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.948 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -142.93 162.55 35.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -126.61 89.3 0.35 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.413 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.34 132.7 42.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.841 0.353 . . . . 0.0 110.908 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.75 146.66 41.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.083 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.76 93.89 30.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.018 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 14' ' ' TYR . 39.4 Cg_exo -60.52 178.68 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.681 2.254 . . . . 0.0 112.201 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.1 123.57 5.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.967 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.3 138.31 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.091 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -138.92 155.32 48.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.475 ' CE2' HG23 ' A' ' 10' ' ' ILE . 62.5 m-85 -146.5 153.13 40.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -147.35 129.64 15.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.671 ' HB3' HG23 ' A' ' 45' ' ' ILE . . . -134.01 141.9 47.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.006 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.471 ' HB3' ' CB ' ' A' ' 7' ' ' HIS . . . -123.49 116.52 23.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.086 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -126.08 73.78 1.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.789 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.83 -135.58 32.78 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.411 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.31 -20.99 48.31 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.377 2.051 . . . . 0.0 112.346 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -101.57 120.72 40.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.909 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -113.17 153.15 28.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.671 HG23 ' HB3' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -141.71 140.78 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.129 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -137.22 130.04 30.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.977 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.616 HD23 ' HG ' ' A' ' 71' ' ' LEU . 2.8 mt -116.45 166.79 11.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.549 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -165.53 141.5 5.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -122.54 160.2 26.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.946 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -141.51 128.67 20.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.938 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.67 119.21 4.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.84 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -64.11 151.56 42.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -119.01 95.95 0.64 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.47 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.2 146.28 69.32 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.51 2.14 . . . . 0.0 112.263 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.3 p -67.31 147.56 12.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.061 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -59.15 154.65 15.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.003 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 61.17 87.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.861 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.0 t -104.65 166.32 10.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.4 -68.19 0.91 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.078 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 144.11 44.92 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.484 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -84.2 -58.81 2.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 110.94 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -176.69 135.24 0.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.84 115.85 0.72 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.563 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.5 p -117.57 164.02 15.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 0.0 110.866 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -104.74 163.65 12.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 66' ' ' PHE . 4.1 p90 -152.69 165.41 35.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -125.23 145.98 49.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.984 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.72 95.79 2.82 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.942 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.47 153.25 44.47 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.506 2.137 . . . . 0.0 112.267 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.549 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -144.38 128.47 17.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.006 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.616 ' HG ' HD23 ' A' ' 47' ' ' LEU . 1.2 mp -132.15 154.18 49.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.832 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -154.82 157.58 38.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.885 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.455 HG23 ' H ' ' A' ' 89' ' ' GLY . 31.6 m -144.69 156.79 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.055 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -134.81 117.68 16.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -103.62 114.43 28.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -83.03 99.38 9.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.66 -54.68 5.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.84 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.8 tp 61.79 152.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -154.42 -60.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.965 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -147.92 -172.72 4.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.92 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -84.01 -32.95 24.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.29 -55.9 20.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.808 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.535 ' HB3' HG12 ' A' ' 120' ' ' VAL . 6.2 p90 -133.67 148.29 51.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.9 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -122.04 160.38 25.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -127.56 164.37 22.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -179.75 -177.65 48.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.482 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.7 155.62 43.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.817 0.341 . . . . 0.0 110.901 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.8 p -142.97 110.12 5.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.455 ' H ' HG23 ' A' ' 73' ' ' VAL . . . -113.98 179.93 18.86 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.505 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -177.71 170.41 42.77 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.471 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -148.59 144.43 27.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.341 . . . . 0.0 110.895 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.8 mtp85 -141.05 174.45 10.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.9 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -151.51 169.31 22.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -138.0 122.16 18.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -95.4 127.75 9.26 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.441 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.08 130.84 39.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.774 0.321 . . . . 0.0 110.916 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -133.86 139.7 46.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.896 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -152.92 31.61 0.49 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 101' ' ' GLU . 21.4 t -131.86 127.95 59.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.74 -31.02 66.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.963 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.402 ' H ' HG12 ' A' ' 99' ' ' VAL . 8.2 pt-20 -119.83 89.16 41.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.957 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.23 168.2 21.56 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.546 2.164 . . . . 0.0 112.321 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -176.54 -65.66 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.535 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.83 32.52 0.4 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -137.89 93.84 2.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.43 -175.76 3.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.823 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -138.2 124.4 20.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.152 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -129.93 154.69 47.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.829 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.3 mtm -137.95 124.84 21.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.956 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -89.23 135.97 33.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.844 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -123.58 126.7 47.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.027 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -107.12 145.25 32.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.792 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.401 ' HG3' ' CE1' ' A' ' 135' ' ' TYR . 20.6 tttm -139.91 134.3 31.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.034 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.418 ' O ' HG23 ' A' ' 114' ' ' ILE . 2.1 tt -152.76 126.2 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.905 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.597 ' HB2' ' HA ' ' A' ' 133' ' ' SER . . . -150.57 106.35 3.1 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.305 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.86 137.31 34.88 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.452 2.101 . . . . 0.0 112.072 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -105.92 141.05 37.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.024 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 70.4 p-90 -148.64 131.66 16.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.853 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -123.13 143.94 49.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.967 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.535 HG12 ' HB3' ' A' ' 83' ' ' PHE . 30.4 m -144.26 125.59 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.059 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.87 151.71 30.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.891 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.6 tp -124.01 -48.47 1.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.953 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.27 -176.99 5.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.44 132.01 46.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 60.13 32.63 21.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.767 HD23 HD21 ' A' ' 157' ' ' LEU . 0.1 OUTLIER -146.53 107.9 4.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -118.53 137.76 52.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.684 ' CZ ' HD12 ' A' ' 157' ' ' LEU . 2.9 m-85 -102.08 141.19 35.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.834 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -132.32 138.59 47.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.77 147.27 14.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.472 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TRP . . . . . 0.515 ' HE3' ' HB1' ' A' ' 115' ' ' ALA . 26.2 p-90 -173.06 149.5 1.85 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.862 0.363 . . . . 0.0 111.102 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.27 135.74 53.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.617 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.597 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 3.6 t -108.37 153.5 23.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.132 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 53.4 mtp -134.98 118.38 16.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.768 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.401 ' CE1' ' HG3' ' A' ' 113' ' ' LYS . 1.9 m-85 -102.45 133.82 46.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.949 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.839 ' HG3' HG23 ' A' ' 149' ' ' THR . 3.9 mttm -138.73 114.12 9.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.79 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -121.08 141.16 51.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.97 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -172.84 140.38 0.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.055 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -96.08 -52.9 3.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.023 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 176.38 -48.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.981 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 mt -80.92 -23.24 39.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -54.58 -29.45 51.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.052 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.6 p -59.74 -27.51 66.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.023 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.7 m -56.79 -34.13 67.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.966 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -90.78 -28.9 14.45 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.476 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 59.93 84.31 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.869 0.366 . . . . 0.0 110.841 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -87.8 164.06 16.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.108 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.26 158.43 19.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.855 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.839 HG23 ' HG3' ' A' ' 136' ' ' LYS . 2.4 m -84.74 154.55 22.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.911 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -103.06 121.41 42.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.89 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 27.6 m -106.0 129.12 59.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.077 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -110.77 127.61 55.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.858 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.44 114.54 26.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.427 ' HB3' ' CE2' ' A' ' 131' ' ' TRP . 0.6 OUTLIER -121.09 116.39 24.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.851 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.0 m -145.28 145.95 31.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.833 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -163.57 -162.82 15.06 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.53 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.767 HD21 HD23 ' A' ' 126' ' ' LEU . 6.6 tt -151.62 149.9 29.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.845 0.355 . . . . 0.0 110.91 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.453 ' N ' HD23 ' A' ' 157' ' ' LEU . 2.9 mt-30 -118.59 131.7 56.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -127.74 100.16 5.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.701 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 9.4 t -99.81 126.23 45.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.983 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -104.11 -30.09 10.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.775 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -165.36 177.22 7.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.711 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -81.92 0.63 38.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.363 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.605 HG22 ' O ' ' A' ' 200' ' ' THR . 0.2 OUTLIER -111.84 -26.56 8.88 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.653 0.263 . . . . 0.0 111.172 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.75 HG12 ' HG ' ' A' ' 199' ' ' LEU . 28.4 m -145.75 141.52 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.232 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.752 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -150.66 -172.24 4.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.013 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.66 143.24 31.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.627 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.79 145.31 32.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.057 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.645 HG23 ' HB2' ' A' ' 195' ' ' ALA . 11.5 p -144.56 137.88 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.944 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -133.12 155.19 49.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.989 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -127.85 119.35 25.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -96.37 136.1 37.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.002 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.9 125.24 10.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.802 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -111.08 145.59 38.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.949 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.85 117.47 3.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -146.67 169.83 27.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.525 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.431 ' CE1' ' HG3' ' A' ' 187' ' ' GLU . 0.3 OUTLIER -133.79 142.34 47.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.774 0.321 . . . . 0.0 110.943 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.48 135.51 53.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 1.6 tpt -84.74 -53.19 5.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 62.85 -79.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.057 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.41 -62.59 0.49 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.873 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.97 -68.98 0.61 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -173.02 137.95 0.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -168.84 34.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.936 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 20.7 m120 60.52 63.19 1.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -95.78 25.61 24.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.499 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.431 ' HG3' ' CE1' ' A' ' 177' ' ' PHE . 15.7 mt-10 -76.49 164.67 25.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.843 0.354 . . . . 0.0 110.897 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -147.14 117.6 7.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.7 t -117.16 136.34 53.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 4.0 m -137.12 145.97 44.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -144.4 121.87 11.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.925 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -144.52 136.37 25.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.989 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.524 HD13 ' O ' ' A' ' 212' ' ' ILE . 4.0 mp -107.07 124.97 63.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.132 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -128.23 115.74 18.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.776 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.645 ' HB2' HG23 ' A' ' 169' ' ' VAL . . . -133.49 125.78 29.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.215 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.694 ' HB2' HG22 ' A' ' 207' ' ' THR . 41.8 p90 -121.52 141.36 51.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.722 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.429 ' O ' ' HD2' ' A' ' 208' ' ' PRO . 8.2 tt -105.66 109.31 63.06 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.134 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.752 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 59.0 Cg_endo -71.35 111.21 3.04 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.368 2.046 . . . . 0.0 112.318 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.75 ' HG ' HG12 ' A' ' 165' ' ' VAL . 0.4 OUTLIER -132.76 127.82 35.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.912 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.605 ' O ' HG22 ' A' ' 164' ' ' THR . 0.7 OUTLIER -137.17 114.16 10.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.09 105.52 7.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.838 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 102.44 -133.3 11.33 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.43 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -105.45 17.18 24.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.721 0.296 . . . . 0.0 111.266 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -136.42 159.89 40.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.791 0.329 . . . . 0.0 110.945 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.35 148.43 47.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.83 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 199' ' ' LEU . 5.8 m -144.17 122.3 6.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.694 HG22 ' HB2' ' A' ' 196' ' ' TYR . 5.2 m -125.04 92.91 46.69 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.123 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 197' ' ' LEU . 26.6 Cg_exo -63.0 171.7 5.8 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.57 2.18 . . . . 0.0 112.178 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.434 ' HB3' HG13 ' A' ' 227' ' ' VAL . 0.1 OUTLIER -128.83 143.25 50.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.783 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.97 136.48 49.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.913 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.8 117.69 14.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.939 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.524 ' O ' HD13 ' A' ' 193' ' ' ILE . 7.6 pt -99.03 125.98 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.4 -132.89 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.547 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -163.92 145.15 8.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 110.842 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? 60.25 175.79 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.818 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.406 ' O ' ' CG ' ' A' ' 216' ' ' TRP . 31.0 p-90 -104.09 106.22 16.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.44 -169.58 1.97 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.894 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -85.18 -65.49 1.0 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 168.43 176.02 38.45 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.522 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -154.7 -46.39 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.942 0.401 . . . . 0.0 110.921 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 164.15 48.85 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.55 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.0 172.57 12.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.832 0.348 . . . . 0.0 110.904 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -111.23 -15.16 13.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.29 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 70.63 -65.46 0.33 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.779 0.324 . . . . 0.0 110.815 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -60.25 -27.5 67.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.948 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -154.52 148.05 25.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.018 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' A' ' 209' ' ' TYR . 13.0 p -114.94 -34.31 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.14 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.625 ' O ' HD12 ' A' ' 229' ' ' LEU . . . -160.77 -166.83 20.31 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.375 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 228' ' ' GLY . 0.1 OUTLIER -160.04 141.65 12.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 111.045 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -122.61 145.51 48.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.768 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -112.53 159.47 18.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.04 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -142.87 117.06 1.08 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.097 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -121.13 136.09 55.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.362 . . . . 0.0 110.998 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.1 100.22 7.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.625 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -65.86 -10.67 40.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.22 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.9 37.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.796 0.331 . . . . 0.0 111.005 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 5.0 t30 69.71 -64.97 0.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -52.78 -43.54 60.34 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.738 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.782 HD23 ' N ' ' A' ' 240' ' ' SER . 2.5 tt -87.0 144.77 26.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.762 0.315 . . . . 0.0 110.891 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.782 ' N ' HD23 ' A' ' 239' ' ' LEU . 16.0 m -134.22 151.48 51.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.815 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.477 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 38.9 t -120.98 141.07 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.77 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.88 118.75 31.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.037 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.544 HD23 ' HE2' ' A' ' 245' ' ' TYR . 1.1 mp -120.68 154.95 34.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.702 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -116.76 131.55 56.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.951 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' TYR . . . . . 0.544 ' HE2' HD23 ' A' ' 243' ' ' LEU . 18.6 m-85 -133.32 146.47 51.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.815 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -172.99 113.46 0.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.147 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -100.59 -41.19 7.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.776 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 59.95 162.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 19.0 t-105 -80.2 110.83 15.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.43 ' HB3' ' CD2' ' A' ' 252' ' ' HIS . 12.0 mt-30 -147.41 117.05 7.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.949 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.18 109.24 20.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' HIS . . . . . 0.43 ' CD2' ' HB3' ' A' ' 250' ' ' GLN . 12.7 p80 -177.0 174.22 1.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.825 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -133.85 152.51 51.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.95 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -112.65 94.44 4.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.922 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -69.81 -107.07 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.514 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.44 109.03 2.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.874 0.368 . . . . 0.0 110.839 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 12.4 m -170.84 145.17 2.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 -135.33 25.24 3.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.017 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -148.38 129.31 14.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.839 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -154.94 43.5 0.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.965 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -100.95 91.78 4.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.909 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -132.57 105.24 7.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -170.69 169.97 6.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.143 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -97.82 161.71 21.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.561 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.761 HG23 ' HB2' ' A' ' 14' ' ' TYR . 4.8 m -144.81 146.56 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 111.119 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -160.92 164.3 34.68 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.453 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.566 HG22 ' HB3' ' A' ' 12' ' ' ALA . 6.7 m -126.78 150.15 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 0.0 111.163 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -143.72 146.45 33.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.835 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -144.11 139.33 28.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.68 147.52 50.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 24.4 t80 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.892 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.831 0.348 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.38 168.66 8.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.18 146.71 29.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -158.63 161.28 37.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.982 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 -177.67 54.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 61.09 84.54 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.864 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 61.5 t60 -105.98 141.51 37.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.998 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -129.59 163.04 26.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.738 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.422 ' C ' HD12 ' A' ' 10' ' ' ILE . 2.0 t30 -160.26 146.32 15.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.997 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.51 HD12 ' N ' ' A' ' 10' ' ' ILE . 3.7 mp -140.81 134.35 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.108 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.81 159.28 24.51 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.571 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.593 ' HB3' ' CG2' ' A' ' 267' ' ' VAL . . . -144.49 138.99 27.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.865 0.364 . . . . 0.0 111.001 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.29 149.1 42.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.993 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -132.15 111.06 11.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -94.48 150.48 20.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.6 pt -140.55 147.79 22.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.027 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -160.18 118.93 2.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -94.06 179.94 5.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.7 m -101.78 127.22 55.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.12 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -89.72 -36.57 15.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.858 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 150.15 -34.59 1.0 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.549 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.51 31.31 3.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.857 0.36 . . . . 0.0 110.908 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.85 35.23 0.37 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.531 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.92 86.22 3.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.853 0.359 . . . . 0.0 110.93 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -177.11 130.29 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.867 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.56 168.71 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.856 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 60.33 -177.63 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 142.05 -27.67 2.28 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.544 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.16 149.42 26.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.848 0.356 . . . . 0.0 110.956 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.47 153.61 24.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.029 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.68 94.0 46.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.988 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.48 158.0 20.72 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.53 2.153 . . . . 0.0 112.198 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.51 133.89 44.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.819 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.72 142.15 30.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.091 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.88 143.68 43.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.967 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -133.89 132.57 40.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -132.0 125.05 30.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.94 136.73 53.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.019 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.864 ' HB3' ' HB3' ' A' ' 7' ' ' HIS . . . -118.96 122.76 42.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.17 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -139.95 86.39 2.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.0 -143.44 44.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.363 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.62 -14.23 41.41 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.457 2.105 . . . . 0.0 112.486 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.6 134.12 45.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.987 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.23 145.46 49.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 46' ' ' ALA . 30.7 mt -131.46 155.36 41.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.217 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.742 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -160.04 136.48 8.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.112 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.49 ' HG ' HD22 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -124.82 146.62 49.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.979 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.606 ' HB3' ' CB ' ' A' ' 70' ' ' GLU . . . -126.48 134.02 51.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.019 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -126.04 110.19 13.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.994 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.19 138.02 36.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.786 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -161.34 166.16 27.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.933 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.65 173.9 6.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.956 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -174.14 90.96 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.562 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.13 148.08 61.91 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.574 2.183 . . . . 0.0 112.288 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.436 HG13 ' O ' ' A' ' 55' ' ' VAL . 10.9 p -77.92 123.8 35.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.098 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.89 129.16 34.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.928 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.49 -69.74 0.83 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.843 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -124.34 -56.93 1.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.84 -60.42 1.92 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.066 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.0 60.43 5.25 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.421 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -114.72 -38.02 4.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.847 0.356 . . . . 0.0 110.999 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.8 ttt-85 -66.15 138.74 57.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.81 128.21 2.31 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.512 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 t -104.59 154.63 19.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.815 0.34 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 18.3 m95 -97.17 159.59 14.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.942 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.67 151.85 34.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.833 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.91 124.58 31.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.27 95.85 4.64 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.877 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.06 142.61 24.94 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.536 2.158 . . . . 0.0 112.408 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.606 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . 19.1 mt-10 -137.79 114.79 10.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.899 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.49 HD22 ' HG ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -102.87 133.89 47.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.741 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.742 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 3.7 tt0 -132.68 127.74 35.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.038 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 p -124.9 136.15 61.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.004 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -122.94 129.13 51.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.029 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -125.62 137.66 53.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.799 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -122.15 121.45 36.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -106.39 -43.31 4.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.728 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 59.65 160.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.981 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -141.63 -47.34 0.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.835 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -147.31 174.91 11.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.79 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -75.17 -29.13 60.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.002 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -84.74 -42.34 15.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.986 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.688 ' CE2' HG13 ' A' ' 120' ' ' VAL . 11.7 m-85 -101.6 169.82 8.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.01 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.57 162.43 33.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.797 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -158.12 144.32 17.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.955 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.82 -176.25 47.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.497 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.92 134.06 5.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.815 0.34 . . . . 0.0 110.901 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.61 ' OG1' ' HB3' ' A' ' 115' ' ' ALA . 69.2 p -118.84 159.36 23.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.32 -170.98 15.29 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.488 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 178.08 159.28 22.52 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.515 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -126.29 148.18 49.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.846 0.355 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.1 ttp85 -136.69 133.61 36.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.893 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -132.19 178.91 6.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.773 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -146.52 146.2 30.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.964 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -134.41 165.26 24.48 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.477 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -111.34 129.63 55.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 0.0 110.935 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -152.64 35.97 0.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -66.41 -43.11 86.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.591 HG12 ' H ' ' A' ' 101' ' ' GLU . 17.4 t -87.2 140.78 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.027 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -59.44 -30.54 68.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.89 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.591 ' H ' HG12 ' A' ' 99' ' ' VAL . 4.7 tt0 -126.1 74.34 72.07 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.6 163.37 5.32 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.56 2.174 . . . . 0.0 112.245 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -140.18 -100.81 0.46 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.455 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.13 31.47 3.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 110.88 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.72 104.78 15.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.872 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -152.99 159.2 42.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.911 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.69 138.17 24.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.109 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -85.14 105.35 15.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.55 148.4 51.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.893 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -156.55 161.76 39.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.85 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.02 109.2 1.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -83.47 140.42 32.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.776 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.54 127.31 17.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.01 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.424 HG22 ' N ' ' A' ' 115' ' ' ALA . 4.6 mt -122.47 154.77 27.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.942 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.61 ' HB3' ' OG1' ' A' ' 88' ' ' THR . . . -147.29 79.74 9.61 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.292 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.8 155.0 19.07 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.562 2.175 . . . . 0.0 112.183 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -122.32 146.15 47.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.008 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -164.99 142.75 6.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.08 151.68 41.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.911 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.688 HG13 ' CE2' ' A' ' 83' ' ' PHE . 23.4 t -147.59 108.23 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -88.35 133.18 34.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.888 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.512 ' O ' HG23 ' A' ' 123' ' ' THR . 3.0 tt -110.99 -32.84 6.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -166.05 -175.07 3.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.833 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -90.99 51.3 1.93 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -165.88 -43.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.43 124.31 51.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -125.29 146.56 49.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.773 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -101.95 146.02 28.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.014 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -125.45 123.32 38.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -110.95 106.77 2.09 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.517 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -133.1 136.18 45.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.788 0.328 . . . . 0.0 110.775 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.3 mt -131.02 161.45 31.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.801 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.3 151.24 49.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.041 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.677 ' SD ' HG12 ' A' ' 151' ' ' VAL . 1.5 mpp? -140.1 133.78 30.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.822 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -130.57 127.72 39.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.971 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.444 ' HA ' HG23 ' A' ' 149' ' ' THR . 3.5 ttpt -146.51 168.1 22.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.774 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 59.55 -176.59 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.777 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 142' ' ' ASN . . . -176.49 -165.95 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.124 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -87.61 -27.47 22.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.967 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -176.65 -39.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.035 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.534 ' H ' HD12 ' A' ' 141' ' ' LEU . 5.3 mp -51.21 -27.77 9.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.178 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.527 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 36.1 t30 -72.47 -29.42 63.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.967 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.51 -62.81 1.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.099 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.7 -47.67 13.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.018 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.22 -35.68 91.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.572 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 60.28 35.27 20.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.884 0.373 . . . . 0.0 110.843 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -134.24 -164.95 1.58 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.048 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.1 t0 65.59 49.04 1.86 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.91 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.444 HG23 ' HA ' ' A' ' 136' ' ' LYS . 2.9 m -149.07 110.7 4.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.846 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -162.91 179.04 7.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.984 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.677 HG12 ' SD ' ' A' ' 134' ' ' MET . 11.1 m -118.19 131.96 69.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.098 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -101.23 169.43 8.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 8.9 m -132.8 140.28 47.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.876 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -135.38 142.91 45.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.32 127.88 23.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.743 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -116.8 142.13 17.24 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.662 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.7 mp -115.23 117.37 30.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.755 0.312 . . . . 0.0 110.787 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -101.26 117.51 35.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.961 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -127.04 102.47 6.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.422 HG22 ' CB ' ' A' ' 166' ' ' ALA . 34.3 p -93.11 128.08 38.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.909 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.07 -31.46 12.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.643 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.584 ' HB2' HG22 ' A' ' 165' ' ' VAL . 7.4 m120 -150.92 174.94 12.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.814 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -76.24 -6.39 51.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.43 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.49 HG23 ' HB2' ' A' ' 201' ' ' LEU . 55.1 m -113.07 -28.95 7.49 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.635 0.255 . . . . 0.0 111.23 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.584 HG22 ' HB2' ' A' ' 162' ' ' ASN . 19.6 m -123.11 139.94 48.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.865 0.364 . . . . 0.0 111.385 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.75 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -141.17 -178.42 5.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.004 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 41.3 tp -141.2 134.73 29.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.934 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 196' ' ' TYR . 51.7 mtt-85 -137.52 114.54 10.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.2 t -99.85 142.67 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.998 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -118.96 123.34 44.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.021 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -116.17 114.85 25.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.723 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -106.43 140.98 38.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.091 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.61 105.17 5.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.689 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.74 145.74 29.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.029 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -136.28 136.16 39.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.752 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -130.51 152.69 19.9 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.498 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -160.41 134.94 7.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.359 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -96.07 131.56 42.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -34.06 35.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.23 83.51 7.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.911 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -176.8 132.76 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 15.5 m -102.35 31.87 3.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -159.98 172.69 17.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.928 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.7 88.34 3.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -155.95 148.49 23.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 96.7 -28.34 13.95 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.519 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -71.44 125.45 27.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.743 0.306 . . . . 0.0 110.942 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -144.56 153.61 42.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.824 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.3 m -122.4 105.53 10.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.968 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.31 114.01 27.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.813 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -109.01 129.4 55.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.017 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -118.28 152.56 35.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.79 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.67 HD13 ' H ' ' A' ' 193' ' ' ILE . 0.2 OUTLIER -136.52 148.09 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.267 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -150.31 127.55 11.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.723 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -119.31 117.26 28.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.97 0.414 . . . . 0.0 111.273 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.439 ' HB3' ' CD1' ' A' ' 209' ' ' TYR . 11.5 p90 -138.28 151.24 47.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.592 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.654 HD11 ' HG2' ' A' ' 208' ' ' PRO . 0.3 OUTLIER -118.54 111.23 38.13 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.242 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.75 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 60.5 Cg_endo -72.8 123.29 8.86 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.385 2.056 . . . . 0.0 112.371 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 198' ' ' PRO . 8.7 mt -126.74 104.48 8.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.845 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.3 t -117.12 117.8 30.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.563 HD13 ' N ' ' A' ' 202' ' ' GLY . 0.9 OUTLIER -147.57 121.63 9.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.563 ' N ' HD13 ' A' ' 201' ' ' LEU . . . 65.46 -119.8 15.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.534 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -118.43 30.57 7.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.905 0.383 . . . . 0.0 110.93 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.71 110.57 9.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 49.3 m -102.71 128.74 49.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.006 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.521 HG23 ' HB2' ' A' ' 199' ' ' LEU . 18.4 m -144.18 124.06 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.759 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.656 HG22 ' HA ' ' A' ' 198' ' ' PRO . 16.0 p -133.0 92.96 24.21 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.421 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.654 ' HG2' HD11 ' A' ' 197' ' ' LEU . 59.0 Cg_exo -52.52 171.77 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.457 2.105 . . . . 0.0 112.113 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.439 ' CD1' ' HB3' ' A' ' 196' ' ' TYR . 0.2 OUTLIER -148.11 140.68 24.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.727 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.766 HG23 ' H ' ' A' ' 226' ' ' ARG . 10.6 m -128.9 150.12 50.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.97 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.693 ' HD2' HG21 ' A' ' 227' ' ' VAL . 9.2 mtt-85 -142.3 112.41 7.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.83 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 1.9 pp -65.33 119.71 10.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -103.96 -125.41 5.61 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.497 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.4 mp -126.8 158.42 36.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.877 0.37 . . . . 0.0 110.812 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -149.37 166.73 28.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.817 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -114.03 -66.27 1.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.964 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 2.6 p -147.62 -56.28 0.23 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.914 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -131.98 -176.46 4.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -82.82 -171.85 47.68 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.462 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -164.1 31.54 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.831 0.348 . . . . 0.0 110.881 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 106.57 -38.11 3.48 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -114.94 151.5 33.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.782 0.325 . . . . 0.0 110.892 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -138.05 163.9 30.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.86 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -98.68 30.07 3.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.935 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.48 120.97 29.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.764 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.766 ' H ' HG23 ' A' ' 210' ' ' THR . 1.1 mtp180 61.25 102.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.693 HG21 ' HD2' ' A' ' 211' ' ' ARG . 14.7 m -72.09 -32.38 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.339 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -167.42 -164.67 23.5 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.488 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 208' ' ' PRO . 0.6 OUTLIER -149.99 119.13 6.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.825 0.345 . . . . 0.0 111.009 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -81.26 144.32 31.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.845 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.63 160.48 27.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.975 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -161.1 117.12 0.75 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.164 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.474 ' HB3' HG22 ' A' ' 241' ' ' VAL . 33.9 t80 -128.6 116.38 19.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.864 0.364 . . . . 0.0 111.163 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 240' ' ' SER . 3.1 p30 -117.88 135.62 53.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.946 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.1 -26.48 60.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.29 -45.76 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.872 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -178.5 -61.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -56.76 -75.83 0.23 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.715 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.808 HD12 ' CD1' ' A' ' 269' ' ' TYR . 7.7 tt -66.45 124.64 23.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.749 0.309 . . . . 0.0 110.764 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 234' ' ' ASP . 2.0 t -148.56 175.86 10.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.178 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.511 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 27.8 m -129.0 167.6 24.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.61 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.414 ' O ' HD12 ' A' ' 243' ' ' LEU . 0.3 OUTLIER -133.63 134.69 43.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.021 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 242' ' ' SER . 3.3 mp -137.55 152.2 49.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -138.83 141.45 38.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.84 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -131.51 165.62 23.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -99.9 -169.68 1.77 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.033 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -114.44 158.57 21.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -170.58 120.5 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -60.1 -34.73 73.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.949 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -132.27 107.8 8.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.957 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.62 116.89 19.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.888 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -102.42 47.52 0.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -97.43 38.0 1.31 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.932 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.51 106.89 15.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.846 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 80.17 -127.41 7.93 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.495 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.98 161.75 17.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.816 0.341 . . . . 0.0 110.868 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.17 127.05 6.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -100.13 31.06 3.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.57 161.38 33.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.975 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -122.01 178.35 4.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.896 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -142.58 158.39 43.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -68.05 104.31 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -133.69 178.09 7.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.08 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -145.38 150.73 22.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.453 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.85 153.55 27.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 0.0 111.12 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -158.62 155.95 26.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.495 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.593 ' CG2' ' HB3' ' A' ' 12' ' ' ALA . 15.3 m -138.11 147.83 25.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.811 0.339 . . . . 0.0 111.14 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -138.24 129.93 28.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.943 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.808 ' CD1' HD12 ' A' ' 239' ' ' LEU . 1.9 t80 -124.8 126.12 45.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.951 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 35.0 t -97.85 151.57 20.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.875 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.783 0.325 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -72.83 119.48 17.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.942 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -61.5 -36.21 79.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.8 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -81.74 -172.57 3.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -166.44 83.8 0.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.95 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -71.57 125.16 26.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.77 132.92 52.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.923 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.87 140.43 38.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -141.5 120.14 12.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.022 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.62 HG22 ' CE1' ' A' ' 36' ' ' PHE . 27.1 pt -110.68 140.72 28.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.09 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.79 159.74 26.94 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.618 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.25 143.89 46.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 111.065 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 30.6 mtt -131.25 138.72 49.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.997 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -147.32 113.83 5.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.92 161.18 17.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 16' ' ' ILE . 6.2 tt -154.23 52.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.038 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.35 98.11 11.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.844 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -153.9 -45.8 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.1 t 66.99 86.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.124 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -111.74 -55.4 2.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.871 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.82 -163.57 9.57 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.518 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -72.35 165.09 25.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.855 0.36 . . . . 0.0 110.938 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.81 -173.56 42.61 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.517 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 60.94 19.58 9.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.663 0.268 . . . . 0.0 111.141 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.65 -30.44 3.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.209 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 67.67 82.03 0.18 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.867 0.365 . . . . 0.0 110.886 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -154.17 116.83 4.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.855 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 158.87 -137.27 5.11 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.54 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.81 150.24 24.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.787 0.327 . . . . 0.0 110.85 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.56 126.23 27.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.037 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -143.18 94.15 6.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.93 146.43 47.42 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.492 2.128 . . . . 0.0 112.363 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.1 m -140.21 152.8 46.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.857 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.2 m -133.6 159.53 42.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -143.93 122.28 12.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.62 ' CE1' HG22 ' A' ' 10' ' ' ILE . 8.8 m-85 -119.85 141.7 49.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.946 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.666 ' OD1' ' HB2' ' A' ' 46' ' ' ALA . 25.1 t30 -143.34 132.52 23.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.998 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.521 ' HB3' HG13 ' A' ' 45' ' ' ILE . . . -126.69 124.08 39.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.041 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.58 113.24 25.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.154 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -122.33 98.56 5.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.816 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.77 -141.79 45.79 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.45 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.58 -18.34 48.6 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.499 2.133 . . . . 0.0 112.441 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -101.47 144.6 30.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 111.016 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -137.73 132.77 33.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.521 HG13 ' HB3' ' A' ' 38' ' ' ALA . 23.7 pt -117.68 156.38 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.131 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.666 ' HB2' ' OD1' ' A' ' 37' ' ' ASN . . . -142.95 157.79 44.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.055 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.0 tt -150.48 120.96 7.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.907 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.61 139.1 49.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.041 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.99 109.66 11.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -95.91 125.05 40.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.862 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -120.19 144.51 47.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.93 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -130.13 140.29 50.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.934 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -156.69 73.97 0.23 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.478 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.5 156.66 53.91 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.563 2.175 . . . . 0.0 112.27 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.6 t -103.56 133.74 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.14 168.32 19.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -167.16 -57.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.6 m -113.85 -40.02 3.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -116.58 126.52 53.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.05 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.42 82.65 0.13 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.474 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -158.57 31.12 0.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.338 . . . . 0.0 110.822 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.402 ' HB2' ' NH1' ' A' ' 62' ' ' ARG . 3.9 ttm105 -162.81 33.04 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.909 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.29 82.8 0.44 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.459 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.67 116.77 27.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.795 0.331 . . . . 0.0 110.926 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -77.89 124.28 27.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -135.18 141.67 45.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.848 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -139.64 134.39 31.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.953 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.97 95.85 14.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.86 159.83 11.06 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.536 2.157 . . . . 0.0 112.275 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.89 149.96 47.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.871 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.92 141.12 23.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.97 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 2.6 tt0 -128.4 151.16 49.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.813 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.506 HG12 ' CD1' ' A' ' 75' ' ' TYR . 28.2 t -127.81 130.67 70.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.151 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.579 ' ND1' HG22 ' A' ' 88' ' ' THR . 0.1 OUTLIER -123.9 121.09 34.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.787 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.506 ' CD1' HG12 ' A' ' 73' ' ' VAL . 1.7 p90 -153.33 106.53 2.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.845 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -92.43 141.03 28.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.957 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -88.52 -47.96 7.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.866 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.8 mt -143.12 171.08 14.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -169.75 111.91 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -143.71 -178.51 5.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.89 -31.45 59.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.916 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.09 -56.14 6.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.968 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -156.76 134.15 10.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.2 m -109.69 138.19 46.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.94 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -124.63 139.84 53.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.18 172.33 35.85 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.502 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.448 ' HB2' ' CE2' ' A' ' 75' ' ' TYR . 17.2 mt -143.31 143.41 31.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.816 0.341 . . . . 0.0 110.817 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.579 HG22 ' ND1' ' A' ' 74' ' ' HIS . 25.2 p -140.82 131.75 26.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.07 -177.93 15.12 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.494 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.87 153.38 24.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.484 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 111' ' ' ARG . 6.4 t80 -131.63 136.61 47.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.86 0.362 . . . . 0.0 110.89 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.6 mtm180 -137.23 159.83 40.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.54 169.77 17.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.824 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.15 130.74 25.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -143.09 129.45 3.76 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.513 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.726 ' HB2' HG21 ' A' ' 106' ' ' THR . 42.9 m-85 -70.37 169.42 13.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.328 . . . . 0.0 110.906 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.59 114.82 13.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.984 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.1 88.44 2.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.918 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.6 m -62.75 -34.63 66.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.036 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -60.51 -47.39 86.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -115.21 87.55 16.24 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.42 119.63 6.57 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.573 2.182 . . . . 0.0 112.335 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 178.42 151.2 9.27 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.607 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.8 tttm -98.48 34.57 1.98 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.784 0.325 . . . . 0.0 110.879 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -98.52 41.26 1.14 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.841 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.726 HG21 ' HB2' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -105.87 179.34 4.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.452 ' H ' HG22 ' A' ' 106' ' ' THR . . . -107.09 116.01 31.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.068 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -107.77 141.25 39.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.827 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.9 ptm -112.69 133.78 54.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.47 127.19 36.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.4 ' O ' ' CD1' ' A' ' 91' ' ' PHE . 12.4 mtt180 -109.97 128.21 55.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.923 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -127.74 113.83 16.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.85 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -119.58 144.27 47.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.953 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.2 tp -140.97 143.54 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.998 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.08 99.78 3.06 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.081 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.63 155.2 69.68 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.433 2.089 . . . . 0.0 112.242 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -112.93 142.96 45.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.998 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.68 130.37 20.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.781 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.15 132.32 29.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.56 HG23 ' HB3' ' A' ' 128' ' ' PHE . 11.8 m -143.44 109.99 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.151 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -72.66 123.31 23.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.951 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.7 tp -101.78 -46.64 4.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.961 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.31 167.62 12.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.85 -30.13 71.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.025 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.559 ' OD2' HD12 ' A' ' 126' ' ' LEU . 2.5 p30 -123.87 40.97 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.011 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.559 HD12 ' OD2' ' A' ' 125' ' ' ASP . 1.2 mp -156.85 133.8 10.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.56 140.51 48.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.836 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.56 ' HB3' HG23 ' A' ' 120' ' ' VAL . 68.8 t80 -104.92 126.82 52.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.978 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -114.86 147.37 39.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.802 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -152.38 133.53 4.15 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.676 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TRP . . . . . 0.427 ' CD1' ' N ' ' A' ' 131' ' ' TRP . 0.1 OUTLIER -160.81 165.19 30.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.819 0.342 . . . . 0.0 110.841 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.46 156.06 47.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.01 110.33 17.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.83 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.5 ttp -113.92 111.57 21.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.839 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -104.9 121.77 44.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.477 ' HA ' HG22 ' A' ' 149' ' ' THR . 3.2 tmtm? -140.53 110.55 6.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.819 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 148' ' ' ASP . 21.4 p90 -129.23 157.8 40.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.963 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -160.66 154.85 23.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.12 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -94.7 -63.99 1.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -173.29 -63.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.88 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.769 ' O ' HG22 ' A' ' 144' ' ' THR . 6.4 tt -85.51 -31.46 22.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -60.24 -20.38 58.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.119 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.408 ' O ' ' CD2' ' A' ' 146' ' ' TYR . 0.8 OUTLIER -52.41 -29.54 24.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.863 0.364 . . . . 0.0 111.176 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 141' ' ' LEU . 9.9 t -70.06 -29.68 66.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.25 -39.42 44.06 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.518 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.408 ' CD2' ' O ' ' A' ' 143' ' ' THR . 7.0 m-85 60.82 76.57 0.36 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.831 0.348 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -139.4 162.56 34.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.101 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . 53.7 m-20 60.48 35.34 20.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.975 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 136' ' ' LYS . 69.8 p -137.25 112.8 9.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.814 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -153.53 -178.56 7.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.917 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.467 HG22 ' N ' ' A' ' 152' ' ' GLU . 9.4 p -129.68 157.82 42.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.993 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.467 ' N ' HG22 ' A' ' 151' ' ' VAL . 4.3 mp0 -124.62 157.43 35.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.975 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 68.6 p -116.77 118.0 31.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.754 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.401 ' HG2' ' CE1' ' A' ' 172' ' ' TYR . 3.5 mp0 -126.2 138.05 53.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.028 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 7.9 t -139.4 138.91 36.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.671 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -132.36 158.33 22.92 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.644 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.9 mp -139.14 130.19 26.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.823 0.344 . . . . 0.0 110.738 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -93.95 146.73 23.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.975 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -139.72 100.15 3.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.787 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.69 115.06 16.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.958 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.6 -49.89 3.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.729 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -131.01 163.89 26.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.799 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -30.95 70.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.931 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -119.22 27.41 8.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.079 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.4 t -148.95 117.62 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.105 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 198' ' ' PRO . . . -124.03 149.96 45.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.184 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' A' ' 197' ' ' LEU . 2.4 mt -132.06 121.97 24.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.733 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.43 ' HD3' ' CE1' ' A' ' 196' ' ' TYR . 40.3 mtt180 -125.27 147.07 49.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.067 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.5 m -147.02 138.61 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 44.1 p30 -146.89 156.41 43.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.118 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.517 ' CD1' HG22 ' A' ' 193' ' ' ILE . 5.2 m-85 -110.13 144.57 38.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.785 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.401 ' CE1' ' HG2' ' A' ' 154' ' ' GLU . 0.3 OUTLIER -121.7 115.87 23.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.97 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.577 HD13 ' HA ' ' A' ' 191' ' ' GLN . 4.3 mm? -109.99 106.93 16.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.14 147.26 24.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -151.36 124.09 8.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.939 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -144.71 178.66 22.42 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.518 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -130.17 146.63 51.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.778 0.323 . . . . 0.0 110.97 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -131.23 173.83 10.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -82.73 -51.32 7.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.853 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -152.09 162.5 41.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.84 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.2 175.75 5.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.925 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.25 34.56 3.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -174.7 -43.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -68.14 122.31 18.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.914 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.32 -30.98 33.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.973 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -176.21 -53.82 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.89 126.86 54.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.331 . . . . 0.0 110.945 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -102.94 118.75 37.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.014 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.3 p -122.83 110.08 15.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 5.0 t -106.3 139.91 40.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.942 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.577 ' HA ' HD13 ' A' ' 173' ' ' LEU . 2.7 mt-30 -98.97 130.45 45.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -134.44 157.35 46.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.945 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.517 HG22 ' CD1' ' A' ' 171' ' ' TYR . 1.8 pt -141.18 137.09 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.43 114.31 16.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.846 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -101.3 115.43 30.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.228 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.446 ' HB3' ' CD1' ' A' ' 209' ' ' TYR . 8.4 p90 -128.98 114.95 17.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.623 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.536 ' HB2' HD23 ' A' ' 167' ' ' LEU . 0.4 OUTLIER -108.2 109.38 61.8 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.216 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.403 ' HB2' ' HB3' ' A' ' 166' ' ' ALA . 31.0 Cg_exo -61.73 136.08 60.12 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.561 2.174 . . . . 0.0 112.18 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.2 tp -132.88 127.98 35.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.929 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 7.1 m -132.19 123.18 26.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.967 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 26.8 tp -147.15 102.68 3.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.923 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 77.06 52.03 5.92 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.499 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 59.69 29.61 19.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.77 0.319 . . . . 0.0 110.941 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -104.09 126.21 51.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.09 104.92 16.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 230' ' ' PHE . 22.1 t -118.66 127.42 75.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.05 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.93 92.72 33.03 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.961 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -79.89 172.14 14.47 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.679 2.253 . . . . 0.0 112.244 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.446 ' CD1' ' HB3' ' A' ' 196' ' ' TYR . 0.3 OUTLIER -161.72 143.65 11.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.691 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 32.6 m -131.69 145.39 51.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.017 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.31 141.63 22.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.766 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 14.7 pt -108.85 128.5 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.181 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 95.16 157.48 32.41 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.514 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.772 HD22 ' HB2' ' A' ' 218' ' ' ASN . 2.1 tp -96.14 164.33 12.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 0.0 110.869 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 1.7 ptt-85 -70.12 -39.82 75.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -104.76 -67.28 0.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 57.6 p -176.72 143.89 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.938 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.772 ' HB2' HD22 ' A' ' 214' ' ' LEU . 1.3 t30 -166.98 104.01 0.56 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.851 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -86.82 -43.68 5.97 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.523 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -101.41 157.4 16.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.877 0.37 . . . . 0.0 110.848 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 140.53 163.87 9.69 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.517 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -106.25 129.2 54.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.8 0.333 . . . . 0.0 110.843 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.77 134.1 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.918 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -98.38 29.39 3.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.951 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -66.72 132.3 47.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.831 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.89 -59.16 1.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.951 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 47.4 t -92.28 -81.15 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.153 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 132.83 -149.63 19.59 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.484 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.23 110.93 21.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.778 0.323 . . . . 0.0 110.598 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.541 ' O ' HG13 ' A' ' 206' ' ' VAL . 0.1 OUTLIER -87.39 133.43 33.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.979 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -116.95 155.31 29.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -134.81 117.06 1.69 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.399 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.501 ' O ' HG23 ' A' ' 241' ' ' VAL . 17.3 m-85 -110.36 116.37 31.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.838 0.351 . . . . 0.0 111.027 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -115.45 111.09 20.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.676 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -72.78 -5.42 37.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.347 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.36 41.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.757 0.313 . . . . 0.0 110.938 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 70.0 -64.1 0.37 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.152 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -47.66 -75.66 0.18 Allowed Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.793 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 240' ' ' SER . 7.4 tt -66.51 142.49 57.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.775 0.322 . . . . 0.0 110.799 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.43 ' N ' HD23 ' A' ' 239' ' ' LEU . 0.8 OUTLIER -138.95 164.39 29.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.867 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 233' ' ' TYR . 8.2 t -131.29 151.42 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.942 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.57 126.2 52.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.98 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.28 122.91 12.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.809 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -105.32 141.16 37.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -124.85 153.05 43.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.898 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -97.25 -171.2 2.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.061 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.08 112.9 3.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.878 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.02 97.77 11.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER 60.32 159.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -85.98 -65.5 1.01 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.806 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.4 157.39 17.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.733 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 69.89 -59.4 0.51 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.268 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.2 t70 78.22 79.68 0.07 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.881 0.372 . . . . 0.0 110.851 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.09 83.25 6.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.85 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -133.88 -54.84 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.494 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 68.49 -67.84 0.19 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.313 . . . . 0.0 110.955 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 72.6 m 61.37 155.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.922 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -123.53 -44.05 2.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -114.39 178.6 4.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.97 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -83.4 159.71 21.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.6 117.85 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.878 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -91.14 -178.65 5.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.937 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -122.87 -54.71 1.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.067 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -128.38 147.43 17.43 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.504 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.24 142.97 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.769 0.319 . . . . 0.0 111.135 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -172.48 159.99 31.05 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.517 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.62 152.34 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 111.142 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -136.23 136.04 39.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.969 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -134.35 157.88 45.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 4.8 p -118.86 147.02 44.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.851 -179.93 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.832 0.349 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.75 57.01 0.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 18.2 mtt85 61.04 29.92 19.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.986 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -133.45 66.6 1.55 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.753 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -173.77 -59.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.801 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 11.6 t90 -96.68 102.28 14.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.79 160.16 18.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.798 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.53 125.25 14.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -125.09 120.81 32.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.837 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 pp -130.52 126.74 61.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.12 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.98 164.56 25.79 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.539 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -125.8 147.81 49.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.796 0.332 . . . . 0.0 111.075 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.58 150.92 48.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.924 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -141.44 117.86 10.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.817 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -125.34 139.99 53.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.831 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.1 tp -96.21 139.68 18.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.047 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.79 147.36 44.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.963 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -140.84 131.55 25.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.822 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.4 m -147.96 32.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.081 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.85 172.68 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 153.97 45.82 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.434 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -112.26 114.17 26.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.779 0.324 . . . . 0.0 110.894 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.29 -68.58 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.46 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -133.58 -49.98 0.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.871 0.367 . . . . 0.0 110.909 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.75 118.04 31.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.846 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.43 148.17 30.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.843 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.23 -178.27 4.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.21 46.33 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.488 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.7 mp -89.4 144.63 25.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.826 0.346 . . . . 0.0 110.877 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.88 150.81 33.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.075 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -120.0 94.07 48.32 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.42 178.75 0.21 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.55 2.166 . . . . 0.0 112.258 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.09 135.08 26.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.836 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.59 141.53 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.113 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -140.26 122.25 15.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.929 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.411 ' CZ ' ' HB3' ' A' ' 47' ' ' LEU . 3.7 p90 -144.55 123.76 12.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.76 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -135.82 162.5 32.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.983 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.82 129.61 36.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.013 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.54 109.28 21.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.104 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -108.69 85.44 2.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.803 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.31 -147.57 47.41 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.4 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -51.26 -25.78 18.61 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.506 2.137 . . . . 0.0 112.36 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -92.64 148.4 22.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.809 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -140.6 137.23 33.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.945 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.6 pt -129.92 145.49 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.964 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.19 155.78 49.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.222 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 36' ' ' PHE . 3.6 mp -142.3 144.85 33.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.739 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -118.31 143.43 46.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.08 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -141.47 160.02 41.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.63 148.04 32.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.868 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.56 -179.53 4.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.81 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -153.03 139.83 19.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.981 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.23 65.63 0.25 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.459 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 145.01 56.06 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.563 2.175 . . . . 0.0 112.294 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.05 139.8 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.17 104.8 2.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -125.3 -44.58 1.87 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.935 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -152.38 150.33 29.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -97.29 153.99 17.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.145 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.95 38.22 3.2 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.504 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.24 67.14 0.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.946 0.403 . . . . 0.0 110.827 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -73.58 85.34 1.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.909 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -121.19 147.67 17.46 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.533 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.8 p -85.95 140.98 29.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.804 0.335 . . . . 0.0 110.904 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 7.6 m0 -122.37 135.45 54.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.823 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -116.44 173.39 6.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.03 134.91 47.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.75 95.87 24.86 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.884 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.34 170.25 18.8 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.484 2.123 . . . . 0.0 112.253 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.739 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 2.0 tt0 -153.59 140.34 19.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.025 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mt -126.04 146.31 49.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.804 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -152.28 119.89 6.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.031 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.39 138.87 31.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.042 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -129.52 135.14 48.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.064 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -124.05 110.8 15.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.712 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -65.59 137.14 57.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.043 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -50.92 147.09 5.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.199 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 16.8 mt -72.37 -66.3 0.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.743 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -71.1 -173.5 0.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.689 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -175.2 -32.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.41 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -45.88 -30.15 1.62 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.489 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.404 ' HB3' ' CD2' ' A' ' 83' ' ' PHE . 1.2 t70 -164.34 -64.97 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.97 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.437 ' CD1' HG13 ' A' ' 120' ' ' VAL . 23.5 m-85 -104.31 118.61 37.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.85 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.37 173.79 6.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.74 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.46 ' HE1' HD11 ' A' ' 87' ' ' LEU . 12.1 t80 -162.36 117.06 1.84 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.032 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.472 ' C ' HD12 ' A' ' 87' ' ' LEU . . . -132.19 -162.42 10.37 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.261 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.472 HD12 ' C ' ' A' ' 86' ' ' GLY . 4.0 mp -155.73 145.24 21.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 0.0 110.981 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 81.7 p -142.84 121.94 12.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.931 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -151.32 -159.01 8.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.522 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 174.3 176.64 42.84 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.554 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.433 ' CD2' ' N ' ' A' ' 91' ' ' PHE . 3.9 m-85 -122.27 173.82 7.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.845 0.355 . . . . 0.0 110.818 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -150.26 128.23 11.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.024 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -131.45 149.44 52.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.827 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.22 138.22 52.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.933 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -106.11 134.8 12.3 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.426 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -122.8 139.28 54.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.347 . . . . 0.0 110.955 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -151.36 102.54 2.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.805 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -173.36 -40.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.962 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.8 m 42.03 72.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.788 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.63 -31.43 72.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -115.72 97.68 49.41 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.25 114.17 1.2 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.499 2.133 . . . . 0.0 112.5 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 166.3 -86.17 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.486 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.67 30.58 0.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.921 0.391 . . . . 0.0 110.948 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.79 98.73 10.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.71 161.03 32.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -128.13 125.99 40.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.056 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -144.06 119.87 10.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.981 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.46 159.28 18.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.785 ' H ' ' HB2' ' A' ' 138' ' ' ALA . 8.0 mt-30 -146.61 104.64 3.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -105.04 127.12 52.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -96.76 122.22 39.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.94 121.72 45.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.899 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.633 HG22 ' HD3' ' A' ' 116' ' ' PRO . 17.5 mt -130.99 132.14 63.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.04 76.43 8.71 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.348 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.633 ' HD3' HG22 ' A' ' 114' ' ' ILE . 44.2 Cg_exo -56.52 168.17 2.35 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.526 2.15 . . . . 0.0 112.132 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -147.17 134.75 20.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.164 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -120.73 124.81 46.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.66 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -100.14 125.92 46.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.959 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.437 HG13 ' CD1' ' A' ' 83' ' ' PHE . 22.3 t -140.37 116.96 8.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.059 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -88.66 144.36 26.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.922 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.29 -42.8 2.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -130.27 -170.75 2.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.841 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.44 ' H ' HG22 ' A' ' 123' ' ' THR . 79.1 m-20 -74.94 -47.99 26.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.88 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.713 ' C ' HD12 ' A' ' 126' ' ' LEU . 22.3 m-20 -110.19 29.78 7.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.713 HD12 ' C ' ' A' ' 125' ' ' ASP . 7.9 mp -138.15 133.86 33.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.864 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -142.51 152.71 42.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -141.51 135.29 30.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.802 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -154.55 168.12 27.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.062 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 151.83 177.37 25.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.562 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TRP . . . . . 0.467 ' HA ' ' CE3' ' A' ' 131' ' ' TRP . 0.0 OUTLIER -173.21 -172.67 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.77 0.319 . . . . 0.0 110.777 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.496 HD23 ' O ' ' A' ' 152' ' ' GLU . 6.1 mt -100.83 150.39 22.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.956 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.67 152.19 21.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.936 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 5.0 mtp -132.37 125.43 30.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -118.51 125.6 50.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.938 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.07 156.3 41.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.897 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -110.35 -170.15 1.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.716 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.785 ' HB2' ' H ' ' A' ' 110' ' ' GLN . . . -81.47 149.72 28.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.078 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -62.97 -29.18 70.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.074 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -63.47 -40.12 96.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.008 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.594 ' O ' HG22 ' A' ' 144' ' ' THR . 19.1 mt -95.38 -30.22 14.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.084 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -59.23 -27.19 65.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.945 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 p -57.77 -36.09 71.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.018 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.594 HG22 ' O ' ' A' ' 141' ' ' LEU . 5.6 t -90.67 -33.72 15.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.969 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.68 -29.38 61.49 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.521 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 66.49 -75.8 0.05 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.816 0.341 . . . . 0.0 111.065 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -91.4 -86.92 0.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.21 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.0 t0 51.51 27.0 3.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.824 0.345 . . . . 0.0 111.148 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 37.2 p -83.43 120.83 26.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.971 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -105.26 120.69 42.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.833 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.416 HG23 ' HG2' ' A' ' 175' ' ' ARG . 6.2 m -120.67 116.97 51.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.091 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.496 ' O ' HD23 ' A' ' 132' ' ' LEU . 6.9 mp0 -108.2 153.72 22.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.932 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.4 m -101.12 132.49 46.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -129.43 116.94 19.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.623 HG23 ' HB2' ' A' ' 171' ' ' TYR . 1.4 t -140.69 113.82 8.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -114.53 147.28 18.82 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.678 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.42 HD21 ' HB ' ' A' ' 169' ' ' VAL . 1.9 pp -123.0 117.29 25.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 110.738 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.68 127.06 35.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.106 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -140.81 100.16 3.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.795 HG23 ' HB2' ' A' ' 166' ' ' ALA . 2.8 m -106.95 137.21 45.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.079 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -99.72 -30.92 11.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.798 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.408 ' O ' HG22 ' A' ' 160' ' ' THR . 12.9 t30 -151.11 -179.09 7.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.808 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -87.61 6.23 35.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.373 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 60.2 p -103.41 -31.04 10.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.818 0.342 . . . . 0.0 110.982 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.778 HG23 ' HG ' ' A' ' 199' ' ' LEU . 11.3 p -147.67 152.03 13.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.145 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.795 ' HB2' HG23 ' A' ' 160' ' ' THR . . . -141.7 158.9 43.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.019 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.708 HD12 ' HB3' ' A' ' 197' ' ' LEU . 4.7 tp -115.52 143.01 45.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.952 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 32.1 mtp180 -147.36 124.0 11.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.024 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.42 ' HB ' HD21 ' A' ' 157' ' ' LEU . 21.5 t -124.41 123.76 66.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.007 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -121.1 145.98 47.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.141 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.623 ' HB2' HG23 ' A' ' 155' ' ' THR . 13.3 m-85 -112.92 130.85 55.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.746 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -111.18 138.12 48.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.037 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.761 HD12 ' HA ' ' A' ' 191' ' ' GLN . 4.6 tp -139.95 151.1 45.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.808 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -138.09 144.73 41.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.006 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.428 ' NH1' HD23 ' A' ' 173' ' ' LEU . 0.1 OUTLIER -160.06 116.58 2.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.959 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -123.06 169.91 15.41 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.398 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -150.19 163.93 36.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.804 0.335 . . . . 0.0 110.928 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.89 124.22 34.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.854 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 10.7 mtt -78.17 -27.24 47.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.048 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.84 -51.14 70.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.968 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -156.55 173.67 16.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.904 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.0 m -97.58 38.04 1.32 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -64.39 166.4 8.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -73.49 -43.14 60.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -78.09 86.07 4.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 154.4 -34.44 0.7 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.428 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.74 110.84 20.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.857 0.36 . . . . 0.0 110.845 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -177.13 179.29 1.02 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.82 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.9 m -142.24 148.83 38.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.944 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 17.0 p -130.39 162.6 28.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.761 ' HA ' HD12 ' A' ' 173' ' ' LEU . 4.0 pt20 -137.45 133.24 34.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.936 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -134.74 173.18 11.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.57 HG22 ' CE2' ' A' ' 171' ' ' TYR . 1.1 pt -137.36 142.33 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.249 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.51 114.49 16.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.761 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -115.76 118.97 34.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.251 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.442 ' CD2' ' N ' ' A' ' 196' ' ' TYR . 1.9 p90 -145.36 137.09 25.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.706 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.708 ' HB3' HD12 ' A' ' 167' ' ' LEU . 0.8 OUTLIER -128.37 109.41 19.37 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.053 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.812 ' HA ' HG23 ' A' ' 207' ' ' THR . 23.4 Cg_exo -64.15 142.54 80.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.5 2.133 . . . . 0.0 112.152 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.778 ' HG ' HG23 ' A' ' 165' ' ' VAL . 0.3 OUTLIER -130.02 100.01 5.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.791 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 35.1 p -107.04 102.97 12.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.957 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 2.9 tt -140.54 129.86 23.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.884 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 72.32 -128.78 13.87 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.472 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -117.52 30.1 7.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.359 . . . . 0.0 110.931 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -135.6 149.08 49.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 88.8 p -121.01 121.51 38.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.936 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.653 HG13 ' O ' ' A' ' 230' ' ' PHE . 21.5 t -135.31 139.94 45.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.825 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.812 HG23 ' HA ' ' A' ' 198' ' ' PRO . 2.0 m -138.69 92.97 11.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.403 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.01 111.52 2.47 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.618 2.212 . . . . 0.0 112.116 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -111.23 169.03 9.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 0.0 111.109 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.605 HG22 HG12 ' A' ' 227' ' ' VAL . 14.6 p -138.62 138.86 38.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.843 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -125.2 164.81 19.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.934 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 1.2 pp -64.02 148.97 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.92 -178.52 18.24 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.524 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.543 HD23 ' N ' ' A' ' 215' ' ' ARG . 2.3 tt -121.44 159.39 26.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.772 0.32 . . . . 0.0 110.902 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.543 ' N ' HD23 ' A' ' 214' ' ' LEU . 20.9 ttt85 -154.97 146.22 22.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -171.22 36.52 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.64 -178.34 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -120.07 144.93 47.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.893 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 140.09 -35.1 1.94 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.554 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 60.7 80.13 0.22 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.802 0.334 . . . . 0.0 110.914 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -107.04 -29.85 4.43 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.45 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -115.31 -176.31 2.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.821 0.343 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -110.87 161.81 15.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -97.46 40.22 1.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -117.36 85.48 2.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.991 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.4 144.41 26.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.737 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.605 HG12 HG22 ' A' ' 210' ' ' THR . 16.7 m -145.1 153.32 14.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.259 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -139.44 160.01 25.88 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.312 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.22 113.68 9.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.808 0.337 . . . . 0.0 111.048 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.653 ' O ' HG13 ' A' ' 206' ' ' VAL . 2.0 t80 -97.71 130.6 44.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.721 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -111.05 155.72 22.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.05 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -165.51 117.21 0.74 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.041 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.44 ' HB3' HG22 ' A' ' 241' ' ' VAL . 26.2 t80 -132.38 121.16 23.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.748 0.309 . . . . 0.0 111.181 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 240' ' ' SER . 2.4 p30 -108.71 128.53 54.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -54.98 -24.71 25.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.998 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -156.36 -45.44 0.07 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.836 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 179.51 -55.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -63.72 -78.88 0.17 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.691 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.827 HD23 ' CD2' ' A' ' 269' ' ' TYR . 3.1 mp -66.42 140.0 58.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.794 0.33 . . . . 0.0 110.9 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -157.14 176.84 12.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.048 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.565 HG12 HG12 ' A' ' 267' ' ' VAL . 30.2 m -122.01 170.39 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.825 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 36.4 t -142.27 131.84 23.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.828 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.691 ' HG ' HG12 ' A' ' 265' ' ' VAL . 2.3 tt -136.35 126.86 26.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.002 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -119.45 139.39 52.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -152.02 151.83 31.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.979 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -160.19 -76.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.048 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 63.13 125.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.986 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -76.71 -176.44 3.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER 60.27 109.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.821 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -75.87 145.38 40.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -128.21 160.64 31.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.41 -51.8 2.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.932 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -143.7 -59.28 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.83 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -148.22 156.02 42.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -150.69 -61.94 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.42 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -137.23 173.11 12.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.847 0.356 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 2.9 t -106.46 52.23 0.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.919 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -98.44 27.54 4.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.982 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? 56.84 174.97 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.932 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -83.03 -41.12 19.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 59.7 103.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -72.42 151.91 42.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.86 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -85.77 -72.73 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.045 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -144.58 148.08 19.65 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.445 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.691 HG12 ' HG ' ' A' ' 243' ' ' LEU . 21.8 m -147.47 141.83 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 111.134 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -158.47 175.04 35.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.54 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.565 HG12 HG12 ' A' ' 241' ' ' VAL . 9.2 m -130.33 162.86 37.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.79 0.329 . . . . 0.0 111.148 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -136.33 143.12 43.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.862 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.827 ' CD2' HD23 ' A' ' 239' ' ' LEU . 25.1 m-85 -139.18 101.7 4.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 59.4 p -110.77 131.7 54.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.903 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.838 0.352 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -120.76 36.11 4.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.929 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.26 -44.47 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.99 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -154.9 167.81 29.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.957 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -167.73 96.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.803 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 60.6 p-90 -107.83 149.89 27.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.943 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.505 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -118.2 144.71 45.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -118.72 130.03 55.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.51 128.61 19.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.553 HD12 ' HE1' ' A' ' 36' ' ' PHE . 11.7 tt -155.29 131.21 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.051 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.98 -157.99 7.73 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.553 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.79 -176.95 1.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.332 . . . . 0.0 111.04 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.5 ttt -152.94 150.13 28.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.34 138.21 26.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.854 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -129.98 124.19 32.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.952 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.8 mt 59.71 87.48 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.54 31.35 5.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.901 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.96 124.24 26.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.851 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.23 83.59 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.101 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -65.27 -67.94 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 173.97 -119.67 0.75 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.493 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 60.44 87.63 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.358 . . . . 0.0 110.921 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.65 14.58 77.81 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.776 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 55.72 -178.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.788 0.327 . . . . 0.0 111.119 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -167.04 92.64 0.43 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.921 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.4 mtt -68.53 -67.99 0.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.19 91.47 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.942 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.559 ' O ' HG22 ' A' ' 55' ' ' VAL . . . -85.24 135.44 13.47 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.486 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.36 113.5 25.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.901 0.381 . . . . 0.0 110.918 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.7 119.5 19.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.066 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -121.75 94.09 48.45 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.05 123.83 10.38 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.482 2.121 . . . . 0.0 112.269 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.28 137.97 46.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.026 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -137.22 142.1 38.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -133.29 156.21 48.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.942 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.553 ' HE1' HD12 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -153.5 132.52 12.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.881 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.23 126.55 19.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.966 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.16 135.41 45.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.053 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.505 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -124.45 149.82 46.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.169 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -173.91 140.41 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.83 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.16 -149.39 17.37 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.511 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -86.19 42.03 0.91 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.807 2.338 . . . . 0.0 112.729 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -170.95 163.7 7.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.804 0.335 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -141.28 163.74 32.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.938 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mp -142.31 139.62 29.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.74 144.68 45.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.173 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.06 165.0 24.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.668 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -156.36 135.11 11.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -139.65 118.96 12.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -146.53 160.96 41.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -127.82 144.0 51.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -132.27 127.95 36.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.37 157.24 7.17 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.582 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.93 158.14 57.73 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.645 2.23 . . . . 0.0 112.283 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 28' ' ' GLY . 10.8 m -90.25 121.06 40.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.108 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.11 155.9 26.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.943 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -128.35 101.62 6.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.05 -177.51 5.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.871 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -135.44 -47.27 0.69 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.125 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -159.51 72.16 0.23 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.556 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -162.38 -44.87 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.826 0.346 . . . . 0.0 110.817 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.0 mtt-85 -103.55 -176.47 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 165.88 65.64 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.493 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.52 122.44 47.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.815 0.34 . . . . 0.0 110.918 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -120.14 161.5 20.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -150.27 139.98 21.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -141.12 139.67 34.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.0 mtp180 -130.67 95.89 25.1 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.953 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.86 157.91 34.94 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.559 2.173 . . . . 0.0 112.365 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.668 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 6.4 tp10 -137.87 121.23 17.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 mp -114.65 145.21 42.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -153.82 160.27 42.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 73' ' ' VAL . 12.3 p -158.17 125.85 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.069 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -104.47 153.39 21.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -157.32 119.1 3.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -94.25 148.91 21.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -115.31 -62.51 1.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.837 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.7 mt -123.42 136.48 54.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.94 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -129.96 74.44 1.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -92.19 168.33 11.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -73.71 -27.75 61.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.956 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.445 ' HB3' ' CD2' ' A' ' 83' ' ' PHE . 12.7 m-20 -83.26 -64.21 1.21 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.939 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.538 ' HD1' HG22 ' A' ' 120' ' ' VAL . 12.6 m-85 -124.2 154.59 39.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.954 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.12 147.92 50.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.821 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.462 ' CE2' ' CZ3' ' A' ' 118' ' ' TRP . 29.3 m-85 -123.07 157.72 32.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.916 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -174.04 166.06 38.0 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.51 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.8 mt -144.3 137.07 26.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 0.0 110.874 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.93 123.37 19.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.53 149.81 16.88 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.547 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -161.48 156.68 28.2 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.422 ' HB3' ' CD1' ' A' ' 112' ' ' TRP . 8.1 p90 -150.1 167.71 26.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.789 0.328 . . . . 0.0 110.91 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.0 mtp85 -127.88 150.93 49.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.864 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -129.83 154.17 47.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.852 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -126.62 145.26 50.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -126.67 130.04 6.84 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.52 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -124.29 139.13 54.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.767 0.318 . . . . 0.0 110.914 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -99.21 175.9 5.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -122.59 119.2 30.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.5 t -128.86 -52.15 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.116 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.84 -31.34 23.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.851 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.35 89.92 2.9 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.41 157.02 63.57 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.501 2.134 . . . . 0.0 112.353 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 114.05 20.08 6.13 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.647 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? 56.74 36.48 27.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.839 0.352 . . . . 0.0 111.092 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.57 122.69 20.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.6 t -140.76 167.37 22.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.926 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -124.49 173.78 8.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.076 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -139.71 104.31 4.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.026 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.3 mtm -143.44 154.15 43.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.728 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -166.94 -179.28 4.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.961 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.45 ' HB2' ' ND2' ' A' ' 139' ' ' ASN . 28.0 ttp180 -145.02 134.58 23.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.422 ' CD1' ' HB3' ' A' ' 91' ' ' PHE . 0.3 OUTLIER -107.71 164.54 12.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.814 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -164.02 138.8 5.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.934 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.1 mt -137.77 125.82 31.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.051 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -135.91 107.89 9.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.072 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.51 177.12 5.72 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.474 2.116 . . . . 0.0 112.296 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -131.62 135.43 46.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.929 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.462 ' CZ3' ' CE2' ' A' ' 85' ' ' PHE . 2.9 t-105 -145.34 139.4 26.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.867 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -143.47 149.5 37.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.83 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.538 HG22 ' HD1' ' A' ' 83' ' ' PHE . 21.4 t -136.67 115.89 15.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.158 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.62 103.51 15.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.7 mp -81.37 -51.45 8.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -147.47 177.52 9.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.848 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -60.02 -29.91 68.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.993 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -118.96 36.2 4.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.008 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.411 HD12 ' CE1' ' A' ' 159' ' ' TYR . 0.8 OUTLIER -156.85 125.09 5.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -146.36 128.68 15.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.829 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.34 151.66 19.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -133.84 154.14 51.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.76 136.16 3.82 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.449 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 4.3 p-90 -164.59 138.78 5.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.333 . . . . 0.0 110.987 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.3 mp -95.25 161.57 14.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.9 m -139.29 113.62 8.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.902 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 1.6 ttt -111.44 148.45 33.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -125.37 119.49 28.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.21 167.23 11.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.764 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 60.18 -174.18 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.827 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -168.43 144.63 3.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.893 0.378 . . . . 0.0 111.242 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.45 ' ND2' ' HB2' ' A' ' 111' ' ' ARG . 35.6 m-80 -87.19 -29.59 21.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.903 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -130.5 71.81 1.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.8 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.0 mt -56.59 -25.0 51.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.101 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -60.42 -39.87 88.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 72.3 p -96.45 -34.51 11.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.2 m -91.65 12.66 20.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.361 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.69 -24.66 62.47 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.539 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -89.12 52.88 2.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 0.0 110.901 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -176.09 108.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.108 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.51 -75.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.6 t -135.72 163.46 30.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.983 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.74 129.92 50.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.75 129.08 47.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.091 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.76 151.2 45.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 29.4 m -117.29 139.78 50.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.837 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.95 115.5 23.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.838 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 17.6 m -125.7 137.05 53.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.903 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -150.33 160.34 28.51 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.599 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.418 HD21 ' HB ' ' A' ' 169' ' ' VAL . 0.3 OUTLIER -129.38 134.24 47.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.86 0.362 . . . . 0.0 110.921 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -113.79 114.29 26.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.961 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.411 ' CE1' HD12 ' A' ' 126' ' ' LEU . 9.5 t80 -126.78 113.44 16.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.725 HG23 ' HB2' ' A' ' 166' ' ' ALA . 6.2 m -103.12 136.49 42.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.102 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -103.99 -31.1 9.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.764 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -170.96 173.14 5.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.766 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.62 -14.39 62.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.344 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.711 HG23 HG12 ' A' ' 165' ' ' VAL . 9.1 t -76.24 -46.52 27.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.714 0.292 . . . . 0.0 111.032 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.711 HG12 HG23 ' A' ' 164' ' ' THR . 10.2 p -156.22 154.06 6.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.2 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.885 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -133.36 -172.74 3.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.028 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.404 ' HG ' HD21 ' A' ' 197' ' ' LEU . 1.5 mp -135.87 138.14 42.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.958 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.38 128.31 14.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.921 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.418 ' HB ' HD21 ' A' ' 157' ' ' LEU . 21.2 t -122.27 136.78 57.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.117 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -118.97 149.47 41.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.413 ' CE1' HG12 ' A' ' 193' ' ' ILE . 0.5 OUTLIER -134.81 144.9 47.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -124.48 136.19 53.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.977 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.426 HD12 ' HB3' ' A' ' 191' ' ' GLN . 1.2 tp -147.52 114.51 6.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.2 pm0 -143.67 162.53 35.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.023 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.4 ptt180 -140.17 166.55 24.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.817 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -138.49 160.02 25.45 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.558 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -119.1 130.7 55.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -97.34 162.12 13.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.03 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.99 -31.7 17.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -80.26 125.06 29.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.926 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -107.0 -31.77 8.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.835 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.11 63.94 1.9 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.17 -58.85 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.958 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -173.84 -61.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -176.8 132.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.836 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -96.47 27.97 15.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.512 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -102.33 80.81 1.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.763 0.316 . . . . 0.0 110.862 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.52 137.01 35.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.858 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 11.9 m -130.69 121.47 25.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.956 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 14.0 p -124.35 153.63 41.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.426 ' HB3' HD12 ' A' ' 173' ' ' LEU . 2.8 pp0? -153.96 128.44 9.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.834 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.21 137.85 54.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.5 HD12 HG21 ' A' ' 212' ' ' ILE . 22.6 mt -102.12 139.22 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.094 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 15.5 ttt85 -134.04 133.42 41.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -111.3 126.44 54.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.139 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.418 ' CD1' ' HB3' ' A' ' 209' ' ' TYR . 0.3 OUTLIER -131.67 116.14 16.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.772 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.404 HD21 ' HG ' ' A' ' 167' ' ' LEU . 0.4 OUTLIER -116.81 109.67 42.94 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.087 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.885 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 91.0 Cg_endo -79.0 138.22 14.36 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.409 2.073 . . . . 0.0 112.388 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.526 HD23 ' N ' ' A' ' 200' ' ' THR . 1.7 tt -132.76 155.91 48.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.929 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' THR . . . . . 0.526 ' N ' HD23 ' A' ' 199' ' ' LEU . 44.0 m -132.93 116.94 17.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.22 102.57 3.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.76 -137.52 15.31 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.485 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.03 23.66 14.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 0.0 111.043 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -136.44 132.99 36.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.764 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 84.8 p -96.69 134.44 39.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.954 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 20.8 t -135.38 131.5 51.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.85 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.705 HG22 ' HA ' ' A' ' 198' ' ' PRO . 14.3 p -133.61 92.82 22.59 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.302 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.34 124.71 9.15 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.432 2.088 . . . . 0.0 111.951 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.434 ' CZ ' ' HA3' ' A' ' 228' ' ' GLY . 48.2 p90 -111.12 136.23 50.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.932 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 24.7 m -111.12 159.64 17.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.938 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -127.35 126.76 43.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.851 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.5 HG21 HD12 ' A' ' 193' ' ' ILE . 0.7 OUTLIER -72.58 136.14 26.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.205 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 177.66 56.77 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.57 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.475 HD22 ' HA2' ' A' ' 219' ' ' GLY . 1.7 tt -152.34 74.66 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.864 0.364 . . . . 0.0 110.907 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -109.74 88.17 2.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.83 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -131.06 -53.9 1.04 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.977 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.19 -70.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.867 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -151.13 36.23 0.6 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.804 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.475 ' HA2' HD22 ' A' ' 214' ' ' LEU . . . 71.4 172.57 14.83 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.454 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.34 -56.89 1.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.859 0.361 . . . . 0.0 110.907 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 169.3 -33.81 0.18 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.491 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -84.64 160.68 20.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.776 0.322 . . . . 0.0 110.942 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 60.14 177.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 4.0 t80 60.92 43.27 11.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -157.16 57.25 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.929 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 48.1 mtm-85 60.33 98.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.906 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 17.6 m -86.65 -13.62 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.477 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.434 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . -149.8 171.65 29.82 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.452 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.08 129.53 11.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.918 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -107.01 114.5 28.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.748 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -90.93 162.1 14.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.035 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -153.95 117.03 0.77 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.111 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 240' ' ' SER . 0.8 OUTLIER -110.86 115.45 29.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.791 0.329 . . . . 0.0 111.142 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -120.06 85.44 2.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.564 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.95 -12.7 19.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.272 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.31 35.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.736 0.303 . . . . 0.0 111.137 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 68.91 -65.44 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.061 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -48.43 -59.33 6.59 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.725 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.519 HD23 ' C ' ' A' ' 239' ' ' LEU . 7.6 tt -80.95 107.37 13.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.764 0.316 . . . . 0.0 110.766 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 233' ' ' TYR . 30.5 t -113.19 154.37 26.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.476 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 39.1 t -122.38 142.53 38.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.779 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 27.3 m -116.45 118.84 33.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.008 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 243' ' ' LEU . 0.9 OUTLIER -128.34 124.37 36.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.771 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -105.23 133.56 49.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.945 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -121.9 159.38 26.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -116.76 -79.22 0.59 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.073 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 60.95 98.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -155.42 162.45 40.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -133.02 112.13 11.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -90.83 167.45 12.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -141.74 132.58 25.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 60.26 166.05 0.07 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.865 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.44 104.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.849 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -124.31 -61.8 1.32 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 71.51 -129.71 17.18 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -99.5 -178.07 3.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.86 0.362 . . . . 0.0 110.862 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.25 95.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.985 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -75.18 177.89 6.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -134.7 119.99 18.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.953 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -130.83 177.58 7.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -73.14 120.9 19.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.912 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -94.58 -63.28 1.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -158.11 134.75 9.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.042 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' GLY . . . . . 0.418 ' O ' HD13 ' A' ' 243' ' ' LEU . . . -103.45 136.13 12.75 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.543 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 16.5 t -120.11 141.71 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 111.092 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -166.2 164.31 37.46 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.518 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 5.7 m -132.72 166.73 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.853 0.358 . . . . 0.0 111.109 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -158.75 120.76 3.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.956 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.45 ' HB2' HG23 ' A' ' 10' ' ' ILE . 62.3 m-85 -112.78 105.75 13.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.794 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.59 118.34 36.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.873 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.827 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.883 0.373 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -100.18 103.96 15.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.945 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.79 109.2 5.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.902 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -116.92 -48.43 2.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.916 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -125.76 32.14 5.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -123.84 112.88 17.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.84 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.99 146.17 46.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.4 130.48 52.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.716 ' O ' HD13 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -123.2 129.32 51.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.716 HD13 ' O ' ' A' ' 9' ' ' ASN . 24.0 mm -138.9 127.78 29.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.098 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.96 -178.77 35.23 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.508 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.35 -176.89 5.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 0.0 111.072 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.44 152.36 21.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.82 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -150.89 118.42 6.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.92 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.29 151.06 51.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.863 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.9 mt -148.29 86.61 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.092 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -117.68 175.49 5.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -163.82 117.88 1.52 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.93 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.2 -37.82 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.068 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.65 -68.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.855 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.24 -159.05 4.19 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.457 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 23' ' ' GLY . 29.6 p90 -170.53 -42.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.83 0.348 . . . . 0.0 110.914 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.449 ' N ' ' CD1' ' A' ' 22' ' ' TYR . . . -66.42 105.24 1.23 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.56 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -143.36 137.94 29.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.85 0.357 . . . . 0.0 110.929 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -87.62 -71.76 0.55 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.5 ptm -158.36 -47.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.44 178.14 6.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 157.94 -157.46 28.26 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.529 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.05 159.9 32.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.902 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.84 138.11 31.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.138 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -136.64 94.13 13.54 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.926 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.72 167.41 25.76 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.555 2.17 . . . . 0.0 112.254 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.9 t -152.95 136.45 15.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -115.02 144.76 21.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.159 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -125.77 136.57 53.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.516 ' CZ ' HD12 ' A' ' 10' ' ' ILE . 1.2 m-85 -131.51 161.87 31.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.873 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -165.01 144.72 6.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.3 117.46 9.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.125 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.06 135.41 47.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.122 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -158.12 111.4 2.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.76 -149.29 37.49 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.579 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.76 -10.7 28.28 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.571 2.181 . . . . 0.0 112.6 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -99.87 143.04 30.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 110.941 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -129.99 142.08 50.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.8 mt -129.64 147.54 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.206 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.71 147.46 25.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.027 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.408 HD12 ' CE2' ' A' ' 49' ' ' TYR . 0.3 OUTLIER -146.16 169.22 19.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.934 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.43 137.37 20.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.042 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.408 ' CE2' HD12 ' A' ' 47' ' ' LEU . 70.9 m-85 -115.89 148.94 39.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.951 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -131.46 144.63 51.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -135.2 162.78 31.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -137.17 119.43 15.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.968 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.4 ' N ' ' HD3' ' A' ' 54' ' ' PRO . . . -142.95 60.95 0.53 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.533 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 53' ' ' GLY . 52.0 Cg_exo -54.52 177.93 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.577 2.185 . . . . 0.0 112.238 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 p -77.42 131.06 35.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.065 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -77.55 154.92 31.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.949 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -150.07 -63.07 0.21 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.86 133.71 9.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.814 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.95 -74.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.077 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.66 -49.72 3.16 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.49 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -141.25 31.38 1.74 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.85 0.357 . . . . 0.0 110.93 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.76 97.49 5.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.8 88.74 0.18 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.531 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 64' ' ' THR . 10.1 t -107.36 114.34 28.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.843 0.354 . . . . 0.0 110.899 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.39 153.77 28.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.877 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -140.27 136.84 33.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.37 146.44 46.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -151.2 95.87 3.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.902 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.91 133.33 16.6 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.556 2.17 . . . . 0.0 112.33 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -106.87 125.76 51.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.433 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -121.29 141.25 51.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.804 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -145.67 141.14 27.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.942 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.2 t -127.85 119.54 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.07 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -107.98 121.91 45.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -97.59 140.31 32.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -109.81 105.22 14.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.922 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.47 -46.47 5.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.808 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 tp -138.91 145.3 39.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.861 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -156.63 79.77 0.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.77 -170.59 1.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.978 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -85.38 -22.28 28.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.15 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -120.86 -47.21 2.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.787 0.327 . . . . 0.0 111.065 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.437 ' CE2' HG12 ' A' ' 120' ' ' VAL . 1.6 t80 -103.28 143.67 32.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.057 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.4 t -143.52 155.24 44.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.83 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -153.14 149.39 27.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 171.17 -178.67 43.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.438 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mp -142.39 145.18 33.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.823 0.344 . . . . 0.0 110.939 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.9 m -132.89 123.23 25.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.16 177.61 19.43 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.553 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.47 -175.37 46.97 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.441 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.433 ' CZ ' HD13 ' A' ' 71' ' ' LEU . 36.9 p90 -163.43 149.65 11.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.783 0.325 . . . . 0.0 111.014 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.1 159.88 18.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -130.74 143.43 50.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.851 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -148.84 119.43 7.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.952 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.63 -174.85 43.46 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.478 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -60.58 171.72 1.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.858 0.361 . . . . 0.0 110.852 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -113.73 -47.68 2.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.795 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -142.94 139.4 30.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.558 ' O ' HG13 ' A' ' 99' ' ' VAL . 11.3 p -140.93 113.45 4.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.111 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.17 -41.22 81.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.006 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -116.03 82.82 11.49 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.39 146.95 39.04 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.572 2.181 . . . . 0.0 112.216 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.39 -19.07 52.45 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.669 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.69 -68.06 0.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.837 0.351 . . . . 0.0 111.069 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -154.11 123.5 6.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.887 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.5 t -160.31 147.57 16.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.56 ' HB3' ' CE ' ' A' ' 109' ' ' MET . . . -134.84 162.65 31.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -105.02 111.07 23.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.56 ' CE ' ' HB3' ' A' ' 107' ' ' ALA . 1.8 mpt? -131.23 141.09 49.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.432 ' HG2' ' CD2' ' A' ' 137' ' ' PHE . 5.3 pt20 -163.11 172.16 15.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.0 mtt-85 -152.97 109.23 3.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -87.38 154.51 20.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.815 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.402 ' HE2' ' CE1' ' A' ' 135' ' ' TYR . 65.3 mttt -145.05 125.39 13.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.043 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.3 mt -140.17 124.91 19.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.983 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.706 ' HB2' ' HA ' ' A' ' 133' ' ' SER . . . -149.15 99.49 3.44 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.222 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.07 169.94 0.26 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.463 2.109 . . . . 0.0 112.22 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -125.78 134.9 51.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.001 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -144.56 127.05 15.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.52 142.75 45.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.437 HG12 ' CE2' ' A' ' 83' ' ' PHE . 6.9 m -153.93 118.35 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.188 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -88.09 139.07 30.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.8 tt -102.89 -31.18 10.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.737 HG23 ' H ' ' A' ' 125' ' ' ASP . 12.4 t -156.35 -164.01 1.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.851 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -93.79 20.58 7.43 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.35 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.737 ' H ' HG23 ' A' ' 123' ' ' THR . 2.5 p30 -158.11 26.13 0.26 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.714 0.293 . . . . 0.0 111.094 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.598 ' HB2' HG22 ' A' ' 123' ' ' THR . 0.1 OUTLIER -157.09 108.72 2.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.823 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -113.41 122.36 47.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -105.39 130.89 53.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -145.61 137.29 25.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.04 156.78 26.63 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.545 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 37.4 p-90 -173.01 127.0 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.743 0.306 . . . . 0.0 110.959 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.461 ' O ' HD12 ' A' ' 132' ' ' LEU . 3.1 pp -104.33 124.97 50.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.843 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.706 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 30.7 t -99.76 150.13 22.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.991 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.465 ' CG ' HG12 ' A' ' 151' ' ' VAL . 15.1 mtm -130.56 145.32 51.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.738 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.45 ' N ' ' CD2' ' A' ' 135' ' ' TYR . 2.7 m-85 -119.12 133.62 55.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.907 0.384 . . . . 0.0 110.976 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -128.99 145.63 51.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.802 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.432 ' CD2' ' HG2' ' A' ' 110' ' ' GLN . 0.5 OUTLIER 60.67 164.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -172.28 -177.3 1.79 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.156 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -68.95 -63.89 0.97 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -165.34 32.44 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.888 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 mp -92.91 -31.7 14.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -60.09 -30.89 69.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.943 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 70.2 p -68.66 -31.05 69.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.63 -34.7 19.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.832 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.68 -33.85 20.73 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.474 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 59.75 33.74 21.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 0.0 110.946 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -88.12 174.47 8.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.096 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -101.02 -66.73 0.89 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.884 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.79 148.45 45.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.933 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.444 ' HG2' ' CD2' ' A' ' 135' ' ' TYR . 5.8 tpp180 -105.12 136.42 44.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.828 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.465 HG12 ' CG ' ' A' ' 134' ' ' MET . 28.3 m -149.66 142.58 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.174 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -144.6 127.86 16.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.8 m -96.92 131.93 43.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.893 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.4 ' OE1' ' CD1' ' A' ' 172' ' ' TYR . 25.5 mp0 -124.93 120.39 31.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.977 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 14.9 p -119.19 122.92 43.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -106.3 136.7 13.44 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.3 mt -119.25 118.25 30.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.848 0.356 . . . . 0.0 110.9 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -100.0 142.61 31.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -140.82 100.2 3.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.848 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.28 113.8 14.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.931 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.73 -32.75 16.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.807 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.422 ' HB2' HG22 ' A' ' 165' ' ' VAL . 5.9 m-20 -158.06 -173.38 4.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.813 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -87.73 6.05 36.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.406 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.505 ' O ' HG22 ' A' ' 164' ' ' THR . 22.8 m -136.39 12.89 3.26 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.559 0.219 . . . . 0.0 111.324 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 164' ' ' THR . 16.6 m -158.28 155.12 4.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.852 0.358 . . . . 0.0 111.131 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.692 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -149.43 176.79 10.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.093 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.7 124.09 12.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.433 ' HD2' ' CE2' ' A' ' 196' ' ' TYR . 79.6 mtt180 -124.74 142.04 51.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.1 118.83 16.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.113 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -97.88 138.85 34.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.22 112.33 18.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.4 ' CD1' ' OE1' ' A' ' 154' ' ' GLU . 5.3 m-85 -96.33 138.02 34.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.868 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 6.5 mt -143.5 108.72 5.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.87 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.508 ' HB3' HG23 ' A' ' 190' ' ' THR . 1.6 tt0 -125.07 152.12 44.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -151.23 136.83 17.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.946 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -99.05 150.29 19.25 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.536 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -122.22 162.03 22.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 0.0 110.887 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.83 176.71 7.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.805 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 40.4 mtm -60.49 -42.9 97.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.88 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.5 96.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.904 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -139.35 -55.81 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.1 m -96.85 -53.48 3.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.57 160.49 26.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.841 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 184' ' ' ASN . 1.2 p-10 -128.28 89.37 2.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -152.56 30.93 0.52 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -113.38 32.73 5.92 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.521 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.34 100.54 11.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.825 0.345 . . . . 0.0 110.82 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -80.48 138.12 36.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.807 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.57 129.75 43.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.956 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.508 HG23 ' HB3' ' A' ' 174' ' ' GLU . 1.7 t -150.25 114.86 5.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.79 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -122.02 143.27 49.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.092 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -142.8 152.37 42.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.767 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.597 HD11 HD12 ' A' ' 212' ' ' ILE . 1.7 pp -137.65 134.84 46.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.937 0.398 . . . . 0.0 111.366 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -139.51 124.94 19.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.581 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.547 ' HB3' ' OG1' ' A' ' 210' ' ' THR . . . -119.41 154.43 33.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.058 0.456 . . . . 0.0 111.591 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.573 ' HB2' HG22 ' A' ' 207' ' ' THR . 1.8 p90 -155.35 138.83 15.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.318 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.476 ' O ' ' HD2' ' A' ' 208' ' ' PRO . 5.4 mp -97.94 109.37 51.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.263 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.692 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 87.1 Cg_endo -83.2 108.76 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.486 2.124 . . . . 0.0 112.358 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.29 140.75 52.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.974 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 60.3 p -131.59 128.13 38.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.9 mt -127.82 104.69 7.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 65.63 -96.37 0.25 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.584 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -127.92 31.2 5.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.802 0.334 . . . . 0.0 110.946 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -125.85 155.34 41.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.765 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.57 128.66 29.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.986 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.2 t -140.12 110.97 4.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.855 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.573 HG22 ' HB2' ' A' ' 196' ' ' TYR . 2.1 m -121.33 93.06 48.81 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.404 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 197' ' ' LEU . 33.8 Cg_exo -61.72 171.76 4.33 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.587 2.191 . . . . 0.0 111.949 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.404 ' CD2' ' HB3' ' A' ' 196' ' ' TYR . 0.3 OUTLIER -134.21 127.9 32.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.957 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.547 ' OG1' ' HB3' ' A' ' 195' ' ' ALA . 1.1 p -116.81 126.18 52.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.469 ' HB3' HG21 ' A' ' 227' ' ' VAL . 40.5 ttp180 -146.59 121.45 9.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.849 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.597 HD12 HD11 ' A' ' 193' ' ' ILE . 10.8 mt -66.37 134.68 29.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.091 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -129.98 47.74 1.0 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.477 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.433 HD23 HG23 ' A' ' 212' ' ' ILE . 3.9 mm? -89.6 132.44 35.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 110.974 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.58 33.49 18.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -98.0 -30.31 12.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 1.6 m -174.54 -69.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.908 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -79.49 135.87 36.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -134.44 58.82 0.68 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.601 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.5 -40.11 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.775 0.321 . . . . 0.0 110.912 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 142.78 51.29 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.537 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.71 166.87 23.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.835 0.35 . . . . 0.0 110.831 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 60.52 111.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.928 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -124.76 -59.32 1.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.868 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.513 ' HB3' HG22 ' A' ' 210' ' ' THR . 0.6 OUTLIER -136.79 -56.53 0.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.925 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 5.0 tpp180 -58.07 103.68 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.469 HG21 ' HB3' ' A' ' 211' ' ' ARG . 4.1 m -113.37 -31.51 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.331 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -161.62 179.93 36.7 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.483 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 208' ' ' PRO . 0.4 OUTLIER -152.02 146.12 25.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.85 0.357 . . . . 0.0 111.054 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -109.25 148.82 30.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.732 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.85 137.4 54.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -133.49 117.18 1.84 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.284 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.406 ' HB3' ' CG2' ' A' ' 241' ' ' VAL . 0.3 OUTLIER -113.11 122.5 47.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.898 0.38 . . . . 0.0 111.033 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.44 92.59 3.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.58 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -69.12 -6.84 31.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.431 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.59 31.49 0.13 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.667 0.27 . . . . 0.0 111.117 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 1.2 m120 67.91 -66.1 0.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.037 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -50.6 -59.35 7.96 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.601 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.452 HD22 ' CE1' ' A' ' 269' ' ' TYR . 1.1 mt -69.25 142.59 54.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.69 0.281 . . . . 0.0 110.698 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.8 p -137.0 148.91 47.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.943 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.409 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 40.2 t -116.27 141.18 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.818 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 20.1 m -111.4 126.37 54.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.136 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.1 tt -149.42 124.86 10.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.741 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -105.32 150.64 25.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.059 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -155.54 149.67 25.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -122.69 116.23 23.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.166 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -75.18 -67.94 0.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.8 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 59.48 166.23 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 59.97 162.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.46 155.4 16.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.843 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.06 76.15 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -118.24 -38.77 3.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.957 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.3 t0 62.62 86.16 0.12 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -117.13 -67.26 1.01 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 133.82 170.1 12.25 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.488 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 60.41 30.68 19.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.82 0.343 . . . . 0.0 110.911 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.11 -52.78 0.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.48 138.11 54.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.913 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -144.33 -47.22 0.26 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.847 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -140.15 170.81 15.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.976 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -154.36 152.48 30.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.923 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.84 -53.81 6.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.818 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . 60.88 165.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.16 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -109.1 164.79 12.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.509 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 21.5 t -150.8 138.55 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.952 0.406 . . . . 0.0 111.128 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -153.0 179.03 29.76 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.501 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 6.2 m -149.99 139.45 15.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.904 0.383 . . . . 0.0 111.198 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -129.38 129.36 44.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.452 ' CE1' HD22 ' A' ' 239' ' ' LEU . 0.4 OUTLIER -125.7 123.98 40.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 37.6 p -109.2 134.86 51.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.864 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.922 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.873 0.368 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -145.03 30.56 1.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.839 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -85.87 -60.43 2.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.944 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -76.23 -175.07 3.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -170.66 97.37 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.994 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -89.79 96.99 10.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.825 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.616 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 1.5 m-70 -107.83 157.11 18.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.951 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.11 144.45 50.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.726 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -151.48 133.32 14.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.06 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 11' ' ' GLY . 3.5 mp -128.44 154.93 39.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.407 ' N ' HG22 ' A' ' 10' ' ' ILE . . . -149.9 153.4 25.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.666 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.504 ' HB3' ' CG2' ' A' ' 267' ' ' VAL . . . -129.29 154.84 46.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.825 0.345 . . . . 0.0 110.933 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.9 mtt -139.34 141.48 37.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.96 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.622 ' HB2' HG23 ' A' ' 265' ' ' VAL . 18.8 m-85 -137.83 113.59 9.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.808 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -146.98 159.07 44.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.858 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 pt -77.8 -179.01 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.1 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.28 -63.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.842 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -160.63 98.89 1.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.968 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 19' ' ' VAL . 17.0 m -99.2 87.47 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.111 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -60.69 147.01 43.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.892 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -153.59 -179.52 29.08 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.459 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -171.84 114.72 0.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.797 0.332 . . . . 0.0 110.927 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.94 -132.73 11.37 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.547 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -113.4 110.17 19.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.81 0.338 . . . . 0.0 110.885 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.62 150.41 48.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.813 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.8 ttp -104.35 -45.73 4.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.931 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -76.31 161.18 28.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -135.12 168.76 23.6 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.567 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mp -94.0 140.62 29.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.852 0.358 . . . . 0.0 110.911 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.38 143.65 47.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.133 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -131.7 94.04 26.54 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.425 ' HB3' ' CE1' ' A' ' 14' ' ' TYR . 72.2 Cg_endo -74.84 156.68 43.73 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.555 2.17 . . . . 0.0 112.389 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 p -123.61 140.27 53.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.509 HG23 ' HB2' ' A' ' 49' ' ' TYR . 5.6 m -112.6 127.61 69.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -124.63 122.16 36.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.947 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -112.71 153.43 27.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -147.8 142.9 27.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.981 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.698 ' HB3' HG13 ' A' ' 45' ' ' ILE . . . -135.03 128.24 31.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.064 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.616 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -100.72 124.18 45.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.103 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -136.36 85.93 2.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.22 -150.43 37.08 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.527 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.05 -23.74 22.86 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.566 2.177 . . . . 0.0 112.388 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 20.6 m95 -101.54 150.21 23.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.988 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -142.34 151.76 42.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.804 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.698 HG13 ' HB3' ' A' ' 38' ' ' ALA . 18.7 pt -127.44 158.36 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.173 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.737 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -152.24 128.85 10.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.974 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 tp -120.28 129.2 53.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.929 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.88 139.75 50.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.025 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.509 ' HB2' HG23 ' A' ' 34' ' ' VAL . 2.5 m-85 -133.02 155.43 49.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -115.88 109.73 18.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.756 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -110.86 149.29 30.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -137.32 139.96 41.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.798 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.456 ' N ' ' HD3' ' A' ' 54' ' ' PRO . . . -139.05 61.78 0.57 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.568 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.456 ' HD3' ' N ' ' A' ' 53' ' ' GLY . 4.0 Cg_exo -76.58 177.93 8.21 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.859 2.372 . . . . 0.0 111.986 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.1 t -65.65 129.14 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.953 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -57.33 155.72 8.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.995 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -131.81 159.2 39.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.0 m -112.44 118.42 35.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.783 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -140.19 -47.12 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.106 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 120.94 41.53 0.51 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.483 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.6 tttt 60.2 73.13 0.49 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.883 0.373 . . . . 0.0 110.892 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.86 30.87 3.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.856 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.98 152.86 24.9 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.436 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 p -115.36 149.21 38.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 0.0 110.871 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.5 165.92 23.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.809 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -144.37 133.51 22.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.031 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.57 144.22 51.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.763 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -123.57 95.86 44.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.979 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.01 125.93 9.64 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.53 2.153 . . . . 0.0 112.178 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -127.74 118.49 23.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.057 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 mp -102.48 165.09 11.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.734 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.737 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 25.3 tt0 -160.81 138.19 9.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.126 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.3 t -123.95 115.93 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.797 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -102.03 123.97 46.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.161 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -114.15 123.08 48.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.656 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -65.52 122.9 18.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.053 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.408 ' HB2' ' N ' ' A' ' 85' ' ' PHE . 9.1 p90 -66.09 132.12 47.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.911 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 tp -161.25 140.57 10.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -176.72 -40.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.83 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -143.82 -169.29 3.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.853 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.74 -37.97 48.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.925 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -112.93 -32.24 6.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.022 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -92.43 137.49 32.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.921 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.6 m -145.26 173.2 12.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.408 ' N ' ' HB2' ' A' ' 77' ' ' PHE . 6.5 t80 -162.39 117.08 1.84 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.919 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.67 -162.3 21.35 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.548 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 tp -160.38 116.3 2.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.823 0.344 . . . . 0.0 110.968 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.1 m -111.23 107.81 17.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.827 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -102.93 176.24 24.65 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -172.23 163.15 35.32 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.571 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 92' ' ' ARG . 13.0 t80 -135.12 153.97 51.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.808 0.337 . . . . 0.0 110.862 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.425 ' N ' ' CD1' ' A' ' 91' ' ' PHE . 1.9 ttt180 -149.12 129.89 14.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -137.15 158.9 43.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -132.66 138.98 47.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.69 173.28 39.97 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.533 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -65.84 164.09 15.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.922 0.391 . . . . 0.0 110.829 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -117.59 -178.82 3.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.21 31.54 0.92 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.58 -42.93 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.118 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.89 -34.8 26.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -145.4 84.85 8.26 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.915 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.53 130.55 19.82 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.57 2.18 . . . . 0.0 112.305 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 141.22 -124.87 2.63 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.556 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -114.03 32.89 5.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.85 0.357 . . . . 0.0 110.936 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -88.18 108.76 19.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 p -111.38 166.19 11.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -141.66 162.32 35.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.076 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -140.51 111.13 6.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 47.7 mtt -113.85 134.02 55.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.999 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.4 96.67 5.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.778 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.53 131.52 52.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.965 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -122.23 143.23 49.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.789 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -140.61 131.97 26.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.049 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.6 mp -139.34 147.0 24.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.951 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.58 85.96 5.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.237 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.14 170.49 3.89 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.613 2.209 . . . . 0.0 112.159 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.404 ' O ' ' CD2' ' A' ' 85' ' ' PHE . 7.1 m-20 -131.58 149.77 52.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.823 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -141.52 125.94 17.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.919 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -112.01 135.04 53.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.401 HG12 HD12 ' A' ' 122' ' ' LEU . 21.4 t -142.58 121.74 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.179 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.04 123.44 49.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.401 HD12 HG12 ' A' ' 120' ' ' VAL . 2.4 mp -117.76 -41.15 2.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.56 168.86 11.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.973 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.76 -41.23 96.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.923 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -113.4 36.36 3.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.3 tp -139.27 102.07 4.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.933 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -110.29 123.05 49.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -97.62 149.34 22.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -138.05 135.85 36.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.962 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -117.56 117.17 3.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.508 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -116.2 136.7 52.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 0.0 110.93 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.793 ' CD2' HG23 ' A' ' 153' ' ' THR . 0.2 OUTLIER -124.34 151.63 44.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.82 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.695 ' H ' HD13 ' A' ' 132' ' ' LEU . 0.6 OUTLIER -121.51 130.21 53.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.859 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.4 mtt -150.93 117.84 5.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.423 ' N ' ' CD2' ' A' ' 135' ' ' TYR . 4.9 m-85 -129.2 149.36 51.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -132.99 119.91 20.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.951 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -115.01 135.26 54.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -166.76 135.28 2.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.098 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -96.04 -41.05 8.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.943 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.689 ' O ' HG22 ' A' ' 143' ' ' THR . 0.9 OUTLIER -174.73 -40.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.7 mp -89.16 -31.46 17.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -67.58 -21.89 65.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.223 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.689 HG22 ' O ' ' A' ' 140' ' ' ASP . 11.3 t -54.71 -41.57 70.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.092 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 8.9 t -97.34 -32.78 11.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.924 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -61.78 -51.39 57.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.5 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 59.88 93.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.849 0.357 . . . . 0.0 110.87 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -163.41 158.54 21.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.125 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.5 t0 61.03 32.99 19.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.863 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.76 160.66 31.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.852 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -109.86 129.73 55.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.981 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 151' ' ' VAL . 12.1 p -152.0 124.3 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.056 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -142.51 155.45 45.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.793 HG23 ' CD2' ' A' ' 132' ' ' LEU . 1.3 m -117.83 130.28 56.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.849 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.0 132.28 53.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.3 m -109.28 158.42 17.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.531 ' C ' HD12 ' A' ' 157' ' ' LEU . . . -142.65 126.02 2.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.422 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.598 HD12 ' N ' ' A' ' 157' ' ' LEU . 5.1 mp -115.98 142.46 46.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.788 0.328 . . . . 0.0 110.856 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -124.98 126.76 45.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -138.49 100.15 4.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.83 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.2 p -80.84 128.2 33.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.955 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -104.06 -31.94 9.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.659 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -154.91 165.54 36.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.62 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -69.0 -12.18 61.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.342 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.0 p -113.43 -17.9 12.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.588 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.891 HG12 HD23 ' A' ' 199' ' ' LEU . 28.7 m -139.35 147.86 24.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.922 0.391 . . . . 0.0 111.466 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.659 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -146.91 179.92 7.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.119 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.1 tp -135.53 138.02 42.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.959 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.434 ' HB3' ' CE2' ' A' ' 196' ' ' TYR . 2.3 ttp180 -144.08 149.45 36.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.071 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.3 m -147.24 139.84 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.992 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -117.79 161.34 19.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.981 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.01 151.89 43.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.737 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -127.41 128.36 45.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.046 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.91 105.21 5.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.729 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -89.63 156.05 18.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.412 ' CB ' HG13 ' A' ' 151' ' ' VAL . 15.2 mtp180 -150.42 120.92 7.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.799 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -140.38 154.95 24.4 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.509 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -111.86 130.05 55.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.759 0.314 . . . . 0.0 110.919 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -125.6 157.76 36.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.86 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.84 -51.64 6.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -176.55 152.82 1.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.48 -63.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 64.8 m -134.72 -71.38 0.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.975 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -128.3 33.23 4.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.911 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -67.5 93.33 0.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.921 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.72 -63.75 1.03 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -154.68 -43.95 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.532 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -144.09 130.17 19.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.823 0.344 . . . . 0.0 110.977 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -105.07 129.24 53.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 72.8 p -131.58 130.9 42.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.004 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.92 162.96 13.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.728 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -132.02 122.11 24.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.17 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -140.59 155.59 46.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.637 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 11.8 tt -142.08 141.53 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.971 0.415 . . . . 0.0 111.368 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -128.75 155.36 45.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.436 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.1 130.7 14.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.994 0.426 . . . . 0.0 111.499 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.446 ' HB3' ' CG ' ' A' ' 209' ' ' TYR . 3.0 p90 -140.15 168.58 19.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.339 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.625 ' O ' HD12 ' A' ' 199' ' ' LEU . 0.1 OUTLIER -120.02 109.4 37.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.325 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.659 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 91.5 Cg_endo -80.33 120.68 4.11 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.382 2.055 . . . . 0.0 112.418 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.891 HD23 HG12 ' A' ' 165' ' ' VAL . 5.3 mp -125.79 134.42 51.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.955 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.05 103.94 6.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.904 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 5.7 tt -119.39 96.56 5.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.991 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 56.35 -116.02 6.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.521 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -99.03 29.78 3.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.855 0.36 . . . . 0.0 110.913 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.85 121.99 22.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.766 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.81 128.49 50.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.072 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.3 m -144.27 129.73 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.606 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 57.1 m -138.67 93.17 11.04 Favored Pre-proline 0 C--N 1.327 -0.386 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.681 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 0.758 ' HB3' HD23 ' A' ' 229' ' ' LEU . 58.6 Cg_endo -71.82 137.98 30.71 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.308 2.006 . . . . 0.0 112.001 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.446 ' CG ' ' HB3' ' A' ' 196' ' ' TYR . 6.7 m-85 -111.04 136.46 50.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.808 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 35.8 p -127.14 143.32 51.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.865 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.93 143.19 27.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 1.6 pt -66.24 109.94 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -94.94 -45.84 3.01 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.532 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.89 141.02 49.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 110.903 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 9.6 mmt85 -89.69 -61.19 1.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -103.63 138.86 39.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 48.7 m -91.11 153.08 20.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.897 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -142.74 -67.15 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.843 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -98.51 177.05 30.56 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.479 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.24 97.4 6.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 110.885 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -172.76 48.23 0.17 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.485 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -74.41 108.04 6.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 0.0 110.882 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -95.26 -46.77 6.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.85 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 59.77 32.95 21.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.984 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -153.7 158.68 41.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.924 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -147.47 -47.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 24.5 t -80.0 -68.94 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.045 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.576 ' CA ' ' HB2' ' A' ' 246' ' ' ALA . . . 136.13 -154.74 22.07 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.613 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.758 HD23 ' HB3' ' A' ' 208' ' ' PRO . 1.9 mt -116.71 121.41 41.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.769 0.319 . . . . 0.0 110.941 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -93.78 123.63 37.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 242' ' ' SER . 6.2 m-85 -112.74 155.45 24.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -168.76 117.01 0.69 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.982 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.434 ' CZ ' ' HB ' ' A' ' 241' ' ' VAL . 39.1 p90 -148.03 144.76 28.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.87 0.367 . . . . 0.0 111.246 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -103.56 131.15 50.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.822 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -69.83 -12.8 61.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.358 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -176.09 47.43 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.918 0.389 . . . . 0.0 111.033 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.55 25.96 10.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.985 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -139.51 -71.3 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.377 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 239' ' ' LEU . 8.6 mp -83.39 107.37 15.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.72 0.295 . . . . 0.0 110.833 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 4.8 m -92.59 153.13 19.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.983 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.434 ' HB ' ' CZ ' ' A' ' 233' ' ' TYR . 29.9 t -131.9 122.64 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.77 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 231' ' ' TYR . 1.5 m -107.77 151.17 26.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.231 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.25 131.14 17.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.875 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -117.85 124.24 47.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.849 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -147.25 146.88 29.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.576 ' HB2' ' CA ' ' A' ' 228' ' ' GLY . . . -152.48 -70.46 0.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.051 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 61.31 115.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.964 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -75.88 171.64 14.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.936 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -98.28 166.11 11.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.915 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -170.15 167.97 8.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.842 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -91.15 50.77 1.82 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.91 86.05 2.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.923 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.4 -54.7 6.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -90.15 51.93 2.15 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -147.87 39.26 1.02 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.531 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -155.32 132.91 11.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.813 0.34 . . . . 0.0 110.913 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.9 p -146.5 -61.84 0.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.821 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -158.51 94.42 1.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.806 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.89 155.36 12.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.785 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 66.82 -70.27 0.11 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.045 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 3.2 m80 64.25 101.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.893 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -113.45 77.46 1.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.887 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -143.38 113.3 7.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.151 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -84.57 150.85 25.98 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.484 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.622 HG23 ' HB2' ' A' ' 14' ' ' TYR . 14.3 m -136.84 135.74 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.807 0.336 . . . . 0.0 111.193 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -146.98 163.53 28.62 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.425 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.504 ' CG2' ' HB3' ' A' ' 12' ' ' ALA . 6.1 m -142.7 148.94 19.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.0 111.137 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -131.94 142.57 49.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.787 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' TYR . . . . . 0.425 ' CD1' ' HG ' ' A' ' 239' ' ' LEU . 4.8 m-85 -130.65 105.56 7.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 7.1 m -100.88 124.11 46.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 9.3 t80 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.859 179.95 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.798 0.332 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.35 111.27 1.88 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.935 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -92.84 73.48 4.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -170.27 156.47 5.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.977 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.04 37.96 1.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.94 116.1 6.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.882 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.836 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 21.0 m-70 -134.25 141.73 47.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -119.8 166.42 13.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -165.11 128.03 2.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 10' ' ' ILE . 6.8 tt -129.69 122.87 55.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.139 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.59 155.68 22.72 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.437 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -127.88 163.88 23.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.748 0.308 . . . . 0.0 111.179 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.98 140.02 29.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.886 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.585 ' HB2' HG23 ' A' ' 265' ' ' VAL . 34.4 m-85 -142.68 110.43 5.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -139.7 138.68 36.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.5 mp -119.8 152.46 22.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.113 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -133.46 151.84 51.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.77 140.14 29.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.929 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.1 m -121.9 127.36 75.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.146 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 60.17 -178.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.923 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -159.24 45.7 0.44 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.507 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -90.15 -63.61 1.25 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.752 0.311 . . . . 0.0 110.857 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.4 -45.25 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.484 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -69.5 102.54 1.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.763 0.316 . . . . 0.0 110.911 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.77 31.52 2.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.826 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.2 ttt -99.76 170.09 8.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -95.93 132.41 41.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.944 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.78 -41.1 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.551 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.516 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -89.58 136.01 33.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.881 0.372 . . . . 0.0 110.919 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -131.99 146.63 52.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.059 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -107.59 93.98 11.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.948 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.53 134.82 15.71 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.527 2.152 . . . . 0.0 112.321 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.34 146.06 25.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.887 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.66 HG23 ' HB2' ' A' ' 49' ' ' TYR . 26.0 m -145.13 162.6 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.041 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -146.23 139.53 25.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.956 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -116.37 164.21 14.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.823 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.66 141.86 22.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.961 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' A' ' 45' ' ' ILE . . . -145.84 131.51 18.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.04 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.836 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -115.23 121.53 43.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.106 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.02 71.59 1.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.758 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.54 -143.43 46.98 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.356 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.55 -26.36 16.53 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.554 2.169 . . . . 0.0 112.355 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -100.93 127.27 47.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.975 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -109.54 157.16 19.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.431 ' HB ' ' HB3' ' A' ' 38' ' ' ALA . 2.6 mp -133.81 141.27 44.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.222 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -134.91 138.5 44.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.023 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.62 165.1 20.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.982 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -156.16 149.57 24.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.006 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.66 ' HB2' HG23 ' A' ' 34' ' ' VAL . 1.0 OUTLIER -137.08 155.98 48.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -153.52 114.99 4.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.787 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -121.66 175.56 6.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.998 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -163.43 129.6 3.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.756 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.62 104.9 0.22 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.466 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.59 154.76 72.6 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.477 2.118 . . . . 0.0 112.315 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.1 m -58.93 111.64 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.17 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.88 133.06 34.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.896 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -89.04 -56.83 3.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.84 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.5 t -134.8 85.4 2.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.95 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.85 174.85 12.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.122 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 159.44 -28.45 0.38 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.485 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.59 -60.06 2.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.767 0.318 . . . . 0.0 110.866 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -88.36 119.78 29.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.806 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -172.9 82.67 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.536 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -60.19 153.01 23.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.765 0.317 . . . . 0.0 110.929 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -109.82 119.03 38.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -138.77 122.63 17.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.934 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.8 137.31 39.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.01 95.95 40.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.956 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.54 155.6 54.73 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.506 2.137 . . . . 0.0 112.29 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -136.57 125.63 24.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.8 mt -115.18 141.0 48.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.902 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -149.34 146.65 27.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.791 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.7 m -126.09 150.19 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.217 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.24 143.73 50.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.796 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -141.76 144.0 33.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.69 117.53 25.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.944 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -87.4 -57.82 2.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 61.19 155.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -154.42 -46.79 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -158.62 179.69 8.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.761 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -74.36 -31.47 62.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.827 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -69.57 -72.44 0.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -96.88 161.58 13.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.957 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.32 173.15 11.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.801 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -162.27 152.67 16.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.916 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.77 -177.31 35.67 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.526 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.56 138.56 26.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 110.984 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.0 m -138.66 124.96 20.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -121.09 174.02 15.71 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.481 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.68 148.82 12.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.429 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -142.23 129.47 21.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.837 0.351 . . . . 0.0 110.895 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -109.76 145.38 36.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -164.28 125.57 2.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.871 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -132.77 122.13 24.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.934 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.03 143.3 6.46 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.563 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -129.35 146.54 51.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.845 0.355 . . . . 0.0 110.896 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -163.67 41.05 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.896 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -89.37 53.38 2.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.853 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.5 m -136.59 166.74 25.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.127 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -100.08 -31.28 11.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.21 101.2 47.24 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.02 138.19 43.25 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.316 2.011 . . . . 0.0 112.299 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -96.35 34.13 5.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.513 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.1 mttm 60.15 41.76 16.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.857 0.36 . . . . 0.0 110.935 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.51 109.11 4.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.45 171.23 14.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.865 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -141.45 128.47 20.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.102 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -130.7 107.86 9.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -146.09 160.08 42.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.61 ' H ' ' HB2' ' A' ' 138' ' ' ALA . 9.7 pt20 -143.77 110.46 5.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.938 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -110.6 111.86 23.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 44.5 t-105 -107.92 142.97 37.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.853 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -138.27 137.5 37.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.11 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.1 tp -152.78 133.18 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.74 ' HB2' ' HA ' ' A' ' 133' ' ' SER . . . -154.29 113.05 2.46 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.224 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.8 154.57 53.9 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.428 2.086 . . . . 0.0 112.24 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -106.11 134.95 48.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.947 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -134.59 127.21 30.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.12 138.18 53.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.766 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.49 HG23 ' HB3' ' A' ' 128' ' ' PHE . 12.2 m -147.98 121.23 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.5 140.95 29.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.835 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.8 mt -119.88 -77.1 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.34 -172.82 3.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.875 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.573 ' CB ' HD23 ' A' ' 126' ' ' LEU . 0.5 OUTLIER 60.46 23.2 12.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.161 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.7 t70 57.01 31.27 19.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.182 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.573 HD23 ' CB ' ' A' ' 124' ' ' ASP . 1.6 pp -122.22 136.12 54.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.921 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 -102.76 132.91 48.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.918 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.1 OUTLIER -84.87 125.34 32.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.413 ' HB3' ' CZ3' ' A' ' 131' ' ' TRP . 2.9 m-80 -113.8 155.66 25.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.977 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.28 135.88 2.8 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.443 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TRP . . . . . 0.425 ' CD1' ' HB2' ' A' ' 154' ' ' GLU . 17.4 p90 -162.76 131.98 4.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.779 0.323 . . . . 0.0 110.912 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 132' ' ' LEU . 4.1 pp -100.44 136.01 40.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.74 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 17.3 t -103.9 152.22 22.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.07 122.85 26.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -104.16 141.24 36.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.908 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -133.3 110.43 10.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -81.17 -175.34 5.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.61 ' HB2' ' H ' ' A' ' 110' ' ' GLN . . . -81.43 -168.4 1.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.024 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -80.16 -30.97 38.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.071 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.21 -29.38 8.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.961 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.405 ' HB3' ' HB3' ' A' ' 138' ' ' ALA . 17.6 tp -72.62 -24.6 61.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.114 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -72.14 -27.42 62.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.173 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 48.2 p -71.2 -56.42 6.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.216 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 8.3 m -84.62 -27.82 26.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.239 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.17 -52.93 46.26 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.671 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -177.71 -72.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.806 0.336 . . . . 0.0 110.918 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -143.55 -169.72 3.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.038 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.87 -45.18 12.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 37.4 p -126.67 155.1 43.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 25.9 mtp180 -133.09 123.48 25.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.36 115.27 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.094 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -114.94 151.4 34.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 33.1 m -128.58 128.31 43.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.818 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.425 ' HB2' ' CD1' ' A' ' 131' ' ' TRP . 0.8 OUTLIER -122.36 145.21 48.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.004 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.57 138.38 25.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.769 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -137.57 171.69 23.11 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.48 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.456 HD21 HD13 ' A' ' 126' ' ' LEU . 1.0 OUTLIER -141.44 117.37 10.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.803 0.335 . . . . 0.0 110.854 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -92.75 121.8 34.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.937 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -126.83 104.09 7.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.73 125.59 51.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.95 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -102.79 -31.22 10.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.795 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.32 -178.12 7.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.703 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -87.43 6.15 35.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.4 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 51.5 p -115.73 -32.25 5.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.648 0.261 . . . . 0.0 111.162 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.588 HG13 ' CD1' ' A' ' 199' ' ' LEU . 21.7 t -132.2 136.06 57.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.311 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.89 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -139.16 179.24 6.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.002 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.62 HD21 HD23 ' A' ' 197' ' ' LEU . 0.5 OUTLIER -135.42 141.33 45.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.011 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.31 107.51 4.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.837 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.5 m -106.21 155.0 7.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.07 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -135.72 156.05 49.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.993 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.01 106.47 5.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.821 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -90.06 134.78 34.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.926 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 8.2 tt -153.65 105.24 2.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.772 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -104.22 166.09 10.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.998 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -145.92 151.31 37.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.769 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -139.19 151.98 22.1 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.492 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -120.35 157.72 28.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 110.876 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.3 151.71 20.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.859 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 2.1 ttt -73.58 -47.68 38.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.924 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -176.03 82.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.969 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -170.39 -60.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.922 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.2 m -74.65 80.56 2.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.03 30.36 5.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.38 -46.4 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.916 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -58.78 166.94 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -90.49 49.77 3.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.589 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 45.3 -168.44 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.823 0.344 . . . . 0.0 111.391 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -93.36 130.83 38.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.3 111.37 6.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.882 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.69 155.57 29.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.802 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -148.84 142.15 25.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.956 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -143.0 144.13 32.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.768 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 27.3 mt -105.65 138.37 31.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.263 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.08 109.69 4.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.766 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 210' ' ' THR . . . -106.53 136.96 45.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.255 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' TYR . . . . . 0.427 ' CD2' ' HB3' ' A' ' 209' ' ' TYR . 28.0 m-85 -140.47 123.3 16.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.615 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 197' ' ' LEU . 2.3 mp -111.02 109.64 57.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.055 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.89 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 96.5 Cg_endo -79.48 120.64 4.47 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.491 2.128 . . . . 0.0 112.308 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.588 ' CD1' HG13 ' A' ' 165' ' ' VAL . 0.1 OUTLIER -127.46 115.24 18.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.836 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.4 m -134.37 118.39 17.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.959 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.632 ' N ' HD23 ' A' ' 201' ' ' LEU . 0.5 OUTLIER -137.64 104.44 5.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 84.85 -117.3 4.47 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.513 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -116.76 30.72 7.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.849 0.357 . . . . 0.0 110.926 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -134.87 117.99 16.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.1 m -104.44 130.23 52.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.974 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.26 124.07 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.779 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.531 HG23 ' C ' ' A' ' 197' ' ' LEU . 41.9 m -138.78 92.8 11.07 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.477 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.16 143.39 11.31 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.612 2.208 . . . . 0.0 112.185 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.461 ' CD1' HG23 ' A' ' 227' ' ' VAL . 15.1 p90 -111.23 142.38 43.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.983 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.678 ' O ' ' HB3' ' A' ' 195' ' ' ALA . 11.6 p -131.58 142.29 49.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -145.06 124.0 12.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.885 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.1 tt -88.22 147.76 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.094 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -107.02 161.83 13.67 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.454 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 5.5 tp -145.75 40.2 1.17 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.827 0.346 . . . . 0.0 110.926 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 15.4 tpt85 -137.98 153.92 49.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -117.91 96.43 5.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 82.0 p -106.08 31.79 4.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 60.61 103.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.723 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 138.8 149.76 5.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.51 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -91.55 152.37 20.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.774 0.321 . . . . 0.0 110.983 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 96.27 64.42 0.94 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.599 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -98.74 30.42 3.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.743 0.306 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 59.31 94.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.921 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -96.24 -30.38 13.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.922 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -177.0 136.03 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.856 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.653 ' HA ' HG22 ' A' ' 210' ' ' THR . 38.1 ttm180 63.0 104.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.461 HG23 ' CD1' ' A' ' 209' ' ' TYR . 16.0 m -114.02 -29.91 2.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.337 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.424 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . -150.58 166.13 30.17 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.653 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.94 119.85 13.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.709 0.29 . . . . 0.0 111.072 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.89 145.55 25.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.869 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -126.74 148.55 49.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.125 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -137.79 117.08 1.42 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.292 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' TYR . . . . . 0.402 ' HB2' ' CG2' ' A' ' 241' ' ' VAL . 4.5 m-85 -102.7 118.09 36.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 111.192 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -123.53 90.49 3.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.417 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -56.83 -17.33 8.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.384 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -176.38 46.23 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.846 0.355 . . . . 0.0 111.172 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.93 23.71 5.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.219 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -122.22 -72.26 0.28 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.248 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.78 107.44 11.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.736 0.303 . . . . 0.0 110.625 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.22 134.13 42.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.948 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.493 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 26.0 t -112.89 148.34 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.689 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 4.7 m -119.21 126.04 50.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.937 0.399 . . . . 0.0 111.052 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' LEU . . . . . 0.44 HD11 ' CD1' ' A' ' 262' ' ' TYR . 9.4 tt -143.86 123.6 13.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.782 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -105.25 157.53 17.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.973 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.36 147.62 41.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.836 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . 60.75 160.34 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.117 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.48 ' CE1' ' HB1' ' A' ' 263' ' ' ALA . 9.4 m-85 -142.52 -58.38 0.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.887 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -146.98 132.6 18.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.893 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -77.71 84.85 4.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.823 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -149.07 145.12 27.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -81.83 87.12 6.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -90.52 -36.08 14.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.904 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.34 147.03 32.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -108.54 107.01 17.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 65.26 -91.87 0.13 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.505 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -63.52 148.28 49.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.751 0.31 . . . . 0.0 110.899 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.17 141.48 29.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.875 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.16 30.66 7.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 20.4 tttp -72.14 114.41 10.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -153.09 -46.82 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -62.52 -171.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.836 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.44 ' CD1' HD11 ' A' ' 243' ' ' LEU . 94.2 m-85 -100.76 177.87 4.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.939 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ALA . . . . . 0.48 ' HB1' ' CE1' ' A' ' 247' ' ' PHE . . . -94.18 -64.72 1.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.997 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -126.75 156.91 20.29 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.482 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' ' 14' ' ' TYR . 4.9 m -141.24 152.93 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.914 0.388 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -163.83 173.2 39.86 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.49 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 21.4 t -145.26 152.82 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.776 0.322 . . . . 0.0 111.185 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -142.33 125.37 16.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -127.34 120.81 29.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.923 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.2 p -90.81 141.06 29.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.827 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.884 0.373 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 60.85 103.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.96 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.642 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 21.5 t60 -148.93 136.8 20.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.854 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -116.07 152.12 34.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -143.1 117.52 9.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.757 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.608 HG22 ' HD2' ' A' ' 36' ' ' PHE . 1.2 pp -128.39 132.29 68.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.01 170.65 27.14 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.467 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.661 ' HB3' HG22 ' A' ' 267' ' ' VAL . . . -137.47 177.13 8.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.827 0.346 . . . . 0.0 111.031 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.8 tpp -159.25 137.22 10.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.974 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -147.15 161.78 40.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.885 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.7 mp . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.886 0.374 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.85 131.41 55.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.064 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -115.31 94.0 37.85 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.982 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.51 128.44 12.71 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.527 2.151 . . . . 0.0 112.34 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.6 m -122.39 150.35 42.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.875 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 35' ' ' TYR . 21.5 t -123.01 158.79 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.063 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.476 ' N ' HG12 ' A' ' 34' ' ' VAL . 47.4 m-85 -143.02 133.8 25.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.013 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.608 ' HD2' HG22 ' A' ' 10' ' ' ILE . 41.6 m-85 -132.34 116.06 16.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.551 ' OD1' ' HB2' ' A' ' 46' ' ' ALA . 1.7 m-80 -118.55 133.27 55.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.924 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.24 123.8 44.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 7' ' ' HIS . . . -107.49 116.31 31.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -136.72 83.52 2.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.803 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.63 -137.34 36.89 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.364 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.45 -21.37 46.83 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.408 2.072 . . . . 0.0 112.312 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.3 m95 -94.82 115.21 27.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.884 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -117.36 116.32 26.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mp -95.33 142.77 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.171 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.551 ' HB2' ' OD1' ' A' ' 37' ' ' ASN . . . -145.36 126.9 15.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.051 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.614 ' HB3' HD23 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -139.66 153.61 47.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.958 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -142.56 141.36 32.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.964 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -119.95 152.12 37.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.975 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -116.77 165.76 12.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.853 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.93 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.5 p90 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.745 0.307 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.24 164.8 14.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.834 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -136.82 95.81 12.1 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.67 130.53 17.17 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.541 2.161 . . . . 0.0 112.263 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -128.67 132.23 48.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.614 HD23 ' HB3' ' A' ' 47' ' ' LEU . 35.8 mt -127.76 167.05 17.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.784 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 46' ' ' ALA . 17.9 mt-10 -159.29 151.28 20.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.033 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.01 111.37 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.025 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -98.81 132.7 43.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.851 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -135.47 135.84 40.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.795 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -103.12 121.08 41.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -98.8 -50.39 4.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.17 162.66 0.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.806 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -160.85 -58.86 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.841 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.8 164.91 27.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -63.36 -36.49 83.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.959 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.73 -59.88 2.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.979 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.889 ' CE1' HG13 ' A' ' 120' ' ' VAL . 5.3 m-85 -100.72 128.62 46.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.4 m -109.81 170.02 8.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.873 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.54 156.73 46.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -170.03 168.83 41.73 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.551 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 tp -138.53 125.04 20.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.349 . . . . 0.0 110.836 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.62 146.57 43.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.63 174.49 21.28 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.535 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.74 150.63 17.88 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.496 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -133.34 116.19 15.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.876 0.369 . . . . 0.0 110.862 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.64 135.58 54.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -149.91 133.49 16.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -126.61 133.27 51.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.003 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.386 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.429 -179.93 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.829 0.347 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -147.04 118.07 7.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.922 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -147.72 150.55 34.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.818 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.426 ' HB2' ' CD1' ' A' ' 137' ' ' PHE . 5.0 mt-30 -132.37 177.36 7.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.029 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.8 mtp85 -148.64 114.92 5.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.893 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.409 ' HB2' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -95.35 130.09 42.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.776 0.322 . . . . 0.0 110.474 179.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -104.03 126.72 51.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.011 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.6 mp -140.8 104.41 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.949 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.62 ' HB2' ' HA ' ' A' ' 133' ' ' SER . . . -142.88 100.78 5.42 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.182 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.3 161.2 46.83 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.35 2.033 . . . . 0.0 112.155 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.07 134.79 48.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.98 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -129.05 134.55 48.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.736 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.16 141.51 51.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.959 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.889 HG13 ' CE1' ' A' ' 83' ' ' PHE . 21.6 t -143.44 113.16 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -97.0 110.78 23.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 tp -95.0 -31.94 13.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.8 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 124' ' ' ASP . 0.3 OUTLIER -153.5 176.01 12.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.722 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.498 ' H ' HG22 ' A' ' 123' ' ' THR . 0.7 OUTLIER -72.77 -19.86 61.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.18 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.627 ' O ' HD23 ' A' ' 126' ' ' LEU . 0.3 OUTLIER -119.52 30.2 7.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.748 0.308 . . . . 0.0 111.136 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.627 HD23 ' O ' ' A' ' 125' ' ' ASP . 60.0 mt -149.55 109.22 4.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.899 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.515 ' O ' HD23 ' A' ' 157' ' ' LEU . 5.7 mtt180 -114.72 119.31 36.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.843 ' CE2' HD11 ' A' ' 157' ' ' LEU . 55.0 m-85 -103.03 148.4 25.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.983 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -158.48 140.58 14.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 155' ' ' THR . . . -151.05 147.87 18.34 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.587 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 42.2 p90 -159.87 134.43 7.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.734 0.302 . . . . 0.0 110.903 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.3 mp -102.81 126.22 49.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.99 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.62 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 88.4 p -92.83 114.54 27.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.969 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.774 ' HG3' HG12 ' A' ' 151' ' ' VAL . 9.8 ttm -106.94 141.36 38.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.848 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.06 115.75 18.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.98 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.5 ' HE3' HG22 ' A' ' 149' ' ' THR . 13.1 mttp -149.21 132.51 16.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.835 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 110' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.222 0 CA-C-O 120.848 0.356 . . . . 0.0 111.104 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.5 HG22 ' HE3' ' A' ' 136' ' ' LYS . 11.3 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.699 0.285 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -163.07 166.35 23.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.093 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.774 HG12 ' HG3' ' A' ' 134' ' ' MET . 30.1 m -107.99 141.64 22.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -119.66 158.72 25.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.727 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.5 m -132.05 120.44 22.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.064 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -134.79 107.21 7.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.723 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' ' 171' ' ' TYR . 6.1 t -92.37 168.69 11.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -158.25 120.66 0.99 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.556 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.843 HD11 ' CE2' ' A' ' 128' ' ' PHE . 0.2 OUTLIER -113.27 152.64 29.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.776 0.322 . . . . 0.0 110.867 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -128.84 123.81 33.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.065 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.442 ' CZ ' HD22 ' A' ' 157' ' ' LEU . 24.8 m-85 -120.53 117.32 27.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.86 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.9 118.81 19.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.928 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.66 -63.59 1.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.917 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -125.79 176.06 7.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -64.89 -30.68 71.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.004 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 43.0 p -120.21 27.25 8.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.044 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 23.0 t -153.72 125.21 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.038 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.817 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -126.8 169.63 13.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.276 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.561 HD12 ' HB3' ' A' ' 197' ' ' LEU . 0.4 OUTLIER -135.19 145.16 47.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.795 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -139.04 136.12 34.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.022 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 170' ' ' ASN . 29.5 t -119.0 158.98 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.981 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.49 ' N ' HG12 ' A' ' 169' ' ' VAL . 0.8 OUTLIER -153.53 133.12 12.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.026 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.544 ' HE2' HD21 ' A' ' 173' ' ' LEU . 23.5 t80 -116.36 111.2 19.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.709 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -89.87 135.64 33.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.086 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.544 HD21 ' HE2' ' A' ' 171' ' ' TYR . 22.8 mt -132.13 113.16 12.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.718 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -89.05 148.95 23.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.29 148.41 36.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.901 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -149.84 144.59 12.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.568 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 54.0 t80 . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 0.0 110.874 179.946 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.805 0.336 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.2 m -132.42 100.14 4.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 2.4 m -106.65 150.51 26.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.9 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -130.42 132.14 45.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -135.61 120.99 19.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.754 HD12 HD11 ' A' ' 212' ' ' ILE . 24.8 mt -91.41 128.7 42.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.218 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.38 125.21 14.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.645 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -135.63 154.55 51.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.968 0.413 . . . . 0.0 111.533 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -143.16 148.5 36.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.342 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.561 ' HB3' HD12 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -114.04 109.46 49.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.272 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.817 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 70.0 Cg_endo -74.43 121.68 6.95 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.393 2.062 . . . . 0.0 112.312 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.65 105.87 13.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.866 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 7.0 p -99.25 116.29 31.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.24 103.7 3.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.942 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 59.17 -132.18 52.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.534 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -98.58 30.84 3.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.783 0.325 . . . . 0.0 110.901 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' HIS . . . . . 0.606 ' CD2' HG13 ' A' ' 206' ' ' VAL . 6.5 t60 -129.96 116.83 19.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.699 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.71 123.95 49.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.983 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.606 HG13 ' CD2' ' A' ' 204' ' ' HIS . 15.8 m -141.76 109.71 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.828 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.507 HG23 ' C ' ' A' ' 197' ' ' LEU . 18.6 m -117.49 92.66 41.26 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.305 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' A' ' 197' ' ' LEU . 23.1 Cg_exo -64.79 147.77 89.77 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.512 2.142 . . . . 0.0 111.933 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -111.18 134.7 52.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.852 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.3 p -107.5 138.24 44.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.949 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.2 118.13 8.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.754 HD11 HD12 ' A' ' 193' ' ' ILE . 2.1 pt . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.106 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.541 -0.224 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.671 HD13 ' N ' ' A' ' 230' ' ' PHE . 0.5 OUTLIER -154.92 127.35 7.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 0.0 110.882 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.671 ' N ' HD13 ' A' ' 229' ' ' LEU . 1.7 t80 -111.13 118.74 36.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.843 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -100.83 160.63 14.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -164.34 117.02 0.73 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.157 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -133.66 124.25 26.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 110.891 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -123.38 101.37 7.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.793 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -75.98 -1.39 25.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.23 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -149.35 26.23 0.86 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.72 0.295 . . . . 0.0 111.106 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 2.2 m120 64.74 -75.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.137 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -52.93 -50.04 52.41 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.727 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.99 122.63 32.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.754 0.311 . . . . 0.0 110.88 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 4.0 t -135.39 174.93 10.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.969 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 241' ' ' VAL . 27.6 m -137.32 122.61 25.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.815 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 5.0 m -107.77 139.57 42.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.121 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.631 HD11 HG13 ' A' ' 265' ' ' VAL . 1.4 mp -132.22 129.59 39.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.781 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.26 121.08 43.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 263' ' ' ALA . 0.1 OUTLIER -123.87 136.05 54.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.781 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.1 -179.899 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . 0.406 ' HB2' ' CE2' ' A' ' 245' ' ' TYR . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.73 0.3 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -156.2 152.07 23.51 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.546 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.631 HG13 HD11 ' A' ' 243' ' ' LEU . 17.8 t -135.54 143.52 36.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.808 0.337 . . . . 0.0 111.123 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -154.99 167.18 32.71 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.494 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.661 HG22 ' HB3' ' A' ' 12' ' ' ALA . 31.5 m -124.98 160.42 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 0.0 111.09 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -147.4 139.78 24.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -144.66 156.87 44.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 53.2 p -134.48 140.66 46.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.855 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.1 t0 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.834 0.349 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -172.0 159.66 5.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -148.88 109.37 4.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.898 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -97.18 136.39 37.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -147.18 121.74 9.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.572 HG22 ' HD2' ' A' ' 36' ' ' PHE . 2.1 pp -126.19 129.57 72.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.1 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.96 172.19 22.73 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.543 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.29 142.85 10.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.841 0.353 . . . . 0.0 111.087 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.7 ttm -116.9 158.13 24.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -144.88 130.66 19.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.919 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.95 179.961 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.4 mp . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 120.864 0.364 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.9 128.2 32.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.146 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.62 94.15 48.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.72 178.8 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.503 2.135 . . . . 0.0 112.236 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.64 128.53 8.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.577 HG11 ' CZ ' ' A' ' 36' ' ' PHE . 16.4 t -108.72 159.31 8.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.185 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.468 ' N ' HG12 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -148.83 127.89 12.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.577 ' CZ ' HG11 ' A' ' 34' ' ' VAL . 51.2 m-85 -121.49 147.41 45.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -146.36 143.22 28.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.11 134.74 23.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.975 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.597 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -109.66 147.52 32.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.109 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -174.19 120.52 0.27 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.881 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.37 -149.42 48.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.496 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.426 ' HG2' ' CE3' ' A' ' 43' ' ' TRP . 92.1 Cg_endo -78.93 0.99 9.54 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.656 2.237 . . . . 0.0 112.87 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.426 ' CE3' ' HG2' ' A' ' 42' ' ' PRO . 14.7 p90 -127.48 170.36 12.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.81 0.338 . . . . 0.0 111.045 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -141.08 154.07 45.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.5 mt -121.0 127.26 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.063 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -122.14 148.31 45.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.067 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.6 tp -139.52 164.33 30.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.009 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.568 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -147.82 147.95 30.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.062 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -128.26 153.16 47.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -116.51 151.14 36.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 -179.935 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.845 0.355 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.76 165.99 24.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.86 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.75 95.96 6.23 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.22 135.86 35.64 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.405 2.07 . . . . 0.0 112.259 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -115.58 129.63 56.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.6 mt -116.37 143.05 46.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 3.4 mm-40 -146.51 136.23 23.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.7 t -116.26 149.71 18.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.066 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -131.96 139.11 48.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -153.93 145.02 22.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.525 HE21 HD11 ' A' ' 78' ' ' LEU . 9.4 pt20 -125.6 111.07 14.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.933 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -67.91 -56.36 9.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.81 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.525 HD11 HE21 ' A' ' 76' ' ' GLN . 87.3 mt 58.65 98.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.956 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -80.82 -62.88 1.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -126.86 -179.11 4.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -71.75 -30.57 65.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -80.26 -49.87 11.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.841 ' CE2' HG13 ' A' ' 120' ' ' VAL . 5.5 m-85 -92.61 167.89 11.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.968 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.7 t -156.88 162.81 39.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.947 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.496 ' CZ ' ' CD1' ' A' ' 118' ' ' TRP . 0.3 OUTLIER -127.73 177.36 6.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.831 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.405 ' O ' HD22 ' A' ' 87' ' ' LEU . . . -172.48 116.35 0.61 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.443 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.868 HD12 HD11 ' A' ' 114' ' ' ILE . 2.3 mm? -123.02 119.34 30.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.371 . . . . 0.0 110.991 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.9 t -125.33 104.81 8.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.745 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -128.28 144.31 15.14 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.488 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -141.37 178.63 20.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.542 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -127.54 118.74 24.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.824 0.345 . . . . 0.0 110.839 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.2 tpt85 -100.77 139.34 36.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -167.35 166.37 14.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -142.62 128.78 19.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.9 0.381 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -141.13 104.34 4.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 56.1 tpp -154.11 143.34 21.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.929 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -138.62 103.93 4.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.8 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -111.91 111.43 22.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.986 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -91.35 130.85 37.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.849 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -130.84 120.24 23.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.052 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.868 HD11 HD12 ' A' ' 87' ' ' LEU . 9.0 tp -146.44 115.55 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.863 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -128.79 93.22 37.92 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.334 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.02 178.03 7.81 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.579 2.186 . . . . 0.0 112.223 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -159.52 134.9 8.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.935 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.496 ' CD1' ' CZ ' ' A' ' 85' ' ' PHE . 0.9 OUTLIER -112.25 126.66 55.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.811 179.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.02 113.22 26.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.027 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.841 HG13 ' CE2' ' A' ' 83' ' ' PHE . 25.6 t -119.88 102.11 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.015 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.36 142.45 39.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.014 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.776 ' HB3' HD22 ' A' ' 126' ' ' LEU . 4.7 tt -119.83 -44.41 2.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.69 175.1 11.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -61.16 -31.37 71.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.919 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -116.44 39.96 3.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.776 HD22 ' HB3' ' A' ' 122' ' ' LEU . 2.2 tt -156.86 116.23 3.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.5 mtm-85 -126.12 138.37 53.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.929 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.556 ' CD1' HD12 ' A' ' 157' ' ' LEU . 5.3 t80 -112.46 139.61 47.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.812 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -148.47 143.54 26.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.977 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 144.9 153.06 5.76 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.563 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -172.97 170.93 4.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 0.0 110.813 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.676 HD23 HG23 ' A' ' 153' ' ' THR . 18.9 mt -74.51 132.5 41.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.948 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.5 m -106.91 160.43 15.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 18.0 mtm -142.04 148.24 38.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -154.46 150.31 27.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.22 154.98 42.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.8 p90 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.839 179.924 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.768 0.318 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -109.47 122.72 48.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.925 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.06 117.26 9.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.091 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -124.11 153.78 40.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.011 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.676 HG23 HD23 ' A' ' 132' ' ' LEU . 14.7 m -121.69 123.93 43.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.729 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -116.86 129.76 56.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.986 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 61.5 p -153.41 115.45 4.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.755 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -140.37 -169.37 11.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.776 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.556 HD12 ' CD1' ' A' ' 128' ' ' PHE . 0.3 OUTLIER -139.94 178.12 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.348 . . . . 0.0 110.833 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -140.02 143.56 36.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.9 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.464 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 1.3 t80 -135.25 101.24 4.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.0 m -97.55 108.82 21.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.823 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.464 ' CE2' ' CD1' ' A' ' 159' ' ' TYR . 20.5 m-85 -79.57 -36.99 37.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.95 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -176.53 -165.15 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.78 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -86.58 6.08 32.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.332 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.709 HG23 HG22 ' A' ' 165' ' ' VAL . 8.8 t -93.23 -35.83 12.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.746 0.308 . . . . 0.0 110.943 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.709 HG22 HG23 ' A' ' 164' ' ' THR . 30.5 m -156.81 150.3 9.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.119 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.846 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -131.34 152.24 50.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.15 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.475 HD23 ' H ' ' A' ' 168' ' ' ARG . 0.4 OUTLIER -111.63 146.66 37.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.773 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.475 ' H ' HD23 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -147.22 129.61 15.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.95 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.6 t -131.92 146.63 33.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.978 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -152.41 125.62 8.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.065 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -95.76 161.23 14.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.737 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -135.58 151.11 49.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.008 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.77 105.19 3.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.762 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -101.57 140.8 35.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.962 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.81 113.11 6.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -124.73 146.7 16.28 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.527 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 4.7 p90 . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.859 0.362 . . . . 0.0 110.815 -179.964 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 28.1 p90 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.845 0.355 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 17.5 t -137.61 142.08 41.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 72.1 p -133.45 147.8 51.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.901 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -118.39 135.09 54.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.85 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -130.09 140.92 50.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.727 HD11 HD11 ' A' ' 212' ' ' ILE . 46.1 pt -119.05 138.97 48.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.185 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.75 113.58 11.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.891 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -120.72 116.55 25.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.047 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -136.5 131.3 33.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.932 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.403 ' N ' HD23 ' A' ' 197' ' ' LEU . 0.3 OUTLIER -117.35 109.46 42.17 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.722 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.846 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 28.1 Cg_endo -62.76 136.58 58.51 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.439 2.092 . . . . 0.0 112.393 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.574 HD22 HD11 ' A' ' 201' ' ' LEU . 0.2 OUTLIER -115.62 101.27 8.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.772 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 8.8 t -78.12 127.07 31.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.574 HD11 HD22 ' A' ' 199' ' ' LEU . 4.2 mp -139.84 148.06 41.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -81.88 58.3 4.92 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.503 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -179.8 -62.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.872 0.368 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -136.15 137.93 41.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.863 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 10.5 m -90.54 140.05 30.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.487 ' CG1' HD12 ' A' ' 229' ' ' LEU . 21.7 t -128.28 111.37 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.033 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.93 92.89 5.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.01 171.84 16.7 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.621 2.214 . . . . 0.0 112.294 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -158.05 161.56 38.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.863 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.7 m -139.9 116.1 10.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.3 mtt180 -139.41 134.89 33.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.063 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.727 HD11 HD11 ' A' ' 193' ' ' ILE . 32.4 mt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.125 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.408 -0.277 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.487 HD12 ' CG1' ' A' ' 206' ' ' VAL . 0.8 OUTLIER -129.86 122.92 29.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.886 0.374 . . . . 0.0 110.938 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -109.89 118.04 35.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.814 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.13 159.4 20.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.064 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -154.42 117.01 0.76 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.045 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.517 ' HB3' HG12 ' A' ' 241' ' ' VAL . 0.2 OUTLIER -132.27 115.61 15.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.714 0.292 . . . . 0.0 111.106 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 240' ' ' SER . 3.6 m-20 -81.36 122.7 27.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -60.88 -15.13 27.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.964 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.98 -39.39 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.826 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 178.55 -60.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.001 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -74.19 -70.27 1.27 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.672 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.585 ' H ' HD23 ' A' ' 239' ' ' LEU . 1.2 pt? -66.35 146.84 54.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.718 0.294 . . . . 0.0 110.832 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -148.49 176.87 9.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.274 -179.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.517 HG12 ' HB3' ' A' ' 233' ' ' TYR . 11.4 p -122.86 131.32 73.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.831 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 9.8 m -107.6 139.8 41.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.092 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.66 141.93 46.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.972 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -105.25 120.68 42.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.948 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -108.98 143.94 37.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.833 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.074 -179.96 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.829 0.347 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -78.08 144.62 28.76 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.529 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 23.1 t -117.04 119.8 63.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.834 0.349 . . . . 0.0 111.029 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -137.09 160.39 24.95 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.543 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 12.3 m -135.86 153.13 31.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 0.0 111.157 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -152.03 131.9 13.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.49 ' CE1' ' CE2' ' A' ' 271' ' ' PHE . 4.6 t80 -131.01 126.18 35.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 39.5 t -113.68 147.76 37.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' PHE . . . . . 0.49 ' CE2' ' CE1' ' A' ' 269' ' ' TYR . 3.3 m-85 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.933 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.8 t70 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.803 0.335 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -60.0 99.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.471 ' CB ' ' HB3' ' A' ' 39' ' ' ALA . 3.0 t-80 -94.81 146.17 24.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -126.69 137.01 53.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -151.15 131.57 13.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.475 HG23 ' CE2' ' A' ' 36' ' ' PHE . 22.7 mt -130.53 139.33 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.031 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.81 165.07 29.2 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.549 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.566 ' HB3' HG22 ' A' ' 267' ' ' VAL . . . -150.49 170.54 18.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.797 0.332 . . . . 0.0 111.059 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 57.2 mtm -143.27 153.57 42.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.969 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.761 ' HB2' HG23 ' A' ' 265' ' ' VAL . 10.9 m-85 -146.53 106.08 3.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.838 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.915 -179.948 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.841 0.353 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.75 146.66 41.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.083 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.76 93.89 30.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.018 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 14' ' ' TYR . 39.4 Cg_exo -60.52 178.68 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.681 2.254 . . . . 0.0 112.201 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.1 123.57 5.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.967 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.3 138.31 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.091 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -138.92 155.32 48.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.475 ' CE2' HG23 ' A' ' 10' ' ' ILE . 62.5 m-85 -146.5 153.13 40.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -147.35 129.64 15.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.671 ' HB3' HG23 ' A' ' 45' ' ' ILE . . . -134.01 141.9 47.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.006 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.471 ' HB3' ' CB ' ' A' ' 7' ' ' HIS . . . -123.49 116.52 23.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.086 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -126.08 73.78 1.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.789 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.83 -135.58 32.78 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.411 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.31 -20.99 48.31 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.377 2.051 . . . . 0.0 112.346 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -101.57 120.72 40.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.909 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -113.17 153.15 28.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.671 HG23 ' HB3' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -141.71 140.78 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.129 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -137.22 130.04 30.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.977 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.616 HD23 ' HG ' ' A' ' 71' ' ' LEU . 2.8 mt -116.45 166.79 11.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.549 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -165.53 141.5 5.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -122.54 160.2 26.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.946 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -141.51 128.67 20.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.938 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.84 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 66' ' ' PHE . 4.1 p90 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.868 0.366 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -125.23 145.98 49.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.984 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.72 95.79 2.82 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.942 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.47 153.25 44.47 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.506 2.137 . . . . 0.0 112.267 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.549 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -144.38 128.47 17.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.006 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.616 ' HG ' HD23 ' A' ' 47' ' ' LEU . 1.2 mp -132.15 154.18 49.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.832 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -154.82 157.58 38.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.885 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.455 HG23 ' H ' ' A' ' 89' ' ' GLY . 31.6 m -144.69 156.79 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.055 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -134.81 117.68 16.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -103.62 114.43 28.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -83.03 99.38 9.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.66 -54.68 5.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.84 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.8 tp 61.79 152.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -154.42 -60.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.965 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -147.92 -172.72 4.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.92 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -84.01 -32.95 24.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.29 -55.9 20.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.808 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.535 ' HB3' HG12 ' A' ' 120' ' ' VAL . 6.2 p90 -133.67 148.29 51.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.9 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -122.04 160.38 25.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -127.56 164.37 22.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -179.75 -177.65 48.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.482 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.7 155.62 43.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.817 0.341 . . . . 0.0 110.901 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.8 p -142.97 110.12 5.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.455 ' H ' HG23 ' A' ' 73' ' ' VAL . . . -113.98 179.93 18.86 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.505 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -177.71 170.41 42.77 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.471 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -148.59 144.43 27.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.341 . . . . 0.0 110.895 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.8 mtp85 -141.05 174.45 10.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.9 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -151.51 169.31 22.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -138.0 122.16 18.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.441 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.782 0.325 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -129.93 154.69 47.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.829 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.3 mtm -137.95 124.84 21.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.956 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -89.23 135.97 33.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.844 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -123.58 126.7 47.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.027 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -107.12 145.25 32.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.792 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.401 ' HG3' ' CE1' ' A' ' 135' ' ' TYR . 20.6 tttm -139.91 134.3 31.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.034 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.418 ' O ' HG23 ' A' ' 114' ' ' ILE . 2.1 tt -152.76 126.2 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.905 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.597 ' HB2' ' HA ' ' A' ' 133' ' ' SER . . . -150.57 106.35 3.1 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.305 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.86 137.31 34.88 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.452 2.101 . . . . 0.0 112.072 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -105.92 141.05 37.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.024 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 70.4 p-90 -148.64 131.66 16.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.853 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -123.13 143.94 49.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.967 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.535 HG12 ' HB3' ' A' ' 83' ' ' PHE . 30.4 m -144.26 125.59 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.059 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.87 151.71 30.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.891 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.6 tp -124.01 -48.47 1.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.953 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.27 -176.99 5.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.44 132.01 46.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 60.13 32.63 21.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.767 HD23 HD21 ' A' ' 157' ' ' LEU . 0.1 OUTLIER -146.53 107.9 4.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -118.53 137.76 52.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.684 ' CZ ' HD12 ' A' ' 157' ' ' LEU . 2.9 m-85 -102.08 141.19 35.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.834 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -132.32 138.59 47.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.77 147.27 14.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.472 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . 0.515 ' HE3' ' HB1' ' A' ' 115' ' ' ALA . 26.2 p-90 -173.06 149.5 1.85 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.862 0.363 . . . . 0.0 111.102 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.27 135.74 53.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.617 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.597 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 3.6 t -108.37 153.5 23.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.132 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 53.4 mtp -134.98 118.38 16.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.768 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.401 ' CE1' ' HG3' ' A' ' 113' ' ' LYS . 1.9 m-85 -102.45 133.82 46.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.949 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.839 ' HG3' HG23 ' A' ' 149' ' ' THR . 3.9 mttm -138.73 114.12 9.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.79 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 43.5 p90 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.97 -179.952 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.839 HG23 ' HG3' ' A' ' 136' ' ' LYS . 2.4 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.812 0.339 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -103.06 121.41 42.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.89 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 27.6 m -106.0 129.12 59.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.077 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -110.77 127.61 55.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.858 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.44 114.54 26.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.427 ' HB3' ' CE2' ' A' ' 131' ' ' TRP . 0.6 OUTLIER -121.09 116.39 24.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.851 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.0 m -145.28 145.95 31.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.833 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -163.57 -162.82 15.06 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.53 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.767 HD21 HD23 ' A' ' 126' ' ' LEU . 6.6 tt -151.62 149.9 29.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.845 0.355 . . . . 0.0 110.91 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.453 ' N ' HD23 ' A' ' 157' ' ' LEU . 2.9 mt-30 -118.59 131.7 56.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -127.74 100.16 5.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.701 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 9.4 t -99.81 126.23 45.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.983 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -104.11 -30.09 10.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.775 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -165.36 177.22 7.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.711 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -81.92 0.63 38.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.363 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.605 HG22 ' O ' ' A' ' 200' ' ' THR . 0.2 OUTLIER -111.84 -26.56 8.88 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.653 0.263 . . . . 0.0 111.172 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.75 HG12 ' HG ' ' A' ' 199' ' ' LEU . 28.4 m -145.75 141.52 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.232 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.752 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -150.66 -172.24 4.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.013 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.66 143.24 31.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.627 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.79 145.31 32.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.057 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.645 HG23 ' HB2' ' A' ' 195' ' ' ALA . 11.5 p -144.56 137.88 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.944 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -133.12 155.19 49.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.989 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -127.85 119.35 25.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -96.37 136.1 37.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.002 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.9 125.24 10.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.802 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -111.08 145.59 38.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.949 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.85 117.47 3.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -146.67 169.83 27.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.525 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.774 0.321 . . . . 0.0 110.943 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.818 0.342 . . . . 0.0 110.836 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.7 t -117.16 136.34 53.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 4.0 m -137.12 145.97 44.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -144.4 121.87 11.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.925 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -144.52 136.37 25.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.989 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.524 HD13 ' O ' ' A' ' 212' ' ' ILE . 4.0 mp -107.07 124.97 63.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.132 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -128.23 115.74 18.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.776 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.645 ' HB2' HG23 ' A' ' 169' ' ' VAL . . . -133.49 125.78 29.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.215 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.694 ' HB2' HG22 ' A' ' 207' ' ' THR . 41.8 p90 -121.52 141.36 51.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.722 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.429 ' O ' ' HD2' ' A' ' 208' ' ' PRO . 8.2 tt -105.66 109.31 63.06 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.134 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.752 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 59.0 Cg_endo -71.35 111.21 3.04 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.368 2.046 . . . . 0.0 112.318 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.75 ' HG ' HG12 ' A' ' 165' ' ' VAL . 0.4 OUTLIER -132.76 127.82 35.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.912 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . 0.605 ' O ' HG22 ' A' ' 164' ' ' THR . 0.7 OUTLIER -137.17 114.16 10.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.09 105.52 7.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.838 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 102.44 -133.3 11.33 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.43 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -105.45 17.18 24.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.721 0.296 . . . . 0.0 111.266 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -136.42 159.89 40.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.791 0.329 . . . . 0.0 110.945 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.35 148.43 47.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.83 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 199' ' ' LEU . 5.8 m -144.17 122.3 6.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.694 HG22 ' HB2' ' A' ' 196' ' ' TYR . 5.2 m -125.04 92.91 46.69 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.123 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 197' ' ' LEU . 26.6 Cg_exo -63.0 171.7 5.8 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.57 2.18 . . . . 0.0 112.178 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.83 143.25 50.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.783 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.97 136.48 49.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.913 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.8 117.69 14.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.939 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.524 ' O ' HD13 ' A' ' 193' ' ' ILE . 7.6 pt . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.625 ' O ' HD12 ' A' ' 229' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.375 -0.29 . . . . 0.0 112.375 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 228' ' ' GLY . 0.1 OUTLIER -160.04 141.65 12.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 111.045 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -122.61 145.51 48.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.768 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -112.53 159.47 18.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.04 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -142.87 117.06 1.08 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.097 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -121.13 136.09 55.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.362 . . . . 0.0 110.998 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.1 100.22 7.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.625 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -65.86 -10.67 40.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.22 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.9 37.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.796 0.331 . . . . 0.0 111.005 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 5.0 t30 69.71 -64.97 0.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -52.78 -43.54 60.34 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.738 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.782 HD23 ' N ' ' A' ' 240' ' ' SER . 2.5 tt -87.0 144.77 26.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.762 0.315 . . . . 0.0 110.891 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.782 ' N ' HD23 ' A' ' 239' ' ' LEU . 16.0 m -134.22 151.48 51.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.815 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.477 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 38.9 t -120.98 141.07 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.77 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.88 118.75 31.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.037 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.544 HD23 ' HE2' ' A' ' 245' ' ' TYR . 1.1 mp -120.68 154.95 34.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.702 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -116.76 131.55 56.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.951 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . 0.544 ' HE2' HD23 ' A' ' 243' ' ' LEU . 18.6 m-85 -133.32 146.47 51.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.815 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.147 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.791 0.329 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -97.82 161.71 21.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.561 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.761 HG23 ' HB2' ' A' ' 14' ' ' TYR . 4.8 m -144.81 146.56 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 111.119 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -160.92 164.3 34.68 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.453 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.566 HG22 ' HB3' ' A' ' 12' ' ' ALA . 6.7 m -126.78 150.15 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 0.0 111.163 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -143.72 146.45 33.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.835 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -144.11 139.33 28.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.68 147.52 50.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 24.4 t80 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.892 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.883 0.373 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 61.09 84.54 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.864 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 61.5 t60 -105.98 141.51 37.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.998 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -129.59 163.04 26.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.738 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.422 ' C ' HD12 ' A' ' 10' ' ' ILE . 2.0 t30 -160.26 146.32 15.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.997 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.51 HD12 ' N ' ' A' ' 10' ' ' ILE . 3.7 mp -140.81 134.35 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.108 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.81 159.28 24.51 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.571 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.593 ' HB3' ' CG2' ' A' ' 267' ' ' VAL . . . -144.49 138.99 27.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.865 0.364 . . . . 0.0 111.001 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.29 149.1 42.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.993 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -132.15 111.06 11.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 -179.905 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.848 0.356 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.47 153.61 24.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.029 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.68 94.0 46.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.988 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.48 158.0 20.72 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.53 2.153 . . . . 0.0 112.198 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.51 133.89 44.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.819 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.72 142.15 30.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.091 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.88 143.68 43.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.967 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -133.89 132.57 40.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -132.0 125.05 30.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.94 136.73 53.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.019 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.864 ' HB3' ' HB3' ' A' ' 7' ' ' HIS . . . -118.96 122.76 42.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.17 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -139.95 86.39 2.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.0 -143.44 44.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.363 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.62 -14.23 41.41 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.457 2.105 . . . . 0.0 112.486 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.6 134.12 45.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.987 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.23 145.46 49.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 46' ' ' ALA . 30.7 mt -131.46 155.36 41.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.217 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.742 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -160.04 136.48 8.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.112 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.49 ' HG ' HD22 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -124.82 146.62 49.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.979 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.606 ' HB3' ' CB ' ' A' ' 70' ' ' GLU . . . -126.48 134.02 51.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.019 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -126.04 110.19 13.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.994 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.19 138.02 36.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.786 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.933 179.974 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.803 0.335 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.91 124.58 31.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.27 95.85 4.64 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.877 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.06 142.61 24.94 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.536 2.158 . . . . 0.0 112.408 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.606 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . 19.1 mt-10 -137.79 114.79 10.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.899 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.49 HD22 ' HG ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -102.87 133.89 47.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.741 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.742 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 3.7 tt0 -132.68 127.74 35.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.038 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 p -124.9 136.15 61.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.004 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -122.94 129.13 51.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.029 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -125.62 137.66 53.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.799 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -122.15 121.45 36.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -106.39 -43.31 4.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.728 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 59.65 160.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.981 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -141.63 -47.34 0.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.835 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -147.31 174.91 11.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.79 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -75.17 -29.13 60.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.002 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -84.74 -42.34 15.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.986 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.688 ' CE2' HG13 ' A' ' 120' ' ' VAL . 11.7 m-85 -101.6 169.82 8.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.01 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.57 162.43 33.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.797 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -158.12 144.32 17.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.955 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.82 -176.25 47.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.497 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.92 134.06 5.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.815 0.34 . . . . 0.0 110.901 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.61 ' OG1' ' HB3' ' A' ' 115' ' ' ALA . 69.2 p -118.84 159.36 23.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.32 -170.98 15.29 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.488 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 178.08 159.28 22.52 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.515 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -126.29 148.18 49.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.846 0.355 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.1 ttp85 -136.69 133.61 36.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.893 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -132.19 178.91 6.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.773 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -146.52 146.2 30.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.964 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.477 -179.951 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.832 0.348 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -85.14 105.35 15.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.55 148.4 51.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.893 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -156.55 161.76 39.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.85 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.02 109.2 1.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -83.47 140.42 32.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.776 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.54 127.31 17.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.01 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.424 HG22 ' N ' ' A' ' 115' ' ' ALA . 4.6 mt -122.47 154.77 27.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.942 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.61 ' HB3' ' OG1' ' A' ' 88' ' ' THR . . . -147.29 79.74 9.61 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.292 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.8 155.0 19.07 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.562 2.175 . . . . 0.0 112.183 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -122.32 146.15 47.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.008 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -164.99 142.75 6.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.08 151.68 41.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.911 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.688 HG13 ' CE2' ' A' ' 83' ' ' PHE . 23.4 t -147.59 108.23 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -88.35 133.18 34.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.888 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.512 ' O ' HG23 ' A' ' 123' ' ' THR . 3.0 tt -110.99 -32.84 6.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -166.05 -175.07 3.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.833 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -90.99 51.3 1.93 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -165.88 -43.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.43 124.31 51.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -125.29 146.56 49.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.773 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -101.95 146.02 28.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.014 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -125.45 123.32 38.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -110.95 106.77 2.09 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.517 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -133.1 136.18 45.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.788 0.328 . . . . 0.0 110.775 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.3 mt -131.02 161.45 31.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.801 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.3 151.24 49.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.041 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.677 ' SD ' HG12 ' A' ' 151' ' ' VAL . 1.5 mpp? -140.1 133.78 30.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.822 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -130.57 127.72 39.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.971 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.444 ' HA ' HG23 ' A' ' 149' ' ' THR . 3.5 ttpt -146.51 168.1 22.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.774 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.777 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.444 HG23 ' HA ' ' A' ' 136' ' ' LYS . 2.9 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.864 0.364 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -162.91 179.04 7.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.984 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.677 HG12 ' SD ' ' A' ' 134' ' ' MET . 11.1 m -118.19 131.96 69.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.098 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -101.23 169.43 8.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 8.9 m -132.8 140.28 47.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.876 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -135.38 142.91 45.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.32 127.88 23.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.743 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -116.8 142.13 17.24 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.662 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.7 mp -115.23 117.37 30.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.755 0.312 . . . . 0.0 110.787 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -101.26 117.51 35.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.961 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -127.04 102.47 6.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.422 HG22 ' CB ' ' A' ' 166' ' ' ALA . 34.3 p -93.11 128.08 38.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.909 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.07 -31.46 12.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.643 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.584 ' HB2' HG22 ' A' ' 165' ' ' VAL . 7.4 m120 -150.92 174.94 12.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.814 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -76.24 -6.39 51.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.43 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.49 HG23 ' HB2' ' A' ' 201' ' ' LEU . 55.1 m -113.07 -28.95 7.49 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.635 0.255 . . . . 0.0 111.23 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.584 HG22 ' HB2' ' A' ' 162' ' ' ASN . 19.6 m -123.11 139.94 48.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.865 0.364 . . . . 0.0 111.385 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.75 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -141.17 -178.42 5.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.004 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 41.3 tp -141.2 134.73 29.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.934 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 196' ' ' TYR . 51.7 mtt-85 -137.52 114.54 10.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.2 t -99.85 142.67 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.998 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -118.96 123.34 44.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.021 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -116.17 114.85 25.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.723 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -106.43 140.98 38.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.091 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.61 105.17 5.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.689 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.74 145.74 29.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.029 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -136.28 136.16 39.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.752 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -130.51 152.69 19.9 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.498 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 31.1 t80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.359 . . . . 0.0 110.846 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.763 0.316 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.3 m -122.4 105.53 10.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.968 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.31 114.01 27.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.813 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -109.01 129.4 55.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.017 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -118.28 152.56 35.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.79 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.67 HD13 ' H ' ' A' ' 193' ' ' ILE . 0.2 OUTLIER -136.52 148.09 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.267 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -150.31 127.55 11.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.723 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -119.31 117.26 28.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.97 0.414 . . . . 0.0 111.273 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.439 ' HB3' ' CD1' ' A' ' 209' ' ' TYR . 11.5 p90 -138.28 151.24 47.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.592 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.654 HD11 ' HG2' ' A' ' 208' ' ' PRO . 0.3 OUTLIER -118.54 111.23 38.13 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.242 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.75 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 60.5 Cg_endo -72.8 123.29 8.86 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.385 2.056 . . . . 0.0 112.371 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 198' ' ' PRO . 8.7 mt -126.74 104.48 8.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.845 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.3 t -117.12 117.8 30.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.563 HD13 ' N ' ' A' ' 202' ' ' GLY . 0.9 OUTLIER -147.57 121.63 9.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . 0.563 ' N ' HD13 ' A' ' 201' ' ' LEU . . . 65.46 -119.8 15.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.534 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -118.43 30.57 7.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.905 0.383 . . . . 0.0 110.93 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.71 110.57 9.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 49.3 m -102.71 128.74 49.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.006 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.521 HG23 ' HB2' ' A' ' 199' ' ' LEU . 18.4 m -144.18 124.06 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.759 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.656 HG22 ' HA ' ' A' ' 198' ' ' PRO . 16.0 p -133.0 92.96 24.21 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.421 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.654 ' HG2' HD11 ' A' ' 197' ' ' LEU . 59.0 Cg_exo -52.52 171.77 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.457 2.105 . . . . 0.0 112.113 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.439 ' CD1' ' HB3' ' A' ' 196' ' ' TYR . 0.2 OUTLIER -148.11 140.68 24.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.727 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 10.6 m -128.9 150.12 50.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.97 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -142.3 112.41 7.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.83 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 1.9 pp . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 -179.97 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 208' ' ' PRO . 0.6 OUTLIER -149.99 119.13 6.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.825 0.345 . . . . 0.0 111.009 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -81.26 144.32 31.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.845 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.63 160.48 27.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.975 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -161.1 117.12 0.75 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.164 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.474 ' HB3' HG22 ' A' ' 241' ' ' VAL . 33.9 t80 -128.6 116.38 19.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.864 0.364 . . . . 0.0 111.163 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 240' ' ' SER . 3.1 p30 -117.88 135.62 53.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.946 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.1 -26.48 60.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.29 -45.76 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.872 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -178.5 -61.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -56.76 -75.83 0.23 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.715 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.808 HD12 ' CD1' ' A' ' 269' ' ' TYR . 7.7 tt -66.45 124.64 23.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.749 0.309 . . . . 0.0 110.764 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 234' ' ' ASP . 2.0 t -148.56 175.86 10.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.178 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.511 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 27.8 m -129.0 167.6 24.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.61 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.414 ' O ' HD12 ' A' ' 243' ' ' LEU . 0.3 OUTLIER -133.63 134.69 43.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.021 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 242' ' ' SER . 3.3 mp -137.55 152.2 49.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -138.83 141.45 38.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.84 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -131.51 165.62 23.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.033 -179.979 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.798 0.332 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -145.38 150.73 22.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.453 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.85 153.55 27.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 0.0 111.12 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -158.62 155.95 26.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.495 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.593 ' CG2' ' HB3' ' A' ' 12' ' ' ALA . 15.3 m -138.11 147.83 25.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.811 0.339 . . . . 0.0 111.14 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -138.24 129.93 28.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.943 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.808 ' CD1' HD12 ' A' ' 239' ' ' LEU . 1.9 t80 -124.8 126.12 45.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.951 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 35.0 t -97.85 151.57 20.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.875 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 t70 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.874 0.368 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -71.57 125.16 26.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.77 132.92 52.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.923 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.87 140.43 38.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -141.5 120.14 12.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.022 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.62 HG22 ' CE1' ' A' ' 36' ' ' PHE . 27.1 pt -110.68 140.72 28.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.09 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.79 159.74 26.94 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.618 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.25 143.89 46.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 111.065 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 30.6 mtt -131.25 138.72 49.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.997 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -147.32 113.83 5.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.787 0.327 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.56 126.23 27.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.037 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -143.18 94.15 6.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.93 146.43 47.42 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.492 2.128 . . . . 0.0 112.363 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.1 m -140.21 152.8 46.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.857 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.2 m -133.6 159.53 42.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -143.93 122.28 12.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.62 ' CE1' HG22 ' A' ' 10' ' ' ILE . 8.8 m-85 -119.85 141.7 49.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.946 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.666 ' OD1' ' HB2' ' A' ' 46' ' ' ALA . 25.1 t30 -143.34 132.52 23.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.998 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.521 ' HB3' HG13 ' A' ' 45' ' ' ILE . . . -126.69 124.08 39.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.041 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.58 113.24 25.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.154 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -122.33 98.56 5.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.816 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.77 -141.79 45.79 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.45 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.58 -18.34 48.6 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.499 2.133 . . . . 0.0 112.441 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -101.47 144.6 30.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 111.016 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -137.73 132.77 33.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.521 HG13 ' HB3' ' A' ' 38' ' ' ALA . 23.7 pt -117.68 156.38 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.131 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.666 ' HB2' ' OD1' ' A' ' 37' ' ' ASN . . . -142.95 157.79 44.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.055 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.0 tt -150.48 120.96 7.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.907 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.61 139.1 49.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.041 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.99 109.66 11.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -95.91 125.05 40.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.862 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.93 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.881 0.372 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -139.64 134.39 31.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.953 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.97 95.85 14.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.86 159.83 11.06 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.536 2.157 . . . . 0.0 112.275 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.89 149.96 47.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.871 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.92 141.12 23.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.97 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 2.6 tt0 -128.4 151.16 49.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.813 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.506 HG12 ' CD1' ' A' ' 75' ' ' TYR . 28.2 t -127.81 130.67 70.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.151 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.779 ' CD2' HG22 ' A' ' 88' ' ' THR . 4.3 m170 -123.9 121.09 34.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.787 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.506 ' CD1' HG12 ' A' ' 73' ' ' VAL . 1.7 p90 -153.33 106.53 2.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.845 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -92.43 141.03 28.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.957 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -88.52 -47.96 7.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.866 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.8 mt -143.12 171.08 14.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -169.75 111.91 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -143.71 -178.51 5.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.89 -31.45 59.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.916 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.09 -56.14 6.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.968 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -156.76 134.15 10.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.2 m -109.69 138.19 46.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.94 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -124.63 139.84 53.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.18 172.33 35.85 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.502 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.448 ' HB2' ' CE2' ' A' ' 75' ' ' TYR . 17.2 mt -143.31 143.41 31.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.816 0.341 . . . . 0.0 110.817 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.779 HG22 ' CD2' ' A' ' 74' ' ' HIS . 25.2 p -140.82 131.75 26.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.07 -177.93 15.12 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.494 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.87 153.38 24.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.484 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 111' ' ' ARG . 6.4 t80 -131.63 136.61 47.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.86 0.362 . . . . 0.0 110.89 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.6 mtm180 -137.23 159.83 40.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.54 169.77 17.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.824 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.15 130.74 25.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.513 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.876 0.37 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -107.77 141.25 39.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.827 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.9 ptm -112.69 133.78 54.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.47 127.19 36.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.4 ' O ' ' CD1' ' A' ' 91' ' ' PHE . 12.4 mtt180 -109.97 128.21 55.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.923 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -127.74 113.83 16.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.85 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -119.58 144.27 47.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.953 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.2 tp -140.97 143.54 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.998 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.08 99.78 3.06 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.081 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.63 155.2 69.68 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.433 2.089 . . . . 0.0 112.242 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -112.93 142.96 45.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.998 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.68 130.37 20.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.781 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.15 132.32 29.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.56 HG23 ' HB3' ' A' ' 128' ' ' PHE . 11.8 m -143.44 109.99 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.151 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -72.66 123.31 23.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.951 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.7 tp -101.78 -46.64 4.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.961 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.31 167.62 12.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.85 -30.13 71.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.025 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.559 ' OD2' HD12 ' A' ' 126' ' ' LEU . 2.5 p30 -123.87 40.97 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.011 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.559 HD12 ' OD2' ' A' ' 125' ' ' ASP . 1.2 mp -156.85 133.8 10.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.56 140.51 48.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.836 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.56 ' HB3' HG23 ' A' ' 120' ' ' VAL . 68.8 t80 -104.92 126.82 52.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.978 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -114.86 147.37 39.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.802 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -152.38 133.53 4.15 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.676 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . 0.427 ' CD1' ' N ' ' A' ' 131' ' ' TRP . 0.1 OUTLIER -160.81 165.19 30.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.819 0.342 . . . . 0.0 110.841 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.46 156.06 47.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.01 110.33 17.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.83 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.5 ttp -113.92 111.57 21.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.839 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -104.9 121.77 44.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.477 ' HA ' HG22 ' A' ' 149' ' ' THR . 3.2 tmtm? -140.53 110.55 6.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.819 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.4 p90 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.963 179.984 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 136' ' ' LYS . 69.8 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.79 0.328 . . . . 0.0 110.814 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -153.53 -178.56 7.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.917 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.467 HG22 ' N ' ' A' ' 152' ' ' GLU . 9.4 p -129.68 157.82 42.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.993 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.467 ' N ' HG22 ' A' ' 151' ' ' VAL . 4.3 mp0 -124.62 157.43 35.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.975 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 68.6 p -116.77 118.0 31.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.754 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.401 ' HG2' ' CE1' ' A' ' 172' ' ' TYR . 3.5 mp0 -126.2 138.05 53.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.028 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 7.9 t -139.4 138.91 36.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.671 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -132.36 158.33 22.92 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.644 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.9 mp -139.14 130.19 26.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.823 0.344 . . . . 0.0 110.738 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -93.95 146.73 23.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.975 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -139.72 100.15 3.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.787 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.69 115.06 16.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.958 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.6 -49.89 3.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.729 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -131.01 163.89 26.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.799 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -30.95 70.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.931 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -119.22 27.41 8.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.079 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.4 t -148.95 117.62 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.105 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 198' ' ' PRO . . . -124.03 149.96 45.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.184 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' A' ' 197' ' ' LEU . 2.4 mt -132.06 121.97 24.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.733 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.43 ' HD3' ' CE1' ' A' ' 196' ' ' TYR . 40.3 mtt180 -125.27 147.07 49.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.067 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.5 m -147.02 138.61 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 44.1 p30 -146.89 156.41 43.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.118 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.517 ' CD1' HG22 ' A' ' 193' ' ' ILE . 5.2 m-85 -110.13 144.57 38.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.785 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.401 ' CE1' ' HG2' ' A' ' 154' ' ' GLU . 0.3 OUTLIER -121.7 115.87 23.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.97 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.577 HD13 ' HA ' ' A' ' 191' ' ' GLN . 4.3 mm? -109.99 106.93 16.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.14 147.26 24.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -151.36 124.09 8.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.939 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -144.71 178.66 22.42 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.518 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 12.6 t80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.778 0.323 . . . . 0.0 110.97 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 13.0 t80 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.83 0.348 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.3 p -122.83 110.08 15.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 5.0 t -106.3 139.91 40.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.942 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.577 ' HA ' HD13 ' A' ' 173' ' ' LEU . 2.7 mt-30 -98.97 130.45 45.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -134.44 157.35 46.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.945 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.517 HG22 ' CD1' ' A' ' 171' ' ' TYR . 1.8 pt -141.18 137.09 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.43 114.31 16.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.846 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -101.3 115.43 30.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.228 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.446 ' HB3' ' CD1' ' A' ' 209' ' ' TYR . 8.4 p90 -128.98 114.95 17.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.623 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.536 ' HB2' HD23 ' A' ' 167' ' ' LEU . 0.4 OUTLIER -108.2 109.38 61.8 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.216 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.403 ' HB2' ' HB3' ' A' ' 166' ' ' ALA . 31.0 Cg_exo -61.73 136.08 60.12 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.561 2.174 . . . . 0.0 112.18 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.2 tp -132.88 127.98 35.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.929 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 7.1 m -132.19 123.18 26.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.967 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 26.8 tp -147.15 102.68 3.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.923 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 77.06 52.03 5.92 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.499 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 59.69 29.61 19.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.77 0.319 . . . . 0.0 110.941 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -104.09 126.21 51.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.09 104.92 16.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 230' ' ' PHE . 22.1 t -118.66 127.42 75.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.05 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.93 92.72 33.03 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.961 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -79.89 172.14 14.47 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.679 2.253 . . . . 0.0 112.244 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.446 ' CD1' ' HB3' ' A' ' 196' ' ' TYR . 0.3 OUTLIER -161.72 143.65 11.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.691 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 32.6 m -131.69 145.39 51.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.017 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.31 141.63 22.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.766 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 14.7 pt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.181 -179.919 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.23 110.93 21.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.778 0.323 . . . . 0.0 110.598 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.541 ' O ' HG13 ' A' ' 206' ' ' VAL . 0.1 OUTLIER -87.39 133.43 33.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.979 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -116.95 155.31 29.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -134.81 117.06 1.69 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.399 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.501 ' O ' HG23 ' A' ' 241' ' ' VAL . 17.3 m-85 -110.36 116.37 31.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.838 0.351 . . . . 0.0 111.027 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -115.45 111.09 20.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.676 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -72.78 -5.42 37.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.347 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.36 41.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.757 0.313 . . . . 0.0 110.938 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 70.0 -64.1 0.37 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.152 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -47.66 -75.66 0.18 Allowed Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.793 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 240' ' ' SER . 7.4 tt -66.51 142.49 57.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.775 0.322 . . . . 0.0 110.799 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.43 ' N ' HD23 ' A' ' 239' ' ' LEU . 0.8 OUTLIER -138.95 164.39 29.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.867 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 233' ' ' TYR . 8.2 t -131.29 151.42 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.942 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.57 126.2 52.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.98 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.28 122.91 12.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.809 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -105.32 141.16 37.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -124.85 153.05 43.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.898 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.061 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.795 0.331 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -128.38 147.43 17.43 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.504 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.24 142.97 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.769 0.319 . . . . 0.0 111.135 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -172.48 159.99 31.05 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.517 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.62 152.34 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 111.142 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -136.23 136.04 39.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.969 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -134.35 157.88 45.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 4.8 p -118.86 147.02 44.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.851 -179.93 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 t0 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.836 0.351 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 11.6 t90 -96.68 102.28 14.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.79 160.16 18.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.798 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.53 125.25 14.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -125.09 120.81 32.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.837 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 pp -130.52 126.74 61.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.12 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.98 164.56 25.79 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.539 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -125.8 147.81 49.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.796 0.332 . . . . 0.0 111.075 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.58 150.92 48.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.924 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -141.44 117.86 10.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.817 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.831 179.994 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.826 0.346 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.88 150.81 33.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.075 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -120.0 94.07 48.32 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.42 178.75 0.21 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.55 2.166 . . . . 0.0 112.258 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.09 135.08 26.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.836 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.59 141.53 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.113 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -140.26 122.25 15.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.929 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.411 ' CZ ' ' HB3' ' A' ' 47' ' ' LEU . 3.7 p90 -144.55 123.76 12.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.76 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -135.82 162.5 32.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.983 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.82 129.61 36.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.013 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.54 109.28 21.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.104 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -108.69 85.44 2.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.803 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.31 -147.57 47.41 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.4 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -51.26 -25.78 18.61 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.506 2.137 . . . . 0.0 112.36 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -92.64 148.4 22.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.809 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -140.6 137.23 33.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.945 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.6 pt -129.92 145.49 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.964 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.19 155.78 49.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.222 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 36' ' ' PHE . 3.6 mp -142.3 144.85 33.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.739 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -118.31 143.43 46.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.08 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -141.47 160.02 41.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.63 148.04 32.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.868 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.81 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.878 0.37 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.03 134.91 47.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.75 95.87 24.86 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.884 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.34 170.25 18.8 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.484 2.123 . . . . 0.0 112.253 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.739 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 2.0 tt0 -153.59 140.34 19.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.025 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mt -126.04 146.31 49.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.804 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -152.28 119.89 6.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.031 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.39 138.87 31.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.042 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -129.52 135.14 48.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.064 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -124.05 110.8 15.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.712 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -65.59 137.14 57.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.043 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -50.92 147.09 5.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.199 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 16.8 mt -72.37 -66.3 0.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.743 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -71.1 -173.5 0.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.689 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -175.2 -32.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.41 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -45.88 -30.15 1.62 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.489 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.404 ' HB3' ' CD2' ' A' ' 83' ' ' PHE . 1.2 t70 -164.34 -64.97 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.97 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.437 ' CD1' HG13 ' A' ' 120' ' ' VAL . 23.5 m-85 -104.31 118.61 37.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.85 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.37 173.79 6.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.74 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.46 ' HE1' HD11 ' A' ' 87' ' ' LEU . 12.1 t80 -162.36 117.06 1.84 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.032 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.472 ' C ' HD12 ' A' ' 87' ' ' LEU . . . -132.19 -162.42 10.37 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.261 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.472 HD12 ' C ' ' A' ' 86' ' ' GLY . 4.0 mp -155.73 145.24 21.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 0.0 110.981 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 81.7 p -142.84 121.94 12.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.931 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -151.32 -159.01 8.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.522 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 174.3 176.64 42.84 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.554 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.433 ' CD2' ' N ' ' A' ' 91' ' ' PHE . 3.9 m-85 -122.27 173.82 7.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.845 0.355 . . . . 0.0 110.818 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -150.26 128.23 11.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.024 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -131.45 149.44 52.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.827 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.22 138.22 52.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.933 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.426 -179.973 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.764 0.316 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -144.06 119.87 10.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.981 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.46 159.28 18.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -146.61 104.64 3.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -105.04 127.12 52.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -96.76 122.22 39.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.94 121.72 45.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.899 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.633 HG22 ' HD3' ' A' ' 116' ' ' PRO . 17.5 mt -130.99 132.14 63.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.04 76.43 8.71 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.348 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.633 ' HD3' HG22 ' A' ' 114' ' ' ILE . 44.2 Cg_exo -56.52 168.17 2.35 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.526 2.15 . . . . 0.0 112.132 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -147.17 134.75 20.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.164 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -120.73 124.81 46.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.66 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -100.14 125.92 46.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.959 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.437 HG13 ' CD1' ' A' ' 83' ' ' PHE . 22.3 t -140.37 116.96 8.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.059 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -88.66 144.36 26.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.922 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.29 -42.8 2.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -130.27 -170.75 2.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.841 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.44 ' H ' HG22 ' A' ' 123' ' ' THR . 79.1 m-20 -74.94 -47.99 26.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.88 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.713 ' C ' HD12 ' A' ' 126' ' ' LEU . 22.3 m-20 -110.19 29.78 7.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.713 HD12 ' C ' ' A' ' 125' ' ' ASP . 7.9 mp -138.15 133.86 33.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.864 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -142.51 152.71 42.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -141.51 135.29 30.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.802 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -154.55 168.12 27.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.062 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 151.83 177.37 25.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.562 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . 0.467 ' HA ' ' CE3' ' A' ' 131' ' ' TRP . 0.0 OUTLIER -173.21 -172.67 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.77 0.319 . . . . 0.0 110.777 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.496 HD23 ' O ' ' A' ' 152' ' ' GLU . 6.1 mt -100.83 150.39 22.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.956 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.67 152.19 21.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.936 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 5.0 mtp -132.37 125.43 30.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -118.51 125.6 50.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.938 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.07 156.3 41.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.897 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.716 -179.948 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 37.2 p . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.763 0.316 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -105.26 120.69 42.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.833 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.416 HG23 ' HG2' ' A' ' 175' ' ' ARG . 6.2 m -120.67 116.97 51.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.091 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.496 ' O ' HD23 ' A' ' 132' ' ' LEU . 6.9 mp0 -108.2 153.72 22.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.932 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.4 m -101.12 132.49 46.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -129.43 116.94 19.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . 0.623 HG23 ' HB2' ' A' ' 171' ' ' TYR . 1.4 t -140.69 113.82 8.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -114.53 147.28 18.82 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.678 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.42 HD21 ' HB ' ' A' ' 169' ' ' VAL . 1.9 pp -123.0 117.29 25.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 110.738 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.68 127.06 35.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.106 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -140.81 100.16 3.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.795 HG23 ' HB2' ' A' ' 166' ' ' ALA . 2.8 m -106.95 137.21 45.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.079 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -99.72 -30.92 11.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.798 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.408 ' O ' HG22 ' A' ' 160' ' ' THR . 12.9 t30 -151.11 -179.09 7.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.808 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -87.61 6.23 35.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.373 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 60.2 p -103.41 -31.04 10.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.818 0.342 . . . . 0.0 110.982 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.778 HG23 ' HG ' ' A' ' 199' ' ' LEU . 11.3 p -147.67 152.03 13.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.145 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.795 ' HB2' HG23 ' A' ' 160' ' ' THR . . . -141.7 158.9 43.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.019 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.708 HD12 ' HB3' ' A' ' 197' ' ' LEU . 4.7 tp -115.52 143.01 45.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.952 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 32.1 mtp180 -147.36 124.0 11.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.024 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.42 ' HB ' HD21 ' A' ' 157' ' ' LEU . 21.5 t -124.41 123.76 66.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.007 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -121.1 145.98 47.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.141 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.623 ' HB2' HG23 ' A' ' 155' ' ' THR . 13.3 m-85 -112.92 130.85 55.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.746 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -111.18 138.12 48.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.037 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.761 HD12 ' HA ' ' A' ' 191' ' ' GLN . 4.6 tp -139.95 151.1 45.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.808 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -138.09 144.73 41.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.006 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.428 ' NH1' HD23 ' A' ' 173' ' ' LEU . 0.1 OUTLIER -160.06 116.58 2.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.959 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -123.06 169.91 15.41 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.398 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 34.8 t80 . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.804 0.335 . . . . 0.0 110.928 -179.941 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.791 0.329 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.9 m -142.24 148.83 38.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.944 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 17.0 p -130.39 162.6 28.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.761 ' HA ' HD12 ' A' ' 173' ' ' LEU . 4.0 pt20 -137.45 133.24 34.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.936 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -134.74 173.18 11.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.57 HG22 ' CE2' ' A' ' 171' ' ' TYR . 1.1 pt -137.36 142.33 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.249 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.51 114.49 16.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.761 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -115.76 118.97 34.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.251 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.442 ' CD2' ' N ' ' A' ' 196' ' ' TYR . 1.9 p90 -145.36 137.09 25.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.706 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.708 ' HB3' HD12 ' A' ' 167' ' ' LEU . 0.8 OUTLIER -128.37 109.41 19.37 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.053 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.812 ' HA ' HG23 ' A' ' 207' ' ' THR . 23.4 Cg_exo -64.15 142.54 80.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.5 2.133 . . . . 0.0 112.152 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.778 ' HG ' HG23 ' A' ' 165' ' ' VAL . 0.3 OUTLIER -130.02 100.01 5.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.791 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 35.1 p -107.04 102.97 12.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.957 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 2.9 tt -140.54 129.86 23.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.884 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 72.32 -128.78 13.87 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.472 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -117.52 30.1 7.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.359 . . . . 0.0 110.931 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -135.6 149.08 49.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 88.8 p -121.01 121.51 38.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.936 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.653 HG13 ' O ' ' A' ' 230' ' ' PHE . 21.5 t -135.31 139.94 45.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.825 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.812 HG23 ' HA ' ' A' ' 198' ' ' PRO . 2.0 m -138.69 92.97 11.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.403 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.01 111.52 2.47 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.618 2.212 . . . . 0.0 112.116 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -111.23 169.03 9.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 0.0 111.109 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 14.6 p -138.62 138.86 38.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.843 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -125.2 164.81 19.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.934 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 1.2 pp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 179.986 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.312 -0.315 . . . . 0.0 112.312 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.22 113.68 9.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.808 0.337 . . . . 0.0 111.048 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.653 ' O ' HG13 ' A' ' 206' ' ' VAL . 2.0 t80 -97.71 130.6 44.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.721 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -111.05 155.72 22.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.05 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -165.51 117.21 0.74 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.041 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.44 ' HB3' HG22 ' A' ' 241' ' ' VAL . 26.2 t80 -132.38 121.16 23.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.748 0.309 . . . . 0.0 111.181 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 240' ' ' SER . 2.4 p30 -108.71 128.53 54.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -54.98 -24.71 25.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.998 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -156.36 -45.44 0.07 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.836 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 179.51 -55.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -63.72 -78.88 0.17 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.691 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.827 HD23 ' CD2' ' A' ' 269' ' ' TYR . 3.1 mp -66.42 140.0 58.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.794 0.33 . . . . 0.0 110.9 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -157.14 176.84 12.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.048 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.565 HG12 HG12 ' A' ' 267' ' ' VAL . 30.2 m -122.01 170.39 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.825 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 36.4 t -142.27 131.84 23.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.828 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.691 ' HG ' HG12 ' A' ' 265' ' ' VAL . 2.3 tt -136.35 126.86 26.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.002 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -119.45 139.39 52.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -152.02 151.83 31.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.979 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.048 -179.982 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.809 0.337 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -144.58 148.08 19.65 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.445 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.691 HG12 ' HG ' ' A' ' 243' ' ' LEU . 21.8 m -147.47 141.83 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 111.134 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -158.47 175.04 35.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.54 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.565 HG12 HG12 ' A' ' 241' ' ' VAL . 9.2 m -130.33 162.86 37.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.79 0.329 . . . . 0.0 111.148 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -136.33 143.12 43.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.862 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.827 ' CD2' HD23 ' A' ' 239' ' ' LEU . 25.1 m-85 -139.18 101.7 4.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 59.4 p -110.77 131.7 54.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.903 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.5 t70 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.84 0.352 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 60.6 p-90 -107.83 149.89 27.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.943 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.505 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -118.2 144.71 45.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -118.72 130.03 55.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.51 128.61 19.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.553 HD12 ' HE1' ' A' ' 36' ' ' PHE . 11.7 tt -155.29 131.21 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.051 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.98 -157.99 7.73 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.553 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.79 -176.95 1.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.332 . . . . 0.0 111.04 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.5 ttt -152.94 150.13 28.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.34 138.21 26.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.854 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.952 179.987 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.901 0.381 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.7 119.5 19.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.066 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -121.75 94.09 48.45 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.05 123.83 10.38 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.482 2.121 . . . . 0.0 112.269 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.28 137.97 46.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.026 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -137.22 142.1 38.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -133.29 156.21 48.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.942 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.553 ' HE1' HD12 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -153.5 132.52 12.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.881 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.23 126.55 19.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.966 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.16 135.41 45.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.053 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.505 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -124.45 149.82 46.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.169 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -173.91 140.41 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.83 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.16 -149.39 17.37 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.511 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -86.19 42.03 0.91 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.807 2.338 . . . . 0.0 112.729 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -170.95 163.7 7.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.804 0.335 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -141.28 163.74 32.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.938 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mp -142.31 139.62 29.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.74 144.68 45.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.173 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.06 165.0 24.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.668 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -156.36 135.11 11.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -139.65 118.96 12.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -146.53 160.96 41.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.795 0.331 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -141.12 139.67 34.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.0 mtp180 -130.67 95.89 25.1 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.953 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.86 157.91 34.94 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.559 2.173 . . . . 0.0 112.365 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.668 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 6.4 tp10 -137.87 121.23 17.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 mp -114.65 145.21 42.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -153.82 160.27 42.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 73' ' ' VAL . 12.3 p -158.17 125.85 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.069 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -104.47 153.39 21.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -157.32 119.1 3.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -94.25 148.91 21.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -115.31 -62.51 1.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.837 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.7 mt -123.42 136.48 54.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.94 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -129.96 74.44 1.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -92.19 168.33 11.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -73.71 -27.75 61.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.956 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.445 ' HB3' ' CD2' ' A' ' 83' ' ' PHE . 12.7 m-20 -83.26 -64.21 1.21 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.939 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.538 ' HD1' HG22 ' A' ' 120' ' ' VAL . 12.6 m-85 -124.2 154.59 39.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.954 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.12 147.92 50.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.821 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.462 ' CE2' ' CZ3' ' A' ' 118' ' ' TRP . 29.3 m-85 -123.07 157.72 32.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.916 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -174.04 166.06 38.0 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.51 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.8 mt -144.3 137.07 26.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 0.0 110.874 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.93 123.37 19.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.53 149.81 16.88 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.547 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -161.48 156.68 28.2 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.422 ' HB3' ' CD1' ' A' ' 112' ' ' TRP . 8.1 p90 -150.1 167.71 26.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.789 0.328 . . . . 0.0 110.91 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.0 mtp85 -127.88 150.93 49.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.864 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -129.83 154.17 47.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.852 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -126.62 145.26 50.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.52 179.955 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.05 0 CA-C-O 120.801 0.334 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -139.71 104.31 4.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.026 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.3 mtm -143.44 154.15 43.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.728 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -166.94 -179.28 4.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.961 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -145.02 134.58 23.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.422 ' CD1' ' HB3' ' A' ' 91' ' ' PHE . 0.3 OUTLIER -107.71 164.54 12.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.814 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -164.02 138.8 5.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.934 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.1 mt -137.77 125.82 31.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.051 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -135.91 107.89 9.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.072 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.51 177.12 5.72 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.474 2.116 . . . . 0.0 112.296 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -131.62 135.43 46.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.929 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.462 ' CZ3' ' CE2' ' A' ' 85' ' ' PHE . 2.9 t-105 -145.34 139.4 26.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.867 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -143.47 149.5 37.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.83 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.538 HG22 ' HD1' ' A' ' 83' ' ' PHE . 21.4 t -136.67 115.89 15.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.158 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.62 103.51 15.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.7 mp -81.37 -51.45 8.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -147.47 177.52 9.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.848 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -60.02 -29.91 68.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.993 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -118.96 36.2 4.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.008 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.411 HD12 ' CE1' ' A' ' 159' ' ' TYR . 0.8 OUTLIER -156.85 125.09 5.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -146.36 128.68 15.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.829 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.34 151.66 19.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -133.84 154.14 51.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.76 136.16 3.82 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.449 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 4.3 p-90 -164.59 138.78 5.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.333 . . . . 0.0 110.987 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.3 mp -95.25 161.57 14.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.9 m -139.29 113.62 8.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.902 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 1.6 ttt -111.44 148.45 33.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -125.37 119.49 28.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.21 167.23 11.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.764 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.827 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.777 0.322 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.74 129.92 50.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.75 129.08 47.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.091 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.76 151.2 45.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 29.4 m -117.29 139.78 50.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.837 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.95 115.5 23.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.838 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 17.6 m -125.7 137.05 53.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.903 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -150.33 160.34 28.51 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.599 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.418 HD21 ' HB ' ' A' ' 169' ' ' VAL . 0.3 OUTLIER -129.38 134.24 47.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.86 0.362 . . . . 0.0 110.921 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -113.79 114.29 26.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.961 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.411 ' CE1' HD12 ' A' ' 126' ' ' LEU . 9.5 t80 -126.78 113.44 16.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.725 HG23 ' HB2' ' A' ' 166' ' ' ALA . 6.2 m -103.12 136.49 42.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.102 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -103.99 -31.1 9.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.764 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -170.96 173.14 5.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.766 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.62 -14.39 62.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.344 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.711 HG23 HG12 ' A' ' 165' ' ' VAL . 9.1 t -76.24 -46.52 27.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.714 0.292 . . . . 0.0 111.032 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.711 HG12 HG23 ' A' ' 164' ' ' THR . 10.2 p -156.22 154.06 6.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.2 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.885 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -133.36 -172.74 3.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.028 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.404 ' HG ' HD21 ' A' ' 197' ' ' LEU . 1.5 mp -135.87 138.14 42.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.958 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.38 128.31 14.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.921 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.418 ' HB ' HD21 ' A' ' 157' ' ' LEU . 21.2 t -122.27 136.78 57.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.117 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -118.97 149.47 41.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.413 ' CE1' HG12 ' A' ' 193' ' ' ILE . 0.5 OUTLIER -134.81 144.9 47.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -124.48 136.19 53.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.977 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.426 HD12 ' HB3' ' A' ' 191' ' ' GLN . 1.2 tp -147.52 114.51 6.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.2 pm0 -143.67 162.53 35.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.023 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.4 ptt180 -140.17 166.55 24.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.817 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -138.49 160.02 25.45 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.558 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 7.1 t80 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 0.0 110.904 179.987 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.892 0.377 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 11.9 m -130.69 121.47 25.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.956 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 14.0 p -124.35 153.63 41.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.426 ' HB3' HD12 ' A' ' 173' ' ' LEU . 2.8 pp0? -153.96 128.44 9.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.834 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.21 137.85 54.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.5 HD12 HG21 ' A' ' 212' ' ' ILE . 22.6 mt -102.12 139.22 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.094 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 15.5 ttt85 -134.04 133.42 41.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -111.3 126.44 54.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.139 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.418 ' CD1' ' HB3' ' A' ' 209' ' ' TYR . 0.3 OUTLIER -131.67 116.14 16.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.772 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.404 HD21 ' HG ' ' A' ' 167' ' ' LEU . 0.4 OUTLIER -116.81 109.67 42.94 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.087 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.885 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 91.0 Cg_endo -79.0 138.22 14.36 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.409 2.073 . . . . 0.0 112.388 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.526 HD23 ' N ' ' A' ' 200' ' ' THR . 1.7 tt -132.76 155.91 48.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.929 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . 0.526 ' N ' HD23 ' A' ' 199' ' ' LEU . 44.0 m -132.93 116.94 17.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.22 102.57 3.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.76 -137.52 15.31 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.485 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.03 23.66 14.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 0.0 111.043 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -136.44 132.99 36.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.764 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 84.8 p -96.69 134.44 39.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.954 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 20.8 t -135.38 131.5 51.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.85 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.705 HG22 ' HA ' ' A' ' 198' ' ' PRO . 14.3 p -133.61 92.82 22.59 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.302 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.34 124.71 9.15 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.432 2.088 . . . . 0.0 111.951 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.434 ' CZ ' ' HA3' ' A' ' 228' ' ' GLY . 48.2 p90 -111.12 136.23 50.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.932 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 24.7 m -111.12 159.64 17.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.938 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -127.35 126.76 43.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.851 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.5 HG21 HD12 ' A' ' 193' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.205 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.434 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.452 -0.259 . . . . 0.0 112.452 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.08 129.53 11.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.918 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -107.01 114.5 28.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.748 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -90.93 162.1 14.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.035 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -153.95 117.03 0.77 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.111 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 240' ' ' SER . 0.8 OUTLIER -110.86 115.45 29.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.791 0.329 . . . . 0.0 111.142 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -120.06 85.44 2.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.564 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.95 -12.7 19.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.272 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.31 35.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.736 0.303 . . . . 0.0 111.137 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 68.91 -65.44 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.061 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -48.43 -59.33 6.59 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.725 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.519 HD23 ' C ' ' A' ' 239' ' ' LEU . 7.6 tt -80.95 107.37 13.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.764 0.316 . . . . 0.0 110.766 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 233' ' ' TYR . 30.5 t -113.19 154.37 26.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.476 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 39.1 t -122.38 142.53 38.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.779 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 27.3 m -116.45 118.84 33.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.008 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 243' ' ' LEU . 0.9 OUTLIER -128.34 124.37 36.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.771 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -105.23 133.56 49.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.945 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -121.9 159.38 26.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.073 179.984 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.845 0.355 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . 0.418 ' O ' HD13 ' A' ' 243' ' ' LEU . . . -103.45 136.13 12.75 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.543 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 16.5 t -120.11 141.71 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 111.092 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -166.2 164.31 37.46 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.518 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 5.7 m -132.72 166.73 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.853 0.358 . . . . 0.0 111.109 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -158.75 120.76 3.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.956 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.45 ' HB2' HG23 ' A' ' 10' ' ' ILE . 62.3 m-85 -112.78 105.75 13.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.794 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.59 118.34 36.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.873 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.827 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.783 0.325 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -123.84 112.88 17.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.84 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.99 146.17 46.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.4 130.48 52.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.716 ' O ' HD13 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -123.2 129.32 51.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.716 HD13 ' O ' ' A' ' 9' ' ' ASN . 24.0 mm -138.9 127.78 29.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.098 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.96 -178.77 35.23 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.508 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.35 -176.89 5.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 0.0 111.072 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.44 152.36 21.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.82 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -150.89 118.42 6.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.92 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.863 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.864 0.364 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.84 138.11 31.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.138 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -136.64 94.13 13.54 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.926 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.72 167.41 25.76 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.555 2.17 . . . . 0.0 112.254 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.9 t -152.95 136.45 15.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -115.02 144.76 21.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.159 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -125.77 136.57 53.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.516 ' CZ ' HD12 ' A' ' 10' ' ' ILE . 1.2 m-85 -131.51 161.87 31.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.873 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -165.01 144.72 6.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.3 117.46 9.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.125 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.06 135.41 47.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.122 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -158.12 111.4 2.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.76 -149.29 37.49 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.579 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.76 -10.7 28.28 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.571 2.181 . . . . 0.0 112.6 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -99.87 143.04 30.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 110.941 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -129.99 142.08 50.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.8 mt -129.64 147.54 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.206 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.71 147.46 25.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.027 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.408 HD12 ' CE2' ' A' ' 49' ' ' TYR . 0.3 OUTLIER -146.16 169.22 19.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.934 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.43 137.37 20.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.042 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.408 ' CE2' HD12 ' A' ' 47' ' ' LEU . 70.9 m-85 -115.89 148.94 39.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.951 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -131.46 144.63 51.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 . . . . . 0 N--CA 1.458 -0.073 0 CA-C-O 120.844 0.354 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.37 146.44 46.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -151.2 95.87 3.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.902 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.91 133.33 16.6 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.556 2.17 . . . . 0.0 112.33 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -106.87 125.76 51.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.433 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -121.29 141.25 51.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.804 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -145.67 141.14 27.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.942 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.2 t -127.85 119.54 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.07 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -107.98 121.91 45.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -97.59 140.31 32.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -109.81 105.22 14.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.922 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.47 -46.47 5.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.808 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 tp -138.91 145.3 39.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.861 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -156.63 79.77 0.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.77 -170.59 1.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.978 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -85.38 -22.28 28.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.15 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -120.86 -47.21 2.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.787 0.327 . . . . 0.0 111.065 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.437 ' CE2' HG12 ' A' ' 120' ' ' VAL . 1.6 t80 -103.28 143.67 32.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.057 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.4 t -143.52 155.24 44.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.83 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -153.14 149.39 27.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 171.17 -178.67 43.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.438 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mp -142.39 145.18 33.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.823 0.344 . . . . 0.0 110.939 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.9 m -132.89 123.23 25.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.16 177.61 19.43 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.553 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.47 -175.37 46.97 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.441 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.433 ' CZ ' HD13 ' A' ' 71' ' ' LEU . 36.9 p90 -163.43 149.65 11.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.783 0.325 . . . . 0.0 111.014 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.1 159.88 18.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -130.74 143.43 50.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.851 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -148.84 119.43 7.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.952 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.478 -179.965 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.56 ' HB3' ' CE ' ' A' ' 109' ' ' MET . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.822 0.344 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -105.02 111.07 23.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.56 ' CE ' ' HB3' ' A' ' 107' ' ' ALA . 1.8 mpt? -131.23 141.09 49.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.432 ' HG2' ' CD2' ' A' ' 137' ' ' PHE . 5.3 pt20 -163.11 172.16 15.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.0 mtt-85 -152.97 109.23 3.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -87.38 154.51 20.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.815 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.402 ' HE2' ' CE1' ' A' ' 135' ' ' TYR . 65.3 mttt -145.05 125.39 13.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.043 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.3 mt -140.17 124.91 19.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.983 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.706 ' HB2' ' HA ' ' A' ' 133' ' ' SER . . . -149.15 99.49 3.44 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.222 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.07 169.94 0.26 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.463 2.109 . . . . 0.0 112.22 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -125.78 134.9 51.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.001 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -144.56 127.05 15.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.52 142.75 45.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.437 HG12 ' CE2' ' A' ' 83' ' ' PHE . 6.9 m -153.93 118.35 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.188 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -88.09 139.07 30.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.8 tt -102.89 -31.18 10.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.737 HG23 ' H ' ' A' ' 125' ' ' ASP . 12.4 t -156.35 -164.01 1.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.851 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -93.79 20.58 7.43 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.35 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.737 ' H ' HG23 ' A' ' 123' ' ' THR . 2.5 p30 -158.11 26.13 0.26 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.714 0.293 . . . . 0.0 111.094 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.598 ' HB2' HG22 ' A' ' 123' ' ' THR . 0.1 OUTLIER -157.09 108.72 2.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.823 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -113.41 122.36 47.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -105.39 130.89 53.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -145.61 137.29 25.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.04 156.78 26.63 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.545 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 37.4 p-90 -173.01 127.0 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.743 0.306 . . . . 0.0 110.959 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.461 ' O ' HD12 ' A' ' 132' ' ' LEU . 3.1 pp -104.33 124.97 50.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.843 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.706 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 30.7 t -99.76 150.13 22.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.991 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.465 ' CG ' HG12 ' A' ' 151' ' ' VAL . 15.1 mtm -130.56 145.32 51.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.738 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.45 ' N ' ' CD2' ' A' ' 135' ' ' TYR . 2.7 m-85 -119.12 133.62 55.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.907 0.384 . . . . 0.0 110.976 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -128.99 145.63 51.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.802 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.432 ' CD2' ' HG2' ' A' ' 110' ' ' GLN . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.781 0.325 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.444 ' HG2' ' CD2' ' A' ' 135' ' ' TYR . 5.8 tpp180 -105.12 136.42 44.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.828 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.465 HG12 ' CG ' ' A' ' 134' ' ' MET . 28.3 m -149.66 142.58 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.174 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -144.6 127.86 16.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.8 m -96.92 131.93 43.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.893 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.4 ' OE1' ' CD1' ' A' ' 172' ' ' TYR . 25.5 mp0 -124.93 120.39 31.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.977 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 14.9 p -119.19 122.92 43.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -106.3 136.7 13.44 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.3 mt -119.25 118.25 30.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.848 0.356 . . . . 0.0 110.9 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -100.0 142.61 31.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -140.82 100.2 3.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.848 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.28 113.8 14.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.931 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.73 -32.75 16.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.807 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.422 ' HB2' HG22 ' A' ' 165' ' ' VAL . 5.9 m-20 -158.06 -173.38 4.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.813 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -87.73 6.05 36.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.406 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.505 ' O ' HG22 ' A' ' 164' ' ' THR . 22.8 m -136.39 12.89 3.26 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.559 0.219 . . . . 0.0 111.324 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 164' ' ' THR . 16.6 m -158.28 155.12 4.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.852 0.358 . . . . 0.0 111.131 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.692 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -149.43 176.79 10.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.093 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.7 124.09 12.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.433 ' HD2' ' CE2' ' A' ' 196' ' ' TYR . 79.6 mtt180 -124.74 142.04 51.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.1 118.83 16.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.113 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -97.88 138.85 34.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.22 112.33 18.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.4 ' CD1' ' OE1' ' A' ' 154' ' ' GLU . 5.3 m-85 -96.33 138.02 34.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.868 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 6.5 mt -143.5 108.72 5.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.87 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.508 ' HB3' HG23 ' A' ' 190' ' ' THR . 1.6 tt0 -125.07 152.12 44.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -151.23 136.83 17.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.946 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -99.05 150.29 19.25 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.536 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 1.4 t80 . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 0.0 110.887 -179.994 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 42.9 t80 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.805 0.336 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.57 129.75 43.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.956 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.508 HG23 ' HB3' ' A' ' 174' ' ' GLU . 1.7 t -150.25 114.86 5.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.79 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -122.02 143.27 49.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.092 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -142.8 152.37 42.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.767 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.597 HD11 HD12 ' A' ' 212' ' ' ILE . 1.7 pp -137.65 134.84 46.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.937 0.398 . . . . 0.0 111.366 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -139.51 124.94 19.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.581 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.547 ' HB3' ' OG1' ' A' ' 210' ' ' THR . . . -119.41 154.43 33.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.058 0.456 . . . . 0.0 111.591 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.573 ' HB2' HG22 ' A' ' 207' ' ' THR . 1.8 p90 -155.35 138.83 15.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.318 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.476 ' O ' ' HD2' ' A' ' 208' ' ' PRO . 5.4 mp -97.94 109.37 51.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.263 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.692 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 87.1 Cg_endo -83.2 108.76 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.486 2.124 . . . . 0.0 112.358 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.29 140.75 52.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.974 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 60.3 p -131.59 128.13 38.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.9 mt -127.82 104.69 7.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 65.63 -96.37 0.25 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.584 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -127.92 31.2 5.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.802 0.334 . . . . 0.0 110.946 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -125.85 155.34 41.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.765 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.57 128.66 29.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.986 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.2 t -140.12 110.97 4.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.855 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.573 HG22 ' HB2' ' A' ' 196' ' ' TYR . 2.1 m -121.33 93.06 48.81 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.404 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 197' ' ' LEU . 33.8 Cg_exo -61.72 171.76 4.33 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.587 2.191 . . . . 0.0 111.949 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.404 ' CD2' ' HB3' ' A' ' 196' ' ' TYR . 0.3 OUTLIER -134.21 127.9 32.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.957 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.547 ' OG1' ' HB3' ' A' ' 195' ' ' ALA . 1.1 p -116.81 126.18 52.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 40.5 ttp180 -146.59 121.45 9.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.849 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.597 HD12 HD11 ' A' ' 193' ' ' ILE . 10.8 mt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.091 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 208' ' ' PRO . 0.4 OUTLIER -152.02 146.12 25.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.85 0.357 . . . . 0.0 111.054 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -109.25 148.82 30.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.732 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.85 137.4 54.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -133.49 117.18 1.84 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.284 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.406 ' HB3' ' CG2' ' A' ' 241' ' ' VAL . 0.3 OUTLIER -113.11 122.5 47.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.898 0.38 . . . . 0.0 111.033 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.44 92.59 3.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.58 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -69.12 -6.84 31.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.431 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.59 31.49 0.13 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.667 0.27 . . . . 0.0 111.117 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 1.2 m120 67.91 -66.1 0.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.037 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -50.6 -59.35 7.96 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.601 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.452 HD22 ' CE1' ' A' ' 269' ' ' TYR . 1.1 mt -69.25 142.59 54.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.69 0.281 . . . . 0.0 110.698 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.8 p -137.0 148.91 47.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.943 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.409 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 40.2 t -116.27 141.18 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.818 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 20.1 m -111.4 126.37 54.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.136 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.1 tt -149.42 124.86 10.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.741 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -105.32 150.64 25.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.059 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -155.54 149.67 25.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.166 -179.993 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.817 0.342 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -109.1 164.79 12.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.509 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 21.5 t -150.8 138.55 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.952 0.406 . . . . 0.0 111.128 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -153.0 179.03 29.76 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.501 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 6.2 m -149.99 139.45 15.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.904 0.383 . . . . 0.0 111.198 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -129.38 129.36 44.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.452 ' CE1' HD22 ' A' ' 239' ' ' LEU . 0.4 OUTLIER -125.7 123.98 40.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 37.6 p -109.2 134.86 51.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.864 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.922 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.772 0.32 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -89.79 96.99 10.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.825 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.616 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 1.5 m-70 -107.83 157.11 18.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.951 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.11 144.45 50.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.726 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -151.48 133.32 14.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.06 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 11' ' ' GLY . 3.5 mp -128.44 154.93 39.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.407 ' N ' HG22 ' A' ' 10' ' ' ILE . . . -149.9 153.4 25.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.666 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.504 ' HB3' ' CG2' ' A' ' 267' ' ' VAL . . . -129.29 154.84 46.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.825 0.345 . . . . 0.0 110.933 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.9 mtt -139.34 141.48 37.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.96 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.622 ' HB2' HG23 ' A' ' 265' ' ' VAL . 18.8 m-85 -137.83 113.59 9.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.808 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.858 -179.856 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.852 0.358 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.38 143.65 47.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.133 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -131.7 94.04 26.54 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.425 ' HB3' ' CE1' ' A' ' 14' ' ' TYR . 72.2 Cg_endo -74.84 156.68 43.73 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.555 2.17 . . . . 0.0 112.389 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 p -123.61 140.27 53.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.509 HG23 ' HB2' ' A' ' 49' ' ' TYR . 5.6 m -112.6 127.61 69.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -124.63 122.16 36.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.947 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -112.71 153.43 27.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -147.8 142.9 27.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.981 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.698 ' HB3' HG13 ' A' ' 45' ' ' ILE . . . -135.03 128.24 31.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.064 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.616 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -100.72 124.18 45.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.103 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -136.36 85.93 2.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.22 -150.43 37.08 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.527 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.05 -23.74 22.86 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.566 2.177 . . . . 0.0 112.388 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 20.6 m95 -101.54 150.21 23.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.988 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -142.34 151.76 42.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.804 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.698 HG13 ' HB3' ' A' ' 38' ' ' ALA . 18.7 pt -127.44 158.36 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.173 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.737 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -152.24 128.85 10.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.974 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 tp -120.28 129.2 53.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.929 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.88 139.75 50.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.025 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.509 ' HB2' HG23 ' A' ' 34' ' ' VAL . 2.5 m-85 -133.02 155.43 49.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -115.88 109.73 18.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.756 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.849 -179.945 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.2 t80 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.761 0.315 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.57 144.22 51.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.763 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -123.57 95.86 44.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.979 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.01 125.93 9.64 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.53 2.153 . . . . 0.0 112.178 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -127.74 118.49 23.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.057 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 mp -102.48 165.09 11.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.734 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.737 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 25.3 tt0 -160.81 138.19 9.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.126 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.3 t -123.95 115.93 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.797 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -102.03 123.97 46.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.161 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -114.15 123.08 48.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.656 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -65.52 122.9 18.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.053 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.408 ' HB2' ' N ' ' A' ' 85' ' ' PHE . 9.1 p90 -66.09 132.12 47.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.911 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 tp -161.25 140.57 10.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -176.72 -40.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.83 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -143.82 -169.29 3.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.853 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.74 -37.97 48.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.925 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -112.93 -32.24 6.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.022 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -92.43 137.49 32.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.921 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.6 m -145.26 173.2 12.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.408 ' N ' ' HB2' ' A' ' 77' ' ' PHE . 6.5 t80 -162.39 117.08 1.84 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.919 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.67 -162.3 21.35 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.548 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 tp -160.38 116.3 2.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.823 0.344 . . . . 0.0 110.968 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.1 m -111.23 107.81 17.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.827 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -102.93 176.24 24.65 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -172.23 163.15 35.32 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.571 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 92' ' ' ARG . 13.0 t80 -135.12 153.97 51.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.808 0.337 . . . . 0.0 110.862 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.425 ' N ' ' CD1' ' A' ' 91' ' ' PHE . 1.9 ttt180 -149.12 129.89 14.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -137.15 158.9 43.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -132.66 138.98 47.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.533 179.982 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.809 0.338 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -140.51 111.13 6.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 47.7 mtt -113.85 134.02 55.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.999 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.4 96.67 5.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.778 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.53 131.52 52.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.965 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -122.23 143.23 49.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.789 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -140.61 131.97 26.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.049 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.6 mp -139.34 147.0 24.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.951 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.58 85.96 5.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.237 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.14 170.49 3.89 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.613 2.209 . . . . 0.0 112.159 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.404 ' O ' ' CD2' ' A' ' 85' ' ' PHE . 7.1 m-20 -131.58 149.77 52.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.823 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -141.52 125.94 17.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.919 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -112.01 135.04 53.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.401 HG12 HD12 ' A' ' 122' ' ' LEU . 21.4 t -142.58 121.74 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.179 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.04 123.44 49.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.401 HD12 HG12 ' A' ' 120' ' ' VAL . 2.4 mp -117.76 -41.15 2.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.56 168.86 11.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.973 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.76 -41.23 96.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.923 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -113.4 36.36 3.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.3 tp -139.27 102.07 4.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.933 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -110.29 123.05 49.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -97.62 149.34 22.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -138.05 135.85 36.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.962 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -117.56 117.17 3.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.508 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -116.2 136.7 52.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 0.0 110.93 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.793 ' CD2' HG23 ' A' ' 153' ' ' THR . 0.2 OUTLIER -124.34 151.63 44.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.82 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.695 ' H ' HD13 ' A' ' 132' ' ' LEU . 0.6 OUTLIER -121.51 130.21 53.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.859 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.4 mtt -150.93 117.84 5.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.423 ' N ' ' CD2' ' A' ' 135' ' ' TYR . 4.9 m-85 -129.2 149.36 51.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -132.99 119.91 20.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.951 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 17.3 t80 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 -179.926 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.822 0.344 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -109.86 129.73 55.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.981 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 151' ' ' VAL . 12.1 p -152.0 124.3 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.056 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -142.51 155.45 45.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.793 HG23 ' CD2' ' A' ' 132' ' ' LEU . 1.3 m -117.83 130.28 56.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.849 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.0 132.28 53.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.3 m -109.28 158.42 17.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.531 ' C ' HD12 ' A' ' 157' ' ' LEU . . . -142.65 126.02 2.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.422 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.598 HD12 ' N ' ' A' ' 157' ' ' LEU . 5.1 mp -115.98 142.46 46.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.788 0.328 . . . . 0.0 110.856 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -124.98 126.76 45.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -138.49 100.15 4.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.83 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.2 p -80.84 128.2 33.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.955 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -104.06 -31.94 9.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.659 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -154.91 165.54 36.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.62 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -69.0 -12.18 61.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.342 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.0 p -113.43 -17.9 12.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.588 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.891 HG12 HD23 ' A' ' 199' ' ' LEU . 28.7 m -139.35 147.86 24.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.922 0.391 . . . . 0.0 111.466 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.659 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -146.91 179.92 7.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.119 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.1 tp -135.53 138.02 42.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.959 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.434 ' HB3' ' CE2' ' A' ' 196' ' ' TYR . 2.3 ttp180 -144.08 149.45 36.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.071 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.3 m -147.24 139.84 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.992 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.79 161.34 19.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.981 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.01 151.89 43.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.737 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -127.41 128.36 45.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.046 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.91 105.21 5.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.729 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -89.63 156.05 18.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.412 ' CB ' HG13 ' A' ' 151' ' ' VAL . 15.2 mtp180 -150.42 120.92 7.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.799 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -140.38 154.95 24.4 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.509 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 53.2 t80 . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 120.759 0.314 . . . . 0.0 110.919 -179.987 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.749 0.309 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 72.8 p -131.58 130.9 42.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.004 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.92 162.96 13.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.728 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -132.02 122.11 24.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.17 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -140.59 155.59 46.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.637 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 11.8 tt -142.08 141.53 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.971 0.415 . . . . 0.0 111.368 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -128.75 155.36 45.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.436 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.1 130.7 14.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.994 0.426 . . . . 0.0 111.499 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.446 ' HB3' ' CG ' ' A' ' 209' ' ' TYR . 3.0 p90 -140.15 168.58 19.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.339 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.625 ' O ' HD12 ' A' ' 199' ' ' LEU . 0.1 OUTLIER -120.02 109.4 37.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.325 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.659 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 91.5 Cg_endo -80.33 120.68 4.11 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.382 2.055 . . . . 0.0 112.418 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.891 HD23 HG12 ' A' ' 165' ' ' VAL . 5.3 mp -125.79 134.42 51.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.955 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.05 103.94 6.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.904 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 5.7 tt -119.39 96.56 5.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.991 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 56.35 -116.02 6.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.521 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -99.03 29.78 3.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.855 0.36 . . . . 0.0 110.913 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.85 121.99 22.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.766 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.81 128.49 50.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.072 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.3 m -144.27 129.73 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.606 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 57.1 m -138.67 93.17 11.04 Favored Pre-proline 0 C--N 1.327 -0.386 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.681 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . 0.758 ' HB3' HD23 ' A' ' 229' ' ' LEU . 58.6 Cg_endo -71.82 137.98 30.71 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.308 2.006 . . . . 0.0 112.001 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.446 ' CG ' ' HB3' ' A' ' 196' ' ' TYR . 6.7 m-85 -111.04 136.46 50.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.808 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 35.8 p -127.14 143.32 51.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.865 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.93 143.19 27.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 1.6 pt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.576 ' CA ' ' HB2' ' A' ' 246' ' ' ALA . . . . . . . . 0 N--CA 1.45 -0.373 0 N-CA-C 112.613 -0.195 . . . . 0.0 112.613 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.758 HD23 ' HB3' ' A' ' 208' ' ' PRO . 1.9 mt -116.71 121.41 41.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.769 0.319 . . . . 0.0 110.941 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -93.78 123.63 37.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 242' ' ' SER . 6.2 m-85 -112.74 155.45 24.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -168.76 117.01 0.69 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.982 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.434 ' CZ ' ' HB ' ' A' ' 241' ' ' VAL . 39.1 p90 -148.03 144.76 28.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.87 0.367 . . . . 0.0 111.246 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -103.56 131.15 50.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.822 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -69.83 -12.8 61.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.358 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -176.09 47.43 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.918 0.389 . . . . 0.0 111.033 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.55 25.96 10.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.985 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -139.51 -71.3 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.377 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 239' ' ' LEU . 8.6 mp -83.39 107.37 15.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.72 0.295 . . . . 0.0 110.833 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 4.8 m -92.59 153.13 19.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.983 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.434 ' HB ' ' CZ ' ' A' ' 233' ' ' TYR . 29.9 t -131.9 122.64 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.77 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 231' ' ' TYR . 1.5 m -107.77 151.17 26.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.231 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.25 131.14 17.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.875 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -117.85 124.24 47.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.849 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -147.25 146.88 29.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . 0.576 ' HB2' ' CA ' ' A' ' 228' ' ' GLY . . . . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.051 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.787 0.327 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -84.57 150.85 25.98 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.484 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.622 HG23 ' HB2' ' A' ' 14' ' ' TYR . 14.3 m -136.84 135.74 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.807 0.336 . . . . 0.0 111.193 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -146.98 163.53 28.62 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.425 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.504 ' CG2' ' HB3' ' A' ' 12' ' ' ALA . 6.1 m -142.7 148.94 19.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.0 111.137 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -131.94 142.57 49.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.787 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . 0.425 ' CD1' ' HG ' ' A' ' 239' ' ' LEU . 4.8 m-85 -130.65 105.56 7.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 7.1 m -100.88 124.11 46.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 9.3 t80 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.859 179.95 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.875 0.369 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.94 116.1 6.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.882 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.836 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 21.0 m-70 -134.25 141.73 47.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -119.8 166.42 13.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -165.11 128.03 2.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 10' ' ' ILE . 6.8 tt -129.69 122.87 55.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.139 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.59 155.68 22.72 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.437 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -127.88 163.88 23.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.748 0.308 . . . . 0.0 111.179 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.98 140.02 29.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.886 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.585 ' HB2' HG23 ' A' ' 265' ' ' VAL . 34.4 m-85 -142.68 110.43 5.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 -179.942 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.881 0.372 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -131.99 146.63 52.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.059 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -107.59 93.98 11.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.948 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.53 134.82 15.71 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.527 2.152 . . . . 0.0 112.321 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.34 146.06 25.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.887 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.66 HG23 ' HB2' ' A' ' 49' ' ' TYR . 26.0 m -145.13 162.6 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.041 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -146.23 139.53 25.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.956 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -116.37 164.21 14.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.823 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.66 141.86 22.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.961 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' A' ' 45' ' ' ILE . . . -145.84 131.51 18.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.04 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.836 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -115.23 121.53 43.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.106 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.02 71.59 1.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.758 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.54 -143.43 46.98 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.356 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.55 -26.36 16.53 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.554 2.169 . . . . 0.0 112.355 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -100.93 127.27 47.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.975 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -109.54 157.16 19.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.431 ' HB ' ' HB3' ' A' ' 38' ' ' ALA . 2.6 mp -133.81 141.27 44.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.222 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -134.91 138.5 44.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.023 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.62 165.1 20.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.982 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -156.16 149.57 24.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.006 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.66 ' HB2' HG23 ' A' ' 34' ' ' VAL . 1.0 OUTLIER -137.08 155.98 48.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -153.52 114.99 4.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.787 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.998 -179.97 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.2 p90 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.791 0.329 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.8 137.31 39.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.01 95.95 40.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.956 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.54 155.6 54.73 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.506 2.137 . . . . 0.0 112.29 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -136.57 125.63 24.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.8 mt -115.18 141.0 48.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.902 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -149.34 146.65 27.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.791 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.7 m -126.09 150.19 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.217 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.454 ' CD2' HG23 ' A' ' 88' ' ' THR . 0.0 OUTLIER -129.24 143.73 50.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.796 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -141.76 144.0 33.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.69 117.53 25.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.944 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -87.4 -57.82 2.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 61.19 155.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -154.42 -46.79 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -158.62 179.69 8.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.761 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -74.36 -31.47 62.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.827 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -69.57 -72.44 0.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -96.88 161.58 13.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.957 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.32 173.15 11.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.801 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -162.27 152.67 16.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.916 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.77 -177.31 35.67 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.526 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.56 138.56 26.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 110.984 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.454 HG23 ' CD2' ' A' ' 74' ' ' HIS . 44.0 m -138.66 124.96 20.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -121.09 174.02 15.71 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.481 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.68 148.82 12.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.429 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -142.23 129.47 21.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.837 0.351 . . . . 0.0 110.895 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -109.76 145.38 36.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -164.28 125.57 2.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.871 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -132.77 122.13 24.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.934 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.563 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 -0.068 0 CA-C-O 120.926 0.394 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -130.7 107.86 9.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -146.09 160.08 42.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -143.77 110.46 5.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.938 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -110.6 111.86 23.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 44.5 t-105 -107.92 142.97 37.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.853 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -138.27 137.5 37.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.11 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.1 tp -152.78 133.18 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.74 ' HB2' ' HA ' ' A' ' 133' ' ' SER . . . -154.29 113.05 2.46 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.224 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.8 154.57 53.9 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.428 2.086 . . . . 0.0 112.24 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -106.11 134.95 48.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.947 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -134.59 127.21 30.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.12 138.18 53.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.766 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.49 HG23 ' HB3' ' A' ' 128' ' ' PHE . 12.2 m -147.98 121.23 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.5 140.95 29.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.835 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.8 mt -119.88 -77.1 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.34 -172.82 3.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.875 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.573 ' CB ' HD23 ' A' ' 126' ' ' LEU . 0.5 OUTLIER 60.46 23.2 12.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.161 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.7 t70 57.01 31.27 19.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.182 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.573 HD23 ' CB ' ' A' ' 124' ' ' ASP . 1.6 pp -122.22 136.12 54.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.921 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 -102.76 132.91 48.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.918 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.1 OUTLIER -84.87 125.34 32.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.413 ' HB3' ' CZ3' ' A' ' 131' ' ' TRP . 2.9 m-80 -113.8 155.66 25.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.977 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.28 135.88 2.8 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.443 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . 0.425 ' CD1' ' HB2' ' A' ' 154' ' ' GLU . 17.4 p90 -162.76 131.98 4.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.779 0.323 . . . . 0.0 110.912 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 132' ' ' LEU . 4.1 pp -100.44 136.01 40.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.74 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 17.3 t -103.9 152.22 22.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.07 122.85 26.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -104.16 141.24 36.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.908 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -133.3 110.43 10.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.888 -179.941 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 37.4 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.832 0.349 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 25.9 mtp180 -133.09 123.48 25.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.36 115.27 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.094 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -114.94 151.4 34.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 33.1 m -128.58 128.31 43.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.818 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.425 ' HB2' ' CD1' ' A' ' 131' ' ' TRP . 0.8 OUTLIER -122.36 145.21 48.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.004 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.57 138.38 25.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.769 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -137.57 171.69 23.11 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.48 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.456 HD21 HD13 ' A' ' 126' ' ' LEU . 1.0 OUTLIER -141.44 117.37 10.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.803 0.335 . . . . 0.0 110.854 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -92.75 121.8 34.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.937 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -126.83 104.09 7.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.73 125.59 51.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.95 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -102.79 -31.22 10.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.795 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.32 -178.12 7.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.703 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -87.43 6.15 35.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.4 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 51.5 p -115.73 -32.25 5.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.648 0.261 . . . . 0.0 111.162 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.588 HG13 ' CD1' ' A' ' 199' ' ' LEU . 21.7 t -132.2 136.06 57.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.311 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.89 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -139.16 179.24 6.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.002 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.62 HD21 HD23 ' A' ' 197' ' ' LEU . 0.5 OUTLIER -135.42 141.33 45.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.011 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.31 107.51 4.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.837 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.5 m -106.21 155.0 7.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.07 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -135.72 156.05 49.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.993 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.01 106.47 5.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.821 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -90.06 134.78 34.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.926 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 8.2 tt -153.65 105.24 2.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.772 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -104.22 166.09 10.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.998 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -145.92 151.31 37.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.769 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -139.19 151.98 22.1 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.492 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 110.876 179.996 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.879 0.371 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.3 111.37 6.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.882 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.69 155.57 29.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.802 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -148.84 142.15 25.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.956 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -143.0 144.13 32.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.768 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 27.3 mt -105.65 138.37 31.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.263 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.08 109.69 4.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.766 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 210' ' ' THR . . . -106.53 136.96 45.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.255 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' TYR . . . . . 0.427 ' CD2' ' HB3' ' A' ' 209' ' ' TYR . 28.0 m-85 -140.47 123.3 16.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.615 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 197' ' ' LEU . 2.3 mp -111.02 109.64 57.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.055 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.89 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 96.5 Cg_endo -79.48 120.64 4.47 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.491 2.128 . . . . 0.0 112.308 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.588 ' CD1' HG13 ' A' ' 165' ' ' VAL . 0.1 OUTLIER -127.46 115.24 18.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.836 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.4 m -134.37 118.39 17.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.959 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.632 ' N ' HD23 ' A' ' 201' ' ' LEU . 0.5 OUTLIER -137.64 104.44 5.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 84.85 -117.3 4.47 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.513 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -116.76 30.72 7.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.849 0.357 . . . . 0.0 110.926 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -134.87 117.99 16.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.1 m -104.44 130.23 52.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.974 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.26 124.07 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.779 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.531 HG23 ' C ' ' A' ' 197' ' ' LEU . 41.9 m -138.78 92.8 11.07 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.477 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.16 143.39 11.31 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.612 2.208 . . . . 0.0 112.185 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.427 ' HB3' ' CD2' ' A' ' 196' ' ' TYR . 15.1 p90 -111.23 142.38 43.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.983 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.678 ' O ' ' HB3' ' A' ' 195' ' ' ALA . 11.6 p -131.58 142.29 49.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -145.06 124.0 12.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.885 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.1 tt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.094 -179.952 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.424 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.653 -0.179 . . . . 0.0 112.653 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.94 119.85 13.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.709 0.29 . . . . 0.0 111.072 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.89 145.55 25.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.869 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -126.74 148.55 49.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.125 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -137.79 117.08 1.42 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.292 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' TYR . . . . . 0.402 ' HB2' ' CG2' ' A' ' 241' ' ' VAL . 4.5 m-85 -102.7 118.09 36.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 111.192 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -123.53 90.49 3.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.417 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -56.83 -17.33 8.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.384 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -176.38 46.23 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.846 0.355 . . . . 0.0 111.172 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.93 23.71 5.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.219 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -122.22 -72.26 0.28 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.248 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.78 107.44 11.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.736 0.303 . . . . 0.0 110.625 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.22 134.13 42.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.948 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.493 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 26.0 t -112.89 148.34 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.689 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 4.7 m -119.21 126.04 50.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.937 0.399 . . . . 0.0 111.052 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 9.4 tt -143.86 123.6 13.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.782 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -105.25 157.53 17.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.973 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.36 147.62 41.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.836 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.117 -179.974 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.831 0.348 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -126.75 156.91 20.29 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.482 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' ' 14' ' ' TYR . 4.9 m -141.24 152.93 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.914 0.388 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -163.83 173.2 39.86 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.49 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 21.4 t -145.26 152.82 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.776 0.322 . . . . 0.0 111.185 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -142.33 125.37 16.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -127.34 120.81 29.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.923 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.2 p -90.81 141.06 29.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.827 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.794 0.331 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -95.58 91.07 5.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.923 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.79 146.42 53.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.953 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -110.06 126.75 54.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.82 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -165.72 -60.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.902 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 60.85 103.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.96 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.642 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 21.5 t60 -148.93 136.8 20.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.854 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -116.07 152.12 34.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.952 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -143.1 117.52 9.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.757 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.608 HG22 ' HD2' ' A' ' 36' ' ' PHE . 1.2 pp -128.39 132.29 68.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.01 170.65 27.14 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.467 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.661 ' HB3' HG22 ' A' ' 267' ' ' VAL . . . -137.47 177.13 8.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.827 0.346 . . . . 0.0 111.031 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.8 tpp -159.25 137.22 10.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.974 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -147.15 161.78 40.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.885 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.03 110.6 13.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.8 mt 67.01 -71.35 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.288 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 57.18 168.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.894 0.378 . . . . 0.0 110.891 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -74.77 76.28 2.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -142.15 -60.27 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.64 117.14 25.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.865 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -165.09 160.34 33.63 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.509 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -141.21 105.14 4.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.818 0.342 . . . . 0.0 110.925 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 172.64 138.61 2.63 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.571 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -121.07 31.64 6.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.804 0.335 . . . . 0.0 110.868 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.94 34.15 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.825 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -175.04 155.23 1.95 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.821 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.37 160.01 40.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.921 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -118.42 -168.81 14.39 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.518 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.7 mp -122.47 133.8 54.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.886 0.374 . . . . 0.0 110.973 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.85 131.41 55.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.064 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -115.31 94.0 37.85 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.982 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.51 128.44 12.71 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.527 2.151 . . . . 0.0 112.34 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.6 m -122.39 150.35 42.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.875 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 35' ' ' TYR . 21.5 t -123.01 158.79 27.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.063 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.476 ' N ' HG12 ' A' ' 34' ' ' VAL . 47.4 m-85 -143.02 133.8 25.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.013 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.608 ' HD2' HG22 ' A' ' 10' ' ' ILE . 41.6 m-85 -132.34 116.06 16.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.551 ' OD1' ' HB2' ' A' ' 46' ' ' ALA . 1.7 m-80 -118.55 133.27 55.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.924 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.24 123.8 44.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 7' ' ' HIS . . . -107.49 116.31 31.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -136.72 83.52 2.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.803 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.63 -137.34 36.89 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.364 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.45 -21.37 46.83 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.408 2.072 . . . . 0.0 112.312 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.3 m95 -94.82 115.21 27.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.884 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -117.36 116.32 26.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.858 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mp -95.33 142.77 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.171 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.551 ' HB2' ' OD1' ' A' ' 37' ' ' ASN . . . -145.36 126.9 15.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.051 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.614 ' HB3' HD23 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -139.66 153.61 47.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.958 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -142.56 141.36 32.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.964 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -119.95 152.12 37.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.975 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -116.77 165.76 12.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.853 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -167.33 167.4 14.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -145.3 128.51 16.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -136.3 57.01 0.68 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.473 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.35 175.92 8.69 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.647 2.231 . . . . 0.0 112.286 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.8 t -85.05 122.24 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.027 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -75.07 149.82 39.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.947 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -161.24 30.0 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.94 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m 58.91 76.78 0.33 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.95 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.41 -70.85 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.148 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.65 -101.19 2.2 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.514 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -117.51 -68.03 0.95 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.773 0.32 . . . . 0.0 110.884 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -119.6 165.34 14.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -104.83 106.17 2.66 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.488 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 64' ' ' THR . 9.8 t -95.79 115.88 28.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.801 0.334 . . . . 0.0 111.011 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -94.49 161.63 14.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.829 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -150.36 136.94 18.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.976 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.24 164.8 14.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.834 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -136.82 95.81 12.1 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.67 130.53 17.17 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.541 2.161 . . . . 0.0 112.263 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -128.67 132.23 48.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.614 HD23 ' HB3' ' A' ' 47' ' ' LEU . 35.8 mt -127.76 167.05 17.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.784 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 46' ' ' ALA . 17.9 mt-10 -159.29 151.28 20.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.033 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.01 111.37 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.025 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -98.81 132.7 43.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.851 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -135.47 135.84 40.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.795 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -103.12 121.08 41.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -98.8 -50.39 4.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.17 162.66 0.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.806 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -160.85 -58.86 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.841 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.8 164.91 27.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -63.36 -36.49 83.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.959 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.73 -59.88 2.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.979 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.889 ' CE1' HG13 ' A' ' 120' ' ' VAL . 5.3 m-85 -100.72 128.62 46.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.4 m -109.81 170.02 8.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.873 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.54 156.73 46.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -170.03 168.83 41.73 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.551 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 tp -138.53 125.04 20.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.832 0.349 . . . . 0.0 110.836 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.62 146.57 43.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.63 174.49 21.28 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.535 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.74 150.63 17.88 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.496 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -133.34 116.19 15.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.876 0.369 . . . . 0.0 110.862 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.64 135.58 54.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -149.91 133.49 16.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -126.61 133.27 51.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.003 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -94.32 143.3 16.48 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.429 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.62 127.0 54.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.893 0.378 . . . . 0.0 110.836 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -123.67 124.33 42.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.969 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -123.32 94.74 4.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.854 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 99' ' ' VAL . 14.8 p -98.54 35.01 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.045 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -107.4 -31.56 8.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.866 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -153.41 87.66 3.82 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -51.07 155.38 6.22 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.603 2.202 . . . . 0.0 112.337 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 143.61 46.02 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.477 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.2 mttp 60.7 30.98 20.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.891 0.377 . . . . 0.0 110.905 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -81.14 85.23 6.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.1 m -153.42 140.05 18.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.92 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -111.48 173.79 6.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.021 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -147.04 118.07 7.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.922 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -147.72 150.55 34.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.818 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.757 ' H ' ' HB2' ' A' ' 138' ' ' ALA . 5.0 mt-30 -132.37 177.36 7.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.029 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.8 mtp85 -148.64 114.92 5.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.893 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.409 ' HB2' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -95.35 130.09 42.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.776 0.322 . . . . 0.0 110.474 179.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.5 tttt -104.03 126.72 51.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.011 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.6 mp -140.8 104.41 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.949 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.62 ' HB2' ' HA ' ' A' ' 133' ' ' SER . . . -142.88 100.78 5.42 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.182 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.3 161.2 46.83 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.35 2.033 . . . . 0.0 112.155 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.07 134.79 48.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.98 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -129.05 134.55 48.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.736 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.16 141.51 51.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.959 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.889 HG13 ' CE1' ' A' ' 83' ' ' PHE . 21.6 t -143.44 113.16 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -97.0 110.78 23.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 tp -95.0 -31.94 13.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.8 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 124' ' ' ASP . 0.3 OUTLIER -153.5 176.01 12.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.722 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.498 ' H ' HG22 ' A' ' 123' ' ' THR . 0.7 OUTLIER -72.77 -19.86 61.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.18 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.627 ' O ' HD23 ' A' ' 126' ' ' LEU . 0.3 OUTLIER -119.52 30.2 7.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.748 0.308 . . . . 0.0 111.136 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.627 HD23 ' O ' ' A' ' 125' ' ' ASP . 60.0 mt -149.55 109.22 4.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.899 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.515 ' O ' HD23 ' A' ' 157' ' ' LEU . 5.7 mtt180 -114.72 119.31 36.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.887 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.843 ' CE2' HD11 ' A' ' 157' ' ' LEU . 55.0 m-85 -103.03 148.4 25.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.983 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -158.48 140.58 14.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 155' ' ' THR . . . -151.05 147.87 18.34 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.587 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 42.2 p90 -159.87 134.43 7.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.734 0.302 . . . . 0.0 110.903 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.3 mp -102.81 126.22 49.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.99 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.62 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 88.4 p -92.83 114.54 27.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.969 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.774 ' HG3' HG12 ' A' ' 151' ' ' VAL . 9.8 ttm -106.94 141.36 38.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.848 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -129.06 115.75 18.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.98 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.5 ' HE3' HG22 ' A' ' 149' ' ' THR . 13.1 mttp -149.21 132.51 16.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.835 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 110' ' ' GLN . 0.2 OUTLIER 177.63 -69.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.848 0.356 . . . . 0.0 111.104 179.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.757 ' HB2' ' H ' ' A' ' 110' ' ' GLN . . . -87.77 163.95 16.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.334 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -96.11 -29.08 14.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.78 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.419 ' O ' ' HB ' ' A' ' 144' ' ' THR . 7.1 m-20 61.27 81.31 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.442 ' O ' HG22 ' A' ' 144' ' ' THR . 8.7 mp -70.79 -34.85 72.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -96.08 -38.2 10.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.364 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 143' ' ' THR . 36.4 m -77.62 -3.54 41.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.774 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 141' ' ' LEU . 2.6 t -56.51 -23.73 41.59 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.818 0.342 . . . . 0.0 111.171 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -55.54 -25.72 43.27 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.829 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.14 -79.87 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.669 0.271 . . . . 0.0 111.041 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -148.99 -177.85 6.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.195 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.401 ' CB ' ' HB2' ' A' ' 140' ' ' ASP . 7.5 p-10 -177.83 -46.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.041 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.5 HG22 ' HE3' ' A' ' 136' ' ' LYS . 11.3 m -133.31 111.44 10.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.877 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? -163.07 166.35 23.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.093 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.774 HG12 ' HG3' ' A' ' 134' ' ' MET . 30.1 m -107.99 141.64 22.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -119.66 158.72 25.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.727 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 26.5 m -132.05 120.44 22.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.064 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -134.79 107.21 7.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.723 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' ' 171' ' ' TYR . 6.1 t -92.37 168.69 11.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -158.25 120.66 0.99 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.556 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.843 HD11 ' CE2' ' A' ' 128' ' ' PHE . 0.2 OUTLIER -113.27 152.64 29.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.776 0.322 . . . . 0.0 110.867 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -128.84 123.81 33.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.065 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.442 ' CZ ' HD22 ' A' ' 157' ' ' LEU . 24.8 m-85 -120.53 117.32 27.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.86 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.9 118.81 19.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.928 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.66 -63.59 1.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.917 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -125.79 176.06 7.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.885 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -64.89 -30.68 71.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.004 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 43.0 p -120.21 27.25 8.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.044 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 23.0 t -153.72 125.21 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.038 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.817 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -126.8 169.63 13.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.276 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.561 HD12 ' HB3' ' A' ' 197' ' ' LEU . 0.4 OUTLIER -135.19 145.16 47.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.795 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -139.04 136.12 34.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.022 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 170' ' ' ASN . 29.5 t -119.0 158.98 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.981 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.49 ' N ' HG12 ' A' ' 169' ' ' VAL . 0.8 OUTLIER -153.53 133.12 12.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.026 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.544 ' HE2' HD21 ' A' ' 173' ' ' LEU . 23.5 t80 -116.36 111.2 19.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.709 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -89.87 135.64 33.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.086 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.544 HD21 ' HE2' ' A' ' 171' ' ' TYR . 22.8 mt -132.13 113.16 12.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.718 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -89.05 148.95 23.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.909 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.29 148.41 36.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.901 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -149.84 144.59 12.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.568 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.407 ' CD2' ' O ' ' A' ' 178' ' ' ASN . 54.0 t80 -172.38 149.46 2.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 0.0 110.874 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . 0.407 ' O ' ' CD2' ' A' ' 177' ' ' PHE . 34.8 m120 -87.48 161.76 17.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.003 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.22 -35.71 76.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -175.36 103.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.9 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -151.11 135.52 16.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.905 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.96 94.56 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.865 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.76 160.63 39.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.852 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -113.51 -35.85 5.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -137.37 30.61 2.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.924 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -68.83 -28.1 73.34 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.468 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.19 136.5 55.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.79 0.329 . . . . 0.0 110.947 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -105.13 137.13 43.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.2 m -132.42 100.14 4.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 2.4 m -106.65 150.51 26.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.9 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -130.42 132.14 45.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -135.61 120.99 19.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.754 HD12 HD11 ' A' ' 212' ' ' ILE . 24.8 mt -91.41 128.7 42.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.218 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.38 125.21 14.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.645 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -135.63 154.55 51.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.968 0.413 . . . . 0.0 111.533 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -143.16 148.5 36.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.342 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.561 ' HB3' HD12 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -114.04 109.46 49.58 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.272 -179.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.817 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 70.0 Cg_endo -74.43 121.68 6.95 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.393 2.062 . . . . 0.0 112.312 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.65 105.87 13.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.866 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 7.0 p -99.25 116.29 31.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.24 103.7 3.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.942 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 59.17 -132.18 52.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.534 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -98.58 30.84 3.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.783 0.325 . . . . 0.0 110.901 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . 0.606 ' CD2' HG13 ' A' ' 206' ' ' VAL . 6.5 t60 -129.96 116.83 19.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.699 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.71 123.95 49.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.983 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.606 HG13 ' CD2' ' A' ' 204' ' ' HIS . 15.8 m -141.76 109.71 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.828 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.507 HG23 ' C ' ' A' ' 197' ' ' LEU . 18.6 m -117.49 92.66 41.26 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.305 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' A' ' 197' ' ' LEU . 23.1 Cg_exo -64.79 147.77 89.77 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.512 2.142 . . . . 0.0 111.933 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -111.18 134.7 52.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.852 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.3 p -107.5 138.24 44.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.949 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.2 118.13 8.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.754 HD11 HD12 ' A' ' 193' ' ' ILE . 2.1 pt -76.91 162.32 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.106 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -151.8 -172.42 20.54 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.555 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 7.6 tp 60.92 37.7 18.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.828 0.347 . . . . 0.0 110.884 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -140.38 26.0 2.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.075 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 18.0 t-105 -177.17 165.88 2.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.849 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 66.62 145.57 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.989 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -65.71 -65.32 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.997 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -72.16 -165.93 8.28 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.573 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -92.69 152.85 19.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.808 0.337 . . . . 0.0 110.856 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -159.44 -57.45 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.505 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -91.1 150.04 21.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.774 0.321 . . . . 0.0 110.888 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -162.53 151.36 14.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.931 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 60.95 168.25 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -92.62 -67.82 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.892 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.74 102.47 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 12.6 m -113.55 -31.82 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.291 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -111.42 167.96 12.65 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.541 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.671 HD13 ' N ' ' A' ' 230' ' ' PHE . 0.5 OUTLIER -154.92 127.35 7.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 0.0 110.882 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.671 ' N ' HD13 ' A' ' 229' ' ' LEU . 1.7 t80 -111.13 118.74 36.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.843 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -100.83 160.63 14.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.936 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -164.34 117.02 0.73 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.157 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -133.66 124.25 26.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.813 0.34 . . . . 0.0 110.891 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -123.38 101.37 7.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.793 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -75.98 -1.39 25.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.23 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -149.35 26.23 0.86 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.72 0.295 . . . . 0.0 111.106 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 2.2 m120 64.74 -75.9 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.137 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -52.93 -50.04 52.41 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.727 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.99 122.63 32.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.754 0.311 . . . . 0.0 110.88 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 4.0 t -135.39 174.93 10.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.969 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 241' ' ' VAL . 27.6 m -137.32 122.61 25.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.815 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 5.0 m -107.77 139.57 42.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.121 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.631 HD11 HG13 ' A' ' 265' ' ' VAL . 1.4 mp -132.22 129.59 39.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.781 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.26 121.08 43.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 263' ' ' ALA . 0.1 OUTLIER -123.87 136.05 54.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.781 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -124.27 174.15 7.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.1 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -158.36 31.55 0.24 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.813 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -94.1 173.35 7.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.88 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER 59.98 162.19 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.926 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -101.34 142.17 33.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.854 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.11 83.48 1.99 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.853 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -131.25 79.44 1.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -162.82 167.3 23.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -137.8 150.81 47.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.898 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -158.59 -160.13 10.11 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.544 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -173.14 36.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.35 . . . . 0.0 110.876 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.1 m -166.08 -44.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.82 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -108.19 139.7 42.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -167.72 129.35 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.899 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -136.32 121.31 18.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.908 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.98 -173.54 2.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -122.71 31.14 6.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.406 ' HB2' ' CE2' ' A' ' 245' ' ' TYR . . . -125.73 167.16 15.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.082 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -156.2 152.07 23.51 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.546 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.631 HG13 HD11 ' A' ' 243' ' ' LEU . 17.8 t -135.54 143.52 36.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.808 0.337 . . . . 0.0 111.123 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -154.99 167.18 32.71 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.494 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.661 HG22 ' HB3' ' A' ' 12' ' ' ALA . 31.5 m -124.98 160.42 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 0.0 111.09 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -147.4 139.78 24.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -144.66 156.87 44.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.876 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 53.2 p -134.48 140.66 46.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.855 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.822 0.344 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.53 -60.99 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.87 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -154.87 -53.75 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 60.87 159.88 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -170.4 -60.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.773 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -172.0 159.66 5.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -148.88 109.37 4.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.898 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -97.18 136.39 37.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -147.18 121.74 9.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.919 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.572 HG22 ' HD2' ' A' ' 36' ' ' PHE . 2.1 pp -126.19 129.57 72.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.1 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.96 172.19 22.73 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.543 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -162.29 142.85 10.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.841 0.353 . . . . 0.0 111.087 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.7 ttm -116.9 158.13 24.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -144.88 130.66 19.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.919 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -93.16 133.66 36.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.95 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 pp -118.61 148.98 21.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.132 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.37 -55.59 2.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.904 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -166.04 133.17 2.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.928 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.1 p -109.47 136.35 45.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.147 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 60.51 100.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.851 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 147.89 -150.57 22.8 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.537 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -99.98 106.0 17.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.813 0.339 . . . . 0.0 110.899 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -126.5 -41.8 0.31 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.499 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -74.21 94.18 2.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.349 . . . . 0.0 110.915 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -153.21 -63.22 0.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -105.65 -54.22 2.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -148.77 125.92 11.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.06 33.97 0.86 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.609 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.4 mp -82.33 157.56 23.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.864 0.364 . . . . 0.0 110.871 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.9 128.2 32.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.146 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.62 94.15 48.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.72 178.8 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.503 2.135 . . . . 0.0 112.236 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.64 128.53 8.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.577 HG11 ' CZ ' ' A' ' 36' ' ' PHE . 16.4 t -108.72 159.31 8.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.185 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.468 ' N ' HG12 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -148.83 127.89 12.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.577 ' CZ ' HG11 ' A' ' 34' ' ' VAL . 51.2 m-85 -121.49 147.41 45.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -146.36 143.22 28.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.89 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.11 134.74 23.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.975 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.597 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -109.66 147.52 32.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.109 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -174.19 120.52 0.27 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.881 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 62.37 -149.42 48.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.496 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.426 ' HG2' ' CE3' ' A' ' 43' ' ' TRP . 92.1 Cg_endo -78.93 0.99 9.54 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.656 2.237 . . . . 0.0 112.87 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.426 ' CE3' ' HG2' ' A' ' 42' ' ' PRO . 14.7 p90 -127.48 170.36 12.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.81 0.338 . . . . 0.0 111.045 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -141.08 154.07 45.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.5 mt -121.0 127.26 75.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.063 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -122.14 148.31 45.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.067 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.6 tp -139.52 164.33 30.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.009 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.568 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -147.82 147.95 30.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.062 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -128.26 153.16 47.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -116.51 151.14 36.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -134.91 126.79 29.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -124.45 126.85 46.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -141.95 91.81 0.18 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.541 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.97 138.13 39.56 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.616 2.21 . . . . 0.0 112.401 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.5 p -63.69 139.26 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.104 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -59.6 174.75 0.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -173.79 -41.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.883 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.52 -59.05 0.77 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -147.23 118.09 7.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.12 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -130.15 36.66 2.28 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.543 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.28 -31.35 21.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 0.0 110.866 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.8 mmt-85 -120.88 -172.54 2.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 120.36 117.85 2.61 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.499 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 m -92.11 119.12 31.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.743 0.306 . . . . 0.0 110.945 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -95.33 155.4 16.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -99.62 170.56 8.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.777 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.76 165.99 24.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.86 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.75 95.96 6.23 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.22 135.86 35.64 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.405 2.07 . . . . 0.0 112.259 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -115.58 129.63 56.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.6 mt -116.37 143.05 46.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 3.4 mm-40 -146.51 136.23 23.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.7 t -116.26 149.71 18.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.066 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -131.96 139.11 48.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -153.93 145.02 22.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.881 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.525 HE21 HD11 ' A' ' 78' ' ' LEU . 9.4 pt20 -125.6 111.07 14.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.933 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -67.91 -56.36 9.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.81 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.525 HD11 HE21 ' A' ' 76' ' ' GLN . 87.3 mt 58.65 98.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.956 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -80.82 -62.88 1.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -126.86 -179.11 4.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -71.75 -30.57 65.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -80.26 -49.87 11.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.841 ' CE2' HG13 ' A' ' 120' ' ' VAL . 5.5 m-85 -92.61 167.89 11.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.968 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.7 t -156.88 162.81 39.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.947 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.496 ' CZ ' ' CD1' ' A' ' 118' ' ' TRP . 0.3 OUTLIER -127.73 177.36 6.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.831 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.405 ' O ' HD22 ' A' ' 87' ' ' LEU . . . -172.48 116.35 0.61 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.443 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.868 HD12 HD11 ' A' ' 114' ' ' ILE . 2.3 mm? -123.02 119.34 30.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.371 . . . . 0.0 110.991 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.9 t -125.33 104.81 8.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.745 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -128.28 144.31 15.14 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.488 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -141.37 178.63 20.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.542 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -127.54 118.74 24.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.824 0.345 . . . . 0.0 110.839 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.2 tpt85 -100.77 139.34 36.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.8 p30 -167.35 166.37 14.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -142.62 128.78 19.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.859 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 175.49 175.85 43.26 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.03 143.16 26.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.825 0.345 . . . . 0.0 110.889 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -158.32 94.19 1.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.913 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.25 167.0 10.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.3 t -127.7 -50.77 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.08 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -69.33 -30.47 68.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.936 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -148.16 104.03 3.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -68.15 142.8 57.04 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.443 2.095 . . . . 0.0 112.281 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -99.36 -110.22 3.08 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.52 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -176.38 -39.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.798 0.333 . . . . 0.0 110.938 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -57.59 123.32 15.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.973 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.5 m -127.79 157.24 40.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.942 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.63 170.36 15.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.065 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -141.13 104.34 4.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.877 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 56.1 tpp -154.11 143.34 21.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.929 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -138.62 103.93 4.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.8 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -111.91 111.43 22.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.986 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -91.35 130.85 37.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.849 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.3 tttp -130.84 120.24 23.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.052 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.868 HD11 HD12 ' A' ' 87' ' ' LEU . 9.0 tp -146.44 115.55 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.863 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -128.79 93.22 37.92 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.334 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.02 178.03 7.81 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.579 2.186 . . . . 0.0 112.223 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -159.52 134.9 8.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.935 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.496 ' CD1' ' CZ ' ' A' ' 85' ' ' PHE . 0.9 OUTLIER -112.25 126.66 55.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.811 179.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.02 113.22 26.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.027 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.841 HG13 ' CE2' ' A' ' 83' ' ' PHE . 25.6 t -119.88 102.11 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.015 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.36 142.45 39.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.014 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.776 ' HB3' HD22 ' A' ' 126' ' ' LEU . 4.7 tt -119.83 -44.41 2.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.69 175.1 11.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -61.16 -31.37 71.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.919 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -116.44 39.96 3.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.776 HD22 ' HB3' ' A' ' 122' ' ' LEU . 2.2 tt -156.86 116.23 3.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.5 mtm-85 -126.12 138.37 53.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.929 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.556 ' CD1' HD12 ' A' ' 157' ' ' LEU . 5.3 t80 -112.46 139.61 47.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.812 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -148.47 143.54 26.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.977 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 144.9 153.06 5.76 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.563 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -172.97 170.93 4.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.785 0.326 . . . . 0.0 110.813 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.676 HD23 HG23 ' A' ' 153' ' ' THR . 18.9 mt -74.51 132.5 41.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.948 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 1.5 m -106.91 160.43 15.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 18.0 mtm -142.04 148.24 38.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -154.46 150.31 27.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.22 154.98 42.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -156.27 113.65 3.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.839 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -161.36 168.72 23.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.138 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -94.59 -56.09 2.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -177.49 -39.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.795 ' O ' HG22 ' A' ' 144' ' ' THR . 0.2 OUTLIER -87.44 -28.33 22.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.95 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -75.18 -27.28 59.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.038 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.92 -36.76 72.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.071 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.795 HG22 ' O ' ' A' ' 141' ' ' LEU . 13.4 t -72.08 -10.67 60.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.365 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.43 -29.96 57.9 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.628 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 60.66 32.64 20.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.792 0.329 . . . . 0.0 110.946 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -150.04 -179.68 7.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.144 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.45 37.1 16.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.21 153.01 26.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.941 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -109.47 122.72 48.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.925 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.06 117.26 9.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.091 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -124.11 153.78 40.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.011 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.676 HG23 HD23 ' A' ' 132' ' ' LEU . 14.7 m -121.69 123.93 43.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.729 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -116.86 129.76 56.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.986 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 61.5 p -153.41 115.45 4.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.755 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -140.37 -169.37 11.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.776 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.556 HD12 ' CD1' ' A' ' 128' ' ' PHE . 0.3 OUTLIER -139.94 178.12 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.348 . . . . 0.0 110.833 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -140.02 143.56 36.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.9 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.464 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 1.3 t80 -135.25 101.24 4.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.0 m -97.55 108.82 21.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.823 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.464 ' CE2' ' CD1' ' A' ' 159' ' ' TYR . 20.5 m-85 -79.57 -36.99 37.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.95 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -176.53 -165.15 0.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.78 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -86.58 6.08 32.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.332 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.709 HG23 HG22 ' A' ' 165' ' ' VAL . 8.8 t -93.23 -35.83 12.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.746 0.308 . . . . 0.0 110.943 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.709 HG22 HG23 ' A' ' 164' ' ' THR . 30.5 m -156.81 150.3 9.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.119 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.846 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -131.34 152.24 50.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.15 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.475 HD23 ' H ' ' A' ' 168' ' ' ARG . 0.4 OUTLIER -111.63 146.66 37.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.773 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.475 ' H ' HD23 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -147.22 129.61 15.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.95 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.6 t -131.92 146.63 33.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.978 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -152.41 125.62 8.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.065 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -95.76 161.23 14.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.737 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -135.58 151.11 49.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.008 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.77 105.19 3.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.762 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -101.57 140.8 35.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.962 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.81 113.11 6.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -124.73 146.7 16.28 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.527 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -164.11 160.34 21.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.859 0.362 . . . . 0.0 110.815 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.89 125.32 38.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -23.85 66.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -54.99 -74.41 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.106 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -169.9 37.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.973 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.11 121.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.902 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.44 33.18 2.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.939 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 68.77 -67.45 0.21 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.976 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -97.28 34.24 1.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.943 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -118.61 -36.73 0.89 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.507 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -93.52 102.91 15.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 0.0 110.985 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -156.36 172.44 18.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.881 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 17.5 t -137.61 142.08 41.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 72.1 p -133.45 147.8 51.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.901 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -118.39 135.09 54.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.85 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -130.09 140.92 50.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.727 HD11 HD11 ' A' ' 212' ' ' ILE . 46.1 pt -119.05 138.97 48.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.185 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.75 113.58 11.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.891 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -120.72 116.55 25.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.047 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -136.5 131.3 33.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.932 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.403 ' N ' HD23 ' A' ' 197' ' ' LEU . 0.3 OUTLIER -117.35 109.46 42.17 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.722 179.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.846 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 28.1 Cg_endo -62.76 136.58 58.51 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.439 2.092 . . . . 0.0 112.393 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.574 HD22 HD11 ' A' ' 201' ' ' LEU . 0.2 OUTLIER -115.62 101.27 8.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.772 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 8.8 t -78.12 127.07 31.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.574 HD11 HD22 ' A' ' 199' ' ' LEU . 4.2 mp -139.84 148.06 41.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -81.88 58.3 4.92 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.503 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -179.8 -62.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.872 0.368 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -136.15 137.93 41.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.863 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 10.5 m -90.54 140.05 30.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.487 ' CG1' HD12 ' A' ' 229' ' ' LEU . 21.7 t -128.28 111.37 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.033 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -104.93 92.89 5.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.01 171.84 16.7 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.621 2.214 . . . . 0.0 112.294 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -158.05 161.56 38.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.863 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.7 m -139.9 116.1 10.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 42.3 mtt180 -139.41 134.89 33.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.063 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.743 HG22 ' H ' ' A' ' 214' ' ' LEU . 32.4 mt -76.65 141.7 15.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.125 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -103.62 -2.88 46.83 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.838 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.743 ' H ' HG22 ' A' ' 212' ' ' ILE . 73.6 mt 61.28 179.97 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.343 . . . . 0.0 110.841 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.83 126.54 36.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.876 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -142.24 -60.24 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 58.3 m -105.86 -179.21 3.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -160.0 128.27 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.907 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -176.18 -111.42 0.28 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.533 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -64.88 138.54 58.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.83 0.348 . . . . 0.0 110.892 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 72.84 -158.01 52.85 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.53 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -131.04 -48.23 1.01 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.812 0.339 . . . . 0.0 110.842 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.65 154.42 44.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.829 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.23 -58.82 2.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -151.88 123.65 7.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.425 ' HG2' HG22 ' A' ' 227' ' ' VAL . 0.0 OUTLIER -130.06 -34.45 1.68 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.227 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.425 HG22 ' HG2' ' A' ' 226' ' ' ARG . 21.0 m -147.87 139.85 18.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 0.0 111.167 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -116.27 150.23 18.64 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.408 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.487 HD12 ' CG1' ' A' ' 206' ' ' VAL . 0.8 OUTLIER -129.86 122.92 29.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.886 0.374 . . . . 0.0 110.938 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -109.89 118.04 35.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.814 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.13 159.4 20.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.064 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -154.42 117.01 0.76 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.045 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.517 ' HB3' HG12 ' A' ' 241' ' ' VAL . 0.2 OUTLIER -132.27 115.61 15.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.714 0.292 . . . . 0.0 111.106 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 240' ' ' SER . 3.6 m-20 -81.36 122.7 27.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -60.88 -15.13 27.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.964 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.98 -39.39 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.826 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 178.55 -60.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.001 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -74.19 -70.27 1.27 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.672 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.585 ' H ' HD23 ' A' ' 239' ' ' LEU . 1.2 pt? -66.35 146.84 54.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.718 0.294 . . . . 0.0 110.832 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -148.49 176.87 9.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.274 -179.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.517 HG12 ' HB3' ' A' ' 233' ' ' TYR . 11.4 p -122.86 131.32 73.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.831 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 9.8 m -107.6 139.8 41.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.092 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.66 141.93 46.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.972 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -105.25 120.68 42.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.948 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -108.98 143.94 37.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.833 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -172.09 -167.92 0.52 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.074 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 61.96 107.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.925 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.75 -46.68 0.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 4.9 m0 68.68 -68.06 0.19 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.99 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -131.26 -72.86 0.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.936 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 35.6 t0 61.05 77.51 0.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.822 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -105.93 -36.13 7.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.897 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -145.28 105.01 4.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.926 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.7 111.59 2.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -119.2 45.94 1.19 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.572 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.72 135.81 40.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.854 0.359 . . . . 0.0 110.869 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 48.1 t -76.61 -31.63 57.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.929 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -130.68 129.93 43.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.877 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -164.19 139.19 5.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -155.12 112.74 3.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.961 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -143.02 106.69 4.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.918 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 62.22 117.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.991 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -163.72 132.74 3.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.05 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -78.08 144.62 28.76 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.529 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 23.1 t -117.04 119.8 63.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.834 0.349 . . . . 0.0 111.029 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -137.09 160.39 24.95 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.543 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 12.3 m -135.86 153.13 31.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 0.0 111.157 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -152.03 131.9 13.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.49 ' CE1' ' CE2' ' A' ' 271' ' ' PHE . 4.6 t80 -131.01 126.18 35.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 39.5 t -113.68 147.76 37.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' PHE . . . . . 0.49 ' CE2' ' CE1' ' A' ' 269' ' ' TYR . 3.3 m-85 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.933 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.851 0.358 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -123.14 85.48 2.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.72 -55.71 3.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.78 -176.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.828 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -160.97 81.44 0.64 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -60.0 99.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.471 ' CB ' ' HB3' ' A' ' 39' ' ' ALA . 3.0 t-80 -94.81 146.17 24.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -126.69 137.01 53.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -151.15 131.57 13.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.475 HG23 ' CE2' ' A' ' 36' ' ' PHE . 22.7 mt -130.53 139.33 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.031 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -148.81 165.07 29.2 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.549 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.566 ' HB3' HG22 ' A' ' 267' ' ' VAL . . . -150.49 170.54 18.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.797 0.332 . . . . 0.0 111.059 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 57.2 mtm -143.27 153.57 42.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.969 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.761 ' HB2' HG23 ' A' ' 265' ' ' VAL . 10.9 m-85 -146.53 106.08 3.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.838 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -105.76 162.95 13.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.915 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.6 mt -119.84 77.09 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.05 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -94.39 137.01 34.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.946 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -159.34 161.78 35.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.921 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.529 ' O ' HG22 ' A' ' 19' ' ' VAL . 12.3 p -156.43 53.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -149.07 -173.52 4.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.907 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.17 129.96 1.07 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.558 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.78 -47.72 0.33 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 110.889 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.34 126.36 0.82 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.526 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 60.25 173.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.852 0.358 . . . . 0.0 110.914 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -70.14 96.36 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.873 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 12.8 ttp -74.81 -62.29 1.59 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.948 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -142.93 162.55 35.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -126.61 89.3 0.35 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.413 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.34 132.7 42.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.841 0.353 . . . . 0.0 110.908 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.75 146.66 41.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.083 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.76 93.89 30.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.018 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 14' ' ' TYR . 39.4 Cg_exo -60.52 178.68 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.681 2.254 . . . . 0.0 112.201 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.1 123.57 5.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.967 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.3 138.31 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.091 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -138.92 155.32 48.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.475 ' CE2' HG23 ' A' ' 10' ' ' ILE . 62.5 m-85 -146.5 153.13 40.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -147.35 129.64 15.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.671 ' HB3' HG23 ' A' ' 45' ' ' ILE . . . -134.01 141.9 47.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.006 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.471 ' HB3' ' CB ' ' A' ' 7' ' ' HIS . . . -123.49 116.52 23.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.086 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -126.08 73.78 1.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.789 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.83 -135.58 32.78 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.411 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.31 -20.99 48.31 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.377 2.051 . . . . 0.0 112.346 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -101.57 120.72 40.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.909 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.0 ttt180 -113.17 153.15 28.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.671 HG23 ' HB3' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -141.71 140.78 30.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.129 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -137.22 130.04 30.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.977 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.616 HD23 ' HG ' ' A' ' 71' ' ' LEU . 2.8 mt -116.45 166.79 11.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.549 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -165.53 141.5 5.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -122.54 160.2 26.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.946 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -141.51 128.67 20.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.938 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.67 119.21 4.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.84 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -64.11 151.56 42.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -119.01 95.95 0.64 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.47 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.2 146.28 69.32 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.51 2.14 . . . . 0.0 112.263 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.3 p -67.31 147.56 12.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.061 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -59.15 154.65 15.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.003 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 61.17 87.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.861 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.0 t -104.65 166.32 10.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.4 -68.19 0.91 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.078 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 144.11 44.92 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.484 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -84.2 -58.81 2.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 110.94 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -176.69 135.24 0.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.891 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.84 115.85 0.72 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.563 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.5 p -117.57 164.02 15.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 0.0 110.866 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -104.74 163.65 12.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 66' ' ' PHE . 4.1 p90 -152.69 165.41 35.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -125.23 145.98 49.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.984 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.72 95.79 2.82 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.942 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.47 153.25 44.47 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.506 2.137 . . . . 0.0 112.267 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.549 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -144.38 128.47 17.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.006 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.616 ' HG ' HD23 ' A' ' 47' ' ' LEU . 1.2 mp -132.15 154.18 49.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.832 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -154.82 157.58 38.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.885 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.455 HG23 ' H ' ' A' ' 89' ' ' GLY . 31.6 m -144.69 156.79 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.055 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -134.81 117.68 16.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -103.62 114.43 28.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -83.03 99.38 9.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.66 -54.68 5.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.84 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.8 tp 61.79 152.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -154.42 -60.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.965 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -147.92 -172.72 4.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.92 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -84.01 -32.95 24.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.29 -55.9 20.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.808 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.535 ' HB3' HG12 ' A' ' 120' ' ' VAL . 6.2 p90 -133.67 148.29 51.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.9 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.7 t -122.04 160.38 25.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.887 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -127.56 164.37 22.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.937 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -179.75 -177.65 48.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.482 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.7 155.62 43.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.817 0.341 . . . . 0.0 110.901 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 77.8 p -142.97 110.12 5.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.902 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.455 ' H ' HG23 ' A' ' 73' ' ' VAL . . . -113.98 179.93 18.86 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.505 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -177.71 170.41 42.77 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.471 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -148.59 144.43 27.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.815 0.341 . . . . 0.0 110.895 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.8 mtp85 -141.05 174.45 10.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.9 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -151.51 169.31 22.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -138.0 122.16 18.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -95.4 127.75 9.26 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.441 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.08 130.84 39.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.774 0.321 . . . . 0.0 110.916 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -133.86 139.7 46.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.896 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -152.92 31.61 0.49 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.402 HG12 ' H ' ' A' ' 101' ' ' GLU . 21.4 t -131.86 127.95 59.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.74 -31.02 66.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.963 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.402 ' H ' HG12 ' A' ' 99' ' ' VAL . 8.2 pt-20 -119.83 89.16 41.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.957 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.23 168.2 21.56 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.546 2.164 . . . . 0.0 112.321 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -176.54 -65.66 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.535 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.83 32.52 0.4 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -137.89 93.84 2.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.43 -175.76 3.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.823 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -138.2 124.4 20.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.152 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -129.93 154.69 47.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.829 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.3 mtm -137.95 124.84 21.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.956 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -89.23 135.97 33.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.844 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -123.58 126.7 47.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.027 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -107.12 145.25 32.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.792 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.401 ' HG3' ' CE1' ' A' ' 135' ' ' TYR . 20.6 tttm -139.91 134.3 31.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.034 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.418 ' O ' HG23 ' A' ' 114' ' ' ILE . 2.1 tt -152.76 126.2 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.905 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.597 ' HB2' ' HA ' ' A' ' 133' ' ' SER . . . -150.57 106.35 3.1 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.305 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.86 137.31 34.88 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.452 2.101 . . . . 0.0 112.072 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -105.92 141.05 37.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.024 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 70.4 p-90 -148.64 131.66 16.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.853 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -123.13 143.94 49.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.967 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.535 HG12 ' HB3' ' A' ' 83' ' ' PHE . 30.4 m -144.26 125.59 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.059 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.87 151.71 30.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.891 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.6 tp -124.01 -48.47 1.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.953 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.27 -176.99 5.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.929 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.44 132.01 46.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 60.13 32.63 21.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.767 HD23 HD21 ' A' ' 157' ' ' LEU . 0.1 OUTLIER -146.53 107.9 4.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -118.53 137.76 52.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.903 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.684 ' CZ ' HD12 ' A' ' 157' ' ' LEU . 2.9 m-85 -102.08 141.19 35.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.834 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -132.32 138.59 47.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.77 147.27 14.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.472 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . 0.515 ' HE3' ' HB1' ' A' ' 115' ' ' ALA . 26.2 p-90 -173.06 149.5 1.85 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.862 0.363 . . . . 0.0 111.102 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.27 135.74 53.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.617 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.597 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 3.6 t -108.37 153.5 23.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.132 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 53.4 mtp -134.98 118.38 16.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.768 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.401 ' CE1' ' HG3' ' A' ' 113' ' ' LYS . 1.9 m-85 -102.45 133.82 46.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.949 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.839 ' HG3' HG23 ' A' ' 149' ' ' THR . 3.9 mttm -138.73 114.12 9.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.79 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -121.08 141.16 51.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.97 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -172.84 140.38 0.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.055 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -96.08 -52.9 3.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.023 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 176.38 -48.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.981 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 mt -80.92 -23.24 39.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -54.58 -29.45 51.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.052 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.6 p -59.74 -27.51 66.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.023 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.7 m -56.79 -34.13 67.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.966 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -90.78 -28.9 14.45 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.476 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 59.93 84.31 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.869 0.366 . . . . 0.0 110.841 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -87.8 164.06 16.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.108 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.26 158.43 19.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.855 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.839 HG23 ' HG3' ' A' ' 136' ' ' LYS . 2.4 m -84.74 154.55 22.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.911 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -103.06 121.41 42.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.89 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 27.6 m -106.0 129.12 59.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.077 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -110.77 127.61 55.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.858 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.44 114.54 26.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.427 ' HB3' ' CE2' ' A' ' 131' ' ' TRP . 0.6 OUTLIER -121.09 116.39 24.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.851 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.0 m -145.28 145.95 31.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.833 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -163.57 -162.82 15.06 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.53 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.767 HD21 HD23 ' A' ' 126' ' ' LEU . 6.6 tt -151.62 149.9 29.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.845 0.355 . . . . 0.0 110.91 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.453 ' N ' HD23 ' A' ' 157' ' ' LEU . 2.9 mt-30 -118.59 131.7 56.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -127.74 100.16 5.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.701 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 9.4 t -99.81 126.23 45.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.983 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -104.11 -30.09 10.45 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.775 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -165.36 177.22 7.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.711 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -81.92 0.63 38.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.363 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.605 HG22 ' O ' ' A' ' 200' ' ' THR . 0.2 OUTLIER -111.84 -26.56 8.88 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.653 0.263 . . . . 0.0 111.172 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.75 HG12 ' HG ' ' A' ' 199' ' ' LEU . 28.4 m -145.75 141.52 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.232 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.752 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -150.66 -172.24 4.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.013 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.66 143.24 31.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.627 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.79 145.31 32.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.057 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.645 HG23 ' HB2' ' A' ' 195' ' ' ALA . 11.5 p -144.56 137.88 22.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.944 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -133.12 155.19 49.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.989 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -127.85 119.35 25.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.853 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -96.37 136.1 37.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.002 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.9 125.24 10.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.802 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -111.08 145.59 38.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.949 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.85 117.47 3.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -146.67 169.83 27.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.525 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.431 ' CE1' ' HG3' ' A' ' 187' ' ' GLU . 0.3 OUTLIER -133.79 142.34 47.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.774 0.321 . . . . 0.0 110.943 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.48 135.51 53.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 1.6 tpt -84.74 -53.19 5.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 62.85 -79.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.057 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -140.41 -62.59 0.49 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.873 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.97 -68.98 0.61 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -173.02 137.95 0.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -168.84 34.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.936 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 20.7 m120 60.52 63.19 1.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -95.78 25.61 24.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.499 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.431 ' HG3' ' CE1' ' A' ' 177' ' ' PHE . 15.7 mt-10 -76.49 164.67 25.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.843 0.354 . . . . 0.0 110.897 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -147.14 117.6 7.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.7 t -117.16 136.34 53.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 4.0 m -137.12 145.97 44.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -144.4 121.87 11.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.925 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -144.52 136.37 25.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.989 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.524 HD13 ' O ' ' A' ' 212' ' ' ILE . 4.0 mp -107.07 124.97 63.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.132 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -128.23 115.74 18.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.776 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.645 ' HB2' HG23 ' A' ' 169' ' ' VAL . . . -133.49 125.78 29.68 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.215 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.694 ' HB2' HG22 ' A' ' 207' ' ' THR . 41.8 p90 -121.52 141.36 51.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.722 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.429 ' O ' ' HD2' ' A' ' 208' ' ' PRO . 8.2 tt -105.66 109.31 63.06 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.134 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.752 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 59.0 Cg_endo -71.35 111.21 3.04 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.368 2.046 . . . . 0.0 112.318 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.75 ' HG ' HG12 ' A' ' 165' ' ' VAL . 0.4 OUTLIER -132.76 127.82 35.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.912 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.605 ' O ' HG22 ' A' ' 164' ' ' THR . 0.7 OUTLIER -137.17 114.16 10.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.09 105.52 7.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.838 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 102.44 -133.3 11.33 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.43 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -105.45 17.18 24.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.721 0.296 . . . . 0.0 111.266 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -136.42 159.89 40.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.791 0.329 . . . . 0.0 110.945 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.35 148.43 47.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.83 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 199' ' ' LEU . 5.8 m -144.17 122.3 6.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.694 HG22 ' HB2' ' A' ' 196' ' ' TYR . 5.2 m -125.04 92.91 46.69 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.123 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 197' ' ' LEU . 26.6 Cg_exo -63.0 171.7 5.8 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.57 2.18 . . . . 0.0 112.178 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.434 ' HB3' HG13 ' A' ' 227' ' ' VAL . 0.1 OUTLIER -128.83 143.25 50.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.783 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.97 136.48 49.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.913 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.8 117.69 14.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.939 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.524 ' O ' HD13 ' A' ' 193' ' ' ILE . 7.6 pt -99.03 125.98 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.129 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.4 -132.89 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.547 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -163.92 145.15 8.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 110.842 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? 60.25 175.79 0.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.818 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.406 ' O ' ' CG ' ' A' ' 216' ' ' TRP . 31.0 p-90 -104.09 106.22 16.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.44 -169.58 1.97 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.894 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -85.18 -65.49 1.0 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 168.43 176.02 38.45 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.522 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -154.7 -46.39 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.942 0.401 . . . . 0.0 110.921 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 164.15 48.85 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.55 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -132.0 172.57 12.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.832 0.348 . . . . 0.0 110.904 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -111.23 -15.16 13.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.29 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 70.63 -65.46 0.33 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.779 0.324 . . . . 0.0 110.815 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -60.25 -27.5 67.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.948 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -154.52 148.05 25.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.018 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' A' ' 209' ' ' TYR . 13.0 p -114.94 -34.31 2.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.14 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.625 ' O ' HD12 ' A' ' 229' ' ' LEU . . . -160.77 -166.83 20.31 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.375 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 228' ' ' GLY . 0.1 OUTLIER -160.04 141.65 12.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 111.045 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -122.61 145.51 48.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.768 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -112.53 159.47 18.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.04 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -142.87 117.06 1.08 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.097 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -121.13 136.09 55.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.362 . . . . 0.0 110.998 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.1 100.22 7.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.625 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -65.86 -10.67 40.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.22 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.9 37.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.796 0.331 . . . . 0.0 111.005 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 5.0 t30 69.71 -64.97 0.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -52.78 -43.54 60.34 Favored Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.738 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.782 HD23 ' N ' ' A' ' 240' ' ' SER . 2.5 tt -87.0 144.77 26.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.762 0.315 . . . . 0.0 110.891 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.782 ' N ' HD23 ' A' ' 239' ' ' LEU . 16.0 m -134.22 151.48 51.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.815 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.477 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 38.9 t -120.98 141.07 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.77 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.88 118.75 31.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.037 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.544 HD23 ' HE2' ' A' ' 245' ' ' TYR . 1.1 mp -120.68 154.95 34.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.702 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -116.76 131.55 56.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.951 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . 0.544 ' HE2' HD23 ' A' ' 243' ' ' LEU . 18.6 m-85 -133.32 146.47 51.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.815 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -172.99 113.46 0.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.147 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -100.59 -41.19 7.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.776 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 59.95 162.16 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 19.0 t-105 -80.2 110.83 15.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.43 ' HB3' ' CD2' ' A' ' 252' ' ' HIS . 12.0 mt-30 -147.41 117.05 7.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.949 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.18 109.24 20.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.949 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' HIS . . . . . 0.43 ' CD2' ' HB3' ' A' ' 250' ' ' GLN . 12.7 p80 -177.0 174.22 1.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.825 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -133.85 152.51 51.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.95 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -112.65 94.44 4.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.922 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -69.81 -107.07 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.514 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.44 109.03 2.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.874 0.368 . . . . 0.0 110.839 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 12.4 m -170.84 145.17 2.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 -135.33 25.24 3.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.017 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 7.6 mttp -148.38 129.31 14.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.839 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -154.94 43.5 0.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.965 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -100.95 91.78 4.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.909 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -132.57 105.24 7.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -170.69 169.97 6.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.143 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -97.82 161.71 21.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.561 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.761 HG23 ' HB2' ' A' ' 14' ' ' TYR . 4.8 m -144.81 146.56 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.8 0.333 . . . . 0.0 111.119 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -160.92 164.3 34.68 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.453 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.566 HG22 ' HB3' ' A' ' 12' ' ' ALA . 6.7 m -126.78 150.15 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 0.0 111.163 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -143.72 146.45 33.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.835 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -144.11 139.33 28.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.68 147.52 50.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 24.4 t80 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.892 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.831 0.348 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.38 168.66 8.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.18 146.71 29.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -158.63 161.28 37.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.982 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 -177.67 54.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 61.09 84.54 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.864 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 61.5 t60 -105.98 141.51 37.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.998 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -129.59 163.04 26.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.738 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.422 ' C ' HD12 ' A' ' 10' ' ' ILE . 2.0 t30 -160.26 146.32 15.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.997 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.51 HD12 ' N ' ' A' ' 10' ' ' ILE . 3.7 mp -140.81 134.35 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.108 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.81 159.28 24.51 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.571 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.593 ' HB3' ' CG2' ' A' ' 267' ' ' VAL . . . -144.49 138.99 27.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.865 0.364 . . . . 0.0 111.001 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.29 149.1 42.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.993 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -132.15 111.06 11.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.866 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -94.48 150.48 20.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.897 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.6 pt -140.55 147.79 22.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.027 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -160.18 118.93 2.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.879 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -94.06 179.94 5.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.7 m -101.78 127.22 55.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.12 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -89.72 -36.57 15.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.858 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 150.15 -34.59 1.0 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.549 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.51 31.31 3.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.857 0.36 . . . . 0.0 110.908 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.85 35.23 0.37 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.531 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.92 86.22 3.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.853 0.359 . . . . 0.0 110.93 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -177.11 130.29 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.867 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.56 168.71 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.856 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 60.33 -177.63 0.1 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 142.05 -27.67 2.28 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.544 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.16 149.42 26.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.848 0.356 . . . . 0.0 110.956 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.47 153.61 24.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.029 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.68 94.0 46.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.988 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.48 158.0 20.72 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.53 2.153 . . . . 0.0 112.198 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.51 133.89 44.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.819 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.72 142.15 30.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.091 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.88 143.68 43.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.967 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -133.89 132.57 40.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -132.0 125.05 30.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.94 136.73 53.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.019 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.864 ' HB3' ' HB3' ' A' ' 7' ' ' HIS . . . -118.96 122.76 42.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.17 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -139.95 86.39 2.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.0 -143.44 44.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.363 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.62 -14.23 41.41 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.457 2.105 . . . . 0.0 112.486 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.6 134.12 45.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.987 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.23 145.46 49.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 46' ' ' ALA . 30.7 mt -131.46 155.36 41.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.217 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.742 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -160.04 136.48 8.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.112 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.49 ' HG ' HD22 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -124.82 146.62 49.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.979 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.606 ' HB3' ' CB ' ' A' ' 70' ' ' GLU . . . -126.48 134.02 51.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.019 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -126.04 110.19 13.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.994 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.19 138.02 36.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.786 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -161.34 166.16 27.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.933 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.65 173.9 6.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.956 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -174.14 90.96 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.562 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.13 148.08 61.91 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.574 2.183 . . . . 0.0 112.288 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.436 HG13 ' O ' ' A' ' 55' ' ' VAL . 10.9 p -77.92 123.8 35.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.098 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.89 129.16 34.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.928 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.49 -69.74 0.83 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.843 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -124.34 -56.93 1.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.84 -60.42 1.92 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.066 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.0 60.43 5.25 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.421 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -114.72 -38.02 4.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.847 0.356 . . . . 0.0 110.999 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.8 ttt-85 -66.15 138.74 57.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.81 128.21 2.31 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.512 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.9 t -104.59 154.63 19.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.815 0.34 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 18.3 m95 -97.17 159.59 14.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.942 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.67 151.85 34.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.833 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.91 124.58 31.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.27 95.85 4.64 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.877 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.06 142.61 24.94 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.536 2.158 . . . . 0.0 112.408 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.606 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . 19.1 mt-10 -137.79 114.79 10.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.899 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.49 HD22 ' HG ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -102.87 133.89 47.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.741 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.742 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 3.7 tt0 -132.68 127.74 35.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.038 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.1 p -124.9 136.15 61.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.004 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -122.94 129.13 51.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.029 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -125.62 137.66 53.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.799 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -122.15 121.45 36.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.021 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -106.39 -43.31 4.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.728 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 59.65 160.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.981 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -141.63 -47.34 0.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.835 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -147.31 174.91 11.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.79 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -75.17 -29.13 60.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.002 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -84.74 -42.34 15.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.986 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.688 ' CE2' HG13 ' A' ' 120' ' ' VAL . 11.7 m-85 -101.6 169.82 8.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.01 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.57 162.43 33.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.797 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -158.12 144.32 17.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.955 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 175.82 -176.25 47.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.497 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.92 134.06 5.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.815 0.34 . . . . 0.0 110.901 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.61 ' OG1' ' HB3' ' A' ' 115' ' ' ALA . 69.2 p -118.84 159.36 23.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.32 -170.98 15.29 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.488 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 178.08 159.28 22.52 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.515 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -126.29 148.18 49.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.846 0.355 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.1 ttp85 -136.69 133.61 36.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.893 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -132.19 178.91 6.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.773 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -146.52 146.2 30.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.964 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -134.41 165.26 24.48 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.477 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -111.34 129.63 55.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 0.0 110.935 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -152.64 35.97 0.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -66.41 -43.11 86.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.591 HG12 ' H ' ' A' ' 101' ' ' GLU . 17.4 t -87.2 140.78 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.027 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -59.44 -30.54 68.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.89 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.591 ' H ' HG12 ' A' ' 99' ' ' VAL . 4.7 tt0 -126.1 74.34 72.07 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.6 163.37 5.32 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.56 2.174 . . . . 0.0 112.245 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -140.18 -100.81 0.46 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.455 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.13 31.47 3.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.35 . . . . 0.0 110.88 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.72 104.78 15.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.872 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -152.99 159.2 42.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.911 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.69 138.17 24.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.109 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -85.14 105.35 15.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.55 148.4 51.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.893 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -156.55 161.76 39.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.85 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.02 109.2 1.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -83.47 140.42 32.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.776 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.54 127.31 17.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.01 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.424 HG22 ' N ' ' A' ' 115' ' ' ALA . 4.6 mt -122.47 154.77 27.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.942 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.61 ' HB3' ' OG1' ' A' ' 88' ' ' THR . . . -147.29 79.74 9.61 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.292 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.8 155.0 19.07 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.562 2.175 . . . . 0.0 112.183 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -122.32 146.15 47.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.008 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -164.99 142.75 6.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.08 151.68 41.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.911 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.688 HG13 ' CE2' ' A' ' 83' ' ' PHE . 23.4 t -147.59 108.23 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -88.35 133.18 34.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.888 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.512 ' O ' HG23 ' A' ' 123' ' ' THR . 3.0 tt -110.99 -32.84 6.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 122' ' ' LEU . 0.3 OUTLIER -166.05 -175.07 3.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.833 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -90.99 51.3 1.93 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -165.88 -43.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.43 124.31 51.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -125.29 146.56 49.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.773 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -101.95 146.02 28.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.014 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -125.45 123.32 38.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.754 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -110.95 106.77 2.09 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.517 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -133.1 136.18 45.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.788 0.328 . . . . 0.0 110.775 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.3 mt -131.02 161.45 31.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.801 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.3 151.24 49.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.041 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.677 ' SD ' HG12 ' A' ' 151' ' ' VAL . 1.5 mpp? -140.1 133.78 30.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.822 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -130.57 127.72 39.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.971 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.444 ' HA ' HG23 ' A' ' 149' ' ' THR . 3.5 ttpt -146.51 168.1 22.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.774 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 59.55 -176.59 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.777 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 142' ' ' ASN . . . -176.49 -165.95 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.124 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -87.61 -27.47 22.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.967 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -176.65 -39.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.035 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.534 ' H ' HD12 ' A' ' 141' ' ' LEU . 5.3 mp -51.21 -27.77 9.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.178 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.527 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 36.1 t30 -72.47 -29.42 63.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.967 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.51 -62.81 1.5 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.099 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.7 -47.67 13.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.018 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -65.22 -35.68 91.91 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.572 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 60.28 35.27 20.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.884 0.373 . . . . 0.0 110.843 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -134.24 -164.95 1.58 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.048 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.1 t0 65.59 49.04 1.86 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.91 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.444 HG23 ' HA ' ' A' ' 136' ' ' LYS . 2.9 m -149.07 110.7 4.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.846 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.3 mtp180 -162.91 179.04 7.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.984 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.677 HG12 ' SD ' ' A' ' 134' ' ' MET . 11.1 m -118.19 131.96 69.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.098 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -101.23 169.43 8.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 8.9 m -132.8 140.28 47.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.876 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -135.38 142.91 45.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.32 127.88 23.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.743 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -116.8 142.13 17.24 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.662 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.7 mp -115.23 117.37 30.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.755 0.312 . . . . 0.0 110.787 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.0 tm0? -101.26 117.51 35.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.961 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -127.04 102.47 6.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.422 HG22 ' CB ' ' A' ' 166' ' ' ALA . 34.3 p -93.11 128.08 38.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.909 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.07 -31.46 12.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.643 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.584 ' HB2' HG22 ' A' ' 165' ' ' VAL . 7.4 m120 -150.92 174.94 12.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.814 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -76.24 -6.39 51.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.43 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.49 HG23 ' HB2' ' A' ' 201' ' ' LEU . 55.1 m -113.07 -28.95 7.49 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.635 0.255 . . . . 0.0 111.23 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.584 HG22 ' HB2' ' A' ' 162' ' ' ASN . 19.6 m -123.11 139.94 48.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.865 0.364 . . . . 0.0 111.385 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.75 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -141.17 -178.42 5.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.004 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 41.3 tp -141.2 134.73 29.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.934 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 196' ' ' TYR . 51.7 mtt-85 -137.52 114.54 10.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.2 t -99.85 142.67 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.998 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -118.96 123.34 44.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.021 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -116.17 114.85 25.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.723 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -106.43 140.98 38.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.091 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.61 105.17 5.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.689 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.74 145.74 29.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.029 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -136.28 136.16 39.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.752 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -130.51 152.69 19.9 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.498 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -160.41 134.94 7.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.359 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -96.07 131.56 42.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -34.06 35.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.23 83.51 7.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.911 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -176.8 132.76 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.869 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 15.5 m -102.35 31.87 3.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -159.98 172.69 17.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.928 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.7 88.34 3.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -155.95 148.49 23.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 96.7 -28.34 13.95 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.519 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -71.44 125.45 27.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.743 0.306 . . . . 0.0 110.942 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -144.56 153.61 42.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.824 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.3 m -122.4 105.53 10.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.968 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.31 114.01 27.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.813 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -109.01 129.4 55.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.017 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -118.28 152.56 35.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.79 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.67 HD13 ' H ' ' A' ' 193' ' ' ILE . 0.2 OUTLIER -136.52 148.09 27.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.267 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -150.31 127.55 11.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.723 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -119.31 117.26 28.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.97 0.414 . . . . 0.0 111.273 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.439 ' HB3' ' CD1' ' A' ' 209' ' ' TYR . 11.5 p90 -138.28 151.24 47.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.592 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.654 HD11 ' HG2' ' A' ' 208' ' ' PRO . 0.3 OUTLIER -118.54 111.23 38.13 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.242 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.75 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 60.5 Cg_endo -72.8 123.29 8.86 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.385 2.056 . . . . 0.0 112.371 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 198' ' ' PRO . 8.7 mt -126.74 104.48 8.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.845 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.3 t -117.12 117.8 30.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.563 HD13 ' N ' ' A' ' 202' ' ' GLY . 0.9 OUTLIER -147.57 121.63 9.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.563 ' N ' HD13 ' A' ' 201' ' ' LEU . . . 65.46 -119.8 15.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.534 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -118.43 30.57 7.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.905 0.383 . . . . 0.0 110.93 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.71 110.57 9.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 49.3 m -102.71 128.74 49.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.006 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.521 HG23 ' HB2' ' A' ' 199' ' ' LEU . 18.4 m -144.18 124.06 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.759 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.656 HG22 ' HA ' ' A' ' 198' ' ' PRO . 16.0 p -133.0 92.96 24.21 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.421 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.654 ' HG2' HD11 ' A' ' 197' ' ' LEU . 59.0 Cg_exo -52.52 171.77 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.457 2.105 . . . . 0.0 112.113 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.439 ' CD1' ' HB3' ' A' ' 196' ' ' TYR . 0.2 OUTLIER -148.11 140.68 24.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.727 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.766 HG23 ' H ' ' A' ' 226' ' ' ARG . 10.6 m -128.9 150.12 50.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.97 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.693 ' HD2' HG21 ' A' ' 227' ' ' VAL . 9.2 mtt-85 -142.3 112.41 7.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.83 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 1.9 pp -65.33 119.71 10.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -103.96 -125.41 5.61 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.497 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.4 mp -126.8 158.42 36.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.877 0.37 . . . . 0.0 110.812 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -149.37 166.73 28.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.817 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -114.03 -66.27 1.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.964 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 2.6 p -147.62 -56.28 0.23 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.914 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -131.98 -176.46 4.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -82.82 -171.85 47.68 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.462 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -164.1 31.54 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.831 0.348 . . . . 0.0 110.881 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 106.57 -38.11 3.48 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -114.94 151.5 33.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.782 0.325 . . . . 0.0 110.892 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -138.05 163.9 30.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.86 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -98.68 30.07 3.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.935 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.48 120.97 29.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.764 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.766 ' H ' HG23 ' A' ' 210' ' ' THR . 1.1 mtp180 61.25 102.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.856 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.693 HG21 ' HD2' ' A' ' 211' ' ' ARG . 14.7 m -72.09 -32.38 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.339 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -167.42 -164.67 23.5 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.488 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 208' ' ' PRO . 0.6 OUTLIER -149.99 119.13 6.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.825 0.345 . . . . 0.0 111.009 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -81.26 144.32 31.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.845 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.63 160.48 27.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.975 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -161.1 117.12 0.75 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.164 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.474 ' HB3' HG22 ' A' ' 241' ' ' VAL . 33.9 t80 -128.6 116.38 19.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.864 0.364 . . . . 0.0 111.163 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 240' ' ' SER . 3.1 p30 -117.88 135.62 53.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.946 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -57.1 -26.48 60.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.29 -45.76 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.872 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -178.5 -61.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -56.76 -75.83 0.23 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.715 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.808 HD12 ' CD1' ' A' ' 269' ' ' TYR . 7.7 tt -66.45 124.64 23.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.749 0.309 . . . . 0.0 110.764 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 234' ' ' ASP . 2.0 t -148.56 175.86 10.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.178 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.511 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 27.8 m -129.0 167.6 24.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.61 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.414 ' O ' HD12 ' A' ' 243' ' ' LEU . 0.3 OUTLIER -133.63 134.69 43.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.021 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 242' ' ' SER . 3.3 mp -137.55 152.2 49.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.892 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -138.83 141.45 38.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.84 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -131.51 165.62 23.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -99.9 -169.68 1.77 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.033 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -114.44 158.57 21.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -170.58 120.5 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.92 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -60.1 -34.73 73.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.949 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -132.27 107.8 8.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.957 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.62 116.89 19.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.888 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -102.42 47.52 0.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -97.43 38.0 1.31 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.932 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.51 106.89 15.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.846 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 80.17 -127.41 7.93 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.495 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.98 161.75 17.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.816 0.341 . . . . 0.0 110.868 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.17 127.05 6.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -100.13 31.06 3.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.57 161.38 33.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.975 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -122.01 178.35 4.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.896 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -142.58 158.39 43.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -68.05 104.31 1.73 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -133.69 178.09 7.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.08 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -145.38 150.73 22.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.453 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.85 153.55 27.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 0.0 111.12 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -158.62 155.95 26.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.495 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.593 ' CG2' ' HB3' ' A' ' 12' ' ' ALA . 15.3 m -138.11 147.83 25.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.811 0.339 . . . . 0.0 111.14 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -138.24 129.93 28.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.943 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.808 ' CD1' HD12 ' A' ' 239' ' ' LEU . 1.9 t80 -124.8 126.12 45.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.951 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 35.0 t -97.85 151.57 20.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.875 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.783 0.325 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -72.83 119.48 17.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.942 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -61.5 -36.21 79.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.8 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -81.74 -172.57 3.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.856 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -166.44 83.8 0.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.95 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -71.57 125.16 26.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.77 132.92 52.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.923 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.87 140.43 38.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -141.5 120.14 12.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.022 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.62 HG22 ' CE1' ' A' ' 36' ' ' PHE . 27.1 pt -110.68 140.72 28.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.09 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.79 159.74 26.94 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.618 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.25 143.89 46.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.806 0.336 . . . . 0.0 111.065 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 30.6 mtt -131.25 138.72 49.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.997 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -147.32 113.83 5.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.92 161.18 17.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 16' ' ' ILE . 6.2 tt -154.23 52.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.038 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.35 98.11 11.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.844 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -153.9 -45.8 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.1 t 66.99 86.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.124 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -111.74 -55.4 2.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.871 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.82 -163.57 9.57 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.518 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -72.35 165.09 25.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.855 0.36 . . . . 0.0 110.938 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.81 -173.56 42.61 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.517 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 60.94 19.58 9.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.663 0.268 . . . . 0.0 111.141 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.65 -30.44 3.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.209 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 67.67 82.03 0.18 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.867 0.365 . . . . 0.0 110.886 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -154.17 116.83 4.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.855 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 158.87 -137.27 5.11 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.54 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.81 150.24 24.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.787 0.327 . . . . 0.0 110.85 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.56 126.23 27.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.037 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -143.18 94.15 6.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.93 146.43 47.42 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.492 2.128 . . . . 0.0 112.363 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.1 m -140.21 152.8 46.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.857 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.2 m -133.6 159.53 42.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.136 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -143.93 122.28 12.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.62 ' CE1' HG22 ' A' ' 10' ' ' ILE . 8.8 m-85 -119.85 141.7 49.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.946 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.666 ' OD1' ' HB2' ' A' ' 46' ' ' ALA . 25.1 t30 -143.34 132.52 23.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.998 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.521 ' HB3' HG13 ' A' ' 45' ' ' ILE . . . -126.69 124.08 39.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.041 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -109.58 113.24 25.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.154 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -122.33 98.56 5.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.816 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.77 -141.79 45.79 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.45 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.58 -18.34 48.6 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.499 2.133 . . . . 0.0 112.441 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -101.47 144.6 30.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 0.0 111.016 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -137.73 132.77 33.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.521 HG13 ' HB3' ' A' ' 38' ' ' ALA . 23.7 pt -117.68 156.38 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.131 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.666 ' HB2' ' OD1' ' A' ' 37' ' ' ASN . . . -142.95 157.79 44.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.055 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.0 tt -150.48 120.96 7.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.907 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.61 139.1 49.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.041 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.99 109.66 11.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -95.91 125.05 40.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.862 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -120.19 144.51 47.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.93 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -130.13 140.29 50.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.934 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -156.69 73.97 0.23 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.478 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.5 156.66 53.91 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.563 2.175 . . . . 0.0 112.27 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.6 t -103.56 133.74 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.14 168.32 19.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -167.16 -57.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 53.6 m -113.85 -40.02 3.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -116.58 126.52 53.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.05 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.42 82.65 0.13 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.474 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -158.57 31.12 0.23 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.811 0.338 . . . . 0.0 110.822 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.402 ' HB2' ' NH1' ' A' ' 62' ' ' ARG . 3.9 ttm105 -162.81 33.04 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.909 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.29 82.8 0.44 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.459 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.67 116.77 27.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.795 0.331 . . . . 0.0 110.926 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -77.89 124.28 27.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -135.18 141.67 45.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.848 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -139.64 134.39 31.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.953 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.97 95.85 14.95 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.86 159.83 11.06 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.536 2.157 . . . . 0.0 112.275 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.89 149.96 47.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.871 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.92 141.12 23.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.97 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.605 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 2.6 tt0 -128.4 151.16 49.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.813 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.506 HG12 ' CD1' ' A' ' 75' ' ' TYR . 28.2 t -127.81 130.67 70.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.151 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.779 ' CD2' HG22 ' A' ' 88' ' ' THR . 4.3 m170 -123.9 121.09 34.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.787 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.506 ' CD1' HG12 ' A' ' 73' ' ' VAL . 1.7 p90 -153.33 106.53 2.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.845 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -92.43 141.03 28.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.957 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -88.52 -47.96 7.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.866 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.8 mt -143.12 171.08 14.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -169.75 111.91 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.847 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -143.71 -178.51 5.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.89 -31.45 59.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.916 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.09 -56.14 6.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.968 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -156.76 134.15 10.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.2 m -109.69 138.19 46.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.94 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -124.63 139.84 53.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -159.18 172.33 35.85 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.502 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.448 ' HB2' ' CE2' ' A' ' 75' ' ' TYR . 17.2 mt -143.31 143.41 31.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.816 0.341 . . . . 0.0 110.817 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.779 HG22 ' CD2' ' A' ' 74' ' ' HIS . 25.2 p -140.82 131.75 26.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.07 -177.93 15.12 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.494 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.87 153.38 24.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.484 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 111' ' ' ARG . 6.4 t80 -131.63 136.61 47.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.86 0.362 . . . . 0.0 110.89 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.6 mtm180 -137.23 159.83 40.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.54 169.77 17.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.824 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.15 130.74 25.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.879 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -143.09 129.45 3.76 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.513 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.726 ' HB2' HG21 ' A' ' 106' ' ' THR . 42.9 m-85 -70.37 169.42 13.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.328 . . . . 0.0 110.906 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.59 114.82 13.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.984 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.1 88.44 2.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.918 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.6 m -62.75 -34.63 66.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.036 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -60.51 -47.39 86.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -115.21 87.55 16.24 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.42 119.63 6.57 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.573 2.182 . . . . 0.0 112.335 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 178.42 151.2 9.27 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.607 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.8 tttm -98.48 34.57 1.98 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.784 0.325 . . . . 0.0 110.879 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -98.52 41.26 1.14 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.841 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.726 HG21 ' HB2' ' A' ' 96' ' ' TYR . 0.2 OUTLIER -105.87 179.34 4.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.452 ' H ' HG22 ' A' ' 106' ' ' THR . . . -107.09 116.01 31.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.068 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -107.77 141.25 39.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.827 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 19.9 ptm -112.69 133.78 54.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.47 127.19 36.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.822 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.4 ' O ' ' CD1' ' A' ' 91' ' ' PHE . 12.4 mtt180 -109.97 128.21 55.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.923 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -127.74 113.83 16.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.85 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -119.58 144.27 47.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.953 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.2 tp -140.97 143.54 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.998 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.08 99.78 3.06 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.081 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.63 155.2 69.68 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.433 2.089 . . . . 0.0 112.242 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -112.93 142.96 45.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.998 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.68 130.37 20.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.781 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.15 132.32 29.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.56 HG23 ' HB3' ' A' ' 128' ' ' PHE . 11.8 m -143.44 109.99 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.151 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -72.66 123.31 23.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.951 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.7 tp -101.78 -46.64 4.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.961 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.31 167.62 12.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.835 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.85 -30.13 71.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.025 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.559 ' OD2' HD12 ' A' ' 126' ' ' LEU . 2.5 p30 -123.87 40.97 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.011 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.559 HD12 ' OD2' ' A' ' 125' ' ' ASP . 1.2 mp -156.85 133.8 10.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.56 140.51 48.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.836 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.56 ' HB3' HG23 ' A' ' 120' ' ' VAL . 68.8 t80 -104.92 126.82 52.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.978 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -114.86 147.37 39.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.802 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -152.38 133.53 4.15 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.676 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . 0.427 ' CD1' ' N ' ' A' ' 131' ' ' TRP . 0.1 OUTLIER -160.81 165.19 30.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.819 0.342 . . . . 0.0 110.841 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.46 156.06 47.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.01 110.33 17.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.83 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.5 ttp -113.92 111.57 21.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.839 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -104.9 121.77 44.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.477 ' HA ' HG22 ' A' ' 149' ' ' THR . 3.2 tmtm? -140.53 110.55 6.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.819 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 148' ' ' ASP . 21.4 p90 -129.23 157.8 40.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.963 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -160.66 154.85 23.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.12 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -94.7 -63.99 1.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -173.29 -63.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.88 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.769 ' O ' HG22 ' A' ' 144' ' ' THR . 6.4 tt -85.51 -31.46 22.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -60.24 -20.38 58.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.119 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.408 ' O ' ' CD2' ' A' ' 146' ' ' TYR . 0.8 OUTLIER -52.41 -29.54 24.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.863 0.364 . . . . 0.0 111.176 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 141' ' ' LEU . 9.9 t -70.06 -29.68 66.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.25 -39.42 44.06 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.518 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.408 ' CD2' ' O ' ' A' ' 143' ' ' THR . 7.0 m-85 60.82 76.57 0.36 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.831 0.348 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -139.4 162.56 34.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.101 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 137' ' ' PHE . 53.7 m-20 60.48 35.34 20.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.975 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 136' ' ' LYS . 69.8 p -137.25 112.8 9.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.814 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -153.53 -178.56 7.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.917 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.467 HG22 ' N ' ' A' ' 152' ' ' GLU . 9.4 p -129.68 157.82 42.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.993 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.467 ' N ' HG22 ' A' ' 151' ' ' VAL . 4.3 mp0 -124.62 157.43 35.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.975 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 68.6 p -116.77 118.0 31.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.754 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.401 ' HG2' ' CE1' ' A' ' 172' ' ' TYR . 3.5 mp0 -126.2 138.05 53.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.028 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 7.9 t -139.4 138.91 36.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.671 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -132.36 158.33 22.92 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.644 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.9 mp -139.14 130.19 26.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.823 0.344 . . . . 0.0 110.738 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -93.95 146.73 23.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.975 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -139.72 100.15 3.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.787 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.69 115.06 16.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.958 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.6 -49.89 3.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.729 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -131.01 163.89 26.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.799 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -30.95 70.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.931 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -119.22 27.41 8.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.079 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 21.4 t -148.95 117.62 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.105 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 198' ' ' PRO . . . -124.03 149.96 45.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.184 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' A' ' 197' ' ' LEU . 2.4 mt -132.06 121.97 24.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.733 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.43 ' HD3' ' CE1' ' A' ' 196' ' ' TYR . 40.3 mtt180 -125.27 147.07 49.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.067 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.5 m -147.02 138.61 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.865 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 44.1 p30 -146.89 156.41 43.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.118 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.517 ' CD1' HG22 ' A' ' 193' ' ' ILE . 5.2 m-85 -110.13 144.57 38.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.785 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.401 ' CE1' ' HG2' ' A' ' 154' ' ' GLU . 0.3 OUTLIER -121.7 115.87 23.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.97 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.577 HD13 ' HA ' ' A' ' 191' ' ' GLN . 4.3 mm? -109.99 106.93 16.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.14 147.26 24.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -151.36 124.09 8.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.939 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -144.71 178.66 22.42 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.518 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -130.17 146.63 51.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.778 0.323 . . . . 0.0 110.97 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -131.23 173.83 10.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -82.73 -51.32 7.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.853 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -152.09 162.5 41.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.84 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.2 175.75 5.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.925 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.25 34.56 3.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.897 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -174.7 -43.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.935 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -68.14 122.31 18.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.914 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.32 -30.98 33.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.973 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -176.21 -53.82 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.89 126.86 54.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.331 . . . . 0.0 110.945 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -102.94 118.75 37.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.014 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 12.3 p -122.83 110.08 15.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 5.0 t -106.3 139.91 40.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.942 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.577 ' HA ' HD13 ' A' ' 173' ' ' LEU . 2.7 mt-30 -98.97 130.45 45.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -134.44 157.35 46.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.945 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.517 HG22 ' CD1' ' A' ' 171' ' ' TYR . 1.8 pt -141.18 137.09 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.43 114.31 16.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.846 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -101.3 115.43 30.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.228 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.446 ' HB3' ' CD1' ' A' ' 209' ' ' TYR . 8.4 p90 -128.98 114.95 17.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.623 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.536 ' HB2' HD23 ' A' ' 167' ' ' LEU . 0.4 OUTLIER -108.2 109.38 61.8 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.216 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.403 ' HB2' ' HB3' ' A' ' 166' ' ' ALA . 31.0 Cg_exo -61.73 136.08 60.12 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.561 2.174 . . . . 0.0 112.18 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 4.2 tp -132.88 127.98 35.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.929 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 7.1 m -132.19 123.18 26.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.967 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 26.8 tp -147.15 102.68 3.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.923 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 77.06 52.03 5.92 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.499 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 59.69 29.61 19.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.77 0.319 . . . . 0.0 110.941 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -104.09 126.21 51.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.898 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.09 104.92 16.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 230' ' ' PHE . 22.1 t -118.66 127.42 75.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.05 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.93 92.72 33.03 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.961 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -79.89 172.14 14.47 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.679 2.253 . . . . 0.0 112.244 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.446 ' CD1' ' HB3' ' A' ' 196' ' ' TYR . 0.3 OUTLIER -161.72 143.65 11.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.691 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 32.6 m -131.69 145.39 51.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.017 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.31 141.63 22.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.766 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 14.7 pt -108.85 128.5 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.181 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 95.16 157.48 32.41 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.514 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.772 HD22 ' HB2' ' A' ' 218' ' ' ASN . 2.1 tp -96.14 164.33 12.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 0.0 110.869 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 1.7 ptt-85 -70.12 -39.82 75.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -104.76 -67.28 0.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 57.6 p -176.72 143.89 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.938 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.772 ' HB2' HD22 ' A' ' 214' ' ' LEU . 1.3 t30 -166.98 104.01 0.56 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.851 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -86.82 -43.68 5.97 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.523 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -101.41 157.4 16.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.877 0.37 . . . . 0.0 110.848 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 140.53 163.87 9.69 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.517 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -106.25 129.2 54.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.8 0.333 . . . . 0.0 110.843 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.77 134.1 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.918 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -98.38 29.39 3.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.951 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.72 132.3 47.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.831 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.89 -59.16 1.77 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.951 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 47.4 t -92.28 -81.15 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.153 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 132.83 -149.63 19.59 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.484 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.23 110.93 21.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.778 0.323 . . . . 0.0 110.598 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.541 ' O ' HG13 ' A' ' 206' ' ' VAL . 0.1 OUTLIER -87.39 133.43 33.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.979 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -116.95 155.31 29.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -134.81 117.06 1.69 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.399 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.501 ' O ' HG23 ' A' ' 241' ' ' VAL . 17.3 m-85 -110.36 116.37 31.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.838 0.351 . . . . 0.0 111.027 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -115.45 111.09 20.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.676 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -72.78 -5.42 37.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.347 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -178.36 41.12 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.757 0.313 . . . . 0.0 110.938 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 70.0 -64.1 0.37 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.152 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -47.66 -75.66 0.18 Allowed Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.793 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 240' ' ' SER . 7.4 tt -66.51 142.49 57.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.775 0.322 . . . . 0.0 110.799 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.43 ' N ' HD23 ' A' ' 239' ' ' LEU . 0.8 OUTLIER -138.95 164.39 29.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.867 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 233' ' ' TYR . 8.2 t -131.29 151.42 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.942 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.57 126.2 52.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.98 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.28 122.91 12.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.809 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -105.32 141.16 37.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.904 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -124.85 153.05 43.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.898 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -97.25 -171.2 2.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.061 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.08 112.9 3.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.878 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.02 97.77 11.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER 60.32 159.35 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -85.98 -65.5 1.01 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.806 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.4 157.39 17.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.733 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 69.89 -59.4 0.51 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.268 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.2 t70 78.22 79.68 0.07 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.881 0.372 . . . . 0.0 110.851 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.09 83.25 6.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.85 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -133.88 -54.84 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.494 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 68.49 -67.84 0.19 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.313 . . . . 0.0 110.955 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 72.6 m 61.37 155.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.922 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -123.53 -44.05 2.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -114.39 178.6 4.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.97 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -83.4 159.71 21.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.6 117.85 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.878 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -91.14 -178.65 5.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.937 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -122.87 -54.71 1.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.067 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -128.38 147.43 17.43 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.504 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.24 142.97 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.769 0.319 . . . . 0.0 111.135 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -172.48 159.99 31.05 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.517 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.62 152.34 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.826 0.346 . . . . 0.0 111.142 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -136.23 136.04 39.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.969 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -134.35 157.88 45.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 4.8 p -118.86 147.02 44.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.851 -179.93 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.832 0.349 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.75 57.01 0.38 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 18.2 mtt85 61.04 29.92 19.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.986 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -133.45 66.6 1.55 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.753 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -173.77 -59.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.801 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 11.6 t90 -96.68 102.28 14.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.79 160.16 18.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.798 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.53 125.25 14.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -125.09 120.81 32.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.837 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 pp -130.52 126.74 61.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.12 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.98 164.56 25.79 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.539 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -125.8 147.81 49.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.796 0.332 . . . . 0.0 111.075 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.58 150.92 48.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.924 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -141.44 117.86 10.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.817 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -125.34 139.99 53.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.831 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.1 tp -96.21 139.68 18.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.047 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.79 147.36 44.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.963 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -140.84 131.55 25.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.822 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.4 m -147.96 32.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.081 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.85 172.68 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 153.97 45.82 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.434 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -112.26 114.17 26.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.779 0.324 . . . . 0.0 110.894 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.29 -68.58 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.46 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -133.58 -49.98 0.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.871 0.367 . . . . 0.0 110.909 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.75 118.04 31.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.846 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.43 148.17 30.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.843 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.23 -178.27 4.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.21 46.33 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.488 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.7 mp -89.4 144.63 25.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.826 0.346 . . . . 0.0 110.877 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.88 150.81 33.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.075 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -120.0 94.07 48.32 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.906 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.42 178.75 0.21 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.55 2.166 . . . . 0.0 112.258 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.09 135.08 26.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.836 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.59 141.53 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.113 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -140.26 122.25 15.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.929 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.411 ' CZ ' ' HB3' ' A' ' 47' ' ' LEU . 3.7 p90 -144.55 123.76 12.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.76 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -135.82 162.5 32.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.983 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.82 129.61 36.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.013 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.54 109.28 21.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.104 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -108.69 85.44 2.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.803 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.31 -147.57 47.41 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.4 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -51.26 -25.78 18.61 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.506 2.137 . . . . 0.0 112.36 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -92.64 148.4 22.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.809 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -140.6 137.23 33.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.945 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.6 pt -129.92 145.49 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.964 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.19 155.78 49.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.222 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 36' ' ' PHE . 3.6 mp -142.3 144.85 33.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.739 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -118.31 143.43 46.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.08 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -141.47 160.02 41.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -109.63 148.04 32.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.868 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.56 -179.53 4.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.81 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -153.03 139.83 19.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.981 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.23 65.63 0.25 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.459 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 145.01 56.06 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.563 2.175 . . . . 0.0 112.294 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.05 139.8 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.131 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.17 104.8 2.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -125.3 -44.58 1.87 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.935 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -152.38 150.33 29.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.867 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -97.29 153.99 17.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.145 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.95 38.22 3.2 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.504 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.24 67.14 0.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.946 0.403 . . . . 0.0 110.827 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -73.58 85.34 1.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.909 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -121.19 147.67 17.46 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.533 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.8 p -85.95 140.98 29.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.804 0.335 . . . . 0.0 110.904 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 7.6 m0 -122.37 135.45 54.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.823 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -116.44 173.39 6.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -131.03 134.91 47.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.86 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.75 95.87 24.86 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.884 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.34 170.25 18.8 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.484 2.123 . . . . 0.0 112.253 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.739 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 2.0 tt0 -153.59 140.34 19.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.025 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mt -126.04 146.31 49.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.804 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -152.28 119.89 6.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.031 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.39 138.87 31.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.042 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -129.52 135.14 48.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.064 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -124.05 110.8 15.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.712 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -65.59 137.14 57.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.043 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -50.92 147.09 5.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.199 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 16.8 mt -72.37 -66.3 0.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.743 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -71.1 -173.5 0.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.689 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -175.2 -32.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.41 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -45.88 -30.15 1.62 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.489 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.404 ' HB3' ' CD2' ' A' ' 83' ' ' PHE . 1.2 t70 -164.34 -64.97 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.97 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.437 ' CD1' HG13 ' A' ' 120' ' ' VAL . 23.5 m-85 -104.31 118.61 37.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.85 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.37 173.79 6.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.74 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.46 ' HE1' HD11 ' A' ' 87' ' ' LEU . 12.1 t80 -162.36 117.06 1.84 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.032 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.472 ' C ' HD12 ' A' ' 87' ' ' LEU . . . -132.19 -162.42 10.37 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.261 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.472 HD12 ' C ' ' A' ' 86' ' ' GLY . 4.0 mp -155.73 145.24 21.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 0.0 110.981 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 81.7 p -142.84 121.94 12.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.931 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -151.32 -159.01 8.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.522 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 174.3 176.64 42.84 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.554 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.433 ' CD2' ' N ' ' A' ' 91' ' ' PHE . 3.9 m-85 -122.27 173.82 7.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.845 0.355 . . . . 0.0 110.818 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.0 mmt85 -150.26 128.23 11.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.024 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -131.45 149.44 52.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.827 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.22 138.22 52.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.933 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -106.11 134.8 12.3 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.426 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -122.8 139.28 54.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.347 . . . . 0.0 110.955 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -151.36 102.54 2.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.805 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -173.36 -40.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.962 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.8 m 42.03 72.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.788 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.63 -31.43 72.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -115.72 97.68 49.41 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.25 114.17 1.2 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.499 2.133 . . . . 0.0 112.5 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 166.3 -86.17 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.486 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.67 30.58 0.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.921 0.391 . . . . 0.0 110.948 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.79 98.73 10.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.71 161.03 32.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -128.13 125.99 40.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.056 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -144.06 119.87 10.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.981 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.46 159.28 18.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.834 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.785 ' H ' ' HB2' ' A' ' 138' ' ' ALA . 8.0 mt-30 -146.61 104.64 3.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.842 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -105.04 127.12 52.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.876 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -96.76 122.22 39.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.94 121.72 45.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.899 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.633 HG22 ' HD3' ' A' ' 116' ' ' PRO . 17.5 mt -130.99 132.14 63.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.04 76.43 8.71 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.348 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.633 ' HD3' HG22 ' A' ' 114' ' ' ILE . 44.2 Cg_exo -56.52 168.17 2.35 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.526 2.15 . . . . 0.0 112.132 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -147.17 134.75 20.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.164 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -120.73 124.81 46.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.66 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -100.14 125.92 46.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.959 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.437 HG13 ' CD1' ' A' ' 83' ' ' PHE . 22.3 t -140.37 116.96 8.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.059 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 14.9 ttmt -88.66 144.36 26.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.922 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.29 -42.8 2.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -130.27 -170.75 2.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.841 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.44 ' H ' HG22 ' A' ' 123' ' ' THR . 79.1 m-20 -74.94 -47.99 26.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.88 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.713 ' C ' HD12 ' A' ' 126' ' ' LEU . 22.3 m-20 -110.19 29.78 7.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.713 HD12 ' C ' ' A' ' 125' ' ' ASP . 7.9 mp -138.15 133.86 33.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.864 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -142.51 152.71 42.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -141.51 135.29 30.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.802 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -154.55 168.12 27.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.062 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 151.83 177.37 25.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.562 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . 0.467 ' HA ' ' CE3' ' A' ' 131' ' ' TRP . 0.0 OUTLIER -173.21 -172.67 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.77 0.319 . . . . 0.0 110.777 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.496 HD23 ' O ' ' A' ' 152' ' ' GLU . 6.1 mt -100.83 150.39 22.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.956 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -101.67 152.19 21.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.936 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 5.0 mtp -132.37 125.43 30.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -118.51 125.6 50.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.938 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.07 156.3 41.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.897 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -110.35 -170.15 1.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.716 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.785 ' HB2' ' H ' ' A' ' 110' ' ' GLN . . . -81.47 149.72 28.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.078 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -62.97 -29.18 70.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.074 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -63.47 -40.12 96.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.008 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.594 ' O ' HG22 ' A' ' 144' ' ' THR . 19.1 mt -95.38 -30.22 14.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.084 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -59.23 -27.19 65.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.945 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 p -57.77 -36.09 71.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.018 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.594 HG22 ' O ' ' A' ' 141' ' ' LEU . 5.6 t -90.67 -33.72 15.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.969 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.68 -29.38 61.49 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.521 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 66.49 -75.8 0.05 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.816 0.341 . . . . 0.0 111.065 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -91.4 -86.92 0.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.21 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.0 t0 51.51 27.0 3.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.824 0.345 . . . . 0.0 111.148 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 37.2 p -83.43 120.83 26.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.971 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.7 ttp180 -105.26 120.69 42.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.833 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.416 HG23 ' HG2' ' A' ' 175' ' ' ARG . 6.2 m -120.67 116.97 51.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.091 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.496 ' O ' HD23 ' A' ' 132' ' ' LEU . 6.9 mp0 -108.2 153.72 22.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.932 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.4 m -101.12 132.49 46.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.887 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -129.43 116.94 19.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.623 HG23 ' HB2' ' A' ' 171' ' ' TYR . 1.4 t -140.69 113.82 8.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -114.53 147.28 18.82 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.678 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.42 HD21 ' HB ' ' A' ' 169' ' ' VAL . 1.9 pp -123.0 117.29 25.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 110.738 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.68 127.06 35.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.106 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -140.81 100.16 3.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.795 HG23 ' HB2' ' A' ' 166' ' ' ALA . 2.8 m -106.95 137.21 45.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.079 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -99.72 -30.92 11.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.798 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.408 ' O ' HG22 ' A' ' 160' ' ' THR . 12.9 t30 -151.11 -179.09 7.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.808 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -87.61 6.23 35.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.373 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 60.2 p -103.41 -31.04 10.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.818 0.342 . . . . 0.0 110.982 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.778 HG23 ' HG ' ' A' ' 199' ' ' LEU . 11.3 p -147.67 152.03 13.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.145 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.795 ' HB2' HG23 ' A' ' 160' ' ' THR . . . -141.7 158.9 43.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.019 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.708 HD12 ' HB3' ' A' ' 197' ' ' LEU . 4.7 tp -115.52 143.01 45.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.952 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 32.1 mtp180 -147.36 124.0 11.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.024 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.42 ' HB ' HD21 ' A' ' 157' ' ' LEU . 21.5 t -124.41 123.76 66.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.007 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -121.1 145.98 47.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.141 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.623 ' HB2' HG23 ' A' ' 155' ' ' THR . 13.3 m-85 -112.92 130.85 55.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.746 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -111.18 138.12 48.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.037 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.761 HD12 ' HA ' ' A' ' 191' ' ' GLN . 4.6 tp -139.95 151.1 45.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.808 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -138.09 144.73 41.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.006 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.428 ' NH1' HD23 ' A' ' 173' ' ' LEU . 0.1 OUTLIER -160.06 116.58 2.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.959 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -123.06 169.91 15.41 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.398 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -150.19 163.93 36.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.804 0.335 . . . . 0.0 110.928 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -128.89 124.22 34.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.854 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 10.7 mtt -78.17 -27.24 47.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.048 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.84 -51.14 70.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.968 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -156.55 173.67 16.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.904 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.0 m -97.58 38.04 1.32 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -64.39 166.4 8.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -73.49 -43.14 60.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -78.09 86.07 4.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 154.4 -34.44 0.7 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.428 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.74 110.84 20.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.857 0.36 . . . . 0.0 110.845 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -177.13 179.29 1.02 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.82 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.9 m -142.24 148.83 38.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.944 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 17.0 p -130.39 162.6 28.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.761 ' HA ' HD12 ' A' ' 173' ' ' LEU . 4.0 pt20 -137.45 133.24 34.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.936 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -134.74 173.18 11.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.57 HG22 ' CE2' ' A' ' 171' ' ' TYR . 1.1 pt -137.36 142.33 37.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.249 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.51 114.49 16.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.761 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -115.76 118.97 34.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.251 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.442 ' CD2' ' N ' ' A' ' 196' ' ' TYR . 1.9 p90 -145.36 137.09 25.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.706 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.708 ' HB3' HD12 ' A' ' 167' ' ' LEU . 0.8 OUTLIER -128.37 109.41 19.37 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.053 -179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.812 ' HA ' HG23 ' A' ' 207' ' ' THR . 23.4 Cg_exo -64.15 142.54 80.82 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.5 2.133 . . . . 0.0 112.152 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.778 ' HG ' HG23 ' A' ' 165' ' ' VAL . 0.3 OUTLIER -130.02 100.01 5.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.791 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 35.1 p -107.04 102.97 12.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.957 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 2.9 tt -140.54 129.86 23.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.884 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 72.32 -128.78 13.87 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.472 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -117.52 30.1 7.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.855 0.359 . . . . 0.0 110.931 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -135.6 149.08 49.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 88.8 p -121.01 121.51 38.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.936 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.653 HG13 ' O ' ' A' ' 230' ' ' PHE . 21.5 t -135.31 139.94 45.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.825 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.812 HG23 ' HA ' ' A' ' 198' ' ' PRO . 2.0 m -138.69 92.97 11.11 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.403 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.01 111.52 2.47 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.618 2.212 . . . . 0.0 112.116 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -111.23 169.03 9.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 0.0 111.109 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.605 HG22 HG12 ' A' ' 227' ' ' VAL . 14.6 p -138.62 138.86 38.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.843 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 -125.2 164.81 19.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.934 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 1.2 pp -64.02 148.97 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.101 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.92 -178.52 18.24 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.524 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.543 HD23 ' N ' ' A' ' 215' ' ' ARG . 2.3 tt -121.44 159.39 26.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.772 0.32 . . . . 0.0 110.902 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.543 ' N ' HD23 ' A' ' 214' ' ' LEU . 20.9 ttt85 -154.97 146.22 22.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -171.22 36.52 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.64 -178.34 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -120.07 144.93 47.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.893 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 140.09 -35.1 1.94 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.554 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 60.7 80.13 0.22 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.802 0.334 . . . . 0.0 110.914 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -107.04 -29.85 4.43 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.45 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -115.31 -176.31 2.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.821 0.343 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -110.87 161.81 15.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -97.46 40.22 1.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -117.36 85.48 2.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.991 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.4 144.41 26.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.737 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.605 HG12 HG22 ' A' ' 210' ' ' THR . 16.7 m -145.1 153.32 14.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.259 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -139.44 160.01 25.88 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.312 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.22 113.68 9.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.808 0.337 . . . . 0.0 111.048 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.653 ' O ' HG13 ' A' ' 206' ' ' VAL . 2.0 t80 -97.71 130.6 44.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.721 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -111.05 155.72 22.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.05 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -165.51 117.21 0.74 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.041 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.44 ' HB3' HG22 ' A' ' 241' ' ' VAL . 26.2 t80 -132.38 121.16 23.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.748 0.309 . . . . 0.0 111.181 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 240' ' ' SER . 2.4 p30 -108.71 128.53 54.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -54.98 -24.71 25.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.998 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -156.36 -45.44 0.07 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.836 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 179.51 -55.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -63.72 -78.88 0.17 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.691 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.827 HD23 ' CD2' ' A' ' 269' ' ' TYR . 3.1 mp -66.42 140.0 58.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.794 0.33 . . . . 0.0 110.9 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -157.14 176.84 12.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.048 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.565 HG12 HG12 ' A' ' 267' ' ' VAL . 30.2 m -122.01 170.39 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.825 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 36.4 t -142.27 131.84 23.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.828 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.691 ' HG ' HG12 ' A' ' 265' ' ' VAL . 2.3 tt -136.35 126.86 26.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.002 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -119.45 139.39 52.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -152.02 151.83 31.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.979 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -160.19 -76.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.048 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 63.13 125.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.986 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -76.71 -176.44 3.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER 60.27 109.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.821 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -75.87 145.38 40.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -128.21 160.64 31.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.41 -51.8 2.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.932 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -143.7 -59.28 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.83 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -148.22 156.02 42.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -150.69 -61.94 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.42 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -137.23 173.11 12.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.847 0.356 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 2.9 t -106.46 52.23 0.73 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.919 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -98.44 27.54 4.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.982 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 1.8 mtmp? 56.84 174.97 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.932 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -83.03 -41.12 19.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 59.7 103.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -72.42 151.91 42.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.86 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -85.77 -72.73 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.045 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -144.58 148.08 19.65 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.445 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.691 HG12 ' HG ' ' A' ' 243' ' ' LEU . 21.8 m -147.47 141.83 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 0.0 111.134 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -158.47 175.04 35.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.54 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.565 HG12 HG12 ' A' ' 241' ' ' VAL . 9.2 m -130.33 162.86 37.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.79 0.329 . . . . 0.0 111.148 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -136.33 143.12 43.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.862 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.827 ' CD2' HD23 ' A' ' 239' ' ' LEU . 25.1 m-85 -139.18 101.7 4.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 59.4 p -110.77 131.7 54.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.903 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.838 0.352 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -120.76 36.11 4.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.929 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.26 -44.47 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.99 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -154.9 167.81 29.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.957 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -167.73 96.37 0.45 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.803 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 60.6 p-90 -107.83 149.89 27.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.943 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.505 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -118.2 144.71 45.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -118.72 130.03 55.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.51 128.61 19.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.553 HD12 ' HE1' ' A' ' 36' ' ' PHE . 11.7 tt -155.29 131.21 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.051 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.98 -157.99 7.73 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.553 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.79 -176.95 1.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.796 0.332 . . . . 0.0 111.04 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.5 ttt -152.94 150.13 28.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.34 138.21 26.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.854 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -129.98 124.19 32.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.952 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.8 mt 59.71 87.48 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.54 31.35 5.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.901 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.96 124.24 26.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.851 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.23 83.59 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.101 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -65.27 -67.94 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 173.97 -119.67 0.75 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.493 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 60.44 87.63 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.358 . . . . 0.0 110.921 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.65 14.58 77.81 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.776 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 55.72 -178.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.788 0.327 . . . . 0.0 111.119 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -167.04 92.64 0.43 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.921 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.4 mtt -68.53 -67.99 0.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.866 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.19 91.47 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.942 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.559 ' O ' HG22 ' A' ' 55' ' ' VAL . . . -85.24 135.44 13.47 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.486 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.36 113.5 25.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.901 0.381 . . . . 0.0 110.918 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.7 119.5 19.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.066 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -121.75 94.09 48.45 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.05 123.83 10.38 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.482 2.121 . . . . 0.0 112.269 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.28 137.97 46.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.026 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -137.22 142.1 38.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -133.29 156.21 48.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.942 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.553 ' HE1' HD12 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -153.5 132.52 12.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.881 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.23 126.55 19.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.966 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.16 135.41 45.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.053 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.505 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -124.45 149.82 46.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.169 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -173.91 140.41 0.73 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.83 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 54.16 -149.39 17.37 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.511 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -86.19 42.03 0.91 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.807 2.338 . . . . 0.0 112.729 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -170.95 163.7 7.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.804 0.335 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -141.28 163.74 32.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.938 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mp -142.31 139.62 29.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.74 144.68 45.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.173 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.06 165.0 24.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.851 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.668 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -156.36 135.11 11.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -139.65 118.96 12.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -146.53 160.96 41.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -127.82 144.0 51.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.933 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -132.27 127.95 36.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.37 157.24 7.17 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.582 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.93 158.14 57.73 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.645 2.23 . . . . 0.0 112.283 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 28' ' ' GLY . 10.8 m -90.25 121.06 40.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.108 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.11 155.9 26.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.943 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -128.35 101.62 6.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.05 -177.51 5.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.871 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -135.44 -47.27 0.69 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.125 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -159.51 72.16 0.23 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.556 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -162.38 -44.87 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.826 0.346 . . . . 0.0 110.817 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.0 mtt-85 -103.55 -176.47 3.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 165.88 65.64 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.493 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.52 122.44 47.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.815 0.34 . . . . 0.0 110.918 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -120.14 161.5 20.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -150.27 139.98 21.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -141.12 139.67 34.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.0 mtp180 -130.67 95.89 25.1 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.953 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.86 157.91 34.94 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.559 2.173 . . . . 0.0 112.365 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.668 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 6.4 tp10 -137.87 121.23 17.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 mp -114.65 145.21 42.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -153.82 160.27 42.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 73' ' ' VAL . 12.3 p -158.17 125.85 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.069 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -104.47 153.39 21.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -157.32 119.1 3.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -94.25 148.91 21.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -115.31 -62.51 1.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.837 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.7 mt -123.42 136.48 54.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.94 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -129.96 74.44 1.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -92.19 168.33 11.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -73.71 -27.75 61.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.956 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.445 ' HB3' ' CD2' ' A' ' 83' ' ' PHE . 12.7 m-20 -83.26 -64.21 1.21 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.939 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.538 ' HD1' HG22 ' A' ' 120' ' ' VAL . 12.6 m-85 -124.2 154.59 39.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.954 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.12 147.92 50.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.821 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.462 ' CE2' ' CZ3' ' A' ' 118' ' ' TRP . 29.3 m-85 -123.07 157.72 32.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.916 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -174.04 166.06 38.0 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.51 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.8 mt -144.3 137.07 26.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 0.0 110.874 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.93 123.37 19.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.53 149.81 16.88 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.547 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -161.48 156.68 28.2 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.422 ' HB3' ' CD1' ' A' ' 112' ' ' TRP . 8.1 p90 -150.1 167.71 26.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.789 0.328 . . . . 0.0 110.91 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.0 mtp85 -127.88 150.93 49.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.864 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -129.83 154.17 47.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.852 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.432 ' CD2' ' ND2' ' A' ' 139' ' ' ASN . 6.1 m-85 -126.62 145.26 50.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.869 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -126.67 130.04 6.84 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.52 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -124.29 139.13 54.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.767 0.318 . . . . 0.0 110.914 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -99.21 175.9 5.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -122.59 119.2 30.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.5 t -128.86 -52.15 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.116 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.84 -31.34 23.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.851 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.35 89.92 2.9 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.41 157.02 63.57 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.501 2.134 . . . . 0.0 112.353 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 114.05 20.08 6.13 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.647 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? 56.74 36.48 27.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.839 0.352 . . . . 0.0 111.092 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.57 122.69 20.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.6 t -140.76 167.37 22.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.926 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -124.49 173.78 8.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.076 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -139.71 104.31 4.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.026 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.3 mtm -143.44 154.15 43.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.728 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -166.94 -179.28 4.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.961 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -145.02 134.58 23.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.422 ' CD1' ' HB3' ' A' ' 91' ' ' PHE . 0.3 OUTLIER -107.71 164.54 12.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.814 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -164.02 138.8 5.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.934 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 32.1 mt -137.77 125.82 31.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.051 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -135.91 107.89 9.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.072 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.51 177.12 5.72 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.474 2.116 . . . . 0.0 112.296 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -131.62 135.43 46.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.929 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.462 ' CZ3' ' CE2' ' A' ' 85' ' ' PHE . 2.9 t-105 -145.34 139.4 26.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.867 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -143.47 149.5 37.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.83 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.538 HG22 ' HD1' ' A' ' 83' ' ' PHE . 21.4 t -136.67 115.89 15.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.158 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.62 103.51 15.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.7 mp -81.37 -51.45 8.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -147.47 177.52 9.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.848 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -60.02 -29.91 68.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.993 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -118.96 36.2 4.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.008 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.411 HD12 ' CE1' ' A' ' 159' ' ' TYR . 0.8 OUTLIER -156.85 125.09 5.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -146.36 128.68 15.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.829 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.34 151.66 19.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -133.84 154.14 51.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.76 136.16 3.82 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.449 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 4.3 p-90 -164.59 138.78 5.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.333 . . . . 0.0 110.987 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.3 mp -95.25 161.57 14.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.9 m -139.29 113.62 8.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.902 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 1.6 ttt -111.44 148.45 33.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -125.37 119.49 28.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.21 167.23 11.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.764 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 60.18 -174.18 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.827 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -168.43 144.63 3.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.893 0.378 . . . . 0.0 111.242 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.432 ' ND2' ' CD2' ' A' ' 94' ' ' TYR . 16.1 m120 -87.19 -29.59 21.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.903 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -130.5 71.81 1.47 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.8 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.0 mt -56.59 -25.0 51.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.101 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -60.42 -39.87 88.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 72.3 p -96.45 -34.51 11.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 2.2 m -91.65 12.66 20.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.361 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.69 -24.66 62.47 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.539 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -89.12 52.88 2.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.868 0.366 . . . . 0.0 110.901 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -176.09 108.34 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.108 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -63.51 -75.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.6 t -135.72 163.46 30.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.983 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.74 129.92 50.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.75 129.08 47.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.091 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.76 151.2 45.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 29.4 m -117.29 139.78 50.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.837 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.95 115.5 23.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.838 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 17.6 m -125.7 137.05 53.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.903 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -150.33 160.34 28.51 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.599 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.418 HD21 ' HB ' ' A' ' 169' ' ' VAL . 0.3 OUTLIER -129.38 134.24 47.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.86 0.362 . . . . 0.0 110.921 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -113.79 114.29 26.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.961 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.411 ' CE1' HD12 ' A' ' 126' ' ' LEU . 9.5 t80 -126.78 113.44 16.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.725 HG23 ' HB2' ' A' ' 166' ' ' ALA . 6.2 m -103.12 136.49 42.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.102 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -103.99 -31.1 9.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.764 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -170.96 173.14 5.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.766 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.62 -14.39 62.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.344 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.711 HG23 HG12 ' A' ' 165' ' ' VAL . 9.1 t -76.24 -46.52 27.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.714 0.292 . . . . 0.0 111.032 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.711 HG12 HG23 ' A' ' 164' ' ' THR . 10.2 p -156.22 154.06 6.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.2 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.885 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -133.36 -172.74 3.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.028 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.404 ' HG ' HD21 ' A' ' 197' ' ' LEU . 1.5 mp -135.87 138.14 42.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.958 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.38 128.31 14.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.921 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.418 ' HB ' HD21 ' A' ' 157' ' ' LEU . 21.2 t -122.27 136.78 57.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.117 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -118.97 149.47 41.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.413 ' CE1' HG12 ' A' ' 193' ' ' ILE . 0.5 OUTLIER -134.81 144.9 47.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -124.48 136.19 53.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.977 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.426 HD12 ' HB3' ' A' ' 191' ' ' GLN . 1.2 tp -147.52 114.51 6.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 10.2 pm0 -143.67 162.53 35.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.023 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.4 ptt180 -140.17 166.55 24.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.817 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -138.49 160.02 25.45 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.558 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -119.1 130.7 55.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -97.34 162.12 13.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.03 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.99 -31.7 17.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -80.26 125.06 29.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.926 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -107.0 -31.77 8.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.835 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.11 63.94 1.9 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.17 -58.85 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.958 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -173.84 -61.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -176.8 132.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.836 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -96.47 27.97 15.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.512 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -102.33 80.81 1.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.763 0.316 . . . . 0.0 110.862 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.52 137.01 35.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.858 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 11.9 m -130.69 121.47 25.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.956 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 14.0 p -124.35 153.63 41.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.426 ' HB3' HD12 ' A' ' 173' ' ' LEU . 2.8 pp0? -153.96 128.44 9.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.834 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.21 137.85 54.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.5 HD12 HG21 ' A' ' 212' ' ' ILE . 22.6 mt -102.12 139.22 23.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.094 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 15.5 ttt85 -134.04 133.42 41.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -111.3 126.44 54.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.139 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.418 ' CD1' ' HB3' ' A' ' 209' ' ' TYR . 0.3 OUTLIER -131.67 116.14 16.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.772 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.404 HD21 ' HG ' ' A' ' 167' ' ' LEU . 0.4 OUTLIER -116.81 109.67 42.94 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.087 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.885 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 91.0 Cg_endo -79.0 138.22 14.36 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.409 2.073 . . . . 0.0 112.388 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.526 HD23 ' N ' ' A' ' 200' ' ' THR . 1.7 tt -132.76 155.91 48.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.929 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . 0.526 ' N ' HD23 ' A' ' 199' ' ' LEU . 44.0 m -132.93 116.94 17.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.22 102.57 3.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.76 -137.52 15.31 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.485 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.03 23.66 14.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 0.0 111.043 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -136.44 132.99 36.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.764 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 84.8 p -96.69 134.44 39.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.954 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 20.8 t -135.38 131.5 51.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.85 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.705 HG22 ' HA ' ' A' ' 198' ' ' PRO . 14.3 p -133.61 92.82 22.59 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.302 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.34 124.71 9.15 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.432 2.088 . . . . 0.0 111.951 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.434 ' CZ ' ' HA3' ' A' ' 228' ' ' GLY . 48.2 p90 -111.12 136.23 50.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.932 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 24.7 m -111.12 159.64 17.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.938 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 -127.35 126.76 43.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.851 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.5 HG21 HD12 ' A' ' 193' ' ' ILE . 0.7 OUTLIER -72.58 136.14 26.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.205 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 177.66 56.77 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.57 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.475 HD22 ' HA2' ' A' ' 219' ' ' GLY . 1.7 tt -152.34 74.66 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.864 0.364 . . . . 0.0 110.907 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -109.74 88.17 2.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.83 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -131.06 -53.9 1.04 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.977 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.19 -70.97 0.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.867 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -151.13 36.23 0.6 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.804 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.475 ' HA2' HD22 ' A' ' 214' ' ' LEU . . . 71.4 172.57 14.83 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.454 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.34 -56.89 1.15 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.859 0.361 . . . . 0.0 110.907 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 169.3 -33.81 0.18 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.491 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -84.64 160.68 20.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.776 0.322 . . . . 0.0 110.942 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 60.14 177.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 4.0 t80 60.92 43.27 11.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -157.16 57.25 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.929 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 48.1 mtm-85 60.33 98.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.906 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 17.6 m -86.65 -13.62 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.477 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.434 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . -149.8 171.65 29.82 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.452 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.08 129.53 11.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.918 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -107.01 114.5 28.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.748 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -90.93 162.1 14.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.035 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -153.95 117.03 0.77 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.111 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 240' ' ' SER . 0.8 OUTLIER -110.86 115.45 29.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.791 0.329 . . . . 0.0 111.142 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -120.06 85.44 2.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.564 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.95 -12.7 19.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.272 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.31 35.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.736 0.303 . . . . 0.0 111.137 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 68.91 -65.44 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.061 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -48.43 -59.33 6.59 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.725 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.519 HD23 ' C ' ' A' ' 239' ' ' LEU . 7.6 tt -80.95 107.37 13.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.764 0.316 . . . . 0.0 110.766 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 233' ' ' TYR . 30.5 t -113.19 154.37 26.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.476 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 39.1 t -122.38 142.53 38.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.779 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 27.3 m -116.45 118.84 33.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.008 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' A' ' 243' ' ' LEU . 0.9 OUTLIER -128.34 124.37 36.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.771 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -105.23 133.56 49.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.945 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -121.9 159.38 26.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -116.76 -79.22 0.59 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.073 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 60.95 98.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -155.42 162.45 40.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -133.02 112.13 11.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -90.83 167.45 12.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -141.74 132.58 25.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 60.26 166.05 0.07 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.865 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 60.44 104.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.849 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -124.31 -61.8 1.32 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 71.51 -129.71 17.18 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -99.5 -178.07 3.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.86 0.362 . . . . 0.0 110.862 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.25 95.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.985 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -75.18 177.89 6.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -134.7 119.99 18.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.953 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -130.83 177.58 7.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -73.14 120.9 19.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.912 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -94.58 -63.28 1.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -158.11 134.75 9.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.042 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . 0.418 ' O ' HD13 ' A' ' 243' ' ' LEU . . . -103.45 136.13 12.75 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.543 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 16.5 t -120.11 141.71 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.87 0.367 . . . . 0.0 111.092 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -166.2 164.31 37.46 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.518 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 5.7 m -132.72 166.73 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.853 0.358 . . . . 0.0 111.109 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -158.75 120.76 3.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.956 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.45 ' HB2' HG23 ' A' ' 10' ' ' ILE . 62.3 m-85 -112.78 105.75 13.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.794 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.59 118.34 36.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.873 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.827 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.883 0.373 . . . . 0.0 111.175 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -100.18 103.96 15.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.945 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.79 109.2 5.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.902 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -116.92 -48.43 2.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.916 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -125.76 32.14 5.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -123.84 112.88 17.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.84 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.99 146.17 46.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.4 130.48 52.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.716 ' O ' HD13 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -123.2 129.32 51.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.716 HD13 ' O ' ' A' ' 9' ' ' ASN . 24.0 mm -138.9 127.78 29.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.098 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.96 -178.77 35.23 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.508 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.35 -176.89 5.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 0.0 111.072 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.44 152.36 21.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.82 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -150.89 118.42 6.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.92 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.29 151.06 51.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.863 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.9 mt -148.29 86.61 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.092 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -117.68 175.49 5.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -163.82 117.88 1.52 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.93 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.2 -37.82 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.068 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.65 -68.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.855 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.24 -159.05 4.19 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.457 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 23' ' ' GLY . 29.6 p90 -170.53 -42.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.83 0.348 . . . . 0.0 110.914 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.449 ' N ' ' CD1' ' A' ' 22' ' ' TYR . . . -66.42 105.24 1.23 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.56 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -143.36 137.94 29.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.85 0.357 . . . . 0.0 110.929 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -87.62 -71.76 0.55 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.5 ptm -158.36 -47.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.44 178.14 6.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 157.94 -157.46 28.26 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.529 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.05 159.9 32.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.902 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.84 138.11 31.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.138 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -136.64 94.13 13.54 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.926 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.72 167.41 25.76 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.555 2.17 . . . . 0.0 112.254 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.9 t -152.95 136.45 15.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 t -115.02 144.76 21.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.159 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -125.77 136.57 53.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.516 ' CZ ' HD12 ' A' ' 10' ' ' ILE . 1.2 m-85 -131.51 161.87 31.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.873 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -165.01 144.72 6.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.3 117.46 9.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.125 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.06 135.41 47.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.122 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -158.12 111.4 2.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 58.76 -149.29 37.49 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.579 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.76 -10.7 28.28 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.571 2.181 . . . . 0.0 112.6 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -99.87 143.04 30.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.893 0.378 . . . . 0.0 110.941 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -129.99 142.08 50.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.812 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.8 mt -129.64 147.54 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.206 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -153.71 147.46 25.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.027 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.408 HD12 ' CE2' ' A' ' 49' ' ' TYR . 0.3 OUTLIER -146.16 169.22 19.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.934 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -149.43 137.37 20.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.042 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.408 ' CE2' HD12 ' A' ' 47' ' ' LEU . 70.9 m-85 -115.89 148.94 39.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.951 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -131.46 144.63 51.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.2 162.78 31.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -137.17 119.43 15.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.968 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.4 ' N ' ' HD3' ' A' ' 54' ' ' PRO . . . -142.95 60.95 0.53 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.533 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 53' ' ' GLY . 52.0 Cg_exo -54.52 177.93 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.577 2.185 . . . . 0.0 112.238 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 p -77.42 131.06 35.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.065 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -77.55 154.92 31.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.949 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -150.07 -63.07 0.21 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.86 133.71 9.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.814 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.95 -74.0 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.077 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.66 -49.72 3.16 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.49 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -141.25 31.38 1.74 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.85 0.357 . . . . 0.0 110.93 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.76 97.49 5.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.8 88.74 0.18 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.531 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.483 ' O ' HG23 ' A' ' 64' ' ' THR . 10.1 t -107.36 114.34 28.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.843 0.354 . . . . 0.0 110.899 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.39 153.77 28.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.877 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -140.27 136.84 33.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.37 146.44 46.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.87 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -151.2 95.87 3.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.902 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.91 133.33 16.6 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.556 2.17 . . . . 0.0 112.33 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -106.87 125.76 51.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.433 HD13 ' CZ ' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -121.29 141.25 51.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.804 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -145.67 141.14 27.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.942 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.2 t -127.85 119.54 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.07 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -107.98 121.91 45.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -97.59 140.31 32.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -109.81 105.22 14.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.922 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.47 -46.47 5.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.808 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 tp -138.91 145.3 39.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.861 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -156.63 79.77 0.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.77 -170.59 1.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.978 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -85.38 -22.28 28.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.15 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -120.86 -47.21 2.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.787 0.327 . . . . 0.0 111.065 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.437 ' CE2' HG12 ' A' ' 120' ' ' VAL . 1.6 t80 -103.28 143.67 32.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.057 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.4 t -143.52 155.24 44.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.83 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -153.14 149.39 27.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 171.17 -178.67 43.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.438 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mp -142.39 145.18 33.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.823 0.344 . . . . 0.0 110.939 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.9 m -132.89 123.23 25.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.16 177.61 19.43 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.553 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.47 -175.37 46.97 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.441 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.433 ' CZ ' HD13 ' A' ' 71' ' ' LEU . 36.9 p90 -163.43 149.65 11.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.783 0.325 . . . . 0.0 111.014 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -113.1 159.88 18.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -130.74 143.43 50.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.851 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -148.84 119.43 7.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.952 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.63 -174.85 43.46 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.478 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -60.58 171.72 1.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.858 0.361 . . . . 0.0 110.852 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -113.73 -47.68 2.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.795 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -142.94 139.4 30.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.558 ' O ' HG13 ' A' ' 99' ' ' VAL . 11.3 p -140.93 113.45 4.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.111 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.17 -41.22 81.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.006 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -116.03 82.82 11.49 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.39 146.95 39.04 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.572 2.181 . . . . 0.0 112.216 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 101.39 -19.07 52.45 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.669 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.69 -68.06 0.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.837 0.351 . . . . 0.0 111.069 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -154.11 123.5 6.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.887 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.5 t -160.31 147.57 16.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.56 ' HB3' ' CE ' ' A' ' 109' ' ' MET . . . -134.84 162.65 31.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -105.02 111.07 23.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.56 ' CE ' ' HB3' ' A' ' 107' ' ' ALA . 1.8 mpt? -131.23 141.09 49.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.432 ' HG2' ' CD2' ' A' ' 137' ' ' PHE . 5.3 pt20 -163.11 172.16 15.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.915 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.0 mtt-85 -152.97 109.23 3.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 11.0 m95 -87.38 154.51 20.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.815 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.402 ' HE2' ' CE1' ' A' ' 135' ' ' TYR . 65.3 mttt -145.05 125.39 13.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.043 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.3 mt -140.17 124.91 19.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.983 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.706 ' HB2' ' HA ' ' A' ' 133' ' ' SER . . . -149.15 99.49 3.44 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.222 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.07 169.94 0.26 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.463 2.109 . . . . 0.0 112.22 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -125.78 134.9 51.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.001 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -144.56 127.05 15.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.52 142.75 45.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.437 HG12 ' CE2' ' A' ' 83' ' ' PHE . 6.9 m -153.93 118.35 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.188 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -88.09 139.07 30.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.8 tt -102.89 -31.18 10.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.902 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.737 HG23 ' H ' ' A' ' 125' ' ' ASP . 12.4 t -156.35 -164.01 1.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.851 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -93.79 20.58 7.43 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.35 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.737 ' H ' HG23 ' A' ' 123' ' ' THR . 2.5 p30 -158.11 26.13 0.26 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.714 0.293 . . . . 0.0 111.094 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.598 ' HB2' HG22 ' A' ' 123' ' ' THR . 0.1 OUTLIER -157.09 108.72 2.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.823 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -113.41 122.36 47.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -105.39 130.89 53.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -145.61 137.29 25.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.04 156.78 26.63 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.545 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 37.4 p-90 -173.01 127.0 0.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.743 0.306 . . . . 0.0 110.959 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.461 ' O ' HD12 ' A' ' 132' ' ' LEU . 3.1 pp -104.33 124.97 50.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.843 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.706 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 30.7 t -99.76 150.13 22.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.991 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.465 ' CG ' HG12 ' A' ' 151' ' ' VAL . 15.1 mtm -130.56 145.32 51.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.738 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.45 ' N ' ' CD2' ' A' ' 135' ' ' TYR . 2.7 m-85 -119.12 133.62 55.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.907 0.384 . . . . 0.0 110.976 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -128.99 145.63 51.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.802 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.432 ' CD2' ' HG2' ' A' ' 110' ' ' GLN . 0.5 OUTLIER 60.67 164.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -172.28 -177.3 1.79 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.156 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -68.95 -63.89 0.97 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -165.34 32.44 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.888 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.9 mp -92.91 -31.7 14.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -60.09 -30.89 69.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.943 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 70.2 p -68.66 -31.05 69.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.63 -34.7 19.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.832 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.68 -33.85 20.73 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.474 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 59.75 33.74 21.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 0.0 110.946 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -88.12 174.47 8.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.096 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -101.02 -66.73 0.89 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.884 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.79 148.45 45.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.933 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.444 ' HG2' ' CD2' ' A' ' 135' ' ' TYR . 5.8 tpp180 -105.12 136.42 44.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.828 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.465 HG12 ' CG ' ' A' ' 134' ' ' MET . 28.3 m -149.66 142.58 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.174 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -144.6 127.86 16.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.8 m -96.92 131.93 43.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.893 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.4 ' OE1' ' CD1' ' A' ' 172' ' ' TYR . 25.5 mp0 -124.93 120.39 31.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.977 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 14.9 p -119.19 122.92 43.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -106.3 136.7 13.44 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.495 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 3.3 mt -119.25 118.25 30.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.848 0.356 . . . . 0.0 110.9 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -100.0 142.61 31.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -140.82 100.2 3.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.848 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.28 113.8 14.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.931 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.73 -32.75 16.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.807 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.422 ' HB2' HG22 ' A' ' 165' ' ' VAL . 5.9 m-20 -158.06 -173.38 4.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.813 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -87.73 6.05 36.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.406 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.505 ' O ' HG22 ' A' ' 164' ' ' THR . 22.8 m -136.39 12.89 3.26 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.559 0.219 . . . . 0.0 111.324 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 164' ' ' THR . 16.6 m -158.28 155.12 4.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.852 0.358 . . . . 0.0 111.131 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.692 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -149.43 176.79 10.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.093 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.7 124.09 12.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.433 ' HD2' ' CE2' ' A' ' 196' ' ' TYR . 79.6 mtt180 -124.74 142.04 51.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.1 118.83 16.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.113 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -97.88 138.85 34.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.22 112.33 18.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.4 ' CD1' ' OE1' ' A' ' 154' ' ' GLU . 5.3 m-85 -96.33 138.02 34.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.868 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 6.5 mt -143.5 108.72 5.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.87 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.508 ' HB3' HG23 ' A' ' 190' ' ' THR . 1.6 tt0 -125.07 152.12 44.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -151.23 136.83 17.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.946 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -99.05 150.29 19.25 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.536 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -122.22 162.03 22.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.331 . . . . 0.0 110.887 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -126.83 176.71 7.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.805 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 40.4 mtm -60.49 -42.9 97.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.88 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 60.5 96.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.904 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -139.35 -55.81 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 6.1 m -96.85 -53.48 3.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.95 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.57 160.49 26.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.841 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -128.28 89.37 2.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -152.56 30.93 0.52 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -113.38 32.73 5.92 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.521 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.34 100.54 11.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.825 0.345 . . . . 0.0 110.82 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -80.48 138.12 36.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.807 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.57 129.75 43.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.956 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.508 HG23 ' HB3' ' A' ' 174' ' ' GLU . 1.7 t -150.25 114.86 5.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.79 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -122.02 143.27 49.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.092 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -142.8 152.37 42.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.767 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.597 HD11 HD12 ' A' ' 212' ' ' ILE . 1.7 pp -137.65 134.84 46.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.937 0.398 . . . . 0.0 111.366 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -139.51 124.94 19.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.581 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.547 ' HB3' ' OG1' ' A' ' 210' ' ' THR . . . -119.41 154.43 33.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.058 0.456 . . . . 0.0 111.591 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.573 ' HB2' HG22 ' A' ' 207' ' ' THR . 1.8 p90 -155.35 138.83 15.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.318 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.476 ' O ' ' HD2' ' A' ' 208' ' ' PRO . 5.4 mp -97.94 109.37 51.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.263 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.692 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 87.1 Cg_endo -83.2 108.76 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.486 2.124 . . . . 0.0 112.358 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 1.1 pp -126.29 140.75 52.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.974 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 60.3 p -131.59 128.13 38.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.869 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.9 mt -127.82 104.69 7.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 65.63 -96.37 0.25 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.584 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -127.92 31.2 5.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.802 0.334 . . . . 0.0 110.946 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -125.85 155.34 41.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.765 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.57 128.66 29.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.986 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.2 t -140.12 110.97 4.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.855 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.573 HG22 ' HB2' ' A' ' 196' ' ' TYR . 2.1 m -121.33 93.06 48.81 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.404 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 197' ' ' LEU . 33.8 Cg_exo -61.72 171.76 4.33 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.587 2.191 . . . . 0.0 111.949 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.404 ' CD2' ' HB3' ' A' ' 196' ' ' TYR . 0.3 OUTLIER -134.21 127.9 32.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.957 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.547 ' OG1' ' HB3' ' A' ' 195' ' ' ALA . 1.1 p -116.81 126.18 52.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.847 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.469 ' HB3' HG21 ' A' ' 227' ' ' VAL . 40.5 ttp180 -146.59 121.45 9.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.849 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.597 HD12 HD11 ' A' ' 193' ' ' ILE . 10.8 mt -66.37 134.68 29.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.091 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -129.98 47.74 1.0 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.477 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.433 HD23 HG23 ' A' ' 212' ' ' ILE . 3.9 mm? -89.6 132.44 35.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 110.974 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.58 33.49 18.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -98.0 -30.31 12.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 1.6 m -174.54 -69.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.908 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -79.49 135.87 36.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -134.44 58.82 0.68 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.601 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.5 -40.11 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.775 0.321 . . . . 0.0 110.912 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 142.78 51.29 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.537 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.71 166.87 23.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.835 0.35 . . . . 0.0 110.831 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 60.52 111.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.928 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -124.76 -59.32 1.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.868 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.513 ' HB3' HG22 ' A' ' 210' ' ' THR . 0.6 OUTLIER -136.79 -56.53 0.73 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.925 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 5.0 tpp180 -58.07 103.68 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.469 HG21 ' HB3' ' A' ' 211' ' ' ARG . 4.1 m -113.37 -31.51 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.331 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -161.62 179.93 36.7 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.483 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 208' ' ' PRO . 0.4 OUTLIER -152.02 146.12 25.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.85 0.357 . . . . 0.0 111.054 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -109.25 148.82 30.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.732 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.85 137.4 54.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -133.49 117.18 1.84 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.284 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.406 ' HB3' ' CG2' ' A' ' 241' ' ' VAL . 0.3 OUTLIER -113.11 122.5 47.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.898 0.38 . . . . 0.0 111.033 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.44 92.59 3.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.58 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -69.12 -6.84 31.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.431 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.59 31.49 0.13 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.667 0.27 . . . . 0.0 111.117 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 1.2 m120 67.91 -66.1 0.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.037 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -50.6 -59.35 7.96 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.601 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.452 HD22 ' CE1' ' A' ' 269' ' ' TYR . 1.1 mt -69.25 142.59 54.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.69 0.281 . . . . 0.0 110.698 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.8 p -137.0 148.91 47.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.943 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.409 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 40.2 t -116.27 141.18 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.818 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 20.1 m -111.4 126.37 54.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.136 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 1.1 tt -149.42 124.86 10.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.741 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -105.32 150.64 25.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.059 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -155.54 149.67 25.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.829 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -122.69 116.23 23.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.166 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -75.18 -67.94 0.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.8 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 59.48 166.23 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 59.97 162.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.46 155.4 16.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.843 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.06 76.15 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -118.24 -38.77 3.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.957 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.3 t0 62.62 86.16 0.12 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -117.13 -67.26 1.01 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.888 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 133.82 170.1 12.25 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.488 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 60.41 30.68 19.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.82 0.343 . . . . 0.0 110.911 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -139.11 -52.78 0.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.48 138.11 54.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.913 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -144.33 -47.22 0.26 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.847 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -140.15 170.81 15.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.976 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -154.36 152.48 30.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.923 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.84 -53.81 6.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.818 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . 60.88 165.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.16 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -109.1 164.79 12.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.509 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 21.5 t -150.8 138.55 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.952 0.406 . . . . 0.0 111.128 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -153.0 179.03 29.76 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.501 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 6.2 m -149.99 139.45 15.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.904 0.383 . . . . 0.0 111.198 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -129.38 129.36 44.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.452 ' CE1' HD22 ' A' ' 239' ' ' LEU . 0.4 OUTLIER -125.7 123.98 40.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.902 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 37.6 p -109.2 134.86 51.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.864 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.922 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.873 0.368 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -145.03 30.56 1.15 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.839 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -85.87 -60.43 2.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.944 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -76.23 -175.07 3.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -170.66 97.37 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.994 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -89.79 96.99 10.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.825 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.616 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 1.5 m-70 -107.83 157.11 18.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.951 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.11 144.45 50.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.726 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -151.48 133.32 14.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.06 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 11' ' ' GLY . 3.5 mp -128.44 154.93 39.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.407 ' N ' HG22 ' A' ' 10' ' ' ILE . . . -149.9 153.4 25.08 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.666 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.504 ' HB3' ' CG2' ' A' ' 267' ' ' VAL . . . -129.29 154.84 46.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.825 0.345 . . . . 0.0 110.933 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.9 mtt -139.34 141.48 37.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.96 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.622 ' HB2' HG23 ' A' ' 265' ' ' VAL . 18.8 m-85 -137.83 113.59 9.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.808 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -146.98 159.07 44.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.858 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 pt -77.8 -179.01 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.1 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.28 -63.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.842 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -160.63 98.89 1.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.968 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 19' ' ' VAL . 17.0 m -99.2 87.47 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.111 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -60.69 147.01 43.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.892 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -153.59 -179.52 29.08 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.459 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -171.84 114.72 0.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.797 0.332 . . . . 0.0 110.927 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.94 -132.73 11.37 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.547 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -113.4 110.17 19.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.81 0.338 . . . . 0.0 110.885 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.62 150.41 48.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.813 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.8 ttp -104.35 -45.73 4.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.931 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -76.31 161.18 28.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -135.12 168.76 23.6 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.567 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 mp -94.0 140.62 29.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.852 0.358 . . . . 0.0 110.911 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.38 143.65 47.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.133 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -131.7 94.04 26.54 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.869 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.425 ' HB3' ' CE1' ' A' ' 14' ' ' TYR . 72.2 Cg_endo -74.84 156.68 43.73 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.555 2.17 . . . . 0.0 112.389 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 p -123.61 140.27 53.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.509 HG23 ' HB2' ' A' ' 49' ' ' TYR . 5.6 m -112.6 127.61 69.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -124.63 122.16 36.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.947 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -112.71 153.43 27.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -147.8 142.9 27.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.981 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.698 ' HB3' HG13 ' A' ' 45' ' ' ILE . . . -135.03 128.24 31.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.064 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.616 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -100.72 124.18 45.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.103 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -136.36 85.93 2.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 59.22 -150.43 37.08 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.527 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.05 -23.74 22.86 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.566 2.177 . . . . 0.0 112.388 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 20.6 m95 -101.54 150.21 23.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.988 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -142.34 151.76 42.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.804 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.698 HG13 ' HB3' ' A' ' 38' ' ' ALA . 18.7 pt -127.44 158.36 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.173 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.737 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -152.24 128.85 10.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.974 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 tp -120.28 129.2 53.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.929 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.88 139.75 50.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.025 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.509 ' HB2' HG23 ' A' ' 34' ' ' VAL . 2.5 m-85 -133.02 155.43 49.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -115.88 109.73 18.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.756 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -110.86 149.29 30.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -137.32 139.96 41.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.798 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.456 ' N ' ' HD3' ' A' ' 54' ' ' PRO . . . -139.05 61.78 0.57 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.568 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.456 ' HD3' ' N ' ' A' ' 53' ' ' GLY . 4.0 Cg_exo -76.58 177.93 8.21 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.859 2.372 . . . . 0.0 111.986 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.1 t -65.65 129.14 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.953 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -57.33 155.72 8.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.995 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -131.81 159.2 39.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.0 m -112.44 118.42 35.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.783 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -140.19 -47.12 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.106 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 120.94 41.53 0.51 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.483 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.6 tttt 60.2 73.13 0.49 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.883 0.373 . . . . 0.0 110.892 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.86 30.87 3.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.856 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.98 152.86 24.9 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.436 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 p -115.36 149.21 38.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 0.0 110.871 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.5 165.92 23.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.809 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -144.37 133.51 22.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.031 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.57 144.22 51.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.763 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -123.57 95.86 44.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.979 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.01 125.93 9.64 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.53 2.153 . . . . 0.0 112.178 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -127.74 118.49 23.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.057 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 mp -102.48 165.09 11.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.734 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.737 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 25.3 tt0 -160.81 138.19 9.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.126 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.3 t -123.95 115.93 46.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.797 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -102.03 123.97 46.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.161 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -114.15 123.08 48.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.656 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -65.52 122.9 18.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.053 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.408 ' HB2' ' N ' ' A' ' 85' ' ' PHE . 9.1 p90 -66.09 132.12 47.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.911 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 tp -161.25 140.57 10.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -176.72 -40.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.83 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -143.82 -169.29 3.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.853 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.74 -37.97 48.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.925 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -112.93 -32.24 6.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.022 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -92.43 137.49 32.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.921 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.6 m -145.26 173.2 12.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.408 ' N ' ' HB2' ' A' ' 77' ' ' PHE . 6.5 t80 -162.39 117.08 1.84 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.919 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -107.67 -162.3 21.35 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.548 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 tp -160.38 116.3 2.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.823 0.344 . . . . 0.0 110.968 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.1 m -111.23 107.81 17.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.827 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -102.93 176.24 24.65 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -172.23 163.15 35.32 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.571 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 92' ' ' ARG . 13.0 t80 -135.12 153.97 51.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.808 0.337 . . . . 0.0 110.862 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.425 ' N ' ' CD1' ' A' ' 91' ' ' PHE . 1.9 ttt180 -149.12 129.89 14.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -137.15 158.9 43.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -132.66 138.98 47.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -89.69 173.28 39.97 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.533 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -65.84 164.09 15.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.922 0.391 . . . . 0.0 110.829 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.8 p-80 -117.59 -178.82 3.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.878 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.21 31.54 0.92 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.58 -42.93 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.118 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.89 -34.8 26.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -145.4 84.85 8.26 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.915 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.53 130.55 19.82 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.57 2.18 . . . . 0.0 112.305 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 141.22 -124.87 2.63 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.556 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -114.03 32.89 5.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.85 0.357 . . . . 0.0 110.936 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -88.18 108.76 19.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 p -111.38 166.19 11.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.896 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -141.66 162.32 35.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.076 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -140.51 111.13 6.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 47.7 mtt -113.85 134.02 55.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.999 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.4 96.67 5.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.778 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.53 131.52 52.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.965 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -122.23 143.23 49.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.789 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -140.61 131.97 26.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.049 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.6 mp -139.34 147.0 24.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.951 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.58 85.96 5.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.237 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.14 170.49 3.89 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.613 2.209 . . . . 0.0 112.159 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.404 ' O ' ' CD2' ' A' ' 85' ' ' PHE . 7.1 m-20 -131.58 149.77 52.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.823 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -141.52 125.94 17.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.919 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -112.01 135.04 53.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.401 HG12 HD12 ' A' ' 122' ' ' LEU . 21.4 t -142.58 121.74 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.179 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.04 123.44 49.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.903 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.401 HD12 HG12 ' A' ' 120' ' ' VAL . 2.4 mp -117.76 -41.15 2.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.56 168.86 11.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.973 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.76 -41.23 96.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.923 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -113.4 36.36 3.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.3 tp -139.27 102.07 4.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.933 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -110.29 123.05 49.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -97.62 149.34 22.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -138.05 135.85 36.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.962 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -117.56 117.17 3.7 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.508 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -116.2 136.7 52.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 0.0 110.93 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.793 ' CD2' HG23 ' A' ' 153' ' ' THR . 0.2 OUTLIER -124.34 151.63 44.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.82 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.695 ' H ' HD13 ' A' ' 132' ' ' LEU . 0.6 OUTLIER -121.51 130.21 53.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.859 -179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.4 mtt -150.93 117.84 5.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.423 ' N ' ' CD2' ' A' ' 135' ' ' TYR . 4.9 m-85 -129.2 149.36 51.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -132.99 119.91 20.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.951 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -115.01 135.26 54.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.844 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -166.76 135.28 2.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.098 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -96.04 -41.05 8.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.943 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.689 ' O ' HG22 ' A' ' 143' ' ' THR . 0.9 OUTLIER -174.73 -40.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.7 mp -89.16 -31.46 17.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -67.58 -21.89 65.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.223 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.689 HG22 ' O ' ' A' ' 140' ' ' ASP . 11.3 t -54.71 -41.57 70.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.092 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 8.9 t -97.34 -32.78 11.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.924 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -61.78 -51.39 57.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.5 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 59.88 93.1 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.849 0.357 . . . . 0.0 110.87 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -163.41 158.54 21.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.125 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.5 t0 61.03 32.99 19.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.863 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.76 160.66 31.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.852 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -109.86 129.73 55.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.981 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 151' ' ' VAL . 12.1 p -152.0 124.3 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.056 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -142.51 155.45 45.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.793 HG23 ' CD2' ' A' ' 132' ' ' LEU . 1.3 m -117.83 130.28 56.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.849 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.0 132.28 53.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 4.3 m -109.28 158.42 17.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.531 ' C ' HD12 ' A' ' 157' ' ' LEU . . . -142.65 126.02 2.78 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.422 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.598 HD12 ' N ' ' A' ' 157' ' ' LEU . 5.1 mp -115.98 142.46 46.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.788 0.328 . . . . 0.0 110.856 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -124.98 126.76 45.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -138.49 100.15 4.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.83 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 74.2 p -80.84 128.2 33.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.955 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -104.06 -31.94 9.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.659 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -154.91 165.54 36.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.62 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -69.0 -12.18 61.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.342 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.0 p -113.43 -17.9 12.13 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.588 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.891 HG12 HD23 ' A' ' 199' ' ' LEU . 28.7 m -139.35 147.86 24.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.922 0.391 . . . . 0.0 111.466 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.659 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -146.91 179.92 7.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.119 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.1 tp -135.53 138.02 42.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.959 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.434 ' HB3' ' CE2' ' A' ' 196' ' ' TYR . 2.3 ttp180 -144.08 149.45 36.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.071 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.3 m -147.24 139.84 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.992 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.79 161.34 19.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.981 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -124.01 151.89 43.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.737 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -127.41 128.36 45.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.046 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.91 105.21 5.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.729 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -89.63 156.05 18.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.937 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.412 ' CB ' HG13 ' A' ' 151' ' ' VAL . 15.2 mtp180 -150.42 120.92 7.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.799 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -140.38 154.95 24.4 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.509 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -111.86 130.05 55.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.759 0.314 . . . . 0.0 110.919 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -125.6 157.76 36.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.86 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.84 -51.64 6.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -176.55 152.82 1.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.936 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -171.48 -63.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 64.8 m -134.72 -71.38 0.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.975 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -128.3 33.23 4.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.911 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -67.5 93.33 0.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.921 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.72 -63.75 1.03 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -154.68 -43.95 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.532 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -144.09 130.17 19.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.823 0.344 . . . . 0.0 110.977 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -105.07 129.24 53.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 72.8 p -131.58 130.9 42.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.004 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.92 162.96 13.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.728 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -132.02 122.11 24.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.17 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -140.59 155.59 46.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.637 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 11.8 tt -142.08 141.53 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.971 0.415 . . . . 0.0 111.368 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -128.75 155.36 45.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.436 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.1 130.7 14.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.994 0.426 . . . . 0.0 111.499 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.446 ' HB3' ' CG ' ' A' ' 209' ' ' TYR . 3.0 p90 -140.15 168.58 19.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.339 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.625 ' O ' HD12 ' A' ' 199' ' ' LEU . 0.1 OUTLIER -120.02 109.4 37.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.325 -179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.659 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 91.5 Cg_endo -80.33 120.68 4.11 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.382 2.055 . . . . 0.0 112.418 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.891 HD23 HG12 ' A' ' 165' ' ' VAL . 5.3 mp -125.79 134.42 51.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.955 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.05 103.94 6.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.904 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 5.7 tt -119.39 96.56 5.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.991 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 56.35 -116.02 6.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.521 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -99.03 29.78 3.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.855 0.36 . . . . 0.0 110.913 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.85 121.99 22.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.766 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.81 128.49 50.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.072 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.3 m -144.27 129.73 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.606 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 197' ' ' LEU . 57.1 m -138.67 93.17 11.04 Favored Pre-proline 0 C--N 1.327 -0.386 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.681 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 0.758 ' HB3' HD23 ' A' ' 229' ' ' LEU . 58.6 Cg_endo -71.82 137.98 30.71 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.308 2.006 . . . . 0.0 112.001 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.446 ' CG ' ' HB3' ' A' ' 196' ' ' TYR . 6.7 m-85 -111.04 136.46 50.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.808 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 35.8 p -127.14 143.32 51.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.865 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.93 143.19 27.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 1.6 pt -66.24 109.94 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -94.94 -45.84 3.01 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.532 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.89 141.02 49.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.848 0.356 . . . . 0.0 110.903 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 9.6 mmt85 -89.69 -61.19 1.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -103.63 138.86 39.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 48.7 m -91.11 153.08 20.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.897 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -142.74 -67.15 0.37 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.843 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -98.51 177.05 30.56 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.479 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.24 97.4 6.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 110.885 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -172.76 48.23 0.17 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.485 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -74.41 108.04 6.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 0.0 110.882 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -95.26 -46.77 6.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.85 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 59.77 32.95 21.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.984 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -153.7 158.68 41.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.924 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -147.47 -47.12 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 24.5 t -80.0 -68.94 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.045 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.576 ' CA ' ' HB2' ' A' ' 246' ' ' ALA . . . 136.13 -154.74 22.07 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.613 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.758 HD23 ' HB3' ' A' ' 208' ' ' PRO . 1.9 mt -116.71 121.41 41.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.769 0.319 . . . . 0.0 110.941 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -93.78 123.63 37.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 242' ' ' SER . 6.2 m-85 -112.74 155.45 24.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -168.76 117.01 0.69 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.982 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.434 ' CZ ' ' HB ' ' A' ' 241' ' ' VAL . 39.1 p90 -148.03 144.76 28.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.87 0.367 . . . . 0.0 111.246 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -103.56 131.15 50.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.822 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -69.83 -12.8 61.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.358 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -176.09 47.43 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.918 0.389 . . . . 0.0 111.033 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.55 25.96 10.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.985 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -139.51 -71.3 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.377 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 239' ' ' LEU . 8.6 mp -83.39 107.37 15.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.72 0.295 . . . . 0.0 110.833 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 4.8 m -92.59 153.13 19.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.983 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.434 ' HB ' ' CZ ' ' A' ' 233' ' ' TYR . 29.9 t -131.9 122.64 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.77 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 231' ' ' TYR . 1.5 m -107.77 151.17 26.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.231 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.25 131.14 17.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.875 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -117.85 124.24 47.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.849 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -147.25 146.88 29.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.923 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.576 ' HB2' ' CA ' ' A' ' 228' ' ' GLY . . . -152.48 -70.46 0.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.051 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 61.31 115.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.964 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -75.88 171.64 14.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.936 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -98.28 166.11 11.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.915 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -170.15 167.97 8.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.842 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -91.15 50.77 1.82 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' HIS . . . . . 0.421 ' CD2' ' HA3' ' A' ' 255' ' ' GLY . 0.3 OUTLIER -140.91 86.05 2.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.923 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.4 -54.7 6.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.919 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -90.15 51.93 2.15 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . 0.421 ' HA3' ' CD2' ' A' ' 252' ' ' HIS . . . -147.87 39.26 1.02 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.531 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -155.32 132.91 11.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.813 0.34 . . . . 0.0 110.913 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.9 p -146.5 -61.84 0.3 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.821 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -158.51 94.42 1.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.806 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.89 155.36 12.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.785 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 66.82 -70.27 0.11 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.045 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 3.2 m80 64.25 101.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.893 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -113.45 77.46 1.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.887 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . . . . . . . . . . . -143.38 113.3 7.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.151 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -84.57 150.85 25.98 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.484 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.622 HG23 ' HB2' ' A' ' 14' ' ' TYR . 14.3 m -136.84 135.74 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.807 0.336 . . . . 0.0 111.193 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -146.98 163.53 28.62 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.425 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.504 ' CG2' ' HB3' ' A' ' 12' ' ' ALA . 6.1 m -142.7 148.94 19.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.0 111.137 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -131.94 142.57 49.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.787 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . 0.425 ' CD1' ' HG ' ' A' ' 239' ' ' LEU . 4.8 m-85 -130.65 105.56 7.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 7.1 m -100.88 124.11 46.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 9.3 t80 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.859 179.95 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.798 0.332 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.35 111.27 1.88 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.935 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.5 mtp180 -92.84 73.48 4.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.885 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -170.27 156.47 5.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.977 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.04 37.96 1.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.94 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.94 116.1 6.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.882 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.836 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 21.0 m-70 -134.25 141.73 47.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -119.8 166.42 13.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -165.11 128.03 2.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 10' ' ' ILE . 6.8 tt -129.69 122.87 55.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.139 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.59 155.68 22.72 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.437 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -127.88 163.88 23.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.748 0.308 . . . . 0.0 111.179 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.98 140.02 29.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.886 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.585 ' HB2' HG23 ' A' ' 265' ' ' VAL . 34.4 m-85 -142.68 110.43 5.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -139.7 138.68 36.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.883 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.5 mp -119.8 152.46 22.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.113 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -133.46 151.84 51.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.77 140.14 29.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.929 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.1 m -121.9 127.36 75.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.146 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 60.17 -178.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.923 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -159.24 45.7 0.44 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.507 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -90.15 -63.61 1.25 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.752 0.311 . . . . 0.0 110.857 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.4 -45.25 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.484 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -69.5 102.54 1.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.763 0.316 . . . . 0.0 110.911 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.77 31.52 2.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.826 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.2 ttt -99.76 170.09 8.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.925 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -95.93 132.41 41.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.944 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.78 -41.1 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.551 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.516 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -89.58 136.01 33.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.881 0.372 . . . . 0.0 110.919 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -131.99 146.63 52.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.059 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -107.59 93.98 11.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.948 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.53 134.82 15.71 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.527 2.152 . . . . 0.0 112.321 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.34 146.06 25.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.887 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.66 HG23 ' HB2' ' A' ' 49' ' ' TYR . 26.0 m -145.13 162.6 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.041 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -146.23 139.53 25.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.956 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -116.37 164.21 14.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.823 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.66 141.86 22.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.961 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' A' ' 45' ' ' ILE . . . -145.84 131.51 18.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.04 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.836 ' HB3' ' HB2' ' A' ' 7' ' ' HIS . . . -115.23 121.53 43.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.106 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.02 71.59 1.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.758 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.54 -143.43 46.98 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.356 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.55 -26.36 16.53 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.554 2.169 . . . . 0.0 112.355 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -100.93 127.27 47.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.975 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -109.54 157.16 19.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.431 ' HB ' ' HB3' ' A' ' 38' ' ' ALA . 2.6 mp -133.81 141.27 44.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.222 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . . . -134.91 138.5 44.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.023 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.62 165.1 20.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.982 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . . . -156.16 149.57 24.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.006 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.66 ' HB2' HG23 ' A' ' 34' ' ' VAL . 1.0 OUTLIER -137.08 155.98 48.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -153.52 114.99 4.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.787 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -121.66 175.56 6.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.998 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -163.43 129.6 3.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.756 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.62 104.9 0.22 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.466 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.59 154.76 72.6 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.477 2.118 . . . . 0.0 112.315 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.1 m -58.93 111.64 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.17 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.88 133.06 34.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.896 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -89.04 -56.83 3.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.84 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.5 t -134.8 85.4 2.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.95 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.85 174.85 12.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.122 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 159.44 -28.45 0.38 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.485 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.59 -60.06 2.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.767 0.318 . . . . 0.0 110.866 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -88.36 119.78 29.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.806 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -172.9 82.67 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.536 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 m -60.19 153.01 23.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.765 0.317 . . . . 0.0 110.929 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -109.82 119.03 38.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -138.77 122.63 17.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.934 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.8 137.31 39.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.01 95.95 40.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.956 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.54 155.6 54.73 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.506 2.137 . . . . 0.0 112.29 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -136.57 125.63 24.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 44.8 mt -115.18 141.0 48.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.902 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -149.34 146.65 27.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.791 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.7 m -126.09 150.19 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.217 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.454 ' CD2' HG23 ' A' ' 88' ' ' THR . 0.0 OUTLIER -129.24 143.73 50.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.796 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -141.76 144.0 33.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.69 117.53 25.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.944 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -87.4 -57.82 2.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 61.19 155.59 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -154.42 -46.79 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -158.62 179.69 8.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.761 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -74.36 -31.47 62.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.827 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -69.57 -72.44 0.19 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -96.88 161.58 13.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.957 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -142.32 173.15 11.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.801 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -162.27 152.67 16.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.916 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -162.77 -177.31 35.67 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.526 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.56 138.56 26.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 110.984 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.454 HG23 ' CD2' ' A' ' 74' ' ' HIS . 44.0 m -138.66 124.96 20.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -121.09 174.02 15.71 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.481 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.68 148.82 12.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.429 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -142.23 129.47 21.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.837 0.351 . . . . 0.0 110.895 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -109.76 145.38 36.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -164.28 125.57 2.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.871 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -132.77 122.13 24.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.934 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.03 143.3 6.46 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.563 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -129.35 146.54 51.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.845 0.355 . . . . 0.0 110.896 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -163.67 41.05 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.896 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -89.37 53.38 2.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.853 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.5 m -136.59 166.74 25.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.127 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -100.08 -31.28 11.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.21 101.2 47.24 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.02 138.19 43.25 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.316 2.011 . . . . 0.0 112.299 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -96.35 34.13 5.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.513 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.1 mttm 60.15 41.76 16.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.857 0.36 . . . . 0.0 110.935 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.51 109.11 4.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.45 171.23 14.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.865 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -141.45 128.47 20.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.102 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -130.7 107.86 9.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.877 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -146.09 160.08 42.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.894 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.61 ' H ' ' HB2' ' A' ' 138' ' ' ALA . 9.7 pt20 -143.77 110.46 5.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.938 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 75.6 mtt180 -110.6 111.86 23.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 44.5 t-105 -107.92 142.97 37.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.853 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 7.9 tttp -138.27 137.5 37.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.11 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.1 tp -152.78 133.18 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.74 ' HB2' ' HA ' ' A' ' 133' ' ' SER . . . -154.29 113.05 2.46 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.224 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.8 154.57 53.9 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.428 2.086 . . . . 0.0 112.24 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -106.11 134.95 48.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.947 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -134.59 127.21 30.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.12 138.18 53.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.766 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.49 HG23 ' HB3' ' A' ' 128' ' ' PHE . 12.2 m -147.98 121.23 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.116 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.5 140.95 29.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.835 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.8 mt -119.88 -77.1 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.34 -172.82 3.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.875 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.573 ' CB ' HD23 ' A' ' 126' ' ' LEU . 0.5 OUTLIER 60.46 23.2 12.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.161 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.7 t70 57.01 31.27 19.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.182 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.573 HD23 ' CB ' ' A' ' 124' ' ' ASP . 1.6 pp -122.22 136.12 54.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.921 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 21.7 mtp180 -102.76 132.91 48.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.918 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' HB3' HG23 ' A' ' 120' ' ' VAL . 0.1 OUTLIER -84.87 125.34 32.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.413 ' HB3' ' CZ3' ' A' ' 131' ' ' TRP . 2.9 m-80 -113.8 155.66 25.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.977 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.28 135.88 2.8 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.443 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . 0.425 ' CD1' ' HB2' ' A' ' 154' ' ' GLU . 17.4 p90 -162.76 131.98 4.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.779 0.323 . . . . 0.0 110.912 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 132' ' ' LEU . 4.1 pp -100.44 136.01 40.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.74 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 17.3 t -103.9 152.22 22.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.07 122.85 26.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -104.16 141.24 36.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.908 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -133.3 110.43 10.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -81.17 -175.34 5.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.61 ' HB2' ' H ' ' A' ' 110' ' ' GLN . . . -81.43 -168.4 1.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.024 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -80.16 -30.97 38.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.071 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.21 -29.38 8.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.961 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.405 ' HB3' ' HB3' ' A' ' 138' ' ' ALA . 17.6 tp -72.62 -24.6 61.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.114 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -72.14 -27.42 62.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.173 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 48.2 p -71.2 -56.42 6.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.216 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 8.3 m -84.62 -27.82 26.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.239 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -56.17 -52.93 46.26 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.671 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -177.71 -72.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.806 0.336 . . . . 0.0 110.918 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -143.55 -169.72 3.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.038 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.87 -45.18 12.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 37.4 p -126.67 155.1 43.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 25.9 mtp180 -133.09 123.48 25.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.5 t -122.36 115.27 45.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.094 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -114.94 151.4 34.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.95 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 33.1 m -128.58 128.31 43.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.818 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.425 ' HB2' ' CD1' ' A' ' 131' ' ' TRP . 0.8 OUTLIER -122.36 145.21 48.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.004 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.57 138.38 25.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.769 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -137.57 171.69 23.11 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.48 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.456 HD21 HD13 ' A' ' 126' ' ' LEU . 1.0 OUTLIER -141.44 117.37 10.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.803 0.335 . . . . 0.0 110.854 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -92.75 121.8 34.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.937 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -126.83 104.09 7.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.792 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.73 125.59 51.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.95 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -102.79 -31.22 10.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.795 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.32 -178.12 7.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.703 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -87.43 6.15 35.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.4 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 51.5 p -115.73 -32.25 5.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.648 0.261 . . . . 0.0 111.162 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.588 HG13 ' CD1' ' A' ' 199' ' ' LEU . 21.7 t -132.2 136.06 57.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.311 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.89 ' HB3' ' HG2' ' A' ' 198' ' ' PRO . . . -139.16 179.24 6.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.002 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.62 HD21 HD23 ' A' ' 197' ' ' LEU . 0.5 OUTLIER -135.42 141.33 45.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.011 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.31 107.51 4.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.837 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.5 m -106.21 155.0 7.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.07 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -135.72 156.05 49.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.993 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.01 106.47 5.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.821 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -90.06 134.78 34.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.926 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 8.2 tt -153.65 105.24 2.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.772 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -104.22 166.09 10.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.998 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -145.92 151.31 37.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.769 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -139.19 151.98 22.1 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.492 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -120.35 157.72 28.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 110.876 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.3 151.71 20.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.859 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 2.1 ttt -73.58 -47.68 38.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.924 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -176.03 82.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.969 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -170.39 -60.59 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.922 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.2 m -74.65 80.56 2.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.03 30.36 5.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -149.38 -46.4 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.916 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -58.78 166.94 1.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -90.49 49.77 3.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.589 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 45.3 -168.44 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.823 0.344 . . . . 0.0 111.391 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -93.36 130.83 38.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.3 111.37 6.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.882 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.69 155.57 29.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.802 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -148.84 142.15 25.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.956 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -143.0 144.13 32.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.768 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 27.3 mt -105.65 138.37 31.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.263 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.08 109.69 4.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.766 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 210' ' ' THR . . . -106.53 136.96 45.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.255 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' TYR . . . . . 0.427 ' CD2' ' HB3' ' A' ' 209' ' ' TYR . 28.0 m-85 -140.47 123.3 16.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.615 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 197' ' ' LEU . 2.3 mp -111.02 109.64 57.1 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.055 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.89 ' HG2' ' HB3' ' A' ' 166' ' ' ALA . 96.5 Cg_endo -79.48 120.64 4.47 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.491 2.128 . . . . 0.0 112.308 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.588 ' CD1' HG13 ' A' ' 165' ' ' VAL . 0.1 OUTLIER -127.46 115.24 18.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.836 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 3.4 m -134.37 118.39 17.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.959 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.632 ' N ' HD23 ' A' ' 201' ' ' LEU . 0.5 OUTLIER -137.64 104.44 5.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 84.85 -117.3 4.47 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.513 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -116.76 30.72 7.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.849 0.357 . . . . 0.0 110.926 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -134.87 117.99 16.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.1 m -104.44 130.23 52.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.974 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.26 124.07 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.779 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.531 HG23 ' C ' ' A' ' 197' ' ' LEU . 41.9 m -138.78 92.8 11.07 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.477 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.16 143.39 11.31 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.612 2.208 . . . . 0.0 112.185 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.461 ' CD1' HG23 ' A' ' 227' ' ' VAL . 15.1 p90 -111.23 142.38 43.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.983 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.678 ' O ' ' HB3' ' A' ' 195' ' ' ALA . 11.6 p -131.58 142.29 49.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -145.06 124.0 12.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.885 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.1 tt -88.22 147.76 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.094 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -107.02 161.83 13.67 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.454 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 5.5 tp -145.75 40.2 1.17 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.827 0.346 . . . . 0.0 110.926 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 15.4 tpt85 -137.98 153.92 49.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -117.91 96.43 5.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 82.0 p -106.08 31.79 4.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 60.61 103.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.723 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 138.8 149.76 5.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.51 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -91.55 152.37 20.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.774 0.321 . . . . 0.0 110.983 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 96.27 64.42 0.94 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.599 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 -98.74 30.42 3.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.743 0.306 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 59.31 94.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.921 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -96.24 -30.38 13.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.922 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -177.0 136.03 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.856 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.653 ' HA ' HG22 ' A' ' 210' ' ' THR . 38.1 ttm180 63.0 104.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.461 HG23 ' CD1' ' A' ' 209' ' ' TYR . 16.0 m -114.02 -29.91 2.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.337 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.424 ' HA3' ' CZ ' ' A' ' 209' ' ' TYR . . . -150.58 166.13 30.17 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.653 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.94 119.85 13.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.709 0.29 . . . . 0.0 111.072 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.89 145.55 25.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.869 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -126.74 148.55 49.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.125 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 241' ' ' VAL . . . -137.79 117.08 1.42 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.292 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' TYR . . . . . 0.402 ' HB2' ' CG2' ' A' ' 241' ' ' VAL . 4.5 m-85 -102.7 118.09 36.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 111.192 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -123.53 90.49 3.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.417 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -56.83 -17.33 8.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.384 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -176.38 46.23 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.846 0.355 . . . . 0.0 111.172 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 54.93 23.71 5.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.219 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -122.22 -72.26 0.28 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.248 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.78 107.44 11.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.736 0.303 . . . . 0.0 110.625 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.22 134.13 42.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.948 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.493 ' O ' ' HA2' ' A' ' 232' ' ' GLY . 26.0 t -112.89 148.34 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.689 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' SER . . . . . . . . . . . . . 4.7 m -119.21 126.04 50.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.937 0.399 . . . . 0.0 111.052 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' LEU . . . . . 0.44 HD11 ' CD1' ' A' ' 262' ' ' TYR . 9.4 tt -143.86 123.6 13.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.782 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -105.25 157.53 17.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.973 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.36 147.62 41.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.836 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . 60.75 160.34 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.117 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.48 ' CE1' ' HB1' ' A' ' 263' ' ' ALA . 9.4 m-85 -142.52 -58.38 0.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.887 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -146.98 132.6 18.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.893 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -77.71 84.85 4.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.823 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -149.07 145.12 27.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -81.83 87.12 6.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.922 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -90.52 -36.08 14.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.904 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.34 147.03 32.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.886 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -108.54 107.01 17.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 65.26 -91.87 0.13 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.505 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -63.52 148.28 49.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.751 0.31 . . . . 0.0 110.899 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.17 141.48 29.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.875 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.16 30.66 7.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 20.4 tttp -72.14 114.41 10.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -153.09 -46.82 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -62.52 -171.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.836 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.44 ' CD1' HD11 ' A' ' 243' ' ' LEU . 94.2 m-85 -100.76 177.87 4.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.939 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ALA . . . . . 0.48 ' HB1' ' CE1' ' A' ' 247' ' ' PHE . . . -94.18 -64.72 1.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.997 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' GLY . . . . . . . . . . . . . . . -126.75 156.91 20.29 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.482 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.585 HG23 ' HB2' ' A' ' 14' ' ' TYR . 4.9 m -141.24 152.93 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.914 0.388 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . -163.83 173.2 39.86 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.49 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 21.4 t -145.26 152.82 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.776 0.322 . . . . 0.0 111.185 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -142.33 125.37 16.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -127.34 120.81 29.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.923 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.2 p -90.81 141.06 29.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.827 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 stop_ save_